2018 AAN Annual Meeting On-site Guide by American Academy of Neurology

ADVANCING NEUROLOGY. ADVANCING YOU.

}} Annual Meeting Information }} Awards }} Exhibits • Booth Descriptions • Daily Passports • Innovation Hub

ON-SITE GUIDE 2018 AAN ANNUAL MEETING APRIL 21–27, 2018 •

COME CELEBRATE

WHAT'S INSIDE Schedules & Maps

Hotel Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8 Meeting-at-a-Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 Hours of Operation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22 Schedule . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29-67 Saturday, Apri 21 . . . . . . . . . . . . . . . . 29

Wednesday, April 25 . . . . . . . . . . . . . 54

Sunday, April 22 . . . . . . . . . . . . . . . . 33

Thursday, April 26 . . . . . . . . . . . . . . . 60

Monday, April 23 . . . . . . . . . . . . . . . . 40

Friday, April 27 . . . . . . . . . . . . . . . . . 65

Tuesday, April 24 . . . . . . . . . . . . . . . . 47

Meetings

ICW Meetings / Alumni Reunions . . . . . . . . . . . . . . . . 74-82 Saturday, April 21 . . . . . . . . . . . . . . . 74

Wednesday, April 25 . . . . . . . . . . . . . 80

Sunday, April 22 . . . . . . . . . . . . . . . . 74

Thursday, April 26 . . . . . . . . . . . . . . . 82

Monday, April 23 . . . . . . . . . . . . . . . . 75 Tuesday, April 24 . . . . . . . . . . . . . . . . 77

Emerging Science

Emerging Science Presentation Schedule . . . . . . . . . . . . . 85

Exhibitors

Exhibitor Listing—Topic . . . . . . . . . . . . . . . . . . . . . . . . . . 111 Exhibitor Listing—Booth Number . . . . . . . . . . . . . . . . . . . 123 Exhibitor Listing—Descriptions . . . . . . . . . . . . . . . . . . . . . 134

Award

2018 Award Recipients . . . . . . . . . . . . . . . . . . . . . . . . . . . 186

Attendees

Annual Meeting Registrants . . . . . . . . . . . . . . . . . . . . . . . 218

Passport

AAN Annual Meeting Passport . . . . . . . . . . . . . . . . . . . . . 307

All content is current as of April 12, 2018.

INDUSTRY THERAPEUTIC UPDATE FROM ADAMAS PHARMACEUTICALS,INC. HOW CAN WE

FIGHT DYSKINESIA IN

PARKINSON’S DISEASE? Join us for personal and professional perspectives on Parkinson’s disease, with a focus on dyskinesia. This dynamic program features a roundtable discussion among leading experts in the treatment of dyskinesia in Parkinson’s disease, as well as a heartfelt keynote presentation by the daughter of the late, great Muhammad Ali, who lived with Parkinson’s disease for years before he was diagnosed. Don’t miss this opportunity to hear engaging personal and professional perspectives on the impact and management of Parkinson’s disease, with a focus on dyskinesia.

TUESDAY, APRIL 24TH 2018

7:00 PM–10:00 PM REGISTRATION BEGINS AT 6:30 PM

San Diego Ballroom • Westin Bonaventure Hotel • Los Angeles, CA COMPLIMENTARY DINNER WILL BE SERVED

GOCOVRI (amantadine) extended release capsules is the ﬁrst and only medicine approved by the FDA for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications.

IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS

GOCOVRI is contraindicated in patients with creatinine clearance below 15 mL/min/1.73 m2. WARNINGS AND PRECAUTIONS Falling Asleep During Activities of Daily Living and Somnolence: Patients treated with Parkinson’s disease medications have reported falling asleep during activities of daily living. If a patient develops daytime sleepiness during activities that require full attention (eg, driving a motor vehicle, conversations, eating), GOCOVRI should ordinarily be discontinued or the patient should be advised to avoid potentially dangerous activities. Suicidality and Depression: Monitor patients for depression, including suicidal ideation or behavior. Prescribers should consider whether the beneﬁts outweigh the risks of treatment with GOCOVRI in patients with a history of suicidality or depression. Hallucinations/Psychotic Behavior: Patients with a major psychotic disorder should ordinarily not be treated with GOCOVRI because of the risk of exacerbating psychosis. Observe patients for the occurrence of hallucinations throughout treatment, especially at initiation and after dose increases. Dizziness and Orthostatic Hypotension: Monitor patients for dizziness and orthostatic hypotension, especially after starting GOCOVRI or increasing the dose.

PRESENTERS Rajesh Pahwa, MD

Laverne & Joyce Rider Professor of Neurology Kansas Medical Center Chief, Parkinson Disease & Movement Disorder Division Director, Parkinson Foundation Center of Excellence Kansas City, KS

Daniel E. Kremens, MD, JD

Associate Professor of Neurology Department of Neurology Sidney Kimmel Medical College at Thomas Jeﬀerson University Philadelphia, PA

Stuart Isaacson, MD

Associate Professor of Neurology Herbert Wertheim College of Medicine Florida International University Miami, FL Director, Institute for Neurodegenerative Diseases of Florida Parkinson’s Disease and Movement Disorders Center of Boca Raton Alzheimer’s and Memory Disorders Center of South Florida Boca Raton, FL

KEYNOTE SPEAKER

MARYUM ALI Daughter of Muhammad Ali “My Father’s Journey, and What It Means to Me”

IMPORTANT SAFETY INFORMATION (cont.) WARNINGS AND PRECAUTIONS (cont.)

Withdrawal-Emergent Hyperpyrexia and Confusion: Rapid dose reduction or abrupt discontinuation of GOCOVRI, may cause an increase in the symptoms of Parkinson’s disease or cause delirium, agitation, delusions, hallucinations, paranoid reaction, stupor, anxiety, depression, or slurred speech. Avoid sudden discontinuation of GOCOVRI. Impulse Control/Compulsive Behaviors: Patients may experience urges (eg, gambling, sexual, money spending, binge eating) and the inability to control them. It is important for prescribers to ask patients or their caregivers about the development of new or increased urges. Consider dose reduction or stopping medications. ADVERSE REACTIONS The most common adverse reactions (>10%) were hallucination, dizziness, dry mouth, peripheral edema, constipation, fall, and orthostatic hypotension. DRUG INTERACTIONS Other Anticholinergic Drugs: The dose of GOCOVRI should be reduced if atropinelike effects are observed. Drugs Affecting Urinary pH: The pH of the urine has been reported to influence the excretion rate of amantadine. Monitor for efficacy or adverse reactions under conditions that alter the urine pH. Alcohol: Concomitant use with alcohol is not recommended, as it may increase the potential for CNS effects such as dizziness, confusion, lightheadedness, and orthostatic hypotension.

Please see Brief Summary of full Prescribing Information on the next page.

Please vist us at Booth 703 For more information and to preregister for this program, please visit

www.fightdyskinesia.com Seating is limited, so preregistration is recommended.

This promotional, non-CME program is intended only for healthcare professionals involved in the treatment of people with Parkinson’s disease. This is not an AAN-endorsed event.

GOCOVRI™ (amantadine) extended release capsules Brief Summary of full Prescribing Information. See full Prescribing Information. Rx Only. INDICATIONS AND USAGE: GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications. CONTRAINDICATIONS: Contraindicated in patients with creatinine clearance below 15 mL/min/1.73 m2 WARNINGS AND PRECAUTIONS: Falling Asleep During Activities of Daily Living and Somnolence: Patients treated with Parkinson’s disease medications have reported falling asleep while engaged in activities of daily living, including the operation of motor vehicles, which sometimes has resulted in accidents. Patients may not perceive warning signs, such as excessive drowsiness, or they may report feeling alert immediately prior to the event. In controlled clinical trials, somnolence and fatigue were reported in 4% vs. 1% of patients treated with GOCOVRI or placebo, respectively. Before initiating treatment with GOCOVRI, advise patients of the potential to develop drowsiness and specifically ask about factors that may increase the risk for somnolence with GOCOVRI, such as concomitant sedating medications or the presence of a sleep disorder. If a patient develops daytime sleepiness or episodes of falling asleep during activities that require full attention (e.g., driving a motor vehicle, conversations, eating), GOCOVRI should ordinarily be discontinued. If a decision is made to continue GOCOVRI, patients should be advised not to drive and to avoid other potentially dangerous activities. There is insufficient information to establish that dose reduction will eliminate episodes of falling asleep while engaged in activities of daily living or daytime somnolence. Suicidality and Depression: In controlled clinical trials, suicidal ideation or suicide attempt was reported in 2% vs. 0%; depression or depressed mood 6% vs. 1%; confusional state 3% vs. 2%; apathy 2% vs. 0%, in patients treated with GOCOVRI or placebo, respectively. Monitor patients for depression, including suicidal ideation or behavior. Prescribers should consider whether the benefits outweigh the risks of treatment with GOCOVRI in patients with a history of suicidality or depression. Hallucinations/Psychotic Behavior: Patients with a major psychotic disorder should ordinarily not be treated with GOCOVRI because of the risk of exacerbating psychosis. In controlled trials, the incidence of patients who experienced visual hallucination, auditory hallucination, delusions, illusions, or paranoia was 25% vs 3%; hallucinations caused discontinuation of treatment in 8% vs.0%; in patients treated with GOCOVRI or placebo, respectively. Observe patients for the occurrence of hallucinations throughout treatment, especially at initiation and after dose increases. Dizziness and Orthostatic Hypotension: In controlled clinical trials, 29% vs. 2% experienced dizziness, syncope, orthostatic hypotension, presyncope, postural dizziness or hypotension; and 3% vs. 0% discontinued study treatment because of dizziness, postural dizziness, or syncope; in patients receiving GOCOVRI or placebo, respectively. Monitor patients for dizziness and orthostatic hypotension, especially after starting GOCOVRI or increasing the dose. Concomitant use of alcohol with GOCOVRI is not recommended. Withdrawal-Emergent Hyperpyrexia and Confusion: A symptom complex resembling neuroleptic malignant syndrome (characterized by elevated temperature, muscular rigidity, altered consciousness, and autonomic instability), with no other obvious etiology, has been reported in association with rapid dose reduction, withdrawal of, or changes in drugs that increase central dopaminergic tone. Abrupt discontinuation of GOCOVRI may cause an increase in the symptoms of Parkinson’s disease or cause delirium, agitation, delusions, hallucinations, paranoid reaction, stupor, anxiety, depression, or slurred speech. If possible, avoid sudden discontinuation of GOCOVRI. Impulse Control/Compulsive Behaviors: Patients can experience intense urges to gamble, increased sexual urges, intense urges to spend money, binge eating, and/or other intense urges, and the inability to control these urges while taking one or more of the medications, including GOCOVRI, that increase central dopaminergic tone. In some cases, these urges were reported to have stopped when the dose was reduced or the medication was discontinued. Because patients may not recognize these behaviors as abnormal, it is important for prescribers to specifically ask patients or their caregivers about the development of such urges, and to consider dose reduction or stopping GOCOVRI treatment. ADVERSE REACTIONS: Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. GOCOVRI was evaluated in two double-blind, placebocontrolled efficacy trials of similar design and population: Study 1 (123 patients) and Study 2 (75 patients). The study population was approximately 56% male and 94% white, with a mean age of 65 years (age range from 34 years to 82 years). The mean duration of levodopa-induced dyskinesia was 4 years (range 0.1 to 14 years). Active treatment started at 137 mg once daily for one week, followed by a dose increase to 274 mg once daily. The treatment duration was 25 weeks for Study 1 and 13 weeks for Study 2. Study 1 was stopped prematurely unrelated to safety, with 39/100 patients (safety population) treated with GOCOVRI for 24 weeks. The most common adverse reactions reported in >10% of GOCOVRI-treated patients and more frequently than on placebo were: hallucination, dizziness, dry mouth, peripheral edema, constipation, falls, and orthostatic hypotension. The overall rate of discontinuation because of adverse reactions was 20% vs. 8% for patients treated with GOCOVRI or placebo, respectively. Adverse reactions that led to treatment discontinuation in at least 2% of patients were hallucination (8% GOCOVRI vs. 0% placebo), dry mouth (3% GOCOVRI vs. 0% placebo), peripheral edema (3% GOCOVRI vs. 0% placebo), blurred vision (GOCOVRI 3% vs.0% placebo), postural dizziness and syncope (GOCOVRI 2% vs. 0% placebo), abnormal dreams (GOCOVRI 2% vs. 1% placebo), dysphagia (GOCOVRI 2% vs. 0% placebo), and gait disturbance (GOCOVRI 2% vs. 0% placebo). Pooled Analysis of Adverse Reactions Reported for ≥ 3% of Patients Treated with GOCOVRI 274 mg (N=100) or placebo (N=98), respectively: Psychiatric disorders: visual and/or auditory hallucination (21%, 3%); anxiety and/or generalized anxiety (7%, 3%); insomnia (7%, 2%); depression/depressed mood (6%, 1%); abnormal dreams (4%, 2%); confusional state (3%, 2%). Nervous system disorders: dizziness (16%, 1%); headache (6%, 4%); dystonia (3%, 1%). Gastrointestinal disorders: dry mouth (16%, 1%); constipation (13%, 3%); nausea (8%, 3%); vomiting (3%, 0%). General disorders and administration site conditions: peripheral edema (16%, 1%); gait disturbance (3%, 0%). Injury, poisoning and procedural complications: fall (13%, 7%); contusion (6%, 1%). Infection and infestations: urinary tract infection (10%, 5%). Skin and subcutaneous tissue disorders: livedo reticularis (6%, 0%); pigmentation disorder (3%, 0%). Metabolism and nutrition

disorders: decreased appetite (6%, 1%). Vascular disorders: orthostatic hypotension, including postural dizziness, syncope, presyncope, and hypotension (13%, 1%). Eye disorders: blurred vision (4%, 1%); cataract (3%, 1%); dry eye (3%, 0%). Musculoskeletal and connective tissue disorders: joint swelling (3%, 0%), muscle spasm (3%, 0%). Reproductive system and breast disorders: benign prostatic hyperplasia—all male (6%, 2%). Respiratory, thoracic and mediastinal disorders: cough (3%, 0%) Other clinically relevant adverse reactions observed at <3% included somnolence, fatigue, suicide ideation or attempt, apathy, delusions, illusions, and paranoia. Difference in the Frequency of Adverse Reactions by Gender in Patients Treated with GOCOVRI. Adverse reactions reported more frequently in women (n=46) vs. men (n=54), were: dry mouth (22% vs.11%), nausea (13% vs. 4%), livedo reticularis (13% vs. 0%), abnormal dreams (9% vs. 0%) and cataracts (7% vs. 0%), respectively. Men vs. women reported the following adverse reactions more frequently: dizziness (20% vs. 11%), peripheral edema (19% vs. 11%), anxiety (11% vs. 2%), orthostatic hypotension in (7% vs. 2%) and gait disturbance (6% vs. 0%), respectively. Difference in the Frequency of Adverse Reactions by Age in Patients Treated with GOCOVRI. Hallucinations (visual or auditory) were reported in 31% of patients age 65 years and over (n=52), vs.10 % in patients below the age of 65 years (n=48). Falls were reported in 17% of patients age 65 and over, vs. 8% of patients below age 65. Orthostatic hypotension was reported in 8% of patients age 65 and over, compared to 2% of patients below age 65. DRUG INTERACTIONS: Other Anticholinergic Drugs: Products with anticholinergic properties may potentiate the anticholinergic-like side effects of amantadine. The dose of anticholinergic drugs or of GOCOVRI should be reduced if atropine-like effects appear when these drugs are used concurrently. Drugs Affecting Urinary pH: The pH of the urine has been reported to influence the excretion rate of amantadine. Urine pH is altered by diet, drugs (e.g., carbonic anhydrase inhibitors, sodium bicarbonate), and clinical state of the patient (e.g., renal tubular acidosis or severe infections of the urinary tract). Since the excretion rate of amantadine increases rapidly when the urine is acidic, the administration of urine acidifying drugs may increase the elimination of the drug from the body. Alterations of urine pH towards the alkaline condition may lead to an accumulation of the drug with a possible increase in adverse reactions. Monitor for efficacy or adverse reactions under conditions that alter the urine pH to more acidic or alkaline, respectively. Live Attenuated Influenza Vaccines: Due to its antiviral properties, amantadine may interfere with the efficacy of live attenuated influenza vaccines. Therefore, live vaccines are not recommended during treatment with GOCOVRI. Inactivated influenza vaccines may be used, as appropriate. Alcohol: Concomitant use with alcohol is not recommended, as it may increase the potential for CNS effects such as dizziness, confusion, lightheadedness, and orthostatic hypotension, and may result in dose-dumping. USE IN SPECIFIC POPULATIONS: Pregnancy: There are no adequate data on the developmental risk associated with use of amantadine in pregnant women. Based on animal data, may cause fetal harm. Lactation: Amantadine is excreted into human milk, but amounts have not been quantified. There is no information on the risk to a breastfed infant. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for GOCOVRI and any potential adverse effects on the breastfed infant from GOCOVRI or from the underlying maternal condition. Pediatric Use: Safety and effectiveness of GOCOVRI in pediatric patients have not been established. Geriatric Use: In Phase 3 clinical trials, the mean age of patients at study entry was 65 years. Of the total number of patients in clinical studies of GOCOVRI, 46% were less than 65 years of age, 39% were 65-74 years of age, and 15% were 75 years of age or older. Hallucinations and falls occurred more frequently in patients 65 years of age or older, compared to those less than 65 years of age. No dose adjustment is recommended on the basis of age. GOCOVRI is known to be substantially excreted by the kidney, and the risk of adverse reactions may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. Renal Impairment: GOCOVRI is contraindicated for use in patients with end-stage renal disease (creatinine clearance values lower than 15 mL/min/1.73 m2). A 50% dose reduction of GOCOVRI dosage to a starting daily dose of 68.5 mg daily for a week, followed by a daily maintenance dose of 137 mg is recommended in patients with moderate renal impairment (creatinine clearance between 30 and 59 mL/ min/1.73 m2). For patients with severe renal impairment (creatinine clearance between 15 and 29 mL/min/ m2), a daily dose of 68.5 mg is recommended. Overdosage: Deaths have been reported from overdose with amantadine immediate-release. The lowest reported acute lethal dose was 1 gram of amantadine hydrochloride (equivalent to 0.8 g amantadine). Acute toxicity may be attributable to the anticholinergic effects of amantadine. Drug overdose has resulted in cardiac, respiratory, renal, or central nervous system toxicity. Pulmonary edema and respiratory distress (including adult respiratory distress syndrome, ARDS) have been reported with amantadine; renal dysfunction, including increased BUN and decreased creatinine clearance, can occur. Central nervous system effects that have been reported with overdose include agitation, aggressive behavior, hypertonia, hyperkinesia, ataxia, tremor, disorientation, depersonalization, fear, delirium, psychotic reactions, lethargy, and coma. Seizures may be exacerbated in patients with prior history of seizure disorders. Hyperthermia has occurred with amantadine overdose. For acute overdosing, general supportive measures should be employed along with immediate gastric decontamination if appropriate. Give intravenous fluids if necessary. The excretion rate of amantadine increases with acidification of urine, which may increase the elimination of the drug. Monitor patients for arrhythmias and hypotension. Electrocardiographic monitoring may be needed after ingestion because arrhythmias have been reported after overdose, including arrhythmias with fatal outcomes. Adrenergic agents, such as isoproterenol, in patients with an amantadine overdose has been reported to induce arrhythmias. Monitor blood electrolytes, urine pH, and urinary output. Although amantadine is not efficiently removed by hemodialysis, this procedure may be useful in the treatment of amantadine toxicity in patients with renal failure. GOCOVRI, the GOCOVRI logo, Adamas, and the Adamas logo are trademarks of Adamas Pharmaceuticals, Inc. or its related companies ©2018 Adamas Pharmaceuticals, Inc. or its related companies. All rights reserved. GOC-0201 03/18

BEGIN PLANNING YOUR 2018 ANNUAL MEETING EXPERIENCE NOW. Download the new AAN Conferences Mobile App now to put all the information you need for the 2018 Annual Meeting conveniently on your phone or tablet: • Access program details, speakers, and materials • Customize your program schedule • View the hotel map • Explore the Los Angeles City Guide • Find and connect with other conference attendees • Submit your evaluations and claim CME

NEW AAN Conferences App Available for iPhone®, iPad®, or Android® AAN.com/view/MobileApp Sponsored by:

ADVANCING NEUROLOGY. ADVANCING YOU.

TAKE THE

BOOTH #2047

Compete with your peers Test your knowledge of OFF at booth #2047

OFFmatters.com

ACORDA THERAPEUTICS ® and the stylized ACORDA THERAPEUTICS ® logo are registered trademarks of Acorda Therapeutics, Inc. “Live Well. Do Tell.™ ” is a trademark of Acorda Therapeutics, Inc. ©2018 Acorda Therapeutics, Inc. All rights reserved. PD6065 2/18

Ask for your digital copy of the “Live Well. Do Tell.™ ” statement of need.

CESC: 18AM Education Program 8.25" x 10.875" 4C/2S — Perfect Bind

HOTEL LOCATIONS AND INFORMATION

4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

18AM HotelMapPages v304.indd All Pages

2018 AAN Annual Meeting On-site Guide

213-629-1200 323-844-6417 213-612-0021

213-765-8600 213-443-9222

213-624-0000

323-876-8600 213-627-8971 213-232-8800 213-388-8138 213-688-7777 213-621-4455 213-873-8400 323-856-1200 213-625-2211 213-748-1291 213-624-1011 213-358-0000 213-623-9904

213-617-3300 213-748-4141 213-443-9200

213-488-3500 323-856-1970 213-617-1133 213-381-7411 213-632-1200 213-743-8800 213-892-8080 213-624-1000 323-798-1300

WJ effe rso nB lvd

SF igu

Lowest Rates (Single/Double)*

3M ile sO ut

Los Angeles Convention Center 1201 S. Figueroa St, Los Angeles JW Marriott Los Angeles L.A. LIVE Headquarters Hotel—900 W Olympic Blvd Courtyard by Marriott L.A. LIVE 901 W. Olympic Blvd DoubleTree by Hilton Hotel 120 S Los Angeles St Dream Hollywood 6417 Selma Ave Freehand Los Angeles 416 W 8th St Hilton Checkers Los Angeles 535 S Grand Ave Hilton Garden Inn Hollywood 2005 N Highland Ave Hotel Figueroa 939 S Figueroa St Hotel Indigo Downtown 899 Francisco St Hotel Normandie LA 605 Normandie Ave lnterContinental Downtown 900 Wilshire Blvd Kawada Hotel 200 Hill St LEVEL Furnished Living 888 S Olive St Loews Hollywood Hotel 1755 N Highland Ave The Los Angeles Athletic Club 431 W 7th St Luxe City Center Hotel 1020 S Figueroa St Millennium Biltmore Hotel Los Angeles 506 S Grand Ave NoMad LA 649 S Olive St O Hotel 819 S Flower St Omni Los Angeles Hotel at California Plaza 251 S Olive St Radisson Hotel Los Angeles Midtown at USC 3540 S Figueroa St Residence Inn by Marriott Los Angeles L.A. LIVE 901 W Olympic Blvd Sheraton Grand Los Angeles 711 S Hope St The Hollywood Roosevelt 7000 Hollywood Blvd The L.A. Hotel Downtown 333 S Figueroa St The LINE Los Angeles 3515 Wilshire Blvd The Mayfair Hotel 1256 7th St The Ritz-Carlton, Los Angeles 900 W Olympic Blvd The Standard, Downtown LA 55O S Flower St The Westin Bonaventure 404 S Figueroa St W Hollywood 6250 Hollywood Blvd

2M ile sO ut

Hotel Name and Address

3M ile sO ut

** All hotels will be on the shuttle route for the Opening Party at Universal Studios

6M iles Ou t

Hollywood Boulevard

uer oa St SF low er S t

110

M Jefferson / USC Station

SF low er S t

S Figueroa St

2M iles Ou t

5M iles Ou t

SB roa dw ay

SM ain

SS prin g

SH ill S t

Gr an dL ow er

St St

Blvd

Expo Park / USC

W3 9TH ST

E 1st St

5th St

E5 th St

S Alameda St

E4 th St

SS an Ped ro S t

St SL os An ge les St ve

6th St

S Central Ave

E 3r dS t

ARTS DISTRICT

Headquarters Hotel L.A. Live Neighborhood Hotels

6th St 7th St

Arts District Hotels Fashion District Hotels

7th St

Classic Hollywood Hotels Other Conveniently Located Hotels

E1 6t

SS an Ped ro S t

10 EJ effe rso nB lvd

Wa shin gto nB 2M lvd

iles Ou t

Convention Center Metro Light Rail M Metro Stations

S Alameda St

FASHION DISTRICT

Pic o BM lvd LATTC / Ortho Institute Station

110

LATTC / Ortho Institute Station

E1 st

4th St

SC en tra lA ve

Exposition

Pershing Square Station W

6th St

hS t M Jefferson / USC Station

SH ill S t

SG ran dA ve

110

SF igu ero a

SF low er S t

WJ effe rso nB lvd

3rd St

Union Station

Los Angeles Area Hotel Map Key

SL os An ge les

St SF igu ero a

University of Southern California Campus

110

Blv d

SH ill S t SB roa dw ay

Ven ice Blv d

WW ash ing ton Blv d

SO liv eS t

Pico

Oly mp ic

SM ain St

9th St

1s t

Av e

SF igu ero aS t

8th St

St th E8

Ven ice Blv d

SF low er St

L.A. LIVE

110

WP ico Blv d

7th St

SG ran d

PICO-UNION SU nio nA ve

2 22

28 1

6th St

M ap le A

SO liv eS t

7th Street / Metro Center

Civic Center/Grand Park

SL uca sA ve

W 8th St

SM ain

Oly mp ic B lvd

Fra nc isc oS t

HISTORIC DOWNTOWN 29 6 17

7th St

Te mp le

Out iles 2M

Wil shir eB lvd

1s t

SB ea ud ry Av e

SU nio nA ve

W Olympic Blvd

W8 th S t

Ma ple Av e

St SA lva rad o

CITY WEST 6th

1 Mile Out

101

1 Mile Out

SB roa dw ay

2M ile sO ut

Mi les Ou t

Sunset Blvd

Westlake / MacArthur Park 7th St

N Gower St

W3 rd S t

Vine St

Wil shir eB lvd

Selma Ave

t dS 2n

W 8th St

WESTLAKE

N Cahuenga Blvd

Wilshire / Normandie Station

Hollywood Blvd N Highland Ave

Bev M erly Blv d

HOLLYWOOD

Wilshire / Vermont Station

Irolo St

6th St

S Vermont Ave

Blvd W Wilshire 3rd St

KOREATOWN

Franklin Ave

e ea Av N La Br

Ave

Wilshire / Western

101 Franklin Ave

SS prin g

S Western Ave

WILSHIRE CENTER

10 6th St

110

101

Normandie

3M ile sO ut

Wilshire Center

E Oly mpic Blvd

W Martin Luther King Jr Blvd

4/4/18 8:38 AM

MEETING-AT-A-GLANCE

Sat April 21

Sun April 22

6:00 a.m.

7:00 a.m.

8:00 a.m.

C1–4

7:00 a.m.– 9:00 a.m.

7:00 a.m.– 12:30 p.m.

C6-7

C25–34

7:00 a.m.– 4:00 p.m.

7:00 a.m.–9:00 a.m.

8:00 a.m.– 9:00 a.m. 9:00 a.m.

Presidential Plenary Session

C8–14

10:00 a.m.

9:15 a.m.–12:00 p.m.

9:30 a.m.– 11:30 a.m.

3:00 p.m.

C19–24

1:30 p.m.– 3:30 p.m.

AAN Business Meeting 3:00 p.m.–4:00 p.m.

4:00 p.m.

Hot Topics Plenary Session

5:00 p.m.

6:00 p.m.

4:15 p.m.–5:30 p.m.

C35–44 S2–6

1:00 p.m.– 3:00 p.m.

C50–59 N1 S8–10

C45–46

1:00 p.m.– 5:00 p.m.

C47–49

1:00 p.m. 5:30 p.m.

3:30 p.m.– 4:30 p.m.

3:30 p.m.– 5:30 p.m.

Neurobowl®

6:00 p.m.–8:00 p.m. 7:00 p.m.

8:00 p.m.

Industry Therapeutic Updates

7:00 p.m.– 10:00 p.m..

9:00 p.m.

10:00 p.m.

10 2018 AAN Annual Meeting On-site Guide

70th Anniversary Celebration 7:00 p.m.–11:00 p.m.

Experiential Learning Areas 7:00 a.m.–5:30 p.m.

2:00 p.m.

C18

1:00 p.m.– 4:00 p.m.

Poster Session I 11:30 a.m.–5:30 p.m.

1:00 p.m.

C15–17

12:00 p.m.– 4:00 p.m. Experiential Learning Areas 7:30 a.m.–5:30 p.m.

12:00 p.m.

Exhibit Hall 11:30 a.m.–4:00 p.m.

11:00 a.m.

Mon April 23

Tue April 24

C60–68

C96–104

7:00 a.m.–9:00 a.m.

S20

8:00 a.m.– 9:00 a.m.

Contemporary Clinical Issues Plenary Session

Clinical Trials Plenary Session

9:15 a.m.–11:30 a.m.

Faculty and Trainee Reception 6:00 p.m.–9:00 p.m.

Industry Therapeutic Updates

7:00 p.m.– 10:00 p.m..

C119

1:00 p.m.– 1:00 p.m.– 5:30 p.m. 2:15 p.m.

C120–132 S24–26 3:30 p.m.– 5:30 p.m.

Exhibit Hall 11:30 a.m.–4:00 p.m.

1:00 p.m.– 3:00 p.m.

Special Event

Experiential Learning Areas 7:00 a.m.–5:30 p.m.

3:30 p.m.–5:30 p.m.

5:30 p.m.

C105–118 Invited Science N3 S21–23

Poster Session III 11:30 a.m.–7:00 p.m.

C84–95 N2 S17–19

C82–83

1:00 p.m.

Poster Session II 11:30 a.m.–7:00 p.m.

C81

1:00 p.m.– 4:00 p.m.

Experiential Learning Areas 7:00 a.m.–6:15 p.m.

2:15 p.m.

9:15 a.m.–11:30 a.m.

Exhibit Hall 11:30 a.m.–6:00 p.m.

C69–80 S12 S13–16 1:00 p.m.–

6:30 a.m.–8:30 a.m.

7:00 a.m.–9:00 a.m.

S11

1:00 p.m.– 3:00 p.m.

Run/Walk for Brain Research

Emerging Science

5:45 p.m.– 7:00 p.m.

Industry Therapeutic Updates

7:00 p.m.– 10:00 p.m..

MEETING-AT-A-GLANCE

Wed April 25 6:00 a.m.

7:00 a.m.

C133–143

7:00 a.m.–9:00 a.m. 8:00 a.m.

S27

8:00 a.m.– 9:00 a.m. 9:00 a.m.

10:00 a.m.

Frontiers in Neuroscience Plenary Session

9:15 a.m.–11:30 a.m.

2:00 p.m.

C144–156 S29–32

1:00 p.m.– 3:00 p.m.

S28

1:00 p.m.– 2:00 p.m.

C157–158

1:00 p.m.– 5:00 p.m.

3:00 p.m.

4:00 p.m.

5:00 p.m.

6:00 p.m.

C160–171, 244 S33 Invited Science 3:30 p.m.– 4:15 p.m. N4 S34–36 S37 3:30 p.m.–5:30 p.m.

C159

1:00 p.m.– 5:30 p.m.

4:30 p.m.– 5:30 p.m.

Commitment to Cures

Experiential Learning Areas 7:00 a.m.–6:15 p.m.

1:00 p.m.

Poster Session IV 11:30 a.m.–7:00 p.m.

12:00 p.m.

Exhibit Hall 11:30 a.m.–3:00 p.m.

11:00 a.m.

6:00 p.m.–10:00 p.m.

7:00 p.m.

8:00 p.m.

9:00 p.m.

10:00 p.m.

12 2018 AAN Annual Meeting On-site Guide

Industry Therapeutic Updates

7:00 p.m.– 10:00 p.m..

Thur April 26

Fri April 27

C172-181

C216–223

7:00 a.m.–9:00 a.m.

S38

S47

8:00 a.m.– 9:00 a.m.

Controversies in Neurology Plenary Session

Neurology Year in Review: Emerging Therapies Plenary Session

9:15 a.m.–11:30 a.m.

1:00 p.m.– 3:00 p.m.

5:00 p.m.

C235–243 N7 S52–54 3:30 p.m.– 5:30 p.m.

Experiential Learning Areas 7:00 a.m.–5:30 p.m.

3:30 p.m.– 5:30 p.m.

5:30 p.m.

C224–233 C234 S48–51 1:00 p.m.–

Poster Session VI 11:30 a.m.–5:30 p.m.

C197–209 Invited Science N6 S43–46

1:00 p.m.– 2:30 p.m.

Experiential Learning Areas 7:00 a.m.–5:30 p.m.

1:00 p.m.– 3:00 p.m.

Invited C196 Science 1:00 p.m.–

Poster Session V 11:30 a.m.–7:00 p.m.

C182–195 S39 N5 1:00 p.m.– S40–42 2:15 p.m.

9:15 a.m.–11:30 a.m.

Closing Party Happy Hour

5:30 p.m.–7:00 p.m.

C210–215

6:30 p.m.–9:30 p.m.

EXPAND YOUR HORIZONS WITH EXPERIENTIAL LEARNING AREAS

e’re taking learning outside the traditional classroom, every day of the meeting, with dynamic and interactive areas that will offer a variety of real-world experiences to engage you intellectually, emotionally, and socially and offer you fresh ideas to help you personally and professionally.

2. Live Well: Taking Care of Your Patients Starts with Taking Care of You!

1. HeadTalks Discover transformational experiences in this unconventional platform. Non-traditional neurology topics will be discussed in an energizing format that transports you to another time and place.

So uth Ex hib it

Ha ll

Start each day with a guided yoga session to refresh your mind and body. Return to the Kentia Foyer throughout the week for thought-provoking sessions revolving around better self-care practices for both you and your patients.

3. Maximize Your Value and Advocacy to Action Learn the best business practices for neurology and leave with readyto-apply strategies. Find out how to make your voice heard for you, your patients, and the future of neurology.

6. The Member Experience: Personalize Your Journey Connect and be recognized as a valued AAN member. Learn how to personalize your experience and get the most out of your Academy.

West Exhibit Hall

6 West Lobby

2 wn Do

5 4

South Lobby EN TR AN CE

ENTRANCE

4. Navigating Your Career Receive comprehensive information regarding professional development at every career stage. Panel presentations and small group mentoring options throughout the week provide many opportunities to get your questions answered.

5. Research Corner: Moving Neurology Forward See the importance of research on neurology’s future and its impact on patient care. Find your inspiration in research presentations and award winners.

MEETING SPACE FLOOR PLANS 1 Meeting Information 2 X Advocacy to Action/

Maximize Your Value

3 American Brain Foundation 4 Bookbag Distribution 5 Closing Party 6 Exhibit Hall 7 Faculty and Trainee Reception 8 First Timers/Senior Member Lounge 9 X HeadTalks 0 X LiveWell ! Meal Distribution @ Meeting Administration # Mobile App Help Desk $ X Membership Experience % Mothers/Family Room ^ X Navigating Your Career

16 2018 AAN Annual Meeting On-site Guide

& Neurobowl * Overflow Viewing Area ( Plenary Sessions ) Poster Sessions ¡ Prayer Room ™ Press Room £ Publications Area ¢ Registration/Housing/Membership ∞ X Research Corner § Satellite Regisration ¶ Section Meetings • Skills Workshops ª Speaker Ready Room º Shuttle Bus Pickup ⁄ Universal Studios 70 Anniversary ®

Will Call Booth

LOS ANGELES CONVENTION CENTER: Second Level OPEN TO BELOW 500s

503

502B

502A

B C A

15 507

508

510 512 513 514

Down

501A

511A

501B

511B

501C

511C

21 516

504 505 506

517

518

515A

515B

519

8B 30

BE LO W

6B 30

TO OP EN

9B 30

8A 30 7 30 6A 30

Do wn

300s

402B

405

5 30

402A

4C 30

401

4B 30 4A 30

403A

411 THEATER

410 409B

403B

408A

Do wn

408B

404A 406A

409A

Down

OPEN TO BELOW

407

404B 406B

Do wn

wn Do

3B 30 3A 30

400s

2 30 1B 30 1A 30

LOS ANGELES CONVENTION CENTER: Main Level

11 B

WEST EXHIBIT HALL

LOS ANGELES CONVENTION CENTER: Kentia Level

PETREE HALL

1 150C

wn Do

150B 151

153B 152

wn Do

Do wn

153A

25 9 11

23 31

wn Do

150A

153C

Down

2 1

CONCOURSE HALL

wn Do

KE NT IA

SOUTH EXHIBIT HALL

HA LL

K FO ENT YE IA R

Salon 10 Salon 3

DIAMOND BALLROOM Salon 4

Salon 2

Salon 9

Salon 5

Salon 8

JW MARRIOTT: Diamond Ballroom Level

Salon 7 Salon 6

•

Salon 1

Down

Olympic 1

Olympic 2

Atrium 1

Atrium 2

JW MARRIOTT: Meeting Rooms

§ Salon C

PLATINUM BALLROOM

Atrium 3

Plaza II

Georgia I

TO PLATINUM BALLROOM

Olympic 3

Plaza I

Georgia II

LOBBY BELOW

Studio IV Business Center

Salon J

•

Plaza III

Studio III

JW MARRIOTT: Platinum Ballroom Level

Salon I Salon H

Salon B Salon D Salon E Salon G Salon A

Salon F

WESTIN BONAVENTURE: Lobby Level

Down Up

San Fernando A San Gabriel B

GOLD BALLROOM

Salon 1

Salon 2

Salon 3

• Salon 4 Up

18 2018 AAN Annual Meeting On-site Guide

JW MARRIOTT: Gold Ballroom Level

C San Pedro

Palos Verdes

Santa Antia B A

A Santa Barbara B C San Bernadino

Los La La Los Filez Brea Cienga Cerritos

Beaudry A

§ Beaudry B

FDA APPROVED FOR PARKINSON’S DISEASE The Vercise DBS System is designed to offer accurate targeting and precise control to help manage some Parkinson’s disease symptoms and improve patient quality of life.

While at AAN, please visit us at booth# 529. Indications for Use: The Vercise™ Deep Brain Stimulation (DBS) System is indicated for use in bilateral stimulation of the subthalamic nucleus (STN) as an adjunctive therapy in reducing some of the symptoms of moderate to advanced levodoparesponsive Parkinson’s disease (PD) that are not adequately controlled with medication. Contraindications, warnings, precautions, side effects. The Vercise DBS System, or any of its components, is contraindicated for: Diathermy as either a treatment for a medical condition or as part of a surgical procedure, Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS) as the safety of these therapies in patients implanted with the Vercise DBS System has not been established, Magnetic Resonance Imaging (MRI), patients who are unable to operate the system, patients who are poor surgical candidates or who experience unsuccessful test stimulation. Refer to the Instructions for Use provided with the Vercise DBS System or BostonScientific.com for potential adverse effects, warnings, and precautions prior to using this product. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician. All trademarks are the property of their respective owners. NM-466017-AA_NOV2017 © 2017 Boston Scientific Corporation or its affiliates. All rights reserved.

SHUTTLE TRANSPORTATION Date Saturday, April 21

Time

Frequency

6:00 a.m.–4:00 p.m.

Every 30 minutes

4:00 p.m.–9:00 p.m.

Every 15 minutes

Sunday, April 22

6:00 a.m.–10:00 a.m.

Every 15 minutes

10:00 a.m.–4:00 p.m.

Every 30 minutes

4:00 p.m.–6:00 p.m.

Every 15 minutes

70 th Anniversary Celebration Busing 6:30 p.m.–12:00 a.m. Monday, April 23 6:00 a.m.–10:00 a.m.

Tuesday, April 24

Wednesday, April 25

Thursday, April 26

Friday, April 27

Every 15 minutes Every 15 minutes

10:00 a.m.–4:00 p.m.

Every 30 minutes

4:00 p.m.–6:00 p.m.

Every 15 minutes

6:00 a.m.–10:00 a.m.

Every 15 minutes

10:00 a.m.–4:00 p.m.

Every 30 minutes

4:00 p.m.–6:00 p.m.

Every 15 minutes

6:00 a.m.–10:00 a.m.

Every 15 minutes

10:00 a.m.–4:00 p.m.

Every 30 minutes

4:00 p.m.–6:00 p.m.

Every 15 minutes

6:00 a.m.–10:00 a.m.

Every 15 minutes

10:00 a.m.–4:00 p.m.

Every 30 minutes

4:00 p.m.–10:00 p.m.

Every 15 minutes

6:00 a.m.–10:00 a.m.

Every 15 minutes

10:00 a.m.–4:00 p.m.

Every 30 minutes

4:00 p.m.–7:30 p.m.

Every 15 minutes

All buses departing the LACC will leave from the West Lobby off Gilbert Lindsey Drive. Service to the Westin Bonaventure will run on peak every 15 minutes throughout the day.

Walkable Hotels The following hotels are within walking distance of the Los Angeles Convention Center. No shuttle service will be offered except Sunday evening from 6:30 p.m.–12:00 a.m. • • • •

Courtyard by Marriott L.A. Live Hotel Figueroa Hotel Indigo Downtown JW Marriott Los Angeles L.A. Live

• Luxe City Center Hotel • Residence Inn by Marriott Los Angeles L.A. Live • The Ritz-Carlton, Los Angeles

70th Anniversary Celebration Busing For the 70th Anniversary Celebration on Sunday, April 22, the AAN will offer shuttle service. Buses will leave from all hotels on the regular shuttle routes with additional buses leaving from the JW Marriott Los Angeles L.A. Live, Luxe City Center Hotel, and Hotel Indigo Downtown. Guests staying at the Courtyard by Marriott L.A. Live, Hotel Figueroa, Residence Inn, and the Ritz-Carlton should walk to the JW Marriott for pick up.

Accessible Shuttle Information If you require a wheelchair accessible shuttle, please call (619) 921-0307 two hours in advance to schedule a ride. All requests made within two hours will be assisted on a first call, first served basis.

20 2018 AAN Annual Meeting On-site Guide

Route Hotels A Pink

Kawada Hotel—curbside on 2nd Street

DoubleTree by Hilton Los Angeles Downtown

DoubleTree by Hilton Los Angeles Downtown—curbside on Los Angeles Street

Omni Los Angeles Hotel at California Plaza

Omni Los Angeles Hotel at California Plaza—curbside on Olive Street

B Westin Bonaventure Hotel Green & Suites

C Blue

Westin Bonaventure Hotel & Suites—curbside on Figueroa Street

The L.A. Hotel Downtown

Guests should walk to the Westin Bonaventure—curbside on Figueroa Street

Intercontinental Los Angeles Downtown

Intercontinental Los Angeles Downtown—curbside on 7th Street

Sheraton Grand Los Angeles Downtown

Sheraton Grand Los Angeles Downtown—curbside on South Hope

O Hotel D Freehand Los Angeles Orange LEVEL Furnished Living

O Hotel—curbside on Flower Street Freehand Los Angeles—curbside on Olive Street Guest should walk to the Freehand Los Angeles—curbside on Olive Street

Los Angeles Athletic Club Hotel

Los Angeles Athletic Club Hotel-curbside on Olive Street

NoMad Los Angeles

Guests should walk to Los Angeles Athletic Club Hotel— curbside on Olive Street

Hilton Checkers Los Angeles

Hilton Checkers Los Angeles—curbside on Grand Avenue

Millennium Biltmore Hotel

Guests should walk to the Hilton Checkers Los Angeles— curbside on Grand Avenue

The Standard

Guests should walk to the Hilton Checkers Los Angeles— curbside on Grand Avenue

E The LINE Los Angeles Yellow Hotel Normandie F Red

Pick-up Locations

Kawada Hotel

The LINE Los Angeles—curbside on Wilshire Boulevard Hotel Normandie—curbside on West 6th Street

The Mayfair Hotel Los Angeles

The Mayfair Hotel Los Angeles—curbside on 7th Street

Hilton Garden Inn Los Angeles

Hilton Garden Inn Los Angeles—curbside on Highland Avenue

Loews Hollywood

Loews Hollywood—curbside on Highland Avenue

The Hollywood Roosevelt

Guests should walk to the Loews Hollywood—curbside on Highland Avenue

Dream Hotel

Dream Hotel—curbside on Selma Avenue

W Hollywood Hotel

W Hollywood Hotel—curbside on Hollywood Boulevard

G Radisson Hotel Los Angeles Purple at USC

Radisson Hotel Los Angeles at USC—curbside on Figueroa Street

NOTE: For Sunday evening only, shuttles will be added for walkable hotels. See page 20. Wifi on bus sponsored by:

HOURS OF OPERATION Important Phone Number Meeting Information…………………(213) 743–6252 Meeting Administration �� 309 Foyer Saturday, April 21–Friday, April 27

6:30 a.m.–5:30 p.m.

American Brain Foundation Donor Booth ��West Lobby Saturday, April 21–Friday, April 27

7:00 a.m.–5:30 p.m.

Annual Meeting On Demand Booth ��West Lobby Saturday, April 21–Friday, April 27

7:00 a.m.–5:30 p.m.

Career Center �� West Lobby Saturday, April 21–Friday, April 27

7:00 a.m.–5:30 p.m.

Exhibit Hall ��South Exhibit Hall GHJ Sunday, April 22 Monday, April 23 Tuesday, April 24 Wednesday, April 25

11:30 a.m.–4:00 p.m. 11:30 a.m.–6:00 p.m. 11:30 a.m.–4:00 p.m. 11:30 a.m.–3:00 p.m.

Meeting Information �� West Lobby and South Lobby Saturday, April 21–Friday, April 27

6:30 a.m.–5:30 p.m.

Membership �� West Lobby Saturday, April 21–Friday, April 27

6:30 a.m.–5:30 p.m.

Mobile App Support ��West Lobby Saturday, April 21–Friday, April 27

6:30 a.m.–5:30 p.m.

X Experiential Learning Areas Saturday, April 21–Friday, April 27 7:30 a.m. –5:30 p.m.

We're taking learning outside the traditional classroom, every day of the meeting, with dynamic and interactive areas that will offer a variety of real-world experiences to engage you intellectually, emotionally, and socially and offer you fresh ideas to help you personally and professionally.

Advocacy to Action/ Maximize Your Value

South Lobby

HeadTalks

South Lobby

Live Well

Kentia Hall Foyer

Navigating Your Career South Lobby Research Corner

South Lobby

The Member Experience West Lobby

Press Room �� 518 Saturday, April 21–Thursday, April 26 Friday, April 27

7:00 a.m.–5:30 p.m. 7:00 a.m.–1:00 p.m.

Publications Area ��West Lobby Saturday, April 21–Friday, April 27

7:00 a.m.–5:30 p.m.

Registration �� West Lobby Friday, April 20 Saturday, April 21 Sunday, April 22 Monday, April 23 Tuesday, April 24–Friday, April 27

4:00 p.m.–7:00 p.m. 6:30 a.m.–6:00 p.m. 6:30 a.m.–6:30 p.m. 6:30 a.m.–6:00 p.m. 6:30 a.m.–5:30 p.m.

Satellite Registration ��JW Marriott , Studio III Foyer Friday, April 20 Saturday, April 21–Sunday, April 22 Monday, April 23

4:00 p.m.–7:00 p.m. 6:30 a.m.–5:30 p.m. 6:30 a.m.–7:00 p.m.

Satellite Registration �� Westin Bonaventure HotelBeaudry A Friday, April 20 Saturday, April 21– Monday, April 23

4:00 p.m.–7:00 p.m 6:30 a.m.–5:30 p.m.

Speaker Ready Room ��309 Saturday, April 21–Friday, April 27

6:30 a.m.–5:30 p.m.

Universal Studios 70th Anniversary Will Call Booth ��West Lobby Saturday, April 21–Sunday, April 22

6:30 a.m.–6:00 p.m.

Please join us for the Industry Therapeutic Update (ITU) from Sanofi Genzyme: PREDICTING PATIENT TRAJECTORY IN MS: How Advanced Prognostic Measures Can Support More Informed Treatment Decisions

WEDNESDAY, APRIL 25, 2018, 7:00–9:15 PM Buffet dinner from 7:00–7:30 pm Presentation from 7:30–9:15 pm JW Marriott

AGENDA 7:00–7:30:

Buffet Dinner

7:30–7:45:

Welcome and Introduction Daniel Pelletier, MD

7:45–8:10:

Evolving Characterization of MS and Treatment Strategies Barry Singer, MD

8:10–8:35:

Current Approaches: Predicting Individual Patient Disease Trajectory and Informing Treatment Decisions Patricia K. Coyle, MD, FAAN, FANA

8:35–9:00:

Emerging Approaches: Predicting Individual Patient Disease Trajectory and Informing Treatment Decisions Giancarlo Comi, MD

9:00–9:15:

Closing Remarks Daniel Pelletier, MD

PRESENTERS

Daniel Pelletier, MD (Chair)

Barry Singer, MD

Patricia K. Coyle, MD, FAAN, FANA

Giancarlo Comi, MD

LEARN MORE ABOUT OUR COMMITMENT TO MAKING A DIFFERENCE IN MS AT BOOTH 1146 IN THE SOUTH EXHIBIT HALL

This is not an AAN endorsed event, nor will any CME credit be given. ©2018 Genzyme Corporation. All rights reserved. Sanofi and Genzyme registered in U.S. Patent and Trademark Office. SAUS.MS.18.03.1534. March 2018.

2018 ANNUAL MEETING EXHIBIT HALL Visit the Exhibit Hall to preview the latest products and services available in the neurology industry from an array of exhibitors including pharmaceutical companies, medical device vendors, and voluntary health organizations— all dedicated to helping people with neurologic disease live better.

HIGHLIGHTS:

• Innovation Hub: Drop by to experience an array of dynamic events, including topic expert presentations and more • Exhibit Hall Buzz Cafes: Grab a cup of joe and mingle with exhibitors throughout the hall • Exhibit Hall Charging Lounges: Stay connected with hubs that keep your devices charged and ready to use • Association Neighborhood: Connect with nonprofit scientific organizations and voluntary health organizations

• Technology Pavilion: Discover emerging technologies and advances in patient care • Publishers Row: Keep up-to-date on what’s new in neurologic research and patient care • Career Fair: Network with organizations recruiting and offering career resources across the field of neurology

EXCITING PRIZES Complete the Exhibit Hall Passport every day for the chance to win exciting prizes!

SUNDAY April 22 11:30 a.m.–4:00 p.m.

11:30 a.m.–1:00 p.m. Exhibit Hall Opening Luncheon Sponsored by

MONDAY April 23 11:30 a.m.–6:00 p.m.

4:30 p.m.–6:00 p.m. Exhibit Hall Networking Reception Sponsored by

TUESDAY April 24 11:30 a.m.–4:00 p.m.

WEDNESDAY April 25 11:30 a.m.–3:00 p.m.

INNOVATION HUB Located in the center of the Exhibit Hall, this new area will offer dynamic, interactive opportunities to expand your mind into new ways of thinking about your practice, your patients, and the future of neurology. Wine & Paint Sessions will take place daily to allow you to relax, interact, and learn in a novel way

SUNDAY April 22

12:00 p.m.–12:30 p.m. Welcome to the Exhibit Hall 1:00 p.m.–2:00 p.m. Korak Sarkar, MD The M3D Lab: 3d Printing, VR and AR in Medicine 2:00 p.m.–2:30 p.m. Raghav Govindarajan, MD, FAAN Integrating Teleneurology into your Practice-a Hands on Training’ 3:00 p.m.–4:00 p.m. Daniel Potts, MD, FAAN Hand in Hand with Art and Advocacy

MONDAY April 23

11:30 a.m.–12:00 p.m. Jennifer Bickel, MD, FAAN Relaxation Tools: See One, Do One, Teach One 12:00 p.m.–12:30 p.m. Jack W. Tsao, MD, DPhil, FAAN Your Practice a Decade in the Future 12:30 p.m.–1:00 p.m. Tanuja Chitnis, MD, FAAN Innovations for Multiple Sclerosis Monitoring and Care

Teleneurology Displays will let you test with colleagues how telemedicine works—and decide if it is a good fit for your practice

1:00 p.m.–1:30 p.m. Allen Gee, MD, PhD, FAAN Democratizing Technology in Healthcare 2:00 p.m.–2:30 p.m. Jose Posas, MD Concussion: There’s an App for That 3:00 p.m.–3:30 p.m. Jaime Hatcher-Martin, MD Telemovement: Using Telemedicine in an Outpatient Neurology Setting 4:30 p.m.–6:00 p.m. Brainstorm: A Competition for the Innovator in All of Us! Hear your colleagues’ innovative ideas that could transform the face of neurology as they present to a live panel of judges. The panel will provide feedback and finalists will get the opportunity to refine and improve their ideas for the future. The panel will provide feedback and finalists will get the unique opportunity to refine and improve their ideas for the future.

TUESDAY April 24

11:30 a.m.–12:00 p.m. David Evans, MBA Eric Cheng, MD, MS, FAAN Clinical Decision Support for Ordering of Diagnostic Imaging

Displays and Presentations from topic experts will showcase new ideas and new ways of thinking about neurology

12:00 p.m.–12:30 p.m. David Evans, MBA Allison Weathers, MD, FAAN Using Technology to Enhance Patient Engagement 12:30 p.m.–1:00 p.m. Allen Gee, MD, PhD, FAAN Back to the Future, Innovations Revisiting Neurohealth Space 1:00 p.m.–1:30 p.m. Brad Klein, MD, MBA, FAAN Get Paid for Your Mental Status Exams... Use App Technology to Innovate What You Do

WEDNESDAY April 25

11:30 a.m.–12:00 p.m. Elaine Jones, MD, FAAN Balancing Business and Wellness: Non-Traditional Work Settings 12:00 p.m.–12:30 p.m. Anup Patel, MD, FAAN Utilizing Wearable Technology to Improve Neurological Care 1:00 p.m.–1:30 p.m. Lyell Jones, MD, FAAN Using Axon Registry to Improve Your Practice 1:30 p.m.–2:00 p.m. Jennifer Bickel, MD, FAAN Acupuncture FAQ

Please see the Mobile App for most up-to-date schedule and times.

Cure One, Cure Many The American Brain Foundation invests in research for all brain diseases, because advances in a cure for one brain disease will lead to cures for others. This is how we will reach our vision of a world with cures for brain disease. Formerly known as the American Academy of Neurology Foundation, the American Brain Foundation has worked in partnership with the American Academy of Neurology for over 25 years. Stop by our booth located in the West Lobby of the Los Angeles Convention Center to learn more!

We bring researchers and donors together to defeat brain disease.

AmericanBrainFoundation.org

SATURDAY, APRIL 21 7:00 a.m.–9:00 a.m. C1 Mild Cognitive Impairment: Implications for Clinicians C2 Functional Neurologic Disorders I: Movement, Seizures, and Multiple Sclerosis C3 Emergency Room Neuroophthalmology C4 Hyperkinetic Movement Disorders: Videodiagnosis and Treatment 7:00 a.m.–12:30 p.m. C5 Clerkship and Program Directors Conference: Demonstrating Your Impact as a Medical Educator 7:00 a.m.–4:00 p.m. C6 Neurology MOC Prep Course $ (registration required) C7 L Women in Leadership $ (registration required) 7:30 a.m.–8:15 a.m. X Are You My Mentor? How to Select a Good Mentor for Your Research Career 7:45 a.m.–8:15 a.m. X Navigating the AAN Conference From a Coordinator’s Perspective 8:15 a.m.–9:00 a.m. X How Educating Can Improve Productivity During Clinical Activities 8:25 a.m.–9:10 a.m. X Work Life Balance in Research 9:15 a.m.–9:45 a.m. X How to Network at the Annual Meeting: Strategies for Trainees 9:15 a.m.–10:00 a.m. X Patient Centered Teaching

9:20 a.m.–9:50 a.m. X How to Successfully Publish Quality Improvement Projects 9:30 a.m.–10:00 a.m. X What is the Axon Registry? 9:30 a.m.–11:30 a.m. C8 Emergency Neurology: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room C9 Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies C10 More than Medicine: How to Access Home Care, Support Caregivers, and Discuss Complex Situations in Advanced Neurologic Disease C11 Treatment of Pediatric Multiple Sclerosis in the Current Era C12 Functional Neurologic Disorders II: Life Experiences and Management of Functional Disorders C13 Neuroimaging Biomarkers Across the Dementia Spectrum C14 Parkinson’s Disease Update 10:00 a.m.–10:30 a.m. X Sleep: Why You Should Spend Your Career Helping People Do It Right X Mindfulness in the Practice of Clinical Medicine 10:00 a.m.–10:50 a.m. X Investigator Panel: How I Launched My Career with NIH Funding, Private Funding, AAN Research Program Funding and/or Government Funding

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

X PLEASE SEE MOBILE APP AND ROOM LOCATOR FOR MOST UP-TO-DATE INFORMATION

SATURDAY, APRIL 21 10:15 a.m.–10:45 a.m. X Cognitive Biases and Diagnostic Errors at Bedside 11:00 a.m.–11:30 a.m. X Research Careers in Industry 11:00 a.m.–11:45 a.m. X What Your Academy is Doing About Burnout 11:15 a.m.–12:00 p.m. X Choosing a Career in Clinical Practice 11:30 a.m.–12:00 p.m. X Office Hours: Research Careers in Industry X Lily’s Place: Care and Healing for Neonatal Abstinence Syndrome 11:40 a.m.–12:10 p.m. X Funding Clinically Oriented/ Translational Research Before the R01—Consortium and Foundation Opportunities 12:00 p.m.–12:30 p.m. X Navigating the Annual Meeting App and Convention Center Tour X Office Hours: Career Opportunities for Physician Scientists in Industry 12:00 p.m.–12:45 p.m. X Cafe Talk: Burnout Mitigation: What’s in Your Toolbox? 12:00 p.m.–4:00 p.m. Young Investigator Symposium C15 Resident Basic Science I: Neuropharmacology

C16 LLeadership Challenges in

Practice C17 Neurophysiologic Intraoperative Monitoring Skills Workshop $ (registration required) 12:15 p.m.–1:00 p.m. X What I Learned About Research — An Early Career Perspective 12:20 p.m.–12:50 p.m. X How to Find Training: The Best Clinical Research and Methodology Training Options 12:30 p.m–1:00 p.m. X Patient Advocate of the Year Award, Kenneth M. Viste, Jr., MD 12:45 p.m.–1:45 p.m. X Ask Us Anything: Expert Panel on Headache and Facial Pain 1:00 p.m.–1:30 p.m. X Statistics—Sample Size 1:00 p.m.–2:00 p.m. X Are You Getting Paid or Giving Up? Building Relationships with Payers 1:00 p.m.–4:00 p.m. C18 LEducators’ Leadership Program (application required) 1:15 p.m.–2:00 p.m. X Interviewing Skills: Medical Students and Residents 1:30 p.m.–3:30 p.m. C19 Pediatric Neuro-ophthalmology Update C20 The Neurology of Social Behavior

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

30 2018 AAN Annual Meeting On-site Guide

HOT TOPICS PLENARY SESSION Saturday, April 21 4:15 p.m.–5:30 p.m. This session features translational research related to clinical issues of importance. Four outstanding physician-scientists provide summaries of their recent research findings and describe the clinical implications of the results. This plenary session will feature audience response technology to create an interactive attendee experience. Please look for more details during this session at the Annual Meeting.

Moderator E ric Klawiter, MD Member, Science Committee

Coming of Age: Clinical Implementation of Metagenomics for Diagnosis in Meningitis and Encephalitis Michael R. Wilson, MD University of California San Francisco, CA

Opioid Receptor Modulation of Headache A mynah Pradhan, PhD University of Illinois at Chicago, Chicago, IL

Shining a Light on Early Stress Responses and Late-Onset Disease Vulnerability Mark F. Mehler, MD, FAAN Albert Einstein College of Medicine New York, NY

Monitoring Multiple Sclerosis Using Blood Neurofilament Light Protein Jens Kuhle, MD Universitätsspital Basel, Oberwil, Switzerland

SATURDAY, APRIL 21 C21 Evaluation and Management of

Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia C22 Stroke in Young Adults and Women C23 Critical Care Consultations for Neurohospitalists C24 Diagnosis and Treatment of Functional Movement Disorders 1:40 p.m.–2:10 p.m. X Clinical Trials Methodology Course —Information Session with William Meurer MD, MS, CTMC Principal Investigator 1:45 p.m.–2:15 p.m. X Program Coordinators: Wellness Activity 2:00 p.m.–2:30 p.m. X Paths for Success in the Quality Payment Program 2:00 p.m.–2:45 p.m. X Cafe Talk: Narratives in Neurology: Creative Expression to Promote Resilience and Prevent Burnout 2:00 p.m.–3:00 p.m. X Rural Neurology 2:15 p.m.–3:00 p.m. X Teleneurology: Is This for Me? Prehospital and Nontraditional Uses of Teleneurology 2:30 p.m.–3:00 p.m. X Ask the Expert: Paths for QPP Success X My Role as Program Coordinator: Tips and Tricks

3:00 p.m.–3:30 p.m. X Clinical Decision Support for Ordering of Diagnostic Imaging 3:00 p.m.–3:45 p.m. X Acupuncture Demonstration: 4 Gates 3:00 p.m.–4:00 p.m.

AAN Business Meeting 3:15 p.m.–3:45 p.m. X Program Coordinators: Forging Relationships with Incoming Chiefs: Panel Discussion 3:15 p.m.–4:00 p.m. X Social Media for Clinicians 3:15 p.m.–4:15 p.m. X Women in Neurology: Crafting Your Leadership Career: Lessons from Leaders 3:30 p.m.–4:00 p.m. X Growing Research in Medical Marijuana 4:00 p.m.–4:30 p.m. X Program Coordinators: How to Prepare for Clinical Competency Committee (CCC) 4:15 p.m.–5:30 p.m.

Hot Topics Plenary Session 6:00 p.m.–8:00 p.m.

Neurobowl® 7:00 p.m.–10:00 p.m.

Industry Therapeutic Updates (Please see mobile app for most up-todate information)

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

32 2018 AAN Annual Meeting On-site Guide

SUNDAY, APRIL 22 7:00 a.m.–7:45 a.m. X Yoga (All-Levels Vinyasa) 7:00 a.m.–9:00 a.m. C25 Hot Topics and Controversies in Parkinson’s Disease C26 Neuro-ophthalmology I: Visual Loss, Optic Neuropathies, and Papilledema C27 Neurological Intensive Care I: The Essentials C28 Autism Spectrum Disorders What We Know and Where We Are Going C29 Faculty Development: Enhancing Your Role in Student and Resident Training C30 Controversies in Stroke Treatment and Prevention C31 Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies C32 Treatments for Drug-resistant Epilepsy: Surgery, Devices, and Other Updates C33 Clinicopathological Correlation Session in Dementia C34 Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making 7:45 a.m.–8:15 a.m. X Research in Residency: How to Choose the Right Project 8:00 a.m.–9:00 a.m. S1 “Best of” Session: Cerebrovascular Disease and Interventional Neurology

8:00 a.m.–9:10 a.m. X Challenges in Clinicogenetic Correlations: One Gene, Many Phenotypes; One Phenotype, Many Genes 8:15 a.m.–9:00 a.m. X K is for Career Development: Tips From Successful Applications for NIH Career Development Awards 8:30 a.m.–9:00 a.m. X Interviewing Skills: Negotiation 9:15 a.m.–9:45 a.m. X Giving and Receiving Feedback for Medical Students and Residents 9:15 a.m.–12:00 p.m.

Presidential Plenary Session 10:00 a.m.–10:30 a.m. X Autoimmune Neurology 10:15 a.m.–10:45 a.m. X Collaboration Corner: Program Coordinators: Interpreting ACGME Resident and Faculty Survey to Improve Responses 10:45 a.m.–11:15 a.m. X So You Want to Be a Residency Program Director? 11:00 a.m.–11:45 a.m. X Collaboration Corner: Faculty Development and the Role of Program Coordinator

8:00 a.m.–9:00 a.m. X Mind Over Matter: Meditation for the Practicing Neurologist X How Can the Axon Registry Improve My Practice?

X PLEASE SEE MOBILE APP AND ROOM LOCATOR FOR MOST UP-TO-DATE INFORMATION

SUNDAY, APRIL 22 11:30 a.m.–4:00 p.m.

Exhibit Hall • Exhibit Hall Opening Luncheon . . 11:30 a.m.–1:00 p.m. Sponsored by:

12:30 p.m.–5:30 p.m. Medical Student Symposium 12:40 p.m.–1:10 p.m. X Transitioning From an AAN Research Program Grant to NIH Funding 1:00 p.m.–1:30 p.m. X Being a Great Chief Resident

11:30 a.m.–5:30 p.m. P1 Poster Session I Presenters stand by posters 4:00 p.m.–5:30 p.m. 12:00 p.m.–12:30 p.m. X Office Hours: Finding/Working with Epidemiologists on Your Grant 12:00 p.m.–12:45 p.m. X How to Promote Healthy Cognitive Aging: What Should We Tell Our Patients and Ourselves? 12:00 p.m.–12:50 p.m. Epilepsy/Clinical Neurophysiology (EEG) Poster Discussion Session 12:00 p.m.–1:00 p.m. X Neurology Pictionary X Pursuing a Career in Clinical Informatics 12:15 p.m.–1:00 p.m. X Sleep: A Frequently Forgotten Part of Your Patient’s Day 12:30 p.m.–1:00 p.m. X Office Hours: Surviving as a Clinician Researcher Burnout Revisited: Not Just the Doctors

1:00 p.m.–1:45 p.m. X The National Academy of Medicine is Working for You on Clinician Well-Being and Resilience 1:00 p.m.–2:00 p.m. X Meet and Greet with the California Neurological Society The M3D Lab: 3d Printing, VR and AR in Medicine 1:00 p.m.–3:00 p.m. C35 Borderlands of Neurology and Internal Medicine: Chalk Talk C36 Clinical Neurology for Advanced Practice Providers I C37 Nonmotor Manifestations of Parkinson’s Disease I C38 Neurological Intensive Care II: Acute Brain and Spinal Cord Injury and Acute Neuromuscular Dysfunction C39 Therapy in Neurology I: Headache and Stroke C40 Autoimmune Neurology I Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS C41 Peripheral Neuropathy II: Diabetic and Inherited Neuropathies

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

34 2018 AAN Annual Meeting On-site Guide

PRESIDENTIAL PLENARY SESSION Sunday, April 22 9:15 a.m.–12:00 p.m. This session features the AAN’s premier lecture awards for clinically relevant research and a presentation by a leading lecturer. Top researchers speak on some of the most significant findings in neurology in 2018.

Moderator atalia S. Rost, MD, N MPH, FAAN, FAHA Chair, Science Committee

Presidential Lecture California Dreaming: BRAIN and Precision Medicine in 2018 F rancis S. Collins, MD, PhD Director of National Institutes of Health, Bethesda, MD Walter J. Koroshetz, MD, FAAN Director, National Institute of Neurological Disorders and Stroke, Bethesda, MD

George C. Cotzias Lecture How Early-Life Experiences Sculpt Your Brain: From Molecules to Circuits

Sidney Carter Award in Child Neurology Spinal Muscular Atrophy Is a Treatable Neurodegenerative Disease ichard S. Finkel, MD R Nemours Children’s Hospital, Orlando, FL

Robert Wartenberg Lecture Neuro-oncology: How Cancer and the Nervous System Interact L isa M. DeAngelis, MD, FAAN Memorial Sloan-Kettering Cancer Center, New York, NY

T allie Z. Baram, MD, PhD University of CA-Irvine, Irvine, CA

SUNDAY, APRIL 22 C42 Acute and Chronic Clinical Epilepsy

Update Explained in 6 Cases C43 Developing the Treatments of Tomorrow I: Taking Molecules from Lab to Man C44 Neuro-ophthalmology II: Optic Neuritis, Visual Fields, and Anisocoria S2 Clinical Trials and Therapeutic Approaches in Neurodegenerative Diseases • Presentation of the Potamkin Prize for Research in Pick’s, Alzheimer’s, and Related Disease

S3 Movement Disorders: Parkinson’s

1:15 p.m.–2:00 p.m. X Measuring Success: Quality Improvement 101 1:20 p.m.–1:50 p.m. X So You Have a Research Idea— How Do You Turn it into a Project? 1:30 p.m.–2:30 p.m. X Hall of Presidents: Using Past Experience to Solve the Futures Problems 1:45 p.m.–2:15 p.m. X Career Stories: Challenges for the Physician Scientist

Disease: Genetics, Biomarkers, and 2:00 p.m.–2:30 p.m. Diagnosis S4 Neuroepidemiology: X Breaking Down Silos: Using Simulation for Interprofessional Neurodegeneration, Epilepsy, Team Education to Enhance Clinical Cerebrovascular Disease Risks Outcomes in Neurology S5 General Neurology: Advances in Integrating Teleneurology into your Neurotherapeutics Practice —A Hands on Training S6 MS Neuroimaging: X Nuts and Bolts of AAN Research C45 LBeing a Resilient Leader: How Program: Explanations of How Do You Lead the Change? Much Funding is Available and C46 LThe Most Important What Kind of Research Is Accepted Tool in Your Black Bag: 2:00 p.m.–2:45 p.m. Gallup StrengthsFinders™ Assessment $ (registration required) X Work-Life Balance in Neurology 1:00 p.m.–5:30 p.m. C47 Resident Basic Science II: Neuropathology C48 Genomic Neurology Skills Workshop: Developing Practical Knowledge of Tools and Concepts Through Case Studies C49 Neuromuscular Ultrasound Skills Workshop $ (registration required)

2:30 p.m.–3:00 p.m. X Ask the Expert: Teaching Through Simulation X Innovations for Multiple Sclerosis Monitoring and Care 2:40 p.m.–3:10 p.m. X AAN Research Program Alumni Panel Discussion

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

36 2018 AAN Annual Meeting On-site Guide

3:00 p.m.–3:30 p.m. X Tip of the Iceberg: Ultra-High Cost Neurology Drugs 3:00 p.m.–3:45 p.m. X How Your Social Life Might Be Helping (or Harming) Your Brain 3:00 p.m.–4:00 p.m. X Blind Spots: The Impact of Conscious and Unconscious Biases 3:15 p.m.–3:45 p.m. X How to Get Into Leadership in Professional Societies 3:15 p.m.–4:00 p.m. X Social Media for the Millennial Neurologist 3:30 p.m.–4:00 p.m. X TBI in Domestic Violence Victims: Care for Those Who Need it Most Hand in Hand with Art and Advocacy 3:30 p.m.–4:30 p.m. S7 Pain and Palliative Care . . . . . Research Corner—South Lobby • Presentation of the Mitchell B. Max Award for Neuropathic Pain

3:30 p.m.–5:30 p.m. C50 Low and High Pressure Headache: Clinical Presentation and Approach to Evaluation and Management C51 Clinical Neurology for Advanced Practice Providers II C52 Nonmotor Manifestations of Parkinson’s Disease II C53 Neurological Intensive Care III: Vascular Diseases C54 Therapy in Neurology II: Epilepsy and Movement Disorders C55 Autoimmune Neurology II Advanced: Autoimmune Encephalitis at the Frontiers of Neuroscience

C56 Peripheral Neuropathy III: Genetic C57 C58 C59 N1 S8

Testing and Next Generation Sequencing Developing the Treatments of Tomorrow II: Clinical Trials in Neurology Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus Actualización Sobre el Tratamiento de la Esclerosis Múltiple Neuroscience in the Clinic: Autism Myth Busters Progressive MS Therapies and Age-Dependent Factors in MS Therapy

• Presentation of the John Dystel Prize for Multiple Sclerosis Research

S9 Epilepsy/Clinical Neurophysiology (EEG) I

• Presentation of the Alliance Awards: Founders Award

S10 Intracerebral and Subarachnoid Hemorrhage

• Presentation of the Michael S. Pessin Stroke Leadership Prize

4:00 p.m.–4:30 p.m. X Transitioning from Private Practice to Academics X My Patient Owes How Much?!: Understanding Out of Pocket Costs 4:00 p.m.–4:45 p.m. X Cafe Talk: Is that an Emotional or a Cognitive Question? Navigating Difficult Conversations with Communication Skills 4:15 p.m.–4:45 p.m. X Introduction to the Fascinating World of Movement Disorders

X PLEASE SEE MOBILE APP AND ROOM LOCATOR FOR MOST UP-TO-DATE INFORMATION

AAN 70

th Anniversary Celebration

Join Us in Celebrating 70 Years of the AAN Sunday, April 22 • 7:00 p.m.–11:00 p.m. at

TICKETS AVAILABLE FOR PURCHASE ONSITE Tickets are available onsite at Universal Studios for $115 begining at 7:00 p.m.

Ticket includes: • Transportation to/from the event • Delicious food and beverages all evening • Rides and studio tour

SUNDAY, APRIL 22 4:30 p.m.–5:00 p.m. X How to Start a Career in Clinical Trials X What Does BrainPAC Do for Me? 4:30 p.m.–5:30 p.m. X What is that Twitch? 4:45 p.m.–5:15 p.m. X Everything You Wanted to Know About the R&F Section of Neurology 5:00 p.m.–5:30 p.m. X Statistics and Study Design: Pearls and Pitfalls X Café Talk: Improving the Patient AND Doctor Experience: What I Learned from Press Ganey

5:00 p.m.–6:00 p.m. Neuro-ophthalmology/Neurootology Section Meeting Women’s Issues in Neurology Section Meeting Autonomic Nervous System Section Meeting 5:30 p.m.–6:00 p.m. Continuing the Conversation from C58: Neuro-ophthalmology III: Diplopia, Ocular Motility Disorders, and Nystagmus 7:00 p.m.–11:00 p.m.

AAN 70th Anniversary Celebration at Universal Studios Sponsored by:

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

X PLEASE SEE MOBILE APP AND ROOM LOCATOR FOR MOST UP-TO-DATE INFORMATION

MONDAY, APRIL 23 7:00 a.m.–7:45 a.m. X Yoga (All-Levels Vinyasa) 7:00 a.m.–8:00 a.m. Clinical Neurophysiology Section Meeting Spine Section Meeting 7:00 a.m.–9:00 a.m. C60 Balance and Gait Disorders C61 Starting a Practice From the Ground Up: A Guide for Early Career Neurologists C62 Neuro-ophthalmology: Overview and Update C63 Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis C64 Child Neurology I: Pediatric Stroke, MS/Autoimmune C65 Clinical Pearls: Learning from Complex Cases Simple Lessons that Apply to Everyday Problems C66 Update on Medical Management of Stroke C67 Video EEG: Name That Spell C68 Cognitive Impairment Due to Alzheimer’s Disease: Using Old Skills and New Tools for Diagnosis and Treatment 7:30 a.m.–8:00 a.m. X Defining and Managing Your Message as An Early Career Researcher 7:45 a.m.–8:15 a.m. X Using the R&F Section of Neurology for Your Residents and Residency

8:00 a.m.–8:45 a.m. X Cafe Talk: Burnout Mitigation: What’s in Your Toolbox? 8:00 a.m.–9:00 a.m. S11 “Best of” Session: Epilepsy/Clinical Neurophysiology (EEG) 8:10 a.m.–9:00 a.m. X Your CV is Talking About You Behind Your Back, and Your LORs Are Too! 8:15 a.m.–9:00 a.m. X Choosing An Academic Career in Neurology: Perspectives for Early Career Investigators and Foreign Medical Graduates 8:15 a.m.–9:15 a.m. Headache & Facial Pain Section Meeting General Neurology Section Meeting 8:30 a.m.–9:00 a.m. X Tools to Transition From Trainee to Attending X Collaboration Corner: Preparing for Program Evaluation Committee (PEC): Tools for Program Coordinators X How to Meet with your Member of Congress X Office Hours: What Makes a Neuroscience Grant Request Interesting to the AAN? 9:15 a.m.–9:45 a.m. X Collaboration Corner: Program Coordinators: Curriculum Building 101 X How to Evaluate a Practice

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

40 2018 AAN Annual Meeting On-site Guide

9:15 a.m.–11:30 a.m.

Contemporary Clinical Issues Plenary Session 10:00 a.m.–10:30 a.m. X How to be “Useful” on Rotations: Tips for Medical Students 10:15 a.m.–11:00 a.m. X Collaboration Corner: Program Coordinator Best Practices for Recruitment Season

10:45 a.m.–11:15 a.m. X Choosing a Neurohospitalist Career 11:00 a.m.–11:30 a.m. X Colloboration Corner: Closing Session for Program Coordinators 11:30 a.m.–12:00 p.m. X Child Neurology—Staying on Track Relaxation Tools: See One, Do One, Teach One

11:30 a.m.–6:00 p.m.

Exhibit Hall Networking Reception 4:30 p.m.–6:00 p.m.

X PLEASE SEE MOBILE APP AND ROOM LOCATOR FOR MOST UP-TO-DATE INFORMATION

MONDAY, APRIL 23 11:30 a.m.–7:00 p.m. P2 Poster Session II Presenters stand by posters 5:30 p.m.–7:00 p.m.

12:45 p.m.–1:30 p.m. X Transitioning From a Clinical Research Career to an Educational and Clinical Focused Career

11:45 a.m.–12:30 p.m. X Finding Your Niche in Neurology: Perspectives from an Epileptologist and Educator

1:00 p.m.–1:30 p.m. X Subspecialty Sessions: IOM and cEEG Democratizing Technology in Healthcare

11:45 a.m.–12:35 p.m. Neuromuscular and Clinical Neurophysiology (EMG) Poster Discussion Session

1:00 p.m.–2:00 p.m. X Non-Clinical Careers for Neurologists

12:00 p.m.–12:30 p.m. X Office Hours: Working with an Epidemiologist The Future of Neurology

1:00 p.m.–2:15 p.m. S12 Autonomic Disorders

12:00 p.m.–1:00 p.m. History Section Meeting Movement Disorders Section Meeting

1:00 p.m.–3:00 p.m. C69 LContinuing Your Leadership Journey: Uncharted Waters (registration required) C70 Evaluating Tremor in the Office C71 Therapy in Neurology III: Neurological Infectious Diseases and Neuro-ophthalmologic Disorders C72 Sports Neurology: Enhancing Athletic Performance C73 Child Neurology II: Epilepsy and Neuromuscular C74 Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I C75 Safe and Appropriate Opioid Prescribing in Neurology C76 Clinical Approach to Muscle Disease I: Role of Antibodies, Muscle Imaging and Genetic Testing

12:00 p.m.–1:00 p.m. X Is There a Neurologist on This Flight? X Practice Models for Advanced Practice Providers 12:15 p.m.-12:45 p.m. X ELA icon-Mejora Tu Desempeño Como Educador Médico 12:25 p.m.–1:45 p.m. X Perception Is Reality: Are Neurologists Helping Patients Live Well with Dementia? 12:30 p.m.–1:00 p.m. Effectively Incorporating Telehealth into Clinical Research Innovations for Multiple Sclerosis Monitoring and Care

42 2018 AAN Annual Meeting On-site Guide

• Presentation of the Irwin Schatz Award for Autonomic Disorders

CONTEMPORARY CLINICAL ISSUES PLENARY SESSION Monday, April 23 9:15 a.m.–11:30 a.m. This session highlights issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments. Commentary and discussion follow each presentation.

Moderator andolph S. Marshall, MD, FAAN R Vice Chair, Science Committee

Retinal Microvasculature in Predicting Risk of Stroke Subtypes Presenter: Michelle P. Lin, MD

Neuropalliative Care Maisha T. Robinson, MD, MS Mayo Clinic, Jacksonville, FL

J ohns Hopkins University School of Medicine, Baltimore, MD

Discussant: Valerie Biousse, MD

Atlanta, GA

Predictors of Neurodegeneration in Idiopathic REM Sleep Behavior Disorder: A Multicenter Cohort Study Presenter: Ronald Postuma, MD

Biosimilars and Non-biologic Complex Drugs Jeffrey Allan Cohen, MD Cleveland Clinic, Cleveland, OH

Montreal General Hospital, Montreal, QC, Canada

Discussant: A leksandar Videnovic, MD, MSc, FAAN GH Neurological Clinical M Research Institute, Boston, MA

Non-invasive Neuromodulation eborah I. Friedman, MD, D MPH, FAAN

niversity of Texas Southwestern U Medical Center, Dallas, TX

Pediatric Brainstem Encephalitis Outbreak Investigation with Metagenomic Next-Generation Sequencing Presenter: K ristoffer Edgar Leon

niversity of California U San Francisco, San Francisco, CA

Discussant: Shibani Mukerji, MD

Massachusetts General Hospital, Boston, MA

MONDAY, APRIL 23 C77 Epilepsy Surgery Update C78 Therapeutic Temperature

Modulation in the ICU C79 Comprehensive Migraine Education Program I: Diagnosis, Risk Factors, and Neurobiology C80 Present and Future Biomarkers in Dementia: A Case-based Approach S13 Neuromyelitis Optica Spectrum Disorder and other Autoimmune Disorders S14 Education and Patient Outcomes Research S15 Cerebrovascular Disease Epidemiology and Outcomes S16 Neuro-Ophthalmology/NeuroOtology1: 1:00 p.m.–4:00 p.m. C81 LMitigating the Impact of Unconscious Bias Workshop 1:00 p.m.–5:30 p.m. C82 Resident Basic Science III: Neuroanatomy: All the Lesions C83 Neuro-ophthalmology and Neurovestibular Exam Lab Skills Workshop $ (registration required) 1:30 p.m.–2:00 p.m. X Office Hours: Statistics—Sample Size American Brain Foundation Neuroscience Crowdfunding Site 1:30 p.m.–2:30 p.m. Government Service Section Meeting 1:30 p.m.–2:30 p.m. X Eminence-based Medicine vs Evidence-based Medicine 1:45 p.m.–2:15 p.m. X Participating in Advocacy

44 2018 AAN Annual Meeting On-site Guide

1:45 p.m.–2:30 p.m. X Creating a Career in Global Health with Design Thinking 2:00 p.m.–2:30 p.m. X Can Aviation Accidents Teach Neurologists Patient Safety and Error Management? Concussion: There’s an App for That X Office Hours: Finding Mentorship for Early Career Investigators 2:00 p.m.–2:45 p.m. X Physical Exercise and Cognitive Training in Neurology: Application in Aging and Neurodegenerative Disease 2:20 p.m.–2:50 p.m. X Why Study the History of Neurology?—A Panel Discussion Featuring the Lawrence C. McHenry Award and Roland P. Mackay Medical Student Essay Award Winners 2:30 p.m.–3:00 p.m. X Office Hours: Defining and Managing Your Message As An Early Career Scientist Health IT Innovations for the Neurology Office X Writing and Reviewing for the R & F Section of Neurology ® 2:45 p.m.–3:30 p.m. X Up Your Game as a Medical Educator in Neurology 2:50 p.m.–3:20 p.m. X Research in Sleep Medicine: A Panel Discussion Featuring the 2018 Recipients of the Sleep Science Award, the Wayne A. Hening Sleep Medicine Investigator Award, and the S. Weir Mitchell Award

3:00 p.m.–3:30 p.m. Continuing the Conversation: C70 Evaluating Tremor in the Office 3:00 p.m.–3:30 p.m. X Safety and Quality Awards Telemovement: Using Telemedicine in an Outpatient Neurology Setting 3:00 p.m.–3:45 p.m. X Introduction to Acupuncture I: Conceptual Framework and Mechanism of Action 3:00 p.m.–4:00 p.m. X Lifting the Curtain: Ask the AAN Publication Editors Anything! 3:15 p.m.–3:45 p.m. X Utilization of APPs in Neurology Practice Panel 3:30 p.m.–4:00 p.m. X What Does the AAN’s Latest Guideline Mean for My Practice? Scribes: Write or Wrong? 3:30 p.m.–4:30 p.m. Neurohospitalist Section Meeting Critical Care & Emergency Neurology Section Meeting 3:30 p.m.–5:30 p.m. C84 Evidence Based Neurology Foresights for Busy Clinicians C85 Therapy in Neurology IV: Autoimmune PNS Synaptic Disorders and Neuro-Oncology C86 Child Neurology III: Headache, TBI/ Post-concussion C87 Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II C88 Core Concepts in Pain Management: Refractory Neuropathic Pain Practical

Pharmacologics, Advances in Neuromodulation, and a Balanced Look at Cannabinoids C89 Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology C90 Comprehensive Migraine Education Program II: Behavioral and Psychological Approaches, and Preventive and Acute Treatment Advances C91 Chronic Traumatic Encephalopathy: Update C92 What Keeps You Up at Night? Addressing Mistakes and Injuries, In-n-Out-Patient Transition, and Building a Team to Support You C93 Advances in Neurogenetics C94 Hot Topics in Stroke Education and Practice C95 Actualización Sobre las Infecciones del Sistema Nervioso Central y la Medicina Tropical N2 Neuroscience in the Clinic: Antisense Oligonucleotide (ASO) Therapy S17 Sleep • Presentation of the Alliance Awards: S. Weir Mitchell Award • Presentation of the Wayne A. Hening Sleep Medicine Investigator Award • Presentation of the Sleep Science Award

S18 Movement Disorders: Ataxia and Tremor

• Presentation of the Movement Disorders Research Award

S19 Epilepsy/Clinical Neurophysiology (EEG) II

• Presentation of the Dreifuss-Penry Epilepsy Award

3:45 p.m.–4:30 p.m. X Teaching Communication Skills: From Good to Great

X PLEASE SEE MOBILE APP AND ROOM LOCATOR FOR MOST UP-TO-DATE INFORMATION

MONDAY, APRIL 23 4:00 p.m.–4:30 p.m. X Streamlining Clinic Scheduling and Access X Oportunidades de Entrenamiento Clínico en los Estados Unidos para Médicos Graduados en el Extranjero Leveraging Predictive Analytics to Improve No Shows in the Emory Clinic Department of Neurology

4:30 p.m.–6:00 p.m. Brainstorm: A Competition for the Innovator in All of Us 4:45 p.m.–5:30 p.m. X Career Development for Medical Educators 5:00 p.m.–5:30 p.m. X The Ripple Effect of Positive Psychology

4:00 p.m.-4:45 p.m. X Striking the Balance—A Neurologist’s 5:15 p.m.–6:15 p.m. Personal Wellness Journey X Practicing Neurology in the 1960’s and 1970’s 4:15 p.m.–5:00 p.m. X Foundations for Success in the AAN 5:30 p.m.–6:30 p.m. Sports Neurology Section Meeting 4:15 p.m.–5:15 p.m. Business Administration Section X Neurology and Wellness— Why Meeting and How it Affects Your Career 4:30 p.m.–5:00 p.m. X Knowing Your Value: How to Negotiate to Get What You’re Worth 4:30 p.m.–6:00 p.m.

Exhibit Hall Networking Reception Sponsored by:

46 2018 AAN Annual Meeting On-site Guide

5:45 p.m.–6:45 p.m. Multiple Sclerosis Section Meeting 6:00 p.m.–9:00 p.m.

Faculty and Trainee Reception 7:00 p.m.–10:00 p.m.

Industry Therapeutic Updates (Please see mobile app for most up-todate information)

TUESDAY, APRIL 24 6:30 a.m.–8:30 a.m.

2018 AAN Run/Walk for Brain Research $ (registration required) Sponsored by:

C102 Movement Disorders for the

General Neurologist I: New Concepts in the Diagnosis and Management of Parkinson’s Disease C103 Now You See It, Now You Know It: Pathognomonic Neuroophthalmology Examination Findings C104 Sports Concussion Skills Workshop: Event Coverage Foundational Skills and Sport Specific Pearls $ (registration required) 7:45 a.m.–8:15 a.m. X Education Administrator Building Blocks: Navigating the Role of the Administrator and Taking Your Role to the Next Level

7:00 a.m.–7:45 a.m. X Yoga (All-Levels Vinyasa)

8:00 a.m.–8:30 a.m. X Welcome to NINDS Day/Overview of NIH Funding With NINDS Director and NINDS Deputy Director

7:00 a.m.–8:00 a.m. Sleep Medicine Section Meeting Neuroimaging Section Meeting

8:00 a.m.–8:45 a.m. X Self-Management in Neurologic Disease

7:00 a.m.–9:00 a.m. C96 Status Epilepticus C97 Vascular Cognitive Impairment and Dementia: Current Status and Future C98 Multiple Sclerosis Overview I: Clinical Pearls . . . . . . . . . West Exhibit Hall B C99 Good Neurology in Challenging Conditions: Lessons from Military Neurology C100 Basic Principles of Brain Tumors: For Practice and for Certification C101 Approaching the Management of Common Sleep Disorders: Casebased Review for the Non-sleep Specialist

8:00 a.m.–9:00 a.m. X Functional Neuroanatomy for APPS 8:00 a.m.–9:00 a.m. S20 “Best of” Session: Headache 8:15 a.m.–9:00 a.m. X Career Development for Clinician Educators

X PLEASE SEE MOBILE APP AND ROOM LOCATOR FOR MOST UP-TO-DATE INFORMATION

TUESDAY, APRIL 24 8:15 a.m.–9:15 a.m. Neurogenetics Section Meeting Neuroepidemiology Section Meeting 8:30 a.m.–9:00 a.m. X Career Stories: Nuts and Bolts of Academic Leadership—Strategies I Have Learned in My Career X Office Hours: The Researcher Pipeline: The Benefits of Participating in Academic Medicine, Research and Clinical Trials as a Medical Student or Resident 8:40 a.m.–9:10 a.m. X K Awards and Training Programs 9:15 a.m.–11:30 a.m.

Clinical Trials Plenary Session 10:00 a.m.–10:30 a.m. X Choosing a Career in Neurocritical Care 10:45 a.m.–11:15 a.m. X Staying on an Academic Clinical Track 11:30 a.m.–12:00 p.m. X Reviewer to Editorial Board to Editor Clinical Decision Support for Ordering of Diagnostic Imaging 11:30 a.m.–4:00 p.m.

Exhibit Hall 11:30 a.m.–7:00 p.m. P3 Poster Session III Presenters stand by posters 5:30 p.m.–7:00 p.m.

11:45 a.m.–12:30 p.m. X Foreign Medical Graduates Adjustment Skills 11:45 a.m.–12:35 p.m. Aging and Dementia Poster Discussion Session 12:00 p.m.–12:30 p.m. X Introduction to the 2018-2020 TRANSCENDS Scholars X Office Hours: How to Get a K-Award Using Technology to Enhance Patient Engagement 12:00 p.m.–12:45 p.m. X Treatment of Neuropathy Symptoms Without Medication 12:00 p.m.–1:00 p.m. Global Health Section Meeting Neuromuscular Section Meeting 12:00 p.m.–1:00 p.m. X Neurology Game Show: Localize the Lesion X Using EHR for Better Communication with Patients and Colleagues 12:15 p.m.–12:45 p.m. X Neurohospitalists 2.0, How to Craft a Satisfying and Sustainable Career 12:30 p.m.–1:00 p.m. X Office Hours: Bridge Funding Back to the Future: Innovations Revisiting Neurohealth Space 12:40 p.m.–1:10 p.m. X NIH Funding and Professional Development Opportunities for Diverse Researchers

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

48 2018 AAN Annual Meeting On-site Guide

CLINICAL TRIALS PLENARY SESSION Tuesday, April 24 9:15 a.m.–11:30 a.m. This session covers important clinical topics identified from other society meetings that affect patient care. The latest updates within several clinical trials conducted over the course of the last year will be presented. This plenary session will feature audience response technology to create an interactive attendee experience. Please look for more details during this session at the Annual Meeting. Moderators Deborah Hall, MD, PhD, FAAN Member, Science Committee

Holly E. Hinson, MD, MCR Member, Science Committee

Natalia S. Rost, MD, MPH, FAAN, FAHA Chair, Science Committee

niversity of College London U London, United Kingdom

A Randomized, PlaceboControlled, Phase 3 Study of the Safety and Efficacy of Solriamfetol (JZP-110) for the Treatment of Excessive Sleepiness (ES) in Participants with Narcolepsy Types 1 and 2 (NT1/2) Michael J. Thorpy, MD

Expanding the Time Window for Thrombectomy: Results of the DEFUSE 3 Study Gregory W. Albers, MD

A Phase II Trial of Ibudilast in Progressive Multiple Sclerosis Robert J. Fox, MD, FAAN

Effects of IONIS-HTTRx in Patients with Early Huntington’s Disease, Results of the First HTTLowering Drug Trial Sarah J. Tabrizi

ontefiore Medical Center, M Bronx, NY

Stanford University, Stanford, CA

Cleveland Clinic, Cleveland, OH

Patisiran, a RNAi Therapeutic, to Improve Outcomes in Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Polyneuropathy David D. Adams, MD, PhD

Brain Oxygen Optimization in Severe Traumatic Brain Injury (BOOST) Phase 2 Trial: Towards Evidence-Based in the Neurological Intensive Care Unit Ramon R. Diaz-Arrastia, MD, PhD, FAAN

A PHP, Le Kremlin-Bicetre, France

P enn Presbyterian Medical Center, Philadelphia, PA

Precision Medicine: Intracerebroventricular Enzyme Replacement Therapy with Cerliponase Alfa in Children with CLN2 Disease: Results from an Ongoing Multicenter Study Emily C. De Los Reyes, MD ationwide Childrens Hospital, N Columbus, OH

A Double-blind Placebo-controlled Study to Evaluate the Safety and Efficacy of FcRn-antagonist ARGX-113 (efgartigimod) in Generalized Myasthenia Gravis James F. Howard Jr. MD, FAAN niversity of North Carolina, U Chapel Hill, NC

A Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab for the Preventive Treatment of Chronic Migraine: Results of the PROMISE-2 Trial Study Richard B. Lipton MD, FAAN lbert Einstein College of Medicine, New A York, NY

TUESDAY, APRIL 24 12:45 p.m.–1:30 p.m. X Choosing Teleneurology as a Career 1:00 p.m.–1:30 p.m. X Subspecialty Sessions: IOM and cEEG Office Hours: VA Research Funding: X Career Development Awards

Get Paid for Your Mental Status Exams... Use App Technology to Innovate What You Do

1:00 p.m.–1:45 p.m. X Complementary Therapies in Parkinson’s Disease 1:00 p.m.–2:00 p.m. X Understanding Axon Registry and Using it to Improve Your Value 1:00 p.m.–2:15 p.m.

Special Presentation: Don’t Break the Rules, Change the Game: How Bennet Omalu SingleHandedly Changed American Football, Professional Sports, and How the World Perceives Traumatic Brain Injuries Bennet Omalu, MBBS, MPH, MBA with Steven DeKosky, MD, FAAN, FANA, FACP 1:00 p.m.–3:00 p.m. Invited Science: Movement Disorders C105 LMentoring…Growing the Next Generation of Neurologist $ (registration required) C106 Critical Care EEG Monitoring C107 What Do I Do Now?: Assessment and Management of Neuropsychiatric Symptoms in

Neurocognitive Disorders C108 Introduction to Primary Headache Disorders I: Migraine and Other Primary Headaches Including Tension-Type, Hypnic, Primary Stabbing and Nummular Headache Syndromes, Epicrania Fugax and Retinal Migraine C109 Multiple Sclerosis Overview II: Clinical Advances C110 Neurologic Complications in Adults with Down Syndrome C111 Enhancing Your Career and Practice Through Neuropalliative Care C112 Continuum ® Test Your Knowledge: A Multiple-choice Question Review I C113 Sleep for the Practicing Neurologist I: Is it Narcolepsy or Something Else? Diagnostic and Management Challenges in the Central Disorders of Hypersomnolence C114 Concussion: Pathogenesis, Fluid and Imaging Biomarkers, Diagnosis, and Treatment of Post-Concussion Headache C115 Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia C116 Cerebrovascular Disease I: Prevention C117 Introduction to Clinical Research and Methods C118 LLeadership in the Era of Burnout: A Practical Approach to Becoming a True Physician Leader N3 Neuroscience in the Clinic: Challenges in Genetic Diagnosis in Neurology S21 Revascularization in Acute Ischemic Stroke

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

50 2018 AAN Annual Meeting On-site Guide

S22

Advances in Muscular Dystrophy and Congenital Myopathy S23 Biologic and Clinical Discoveries in Neuro-oncology • Presentation of the Neuro-oncology Investigator Award • Presentation of the Neuro-oncology Scientific Award

1:00 p.m.–5:30 p.m. C119 EMG Skills Workshop: Basic $ (registration required) 1:20 p.m.–1:50 p.m. X NIH Grant Review Process

2:00 p.m.–2:45 p.m. X Dancing with Parkinson’s 2:30 p.m.–3:00 p.m. X How to Start a Career in Neurology Education Office Hours: Finding Collaborators X The Why and How of Getting a Billion Dollar EHR to Make Their System Work Better for Neurologists 2:30 p.m.–3:30 p.m. X What is the AAN Doing for Small and Solo Practitioners?

1:30 p.m.–2:00 p.m. 2:30 p.m.–3:30 p.m. X Office Hours: Clinical Research ABPN MOC Information Session Recommendations for Residents and Fellows 2:40 p.m.–3:10 p.m. Liftware Suite of Assistive Devices: X Pain Research Funding Putting the User First Opportunities, Clinical and Basic 1:30 p.m.–2:30 p.m. 2:45 p.m.–3:30 p.m. Ethics Section Meeting X Neurology and Wellness—Why Autoimmune Neurology Section and How it Affects Your Career Meeting 3:00 p.m.–3:30 p.m. 1:30 p.m.–2:30 p.m. Technological Evolution in Sports X Neurological Exam Tips and Tricks Concussion 1:45 p.m.–2:15 p.m. 3:00 p.m.–3:45 p.m. X Academic Career Panel: Find out X StrengthsFinders Social Hour How to Get Your Career Started 3:00 p.m.–4:00 p.m. 1:45 p.m.–2:30 p.m. X Biological and Chemical X The Encompassing Value of the Neuroterrorism and Neurowarfare Patient-Physician Relationship 3:15 p.m.–3:45 p.m. 2:00 p.m.–2:30 p.m. X Staying on Track: A Career as a X NINDS Clinical Trials (new Clinical Researcher NIH definition) and networks, 3:20 p.m.–3:50 p.m. NeuroNEXT, StrokeNET, SIREN Caring for Telemedicine Patients X Pain Research Funding X Opportunities, Clinical and Basic Being a Neurologist in the Digital Age: Managing your Professional Personal Digital Profile

X PLEASE SEE MOBILE APP AND ROOM LOCATOR FOR MOST UP-TO-DATE INFORMATION

TUESDAY, APRIL 24 3:30 p.m.–4:00 p.m. X Maintenance of Certification Update Quantitative Gait Analysis in Neurologic Conditions: Neurodevelopmental Disorders as a Case Example 3:30 p.m.–4:30 p.m. Geriatric Neurology Section Meeting A.B. Baker Section on Neurological Education Meeting 3:30 p.m.–5:30 p.m. C120 Lumbar Radiculopathy, Lumbar Spinal Stenosis, Low Back Pain, and Failed Back Syndrome C121 Introduction to Primary Headache Disorders II: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Thunderclap Headaches C122 Multiple Sclerosis Overview III: The Pathogenesis of Multiple Sclerosis and Mechanism of Action of Treatments for MS C123 Child Neurology: A Case-based Approach C124 The Palliative Care Guide in Neurology: Best Practice in Communication, Advance Care Planning, and End-of-life Care of Patients with Brain Tumors and Other Life-limiting Neurological Disorders C125 Continuum ® Test Your Knowledge: A Multiple-choice Question Review II C126 Sleep for the Practicing Neurologist II: Night Fighting: Sleep Related

Hypermotor Epilepsy, Sleepwalking, and Dream Enactment C127 Concussion Management: Chronic Sequelae and Symptom Targeted Treatment in the Acute, Subacute and Chronic Phase After Concussion C128 Movement Disorders for the General Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypies, and Tics C129 Cerebrovascular Disease II: Update on Guidance-Based Diagnosis and Management of Hemorrhagic Stroke C130 Disorders of Motor Programming: The Apraxias and ActionIntentional Disorders Chalk Talk C131 Introduction to Integrative Neurology C132 Actualization Científica Durante el Congreso Anual I S24 MS Outcome Measures and Biomarkers S25 Advances in Amyotrophic Lateral Sclerosis • Presentation of the Sheila Essay Award: An Award for ALS Research*

S26 Movement Disorders: Parkinson’s Disease Clinical Trials

3:45 p.m.–4:30 p.m. X International Members: What Can the AAN Do For You? 4:00 p.m.–4:30 p.m. X Your Grant Proposal Was Rejected: Now What? Turning a Feedback Into a Successful Project X Successful APP- Physician Team Models Panel

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

52 2018 AAN Annual Meeting On-site Guide

4:00 p.m.–4:45 p.m. X The Sleep Mythbuster!: Illuminating the Facts and Fiction Towards Achieving the Sleep Healthy Neurologist 4:00 p.m.–5:00 p.m. X PALF Reception 4:30 p.m.–5:30 p.m. X Controversies in Neurology: Is the Zombie Apocalypse Upon Us? Local Outbreaks, Bioterrorism or Bioengineering Run Amok… 4:45 p.m.–5:30 p.m. X Teaching During a Busy Clinic 5:00 p.m.–5:30 p.m. X Guided Meditation

5:30 p.m.–6:30 p.m. LGBTQI Section Meeting Pain & Palliative Care Section Meeting 5:45 p.m.–7:00 p.m. Emerging Science Session 7:00 p.m.–10:00 p.m.

Industry Therapeutic Updates (Please see mobile app for most up-todate information)

WEDNESDAY, APRIL 25 7:00 a.m.–7:45 a.m. X Yoga (All-Levels Vinyasa) 7:00 a.m.–9:00 a.m. C133 Higher Cortical Visual Disorders: Case-based Review C134 Tuberculosis of the Central Nervous System C135 Neurocognitive Assessment for Neurologists C136 Multiple Sclerosis Therapy: Diseasemodifying Treatment I . . . . . . . . West Exhibit Hall B C137 What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders C138 Clinical EEG I: Normal EEG, Normal Variants, and How to Avoid The Common Pitfall of Over-reading C139 Neurologic Case Studies in Pregnancy C140 Paroxysmal Movement Disorders C141 Integrating Sleep Medicine Concepts into Your Child Neurology Practice C142 Mastering EMG Waveform Recognition Skills in Just Two Hours! C143 Evaluation and Treatment of Common Spine Disorders 7:30 a.m.–8:00 a.m. X Acute Flaccid Myelitis: Exploring Efforts to Support National Surveillance and the Search for Etiologies 8:00 a.m.–8:45 a.m. X Acupuncture Demonstration: Auriculotherapy

8:00 a.m.–9:00 a.m. S27 “Best of” Session: Movement Disorders 8:00 a.m.–9:00 a.m. X Step Away from the Desktop! Recapturing the Joy in Practice 8:00 a.m.–9:10 a.m. X How to Write and Publish Research Papers, Reviews and Other Scientific Communications 8:15 a.m.–9:00 a.m. X How to Give Effective Feedback 8:15 a.m.–9:15 a.m. Neural Repair & Rehabilitation Section Meeting Neuroendocrinology Section Meeting 8:30 a.m.–9:00 a.m. X Office Hours: Selecting an AAN Research Program Mentor X Being a Great Chief Resident 9:15 a.m.–11:30 a.m.

Frontiers in Neuroscience Plenary Session 10:00 a.m.–10:30 a.m. X Subspecialty Sessions: Neuroimmunology and Neurological Infections 11:30 a.m.–12:00 p.m. Balancing Business and Wellness: Non-Traditional Work Settings 11:30 a.m.–3:00 p.m.

Exhibit Hall

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

54 2018 AAN Annual Meeting On-site Guide

FRONTIERS IN NEUROSCIENCE PLENARY SESSION Wednesday, April 25â&#x20AC;&#x192; 9:15 a.m.â&#x20AC;&#x201C;11:30 a.m. This plenary session features basic and translational research related to clinical issues of importance. Six outstanding physician-scientists provide summaries of their recent research findings and describe the clinical implications of the results.

Moderator Paul M. George, MD, PhD, MSE Member, Science Committee

The Dynamics of the Unconscious Brain Under General Anesthesia Emery Brown, MD, PhD assachusetts Institute of M Technology, Cambridge, MA

Does Connectomics Make Sense? Jeff Lichtman, MD, PhD

Jack M. Parent, MD

niversity of Michigan, Ann Arbor, U MI

BigBrain: A High Resolution 3D Digital Human Brain Atlas

Harvard University, Cambridge, MA

Alan Evans, PhD

Biology of Bedtime: Understanding Circadian Rhythms and Sleep

Pediatric MS: A Unique Window into Environmental and Genetic Risk Factors for MS

Amita Sehgal, PhD

E mmanuelle Waubant, MD, FAAN

niversity of Pennsylvania, U Haverford, PA

Combining Patient-Derived Cell and Animal Models to Uncover Epilepsy Mechanisms and Precision Therapies

cGill University, Montreal, QC, M Canada

UCSF MS Center, San Francisco, CA

WEDNESDAY, APRIL 25 11:30 a.m.–7:00 p.m. P4 Poster Session IV Presenters stand by posters 5:30 p.m.–7:00 p.m. 11:45 a.m.–12:30 p.m. X Neuroimaging Opportunities for the Practicing Neurologist 11:45 a.m.–12:35 p.m. Cerebrovascular Disease and Interventional Neurology Poster Discussion Session 12:00 p.m.–12:30 p.m. X Office Hours: Recruiting Difficult and Underrepresented Populations in Research Utilizing Wearable Technology to Improve Neurological Care X Recruiting Minorities X Ask Me Anything About Remote Care and Telemedicine 12:00 p.m.–12:45 p.m. X Neurology and Wellness—Physician, Heal Thyself 12:00 p.m.–1:00 p.m. Endovascular & Interventional Neurology Section Meeting Neurohealth & Integrative Neurology Section Meeting 12:00 p.m.–1:00 p.m. X Neuro-Jeopardy: Telencephalon Twisters 12:30 p.m.–1:00 p.m. X Office Hours: Navigating Uncommon Pathways in Academic Neurology: A Journey from Bedside to Bench X So You Want to Work for a Hospital?

56 2018 AAN Annual Meeting On-site Guide

12:40 p.m.–1:10 p.m. X Neuroscience of Bias 12:45 p.m.–1:30 p.m. X Clinical Research in the Area of Practice, Quality and Patient Safety 1:00 p.m.–1:30 p.m. X Office Hours: Creating Bridge Funding— How to Use Non-NIH Funding Using Axon Registry to Improve Your Practice X Industry Panel 1:00 p.m.–1:45 p.m. X Lifestyle Medicine: What It Is and Why It Should be Your First Recourse in Patient Care 1:20 p.m.–1:50 p.m. X Community Education in Minority Population 1:00 p.m.–2:00 p.m. S28 Practice, Policy, and Ethics 1:00 p.m.–3:00 p.m. C144 Neurology Update I: Epilepsy, Behavioral Neurology, and Neurologic Infections C145 Severe TBI: From ICU to Rehabilitation C146 Non-Alzheimer’s Dementia I: Frontotemporal Dementias C147 Multiple Sclerosis Therapy: Disease-modifying Treatment II C148 LGBTQI Health in Neurology C149 What Do I Do Now?: Neurologic Consultations in Cancer Patients I C150 Where is the Lesion? A History of Neurological Investigations Part I

C151 Cerebrovascular Disease III: Update 1:30 p.m.–2:00 p.m. on Neuroimaging Modalities and Endovascular Therapies for Acute Ischemic Stroke C152 Nystagmus and Saccadic Intrusions Made Simple C153 Circadian Rhythm Disorders: Implications for Neurology C154 The Global Burden of Neurologic Diseases C155 Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System C156 Clinical EEG II: Focal, Diffuse, and Epileptiform Abnormalities in Adults S29 Child Neurology and Developmental Neurology I S30 Movement Disorders: Dystonia, Chorea, and other Disorders • Presentation of the Jon Stolk Award in Movement Disorders for Young Investigators

S31 Therapeutics, Phenotypes, and Biomarkers in Neuromuscular Disorders S32 Headache: Therapeutics

1:00 p.m.–5:00 p.m. C157 LAdvanced Leadership Training: Preparing for Your Career’s Insurmountable Opportunities C158 LLeadership Strengths in Neurology: The Data, Tools and Practical Application of Strengths for Leadership, Team Building, and Personal Development $ (registration required) 1:00 p.m.–5:30 p.m. C159 Clinical Uses of Botulinum Toxin for Dystonia Skills Workshop $ (registration required)

Acupuncture FAQ

1:30 p.m.–2:30 p.m. Stroke & Vascular Neurology Section Meeting 1:30 p.m.–2:30 p.m. X Parkinson Disease: Raising Your Game 1:45 p.m.–2:30 p.m. X Otoneurology, a Subspecialty Looking to Grow 2:00 p.m.–2:30 p.m. X Office Hours: Comparative Effectiveness Research in Neurology X Office Hours: Mentor-Mentee Relationships The New AAN.com: Innovations to Streamline and Personalize Your Online Experience X Women in Neuroscience 2:00 p.m.–2:45 p.m. X Resiliency for the Neurologist 2:30 p.m.–3:00 p.m. X What Free Technical Assistance for QPP is Available to Me? The Importance of Social Media in a Non-Insurance Based Practice 2:40 p.m.–3:10 p.m. X Patient-Reported Measures in Neurology 2:45 p.m.–3:30 p.m. X Pursing a Career in Healthcare Administration 3:00 p.m.–3:30 p.m.

X PLEASE SEE MOBILE APP AND ROOM LOCATOR FOR MOST UP-TO-DATE INFORMATION

WEDNESDAY, APRIL 25 X

Office Hours: Research Careers in Industry

3:00 p.m.–3:45 p.m. X Introduction to Acupuncture II: Evidence-based Applications for Acupuncture in the Treatment of Neurologic Conditions 3:00 p.m.–4:00 p.m. X Health Care Disparities Among Underserved Populations 3:15 p.m.–4:15 p.m. X Training in Neurology While on a Visa: Challenges and Possible Solutions for Foreign Medical Graduates 3:30 p.m.–4:00 p.m. X Advocacy through Education: A Resident Education Program for Headache 3:30 p.m.–4:15 p.m. S33 Global Health 3:30 p.m.–4:30 p.m. Neuro-infectious Disease Section Meeting Behavioral Neurology Section Meeting 3:30 p.m.–5:30 p.m. Invited Science: Sleep C160 Neurology Update II: Movement Disorders, Spine Disorders, and Sleep Disorders C161 Non-Alzheimer’s Dementia II: Lewy Body Dementias and Other Parkinsonian Dementias C162 Multiple Sclerosis Therapy: Symptom Management C163 How to Run a Practice: Business

Strategies for Neurology Private Practices, Academic Centers, and the Future C164 What Do I Do Now?: Neurologic Consultations in Cancer Patients II C165 Where is the Lesion? A History of Neurological Investigation Part II C166 Cerebrovascular Disease IV: Telestroke C167 Eye Movement Disorders: A Systematic Approach to the Evaluation of Diplopia C168 CNS Toxicities C169 Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System C170 Clinical EEG III: Neonatal and Pediatric C171 Actualización Sobre Opciones Terapéuticas para la Epilepsia Farmacorresistente C244 Joint AAN and AHA/ASA Session: Bridging Racial and Ethnic Disparities in the Management of Stroke and Breakthroughs in Engaging Minority and Rural Communities in Stroke Studies N4 Neuroscience in the Clinic: Opioid Use and Abuse: The Overlapping Neurobiology of Pain and Addiction, and the Path Toward Better Treatments S34 Behavioral and Cognitive Neurology • Presentation of the Norman Geschwind Prize in Behavioral Neurology

S35 Child Neurology and Developmental Neurology II

S36 MS Therapeutics and Clinical Research

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

58 2018 AAN Annual Meeting On-site Guide

3:45 p.m.–4:30 p.m. X Navigating Fellowship in Neurology 4:00 p.m.–4:30 p.m. X Being a Neurologist at a VA Hospital 4:00 p.m.–4:45 p.m. X Diets and Supplements in MS: What’s the Evidence Thus Far? 4:15 p.m.–5:00 p.m. X The Neurology of Voodoo 4:30 p.m.–5:30 p.m. S37 Neurorehabilitation

Educational and Leadership Pearls 5:00 p.m.–5:30 p.m. X Guided Meditation 5:15 p.m.–6:15 p.m. X Neurology, Illustrated: The Neurology in Art 5:30 p.m.–6:30 p.m. Child Neurology Section Meeting 7:00 p.m.–8:00 p.m. Neuro-oncology Section Meeting 7:00 p.m.–10:00 p.m.

Industry Therapeutic Updates

4:45 p.m.–5:30 p.m. (Please see mobile app for most up-toA.B. BakerRoom—Onsite Lifetime Achievement X Overflow dateAd information) CESC: 18AM Guide Half Page in Neurologic Education Award On Site Distrubution Presentation: Ten Clinical, 5.5" x 4.25" 4C/2S — PerfectTop Bind

NEW! OVERFLOW VIEWING AREA A comfortable, convenient area will be available with streaming video and audio for all overflow viewing. Comfortable seating, audio headsets, and charging stations will be available in the rear of the West Exhibit Hall A.

THURSDAY, APRIL 26 7:00 a.m.–7:45 a.m. X Yoga (All-Levels Vinyasa)

8:00 a.m.–9:00 a.m. X Enhancing Epilepsy Care in Your Practice: In-Person Digital Learning 7:00 a.m.–9:00 a.m. and Emotional for Self-Management, C172 Clinical Epilepsy I: Basics Education, and Community Supports from the National Epilepsy Education C173 Using Sleep Medicine to Help Solve and Awareness Collaborative Difficult Neurologic Cases C174 Rehabilitation in Neurology 8:15 a.m.-9:00 a.m. C175 Clinical Pearls in Autoimmune X Benefits of a Semiprivate Practice: Neurology: Real World Cases Interviewing, Contracts, and C176 The Dystonia: Diagnosis, Treatment Compensation and Update on Etiologies 8:15 a.m.–9:15 a.m. C177 So You’ve Diagnosed Your Patient Epilepsy Section Meeting with a Neuroinfectious Disease, Now What? Practical Pearls in the 8:40 a.m.–9:10 a.m. Treatment and Management of X The Pathway to Become a Clinical Neuroinfectious Diseases Trialist C178 Neuro-oncology in 2018: Navigating 9:15 a.m.–11:30 a.m. Current Trends C179 Clinical EMG I: Principles and Controversies in Neurology Practice of NCS and Needle EMG Plenary Session C180 Principles of Genomic Medicine: 11:30 a.m.–7:00 p.m. Clinical Exome Sequencing in Neurologic Disease P5 Poster Session V C181 Preventive Neurology: How Presenters stand by posters 5:30 Neurologists Can Improve p.m.–7:00 p.m. Outcomes That Matter to Patients 11:45 a.m.–12:30 p.m. 8:00 a.m.–8:30 a.m. X Teaching History and Exam with X How to Bridge to Careers in Teleneurology Industry 11:45 a.m.–12:35 p.m. 8:00 a.m.–8:45 a.m. MS and CNS Inflammatory Disease X Sleep and Performance in Elite Poster Discussion Session Athletes 12:00 p.m.–12:30 p.m. 8:00 a.m.–9:00 a.m. X How to Increase Investments in S38 “Best of” Session: Clinical Trial Neuroscience Research Updates in Neuromuscular 12:00 p.m.–12:45 p.m. Disorders X The Purpose Checkup: Find Meaning, Live Longer, Better $ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

60 2018 AAN Annual Meeting On-site Guide

CONTROVERSIES IN NEUROLOGY PLENARY SESSION Thursday, April 26 9:15 a.m.–11:30 a.m. This session features experts discussing the most current and controversial issues in neuroscience. It is set up as a debate format in which two speakers argue one side of a single topic, followed by a rebuttal. This plenary session will feature audience response technology to create an interactive attendee experience. Please look for more details during this session at the Annual Meeting.

Moderators Aleksandar Videnovic, MD, MSc, FAAN Member, Science Committee

A my R. Brooks-Kayal, MD, FAAN Member, Science Committee

Should We Use Biomarkers Alone For Diagnosis of Alzheimer’s? Yes: Michael W. Weiner, MD University of California, San Francisco, San Francisco, CA

No: Maria Glymour, ScD, MS

University of California, San Francisco, San Francisco, CA

Should the Neurologist Be Primarily Responsible for Taking Care of Patients with Functional Disorders? Yes: David L. Perez, MD Massachusetts General Hospital, Boston, MA

No: A ndrea Leigh Haller, MD

F ort Wayne Neurological Center, Fort Wayne, IN

Would You Let Your Child Play Contact Sports? Yes: Jack W. Tsao, MD, DPhil, FAAN Memphis, TN

No: Christopher Giza, MD

UCLA, Dept of Neurosurgery, Los Angeles, CA

THURSDAY, APRIL 26 12:00 p.m.–1:00 p.m. X Who Wants to be a Millionaire 12:15 p.m.–12:45 p.m. X FDA Introductory Seminar on Navigating the Regulatory Landscape for Neurological Devices and Moving Neurotechnologies to Patients and Caregivers

1:00 p.m.–2:30 p.m. Invited Science: The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative

1:00 p.m.–3:00 p.m. C182 Clinical Epilepsy II: Considerations Across the Age Span Pediatrics, Pregnancy, and Elderly 12:30 p.m.–1:00 p.m. C183 Hot Topics in Sleep Neurology X What is the Neurologist C184 Behavioral Neurology I: Network Compensation and Productivity Anatomy of Behavior and Language Survey, and How Can it Increase C185 Neurology Update III: My Value? Neuromuscular, Headache, and X Office Hours: Making the Transition Stroke from Research Fellow to Clinical C186 Myelopathies I: Recognizing and Research Faculty Evaluating Myelopathic Patients for 12:45 p.m.–1:30 p.m. Inflammatory and Vascular Causes X Effective Neurology Residency C187 Cerebellar and Afferent Ataxias: Program Diagnosis and Management C188 Neuroimaging for the General 1:00 p.m.–1:30 p.m. Neurologist I: Spine and Peripheral X Office Hours: Early Career Research Nerve Funding and Career Development C189 Business Strategies for Payer X What Do I Need to Know About Negotiations and/or How to Go off Coding in My Practice? the Grid 1:00 p.m.–1:45 p.m. C190 Neuro-oncologic Predicaments in the Hospital Setting X Medical Marijuana: What do Neurologists Need to Know? C191 Neuro-otology I: The Common Peripheral Vestibular Disorders 1:00 p.m.–2:15 p.m. C192 Clinical EMG II: Neuromuscular S39 History of Neurology Junction Testing and Quantitative • Presentation of the Lawrence C. McHenry EMG Award: C193 Assessment of Rapidly Progressive An Award for the History of Neurology Dementias I: Overview, Infections Presenting as Rapidly Progressive Dementia and Antibody-Mediated Rapidly Progressive Dementia

$ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

62 2018 AAN Annual Meeting On-site Guide

C194 Actualización Sobre el Manejo del

Ictus Cerebrovascular C195 Practical Training in Injection Techniques in the Treatment of Headache Disorders Skills Workshop $ (registration required) N5 Neuroscience in the Clinic: Treatment of Progressive Multiple Sclerosis S40 Acute Stroke Care S41 Neurologic Infections S42 Neurocritical Care 1:00 p.m.–5:30 p.m. C196 Brain Death Skills Workshop: How to Perform a Brain Death Evaluation, Avoid Pitfalls and Convey the News to the Family $ (registration required) 1:30 p.m.–2:30 p.m. X The Value of the Neurologic Exam: Caring for your Patient for $500 or Less 1:45 p.m.–2:30 p.m. X Interviewing Skills 2:00 p.m.–2:45 p.m. X Cafe Talk: Communication in Neurology Practice 2:00 p.m.–3:00 p.m. X Using your Patients as Resources: Group Medical Visits for Improved Wellness and Efficiency 2:30 p.m.–3:00 p.m. X American Brain Foundation Crowdfunding Marketing Strategy 2:45 p.m.–3:30 p.m. X O Funding, Where Art Thou? How to Develop a Full-Time Academic Career in Global Neurology

3:00 p.m.–3:30 p.m. X Women in Neurology: Using Social Media to Build Your Community 3:00 p.m.–3:45 p.m. X Magnifying Your Life Through Poetry 3:00 p.m.–4:00 p.m. X Consejos Prácticos para un Buen Examen Neurológico 3:10 p.m.–3:40 p.m. X What is the American Brain Foundation? 3:30 p.m.-4:00 p.m. X How Do I Know if a Treatment is Backed by Science? 3:30 p.m.–5:30 p.m. Invited Science: Neuro Trauma C197 Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) C198 Behavioral Neurology II: Memory and Attention C199 Neurology Update IV: Multiple Sclerosis, Neuro-ophthalmology, and Autoimmune Encephalopathies C200 Myelopathies II: Approaches to Rehabilitation and Psychosocial Challenges C201 Differential Diagnosis of Neurologic Infections C202 Neuroimaging for the General Neurologist II: Spine and Peripheral Nerve C203 Endovascular Treatment of Acute Stroke and Cerebrovascular Disease C204 Making Sure You Get Paid Under the New Health Care Laws C205 Neuro-otology II: Diagnosis and Treatment of Nuanced Causes of Dizziness

X PLEASE SEE MOBILE APP AND ROOM LOCATOR FOR MOST UP-TO-DATE INFORMATION

THURSDAY, APRIL 26 C206 Clinical EMG III: Nerve Conduction

Criteria and Electrodiagnostic Approaches C207 Mitochondrial Disorders in Neurology C208 Assessment of Rapidly Progressive Dementias II: Neurodegenerative Diseases and Prion Diseases C209 Clinical Usefulness of Botulinum Toxin for Spasticity Skills Workshop $ (registration required) N6 Neuroscience in the Clinic: Neurologic Complications of Cancer Immunotherapy: A New Frontier in Neuro-Inflammation S43 Migraine • Presentation of the Harold Wolff-John Graham Award: An Award for Headache/ Facial Pain Research

S44 MS Risk Factors,

Susceptibility, Diagnosis, and Cognitive Impairment S45 Movement Disorders: Parkinsonian Disorders, Basic Science, and Imaging S46 Advances in Spinal Muscular Atrophy 3:40 p.m.–4:10 p.m. Oportunidades y Consejos para Realizar Proyectos de Investigación Transnacionales 3:45 p.m.–4:30 p.m. X Career Opportunities in Emerging Neurologic Subspecialties

About Your Career Development Award Application Cannabis, Concussion, and Chronic Pain

4:00 p.m.–4:45 p.m. X Structural Acupuncture for Carpal Tunnel Syndrome 4:30 p.m.–5:00 p.m. X Grantwriting 101: Getting Started 4:30 p.m.–5:30 p.m. X Neurology History: Weaving Past with Present 4:45 p.m.–5:30 p.m. X Phonemic Verbal Fluency 6:30 p.m.–9:30 p.m. C210 Case Studies: Unusual Diagnostic and Management of Cases in Neuromuscular Disease C211 Case Studies in the ICU C212 Case Studies: Test Your Knowledge: A Case-based Approach to Neuroimaging C213 Case Studies: Unusual Movement Disorders C214 Case Studies: Challenging Headache Cases C215 Case Studies in Behavioral Neurology: Focus on Frontotemporal Degeneration

3:50 p.m.–4:20 p.m. X American Brain Foundation Crowdfunding Application Process 4:00 p.m.–4:30 p.m. X Office Hours: “Ask Me Anything” $ Additional Fee Required L Leadership University X Experiential Learning Area session C Course N Neuroscience in the Clinic Session P Poster Session S Scientific Platform Session

64 2018 AAN Annual Meeting On-site Guide

FRIDAY, APRIL 27 7:00 a.m.–7:45 a.m.

Yoga (All-Levels Vinyasa)

11:45 a.m.–12:30 p.m.

7:00 a.m.–9:00 a.m.

C216 Neuroendocrine Update: Nuts and Bolts of What You Need to Know

C217 Current Management of Incidental

and Asymptomatic Cerebrovascular Lesions C218 Infections of the Nervous System I: Diagnostic Testing of Neurological Infections C219 The Early-Onset Dementias C220 Drugs and Toxin-induced Neurologic Emergencies C221 REM Sleep Behavior Disorder C222 Therapy of Movement Disorders: A Case-based Approach C223 The Burden of Epilepsy: Managing Comorbidities and Quality of Life 8:00 a.m.-8:45 a.m.

Practice Makes Permanent

8:00 a.m.–9:00 a.m. S47 “Best of” Session: MS and CNS Inflammatory Diseases 8:00 a.m.–9:00 a.m.

Effective Shared Decision Making

8:00 a.m.–9:10 a.m.

Role of Placebo in Neuromuscular Clinical Trials and in Management of NM Disorders

9:15 a.m.–11:30 a.m.

Neurology Year in Review: Emerging Therapies Plenary Session

11:30 a.m.–5:30 p.m. P6 Poster Session VI Presenters stand by posters 4:00 p.m.–5:30 p.m.

From Bench to Bedside to the International Landscape: How to Trail the Path to Project Your Work to the World

11:45 a.m.–12:35 p.m. Movement Disorders Poster Discussion Session 12:00 p.m.–12:30 p.m.

X X

How to Bridge to Careers in Industry Incorporating a Semi-Concierge Model into your Own Neurology Practice

12:00 p.m.–12:45 p.m.

Outsmart Stress

12:00 p.m.–1:00 p.m.

The Neurology of Creativity at the Keyboard

12:40 p.m.–1:10 p.m.

How to Put Together an Effective Research Presentation

12:45 p.m.-1:30 p.m.

Negotiation Skill: You Do Not Get What You Deserve, You Get What You Negotiate For

1:00 p.m.–1:30 p.m.

How Do I Integrate MIPS Improvement Activities Into My Practice?

1:00 p.m.-1:45 p.m.

“Okay Alexa, Turn on the Lights”

1:00 p.m.–3:00 p.m. C224 Neuromyelitis Optica Spectrum Disorders C225 Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia C226 Infections of the Nervous System II: Neuro-ID Emergencies 65

NEUROLOGY YEAR IN REVIEW: EMERGING THERAPIES PLENARY SESSION Friday, April 27 9:15 a.m.–11:30 a.m. This session will feature six speakers, each focusing on the latest research that has happened in the last year within a specific subspecialty topic.

Moderator A ntonio M. P. Omuro, MD Member, Science Committee

A Year in Review of Neuromuscular Diseases: Making Treatments Great Again E ricka P. Simpson, MD, FAAN

Pediatric Epilepsy Kelly G. Knupp, MD

C hildren’s Hospital Colorado, Aurora, CO

Methodist Hospital, Houston, TX

Finally, Some Closure on PFO Closure teven R. Messé, MD, S FAAN, FAHA

ospital of the University of H Pennsylvania, Philadelphia, PA

Headache Medicine 2018: Year in Review Matthew S. Robbins, MD, FAAN

ontefiore Headache Center, Bronx, M NY

66 2018 AAN Annual Meeting On-site Guide

Dementia L iana Apostolova, MD, FAAN I ndiana University School of Medicine, Indianapolis, IN

Neuro-oncology Year in Review: Progress, Breakthroughs, and Future Directions A ntonio M. P. Omuro, MD

niversity of Miami Miller School of U Medicine, Miami, FL

FRIDAY, APRIL 27 C227 Behavioral Neurology: A Case-

based Approach �� Cancelled C228 Neuroimaging for the General Neurologist I: Brain C229 Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders C230 Neurologic Complications of Medical and Surgical Therapies C231 ICD-10-CM: How to Optimize for Accurate Diagnosis and Reimbursement C232 Hot Topics in Headaches and Related Disorders I: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances C233 Actualización Científica Durante el Congreso Anual II S48 Novel Biomarkers in Aging and Dementia S49 Neuro Trauma and Sports Neurology S50 Updates in General Neurology S51 Pediatric MS 1:00 p.m.–5:00 p.m. C234 Epilepsy Skills Workshop: Focus on Treatment $ (registration required) 1:20 p.m.-1:50 p.m.

Brain Science is Cool: Bringing Neurology Residents into Elementary Schools

1:30 p.m.–2:30 p.m.

Live Intraoperative Monitoring

2:00 p.m.–2:30 p.m. X How Should the AAN Be Teaching You Health Policy? 2:40 p.m.–3:10 p.m.

Recruiting Minorities

3:00 p.m.–3:30 p.m.

#AANAdvocacy to Action

3:00 p.m.–4:00 p.m.

Ask Us Anything: Expert Panel on Stroke

3:30 p.m.–5:30 p.m. C235 Neck Pain, Cervical Spinal Stenosis, Cervical Radiculopathy, and Cervical Spondylotic Myelopathy C236 Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission C237 Neurologic Complications of Medical Disease C238 Memory Disorders: A Case-based Approach C239 Infections of the Nervous System III: Advanced Topics in Infectious Neurology C240 Neuroimaging for the General Neurologist II: Brain C241 Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders C242 Coding 101: It’s Not Your Father’s Oldsmobile C243 Hot Topics in Headaches and Related Disorders II: Unusual Headaches, Childhood Headaches, and Concussion Management N7 Neuroscience in the Clinic: REM Sleep Behavior Disorder: Past, Present, Future S52 MS and CNS Inflammatory Disease: Basic Science S53 Epilepsy/Clinical Neurophysiology (EEG) III S54 Ischemic Stroke Prevention 4:00 p.m.–4:30 p.m.

Historical Perspective on Treating Epilepsy

4:30 p.m.–5:30 p.m.

Ask the Expert: Discussion on Multiple Sclerosis

5:30 p.m.–7:00 p.m.

Closing Party Happy Hour

X PLEASE SEE MOBILE APP AND ROOM LOCATOR FOR MOST UP-TO-DATE INFORMATION

Don’t Miss The Closing Party Friday, April 27 5:30 p.m.–7:00 p.m.

Join us at a special early-evening happy hour for: • Food, drinks, and socializing with colleagues • Your favorite jazz standards brought to you live by NEURO JAZZ, a five-piece ensemble led by AAN member Phillip Pearl, MD, FAAN • Philadelphia themed raffle prizes • Souvenir photo booth fun • And more!

AN INDEPENDENTLY-REVIEWED COMPETITIVE GRANT PROGRAM SUPPORTED BY AMGEN TO FUND INNOVATIVE RESEARCH ADVANCING THE UNDERSTANDING OF MIGRAINE

Competitive Grant Program in Migraine Research

Open to junior investigators in the United States US$25,000–50,000 grant awards available for novel research proposals Application deadline: Friday, May 11, 2018

Full details: www.amgenscientificgrants.com/migraine OR scan the QR code

USA-334-80304

WE DIDN’T DEVELOP AN AD FOR THIS PROGRAM BOOK.

We are SK life science and weâ&#x20AC;&#x2122;ve been busy pursuing our passionâ&#x20AC;&#x201D; to unlock the complex mysteries of the brain.

Visit Booth 429 to learn more about our commitment to making life better for those affected by CNS disorders.

SKLifeScienceInc.com

Industry Therapeutic Updates Saturday, April 21 | Monday, April 23 | Tuesday, April 24 | Wednesday, April 25 Registration is free and open to registered Annual Meeting attendees. Representatives from the following companies invite you to an informational session on therapeutic updates. This program provides you the opportunity to learn about current therapies and projects in the industry pipeline.

Saturday, April 21—7:00 p.m. Amgen & Novartis Pharmaceuticals Corp. Enhanced Conversation with the Migraine Patient... Assessment, Diagnosis, and Management Location: JW Marriott LA Live Diamond Salon 5

GE Healthcare TALKING TIME: The Great Diagnosis Debate Location: JW Marriott LA Live Platinum Ballroom A – C

Monday, April 23—7:00 p.m. CSL Behring A PATH FORWARD IN PERIPHERAL NEUROIMMUNOLOGY: A Subcutaneous Alternative for Patients With CIDP Location: Hotel Indigo LA Downtown Orpheum Ballroom Genentech, a member of the Roche Group Treatment Goals: An Interactive Panel Debate Location: JW Marriott LA Live Platinum Ballroom A-D

Ionis Pharmaceuticals Charting the Course in Rare Neurological Disease and the Next Frontier in ATTR Amyloidosis Location: Westin Bonaventure Hotel Beaudry Ballroom B Mitsubishi Tanabe Pharma America Can We Build a New Paradigm from Diagnosis to Treatment? The Role of the Latest ALS Therapy Location: JW Marriott LA Live Gold Ballroom 3

Novartis Pharmaceuticals Corp. Exploring the MS spectrum, biomarkers and digital technology Location: Westin Bonaventure Hotel Palos Verdes Ballroom Sunovion Pharmaceuticals Inc. A Spotlight on Parkinson’s Disease and Innovation Location: JW Marriott LA Live Platinum Ballroom F-J Teva CNS Location: JW Marriott LA Live Gold Ballroom 1

RSVP is recommended for these events. No CME will be given by any accredited organization for the Industry Therapeutic Updates, and the AAN cannot affirm claims pertaining to FDA off-label medication, research use of pre-FDA drugs, or other research information that might be discussed. Industry Therapeutic Updates are industry events. Please visit AAN.com/view/ITU for more information.

| Starting at 7:00 p.m.

Tuesday, April 24—7:00 p.m. Abbott PFO Closure—Addressing the Unmet Need for Reducing the Risk of Recurrent Ischemic Stroke Location: Hotel Indigo LA Downtown Orpheum Ballroom B Adamas Pharmaceuticals How Can We Fight Dyskinesia in Parkinson’s Disease? Location: Westin Bonaventure Hotel San Jose and San Diego Ballrooms Alnylam Pharmaceuticals Advancing the Care of Patients with hATTR Amyloidosis: Diagnostic Challenges and Potential New Therapies Location: Westin Bonaventure Hotel San Francisco Ballrooms H-J

Biogen Navigating an Early Diagnosis of Alzheimer’s Disease: A Call for Action Location: JW Marriott LA Live Diamond Salon 1-4

Biogen Planning for The Future In The MS Treatment Journey Location: JW Marriott LA Live Gold Ballroom 4

Biogen New Frontiers in the Early Diagnosis of MS Location: JW Marriott LA Live Platinum Ballroom C

Sarepta Therapeutics Duchenne Muscular Dystrophy Symposium Location: Hotel Indigo LA Downtown Metropolitan Ballroom

Biogen Looking Beyond the Symptoms to Customize MS Care Location: JW Marriott LA Live Platinum Ballroom H-I

Teva CNS New Understandings of Migraine Pathophysiology and Disease Burden Location: JW Marriott LA Live Gold Ballroom 2

Wednesday, April 25—7:00 p.m. EMD Serono, Inc. Evolving Perspectives and Innovations in Multiple Sclerosis Location: JW Marriott LA Live Platinum Ballroom

Sanofi Genzyme Predicting Patient Trajectory in MS: How Advanced Prognostic Measures Can Support More Informed Treatment Decisions Location: JW Marriott LA Live Gold Ballroom 2-4

ICW MEETINGS AND ALUMNI REUNIONS Saturday, April 21 External Meetings World Federation of Neurology Meetings

8:30 a.m.–5:00 p.m.

JW Georgia I

AUPN Neurology Program Directors Workshop

1:00 p.m.–3:00 p.m.

IND Belasco

Sunday, April 22 External Meetings IDD Neurology Care Planning Meeting

8:00 a.m.–11:30 a.m.

IND Belasco

AUPN New Chair Luncheon

12:15 p.m.–2:15 p.m.

IND Orpheum Ballroom B

Geisinger Health Alumni Reception

5:00 p.m.–6:30 p.m.

IND Olympic & Globe

AAN Meetings Advanced Practice Provider Bring-Your-Own-Lunch Networking Event

11:30 a.m.–12:30 p.m.

LACC 510

Consortium of Neurology Program Directors Business Meeting

12:00 p.m.–4:30 p.m.

LACC 308 AB

Program Coordinator Business Meeting

4:30 p.m.–6:00 p.m.

LACC 308 AB

Autonomic Nervous System Section Meeting

5:00 p.m.–6:00 p.m.

LACC 305

Neuro-ophthalmology/Neuro-otology Section Meeting

5:00 p.m.–6:00 p.m.

LACC Petree Hall C

Women’s Issues in Neurology Section Meeting

5:00 p.m.–6:00 p.m.

74 2018 AAN Annual Meeting On-site Guide

LACC Petree Hall D

Monday, April 23 External Meetings AUPN Chairs Spring Session

12:15 p.m.–2:15 p.m.

IND Metropolitan

Stanford Neurology Reunion

5:30 p.m.–7:00 p.m.

IND Belasco

Northwestern University Alumni Reunion

5:30 p.m.–7:30 p.m.

IND Olympic & Globe

Cleveland Clinic Alumni Reception

6:00 p.m.–7:30 p.m.

INTER Boyle Heights

University of Iowa Alumni Reunion

6:00 p.m.–7:30 p.m.

INTER Broadway

NeuroNEXT Network Social

6:00 p.m.–8:00 p.m.

OHOTEL Mezzanine

University of North Carolina Alumni Reception

6:00 p.m.–8:00 p.m.

WP24 Restaurant

niversity Hospital Cleveland Medical Center/Case Western U Reserve University Resident/Fellows 3rd Annual Alumni Get Together

6:00 p.m.–9:00 p.m.

BILT Cordoban

Association of Indian Neurologists of America Annual Meeting

6:00 p.m.–10:00 p.m.

INTER Hollywood Ballroom

ssociation for Frontotemporal Degeneration A Medical Advisory Council Annual Meeting

6:30 p.m.–8:30 p.m.

WEST San Gabriel C

UPMC Alumni & Friends Reception

7:00 p.m.–9:00 p.m.

Glance Restaurant

LACC ��Los Angeles Convention Center JW �� JW Marriott at LA Live BILT ��Millennium Biltmore Hotel IND �� Hotel Indigo Los Angeles Downtown INTER ��InterContinental Los Angeles Downtown LADT ��L.A. Hotel Downtown OHOTEL �� O Hotel WEST �� The Westin Bonaventure Hotel & Suites

ICW MEETINGS AND ALUMNI REUNIONS AAN Meetings Neurology: Clinical Practice Editorial Board Meeting

6:45 a.m.–8:45 a.m.

LACC 510

Clinical Neurophysiology Section Meeting

7:00 a.m.–8:00 a.m.

LACC Petree Hall C

Spine Section Meeting

7:00 a.m.–8:00 a.m.

LACC Petree Hall D

Industry Roundtable Thank You Breakfast

7:00 a.m.–9:00 a.m.

LACC 308 AB

Consortium of Neurology Advanced Practice Providers Meeting

8:00 a.m.–9:00 a.m.

LACC 306 B

General Neurology Section Meeting

8:15 a.m.–9:15 a.m.

LACC Petree Hall D

Headache & Facial Pain Section Meeting

8:15 a.m.–9:15 a.m.

LACC Petree Hall C

Consortium of Neurology Clerkship Directors Business Meeting

12:00 p.m.–1:00 p.m.

LACC 308 AB

History Section Meeting

12:00 p.m.–1:00 p.m.

LACC Petree Hall C

Movement Disorders Section Meeting

12:00 p.m.–1:00 p.m.

LACC Petree Hall D

Futures in Research Luncheon

12:00 p.m.–2:00 p.m.

JW Platinum Ballroom, Salon E

Government Service Section Meeting

1:30 p.m.–2:30 p.m.

LACC Petree Hall D

Critical Care & Emergency Neurology Section Meeting

3:30 p.m.–4:30 p.m.

LACC Petree Hall D

Neurohospitalist Section Meeting

3:30 p.m.–4:30 p.m.

LACC Petree Hall C

linical Trials Methodology Training Course C Executive Advisory Board Meeting

4:00 p.m.–5:00 p.m.

LACC 305

Advanced Practice Provider Networking Reception

5:00 p.m.–7:00 p.m.

JW Georgia I

Clinical Trials Methodology Course Alumni Reception

5:15 p.m.–6:45 p.m.

LACC 304 C

Business Administration Section Meeting

5:30 p.m.–6:30 p.m.

76 2018 AAN Annual Meeting On-site Guide

LACC Petree Hall D

Sports Neurology Section Meeting

5:30 p.m.–6:30 p.m.

LACC Petree Hall C

American Epilepsy Society Subspecialty Mentoring Session

5:30 p.m.–8:00 p.m.

JW Georgia II

Multiple Sclerosis Section Meeting

5:45 p.m.–6:45 p.m.

LACC West Exhibit Hall B

Tuesday, April 24 External Meetings PPMI Study Activities and Research Update Breakfast

7:30 a.m.–9:00 a.m.

LADT Olympic

hild Neurology Foundation’s Corporate Advisory C Board Spring Meeting

2:00 p.m.–5:00 p.m.

JW Diamond Ballroom, Salon 6/7

Flex Pharma Investigator Meeting

5:00 p.m.–7:00 p.m.

WEST Santa Monica A

University of Minnesota Department of Neurology Alumni Reunion

5:00 p.m.–7:00 p.m.

IND Olympic & Globe

Loma Linda University Health Neurology Reunion

5:00 p.m.–7:30 p.m.

INTER Boyle Heights

Kaiser Permanente Neurology Alumni Reunion

5:00 p.m.–9:00 p.m.

LADT Angeleno

Harvard Neurology Alumni Reception

5:30 p.m.–7:30 p.m.

BILT Athenian

Thomas Jefferson University Alumni Reception

5:30 p.m.–7:30 p.m.

BILT Millennium Boardroom

University of Miami Alumni Association Reception

5:30 p.m.–7:30 p.m.

INTER Broadway

ICW MEETINGS AND ALUMNI REUNIONS University of Cincinnati Alumni and Friends Reception

6:00 p.m.–7:30 p.m.

BILT Moroccan

Baylor Neurology Alumni Reception

6:00 p.m.–8:00 p.m.

BILT Cordoban

olumbia University, The Neurological Institute of C New York Alumni Reception

6:00 p.m.–8:00 p.m.

IND Belasco

J ohns Hopkins Department of Neurology Alumni Reunion and Reception

6:00 p.m.–8:00 p.m.

Prank Bar

Mayo Clinic Alumni Association Event

6:00 p.m.–8:00 p.m.

WEST Santa Barbara A

niversity of Toledo College of Medicine U Alumni Reunion

6:00 p.m.–8:00 p.m.

INTER Majestic

University of Rochester Neurology Alumni Reunion

6:00 p.m.–8:00 p.m.

IND Grand Staircase

NMC Department of Neurological Sciences Faculty U and Alumni Reception

6:00 p.m.–8:00 p.m.

INTER Century

Penn Neurology Reception for Alumni and Friends

6:00 p.m.–8:30 p.m.

BILT Corinthian

Yale Neurology Alumni Reception

6:00 p.m.–8:30 p.m.

INTER Hancock Park

edical University of South Carolina, Department M of Neurology Alumni Reunion

6:00 p.m.–9:00 p.m.

LADT Hollywood & Highland

akistan International Neuroscience Society P North America Association Meeting

6:00 p.m.–9:00 p.m.

LADT California Grand Ballroom, Salon 2

Washington University School of Medicine Alumni Reception

6:00 p.m.–10:00 p.m.

INTER K-Town

Cornell Neurology Alumni Reunion

6:30 p.m.–8:30 p.m.

BILT Mediterranean

Rush Neurology Alumni Reunion

6:30 p.m.–8:30 p.m.

WEST Palos Verdes

University of Virginia Alumni Reunion

7:00 p.m.–9:00 p.m.

INTER Silver Lake

UCLA Alumni Reception

7:30 p.m.–9:30 p.m.

78 2018 AAN Annual Meeting On-site Guide

LADT Olympic

AAN Meetings Neurology Editorial Board Meeting

6:45 a.m.–8:45 a.m.

JW Diamond Ballroom, Salon 5-10

Neuroimaging Section Meeting

7:00 a.m.–8:00 a.m.

LACC Petree Hall D

Sleep Medicine Section Meeting

7:00 a.m.–8:00 a.m.

LACC Petree Hall C

Neuroepidemiology Section Meeting

8:15 a.m.–9:15 a.m.

LACC Petree Hall D

Neurogenetics Section Meeting

8:15 a.m.–9:15 a.m.

LACC Petree Hall C

Global Health Section Meeting

12:00 p.m.–1:00 p.m.

LACC Petree Hall C

Neuromuscular Section Meeting

12:00 p.m.–1:00 p.m.

LACC Petree Hall D

Child Neurology Society Subspecialty Mentoring Session

12:00 p.m.–2:00 p.m.

JW Georgia II

Neurocritical Care Society Subspecialty Mentoring Session

12:00 p.m.–2:00 p.m.

JW Georgia I

Autoimmune Neurology Section Meeting

1:30 p.m.–2:30 p.m.

LACC Petree Hall D

Ethics Section Meeting

1:30 p.m.–2:30 p.m.

LACC Petree Hall C

Oral Archive: Live Interview of Dr. Peter Dyck

2:00 p.m.–3:00 p.m.

LACC 407

Maintenance of Certification Information Session

2:30 p.m.–3:30 p.m.

LACC 308 AB

ICW MEETINGS AND ALUMNI REUNIONS A .B. Baker Section on Neurological Education Meeting

3:30 p.m.–4:30 p.m.

LACC Petree Hall D

Geriatric Neurology Section Meeting

3:30 p.m.–4:30 p.m.

LACC Petree Hall C

Oral Archive: Live Interview of Dr. Sandra Olson

4:30 p.m.–5:30 p.m.

LACC 407

LGBTQI Section Meeting

5:30 p.m.–6:30 p.m.

LACC Petree Hall C

Pain & Palliative Care Section Meeting

5:30 p.m.–6:30 p.m.

LACC Petree Hall D

Wednesday, April 25 External Meetings MedLink Neurology Editorial Board Meeting

7:30 a.m.–9:00 a.m.

IND Belasco

Northeast ALS Consortium Meeting

8:00 a.m.–9:00 a.m.

IND Metropolitan

Neuropals II

12:00 p.m.–6:00 p.m.

INTER Hancock Park

Duke University Neurology Alumni Meeting

5:00 p.m.–7:00 p.m.

IND Olympic

ociety for Behavioral and Cognitive S Neurology Reception

6:00 p.m.–8:00 p.m.

IND Metropolitan

merican Brain Foundation A Commitment To Cures

6:00 p.m.–10:00 p.m.

JW Diamond Ballroom

University of California Irvine Alumni Reunion

7:00 p.m.–9:00 p.m.

INTER Roosevelt

AAN Meetings Neural Repair & Rehabilitation Section Meeting

8:15 a.m.–9:15 a.m.

LACC Petree Hall C

Neuroendocrinology Section Meeting

8:15 a.m.–9:15 a.m.

LACC Petree Hall D

eurology: Neuroimmunology & Neuroinflammation N Neurology: Genetics Editorial Board Meeting

11:00 a.m.–12:30 p.m.

80 2018 AAN Annual Meeting On-site Guide

LACC 512

Endovascular & Interventional Neurology Section Meeting

12:00 p.m.–1:00 p.m.

LACC Petree Hall C

merican Headache Society Subspecialty A Mentoring/Networking Luncheon

12:00 p.m.–2:00 p.m.

JW Georgia II

National MS Society Subspecialty Mentoring Session

12:00 p.m.–2:00 p.m.

JW Georgia I

Neurohealth & Integrative Neurology Section Meeting

12:00 p.m.–3:00 p.m.

LACC Petree Hall D

Stroke & Vascular Neurology Section Meeting

1:30 p.m.–2:30 p.m.

LACC Petree Hall C

Behavioral Neurology Section Meeting

3:30 p.m.–4:30 p.m.

LACC Petree Hall D

Neuro-infectious Disease Section Meeting

3:30 p.m.–4:30 p.m.

LACC Petree Hall C

Child Neurology Section Meeting

5:30 p.m.–6:30 p.m.

LACC Petree Hall D

Sleep Research Society Subspecialty Mentoring Session

6:00 p.m.–8:00 p.m.

JW Georgia II

Parkinson Study Group Subspecialty Mentoring Session

6:00 p.m.–7:30 p.m.

JW Georgia I

Neuro-oncology Section Meeting

7:00 p.m.–8:00 p.m.

LACC Petree Hall C

ICW MEETINGS AND ALUMNI REUNIONS Thursday, April 26 External Meetings Wave Life Sciences Advisory Board Meeting

4:00 p.m.–10:00 p.m.

WEST Santa Anita A

AAN Meetings Advanced Practice Provider Bring-Your-Own-Lunch Networking Event

11:30 a.m.–12:30 p.m.

82 2018 AAN Annual Meeting On-site Guide

LACC 512

Visit Booth 1322 to Hear Experts Discuss RadicavaÂ® Speaker Presentations PRESENTER

PRESENTATION

DATE

TIMES

Dr. Beydoun

Sunday, April 22

12:30-12:50 pm

Dr. Beydoun

Sunday, April 22

1:00-1:20 pm

Dr. Hayat

Monday, April 23

12:30-12:50 pm

Dr. Hayat

Monday, April 23

1:00-1:20 pm

Dr. Beydoun

Monday, April 23

2:30-2:50 pm

Dr. Beydoun

Monday, April 23

3:00-3:20 pm

See the following page for speaker information and an Industry Therapeutic Update from Mitsubishi Tanabe Pharma America, Inc.

Industry Therapeutic Update from Mitsubishi Tanabe Pharma America, Inc.

Dinner and Presentation WHEN:

PRESENTED BY:

Monday, April 23, 2018 Dinner: 7–7:30 PM Presentation: 7:30–9:00 PM

Said R. Beydoun, MD, FAAN Professor of Clinical Neurology Program Director, Clinical Neurophysiology Fellowship Division Chief, Neuromuscular Disorders Keck Medical Center of USC University of Southern California Los Angeles, CA

WHERE: Gold Ballroom 3 JW Marriott Los Angeles L.A. LIVE 900 West Olympic Blvd Los Angeles, CA

Ghazala Hayat, MD, FAAN Director of Neuromuscular & Clinical Neurophysiology Services Department of Neurology St. Louis University St. Louis, MO

Please also join us at Booth 1322 for more information about Radicava®. This Industry Therapeutic Update could mention information related to product(s) not approved in your country. For this reason, we advise you that the contents are not intended for some countries. This event is not an AAN-endorsed event or part of the 2018 AAN Annual Meeting program.

Radicava, the Radicava logo, and the corporate symbol of Mitsubishi Tanabe Pharma America are registered trademarks of Mitsubishi Tanabe Pharma Corporation. For US audiences only. © 2018 Mitsubishi Tanabe Pharma America, Inc. All rights reserved. CP-RC-US-0480 04/18

ollowing is the schedule of Emerging Science abstracts to be presented at the 2018 AAN Annual Meeting. Abstracts qualify for Emerging Science presentations by having key aspects of research conducted after the October 23 abstract submission deadline and must be new and of sufficient scientific importance to warrant expedited presentation and publication. A total of 24 abstracts will be presented as part of the Emerging Science program. Nine dual presentation abstracts will be featured in data blitz format during the first 30 minutes of the Emerging Science Platform session on Tuesday, April 24, from 5:45 p.m. to 6:15 p.m., followed by poster presentations in the same room from 6:15 p.m. to 7:00 p.m. In addition, 13 poster presentations will be included in Poster Session IV on Wednesday, April 25, from 11:30 a.m. to 7:00 p.m. And finally, two abstracts will be presented during the Clinical Trials Plenary Session on Tuesday, April 24, from 9:15 a.m. to 11:30 a.m.

EMERGING SCIENCE

The 2018 Emerging Science abstracts are embargoed until 12:01 a.m. Eastern Standard Time on Friday, April 20.

EMERGING SCIENCE EMERGING SCIENCE PLATFORM SESSION

Tuesday, April 24, 2018, 5:45 p.m. – 7:00 p.m.

001

INTREPID: A Prospective, Double Blinded, Multicenter Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple Source, Constant Current Rechargable System in Parkinson's Disease Jerrold L. Vitek, MD, PhD Minneapolis, MN

002 ABX-1431, A First-in-Class Endocannabinoid Modulator, Improves Tics in Adult Patients with Tourette Syndrome Kirsten Mueller-Vahl, MD Hannover, Germany

003

Longer-term Assessment of the Safety and Efficacy of Nusinersen for the Treatment of Infantileonset Spinal Muscular Atrophy (SMA): An Interim Analysis of the SHINE Study Diana Castro, MD Dallas, TX

004

RG7916 significantly increases SMN Protein in SMA Type 1 Babies Giovanni Baranello Milano, Italy

005

Effect of fingolimod in pediatric MS: further insights from sensitivity, supportive and post-hoc

analyses from PARADIGMS Kumaran Deiva, MD, PhD Le Kremlin-Bicêtre, France

006

MRI and Relapse Results for ALKS 8700 in Patients with Relapsing Remitting Multiple Sclerosis: 1-year Interim Results from the Phase 3 EVOLVE-MS-1 Study Richard Leigh-Pemberton, MD Waltham, MA

007

Ezutromid significantly reduced muscle damage whilst maintaining utrophin in patients with Duchenne muscular dystrophy (DMD) after 24-weeks of treatment Francesco Muntoni, MD London, UK

008

Efficacy, Safety, and Tolerability of Ubrogepant for the Acute Treatment of Migraine: Results from a Single Attack Phase II Study, ACHIEVE I Joel Trugman Madison, NJ

009

Efficacy and safety of erenumab in episodic migraine patients with 2–4 prior preventive treatment failures: Results from the Phase 3b LIBERTY study Uwe Reuter Berlin, Germany

EMERGING SCIENCE POSTER PRESENTATIONS

Poster Session IV, Wednesday, April 25, 2018, 11:30 a.m. – 7:00 p.m.

P4.466 AVXS-101 Gene Replacement Therapy for SMA Type 1: Pivotal Study (STR1VE) Update John W. Day, MD, PhD Palo Alto, CA

P4.467 Effect of ZX008 (Fenfluramine HCl Oral Solution) on Total Seizures in Dravet Syndrome Joseph Sullivan

86 2018 AAN Annual Meeting On-site Guide

San Francisco, CA

P4.468 Transdermal Cannabidiol (CBD) Gel for the Treatment of Focal Epilepsy in Adults John A. Messenheimer, Jr., MD Moncure, NC

P4.469

P4.470

Eptinezumab Achieved Meaningful Reductions in Migraine Activity As Early As Day 1 and Were Sustained Through Week 12: Results From PROMISE-2 (Prevention Of Migraine via Intravenous eptinezumab Safety and Efficacy-2) Phase 3 Trial in Chronic Migraine David B. Kudrow, MD Santa Monica, CA

P4.471

Eptinezumab Reduced Migraine Frequency and Triptan/Ergotamine Use Over Weeks 1-12, and Improved HIT-6 Scores at Months One and Three: Results From the Phase 3 PROMISE-2 Trial in Chronic Migraine Stephen D. Silberstein, MD, FAAN Philadelphia, PA

EMERGING SCIENCE

P4.472

Clinical Development of VX15/2503 Anti-Semaphorin 4D Antibody as a Potential Treatment for Huntington’s Disease Elizabeth Evans, PhD Rochester, NY

P4.473

A Randomized Trial of Deferiprone for Pantothenate Kinase-Associated Neurodegeneration (on behalf of the TIRCON Group) Thomas H. Klopstock, MD Munich, Germany

P4.474

Non-Invasive Peripheral Nerve Stimulation for Symptomatic Relief of Hand Tremor in Essential Tremor Rajesh Pahwa, MD, FAAN Kansas City, KS

P4.475 Natalizumab extended interval dosing (EID) is associated with a significant reduction in

progressive multifocal leukoencephalopathy (PML) risk compared with standard interval dosing (SID) in the TOUCH® Prescribing Program Lana Zhovtis Ryerson, MD New York, NY

P4.476 Withdrawn P4.477 Autologous Haematopoietic Stem Cell Transplantation in Treatment Naïve Patients with ‘Aggressive’ Multiple Sclerosis Joyutpal Das, MBBS Sheffield, UK

P4.478

B Cell Targeted Treatment in Myasthenia Gravis (BeatMG) - A Phase 2 Trial of Rituximab in Myasthenia Gravis: Topline Results Richard J. Nowak, MD New Haven, CT

EMERGING SCIENCE CLINICAL TRIALS PLENARY SESSION

Tuesday, April 24, 2018, 9:15 a.m. – 11:30 a.m.

A double-blind placebo-controlled study to evaluate the safety and efficacy of FcRnantagonist ARGX-113 (efgartigimod) in generalized myasthenia gravis James F. Howard, Jr., MD, FAAN, Chapel Hill, NC A Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab for the Preventive Treatment of Chronic Migraine: Results of the PROMISE-2 (Prevention of Migraine via Intravenous Eptinezumab Safety and Efficacy 2) Trial Richard B. Lipton, MD, FAAN, Bronx, NY

EMERGING SCIENCE PLATFORM SESSION 001

C. Park; Fenna Phibbs; Julie Pilitsis; Fracisco Ponce; Michael Pourfar; Gonzalo Revuelta; 5:45 p.m. – 5:48 p.m. Joshua Rosenow; Sepehr Sani; Lauren Schrock; Mark Sedrak; Mustafa Siddiqui; EMBARGOED FOR RELEASE UNTIL 12:01 Philip Starr; Mariel Szapiel; Michele Tagliati; AM EST ON FRIDAY, APRIL 20, 2018 Istvan Takacs; Stephen Tatter; Alexander INTREPID: A Prospective, Double Blinded, Troster; Ryan Uitti; Leonard Verhagen; Multicenter Randomized Controlled Trial Jerrold Vitek; Robert Wharen; Donald Evaluating Deep Brain Stimulation with a Whiting; Hong Yu; Cindy Zadikoff; Lilly New Multiple Source , Constant Current Rechargable System in Parkinson's Disease Chen, MD; Roshini Jain, MS Jerrold L. Vitek, MD, PhD; Cathrin Beutefisch; Andrew Duker; Jennifer Durphy; Kelly Foote; Monique Giroux; Michal Gostkowski; Robert Gross; Jonathan Jagid; Suketu Khandhar; Paul Larson; Timothy Leichliter; Luca Corneliu; Andre Machado; Adam Mamelak; Alon Mogilner; Guillermo Moguel-Cobos; Jules Nazzaro; Michael Okun; Jill Ostrem; Rajesh Pahwa; Michael 88 2018 AAN Annual Meeting On-site Guide

Objective: INTREPID is designed to assess the improvement in motor function and quality of life in patients with Parkinson's disease (PD) following Deep Brain Stimulation (DBS) using a new device with multiple independent current sources that allowed for activation of individual contacts on the DBS lead thereby permitting a defined distribution of applied current. Background: DBS is an

effective treatment for the motor signs and fluctuations associated with PD. Although DBS efficacy has been substantiated by several randomized controlled trials (RCT), the degree of improvement varies significantly. The INTREPID Study assessed improvement in motor function and quality of life in PD patients following bilateral subthalamic nucleus (STN) DBS using a new device with multiple independent current sources. Design/Methods: INTREPID is a multicenter, prospective, double blinded RCT sponsored by Boston Scientific. Subjects were implanted bilaterally in the STN with a multiple source constant current DBS System (Vercise System). Blinded subjects were randomized to either receive active versus control settings for a 12-week period. All assessments were completed by a blinded assessor. Following the blinded period, subjects received their best therapeutic settings. Improvement in motor function and quality of life was evaluated using a PD diary, UPDRS, PDQ-39, and a battery of neuropsychological assessments. Adverse events were recorded. Results: The study successfully met the primary endpoint (p < 0.001) with a mean difference of 3.03 Âą 4.2 hours from baseline to 12 weeks between the active and the control group in ON time (PD Diary), with no increase in antiparkinsonian medications. The study also met several of the secondary endpoints. The incidence of infection was 2.7% and peri-operative intracranial hemorrhage was 1%. Conclusions: The results of the INTREPID Study demonstrate that the use of a multiple source, constantcurrent DBS system is safe and effective in the treatment of Parkinson's disease symptoms. Study Supported By: Boston Scientific

002 5:48 p.m. â&#x20AC;&#x201C; 5:51 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM EST ON FRIDAY, APRIL 20, 2018

ABX-1431, A First-in-Class Endocannabinoid Modulator, Improves Tics in Adult Patients with Tourette Syndrome Kirsten Mueller-Vahl, MD; Ewgebi Jakubovxki, MD, PhD; Fremer Carolin, MD; Katja Kunert, MD; Chan Beals, MD, PhD; Danielle Bocchino; Evan Friedman; Forrest Hull; Alan Ezekowitz, MD, PhD; Marcus May, PhD; Christoph Schindler, PhD Objective: An inhibitor of the major clearance pathway of the primary endocannabinoid in the human brain (2-arachidonoylglycerol (2-AG)) was used to study the effects of elevating endocannabinoid tone in TS. Background: TS is a neurodevelopmental condition characterized by motor and vocal tics with onset in childhood. ABX-1431 is a first-in-class, oral, highly selective inhibitor of the enzyme monoacylglycerol lipase (MGLL) that raises nervous system concentrations of the endocannabinoid 2-AG, which acts as an agonist on presynaptic central cannabinoid (CB1) receptors. Since 2-AG exerts feedback inhibition on neurotransmitter release, and MGLL in abundant in the basal ganglia, ABX-1431 may improve tics and comorbidities in TS. Design/Methods: 20 adult patients (16 men, 4 women, age 18-54) with moderate-severe TS were treated in a single-dose crossover study with 40 mg ABX-1431 or placebo. Endpoints were tic severity according to the Yale Global Tic Severity Scale Total Tic Score (YGTSS-TTS), the Modified Rush Video89

EMERGING SCIENCE Based Tic Rating Scale (MRVS), and the self-assessment Adult Tic Questionnaire (ATQ), and premonitory urges according to the Premonitory Urge for Tics Scale (PUTS). Results: Patients displayed a placeboadjusted ABX-1431-related tic improvement in the YGTSS-TTS at 8 hours (p=0.0384), with improvement in motor tics at 4 hours (p=0.0016) and 8 hours (p=0.0049), and a reduction in self-reported tic intensity (ATQ) at 4 hours (p=0.0005) and 8 hours (p=0.0008). A placebo-adjusted ABX1431-related improvement in premonitory urges was observed at 4 hours (PUTS, p=0.0369), while no significant difference was observed with the MRVS. The most common adverse events were headache, somnolence, and fatigue, which resolved. Conclusions: Our data suggest that modulation of the endocannabinoid system by selective inhibition of MGLL improves tics in TS. ABX-1431 may provide a unique treatment profile for TS, and holds promise as a novel mechanism to treat movement disorders and neuropsychiatric conditions.

from the SHINE study (NCT02594124) for patients with infantile-onset SMA (most likely to develop Type I) who transitioned from ENDEAR. Background: Nusinersen is an antisense oligonucleotide approved for the treatment of SMA. It has demonstrated a favorable benefit:risk profile and shown significant and clinically meaningful efficacy on motor function across a broad spectrum of SMA populations, and time to death or permanent ventilation (EFS) in infantile-onset SMA. Design/Methods: SHINE is an open-label extension study for infants/children who participated in the ENDEAR, CHERISH, CS12 or CS3A nusinersen trials. Nusinersen doses were administered according to the regimen and participant’s cohort from the previous trial. Primary endpoint is safety/tolerability; secondary endpoints include achievement of HINE Section 2 motor milestones, and EFS. Results: The cutoff date was June 30, 2017; 89 patients transitioned from ENDEAR, 65/81 previously randomized to nusinersen and 24/41 to sham-control. Within SHINE only, 83 patients had an adverse event (AE). There were no treatment-related 003 serious AEs. The most frequent AEs 5:51 p.m. – 5:54 p.m. were pyrexia and upper respiratory tract infection. Mean (95% CI) change in HINE-2 EMBARGOED FOR RELEASE UNTIL 12:01 total score from nusinersen initiation to AM EST ON FRIDAY, APRIL 20, 2018 Longer-term Assessment of the Safety and last observed visit was 1.1 (0.20–1.90) for patients who received sham-control Efficacy of Nusinersen for the Treatment of Infantile-onset Spinal Muscular Atrophy in ENDEAR and nusinersen in SHINE (n=20/24) and 5.8 (4.58–7.04) for those (SMA): An Interim Analysis of the SHINE who received nusinersen in ENDEAR and Study SHINE (n=74/81; pooled ENDEAR/SHINE data). Median (95% CI) EFS time among Diana Castro, MD; Michelle A. Farrar; patients treated with sham-control in Richard Finkel, MD; Mar Tulinius; Kristin Krosschell; Kayoko Saito; Yiwei Zhang; Ishir ENDEAR was 22.6 (13.6–31.3) weeks versus 73.0 (36.3–NA) weeks among those who Bhan; Wildon Farwell; Sandra P. Reyna received nusinersen in ENDEAR and SHINE. Conclusions: Improvements in motor Objective: To present interim results function and EFS continued among patients 90 2018 AAN Annual Meeting On-site Guide

who initiated nusinersen in ENDEAR and motor function improved among those who initiated nusinersen in SHINE. Further analysis of SHINE data will provide additional information on the long-term safety/tolerability and efficacy of repeated nusinersen doses across multiple SMA populations.

EMERGING SCIENCE

alternative splicing of a related SMN2 gene. The published median time to death or permanent ventilation in Type 1 patients with two SMN2 gene copies is 10.5 months of age (Finkel, Neurology 2014). RG7916 is an orally administered, centrally and peripherally distributed small molecule that modulates SMN2 pre-mRNA splicing to increase SMN protein. Design/Methods: Study Supported By: Biogen The exploratory Part 1 (n=8–24) of the FIREFISH study assesses safety, tolerability, pharmacokinetics and pharmacodynamics 004 of RG7916 at different dose levels. The 5:54 p.m. – 5:57 p.m. confirmatory Part 2 (n=40) will assess safety and efficacy of RG7916. Results: A EMBARGOED FOR RELEASE UNTIL 12:01 dose-dependent increase in SMN protein AM EST ON FRIDAY, APRIL 20, 2018 levels in blood was observed, with an up RG7916 significantly increases SMN Protein to 6.5 -fold increase versus baseline after in SMA Type 1 Babies 4 weeks of treatment at the highest dose of RG7916 (range 2.0 – 6.5). To date, no Giovanni Baranello; Heidemarie Kletzl; safety-related stopping rules have been Yumi Cleary; Gillian Armstrong; John Day, met, and while follow up was limited, no MD, PhD; Andrea Klein; Eugenio Mercuri; patient lost the ability to swallow, required Laurent Servais; Nicholas Deconinck; tracheostomy, or reached permanent Riccardo Masson; Tim Seabrook; Christian ventilation. Updated survival data will be Czech; Marianne Gerber; Fung Lee; Kristina presented. Conclusions: The up to 6.5Gelblin; Stephane Nave; Ksenija Gorni; fold increase in SMN protein observed in Omar Khwaja, MD FIREFISH Part 1 compares favorably with the approximately 2-fold difference in SMN Objective: Interim SMN protein data protein levels between SMA severity types from FIREFISH Part 1 are presented for (e.g., Type 2 vs. Type 1). All doses explored the first time. FIREFISH (NCT02913482) so far have been well tolerated. FIREFISH is is a multi-center, open-label, seamless currently recruiting globally. study of RG7916 (RO7034067) in babies aged 1–7 months with Type 1 spinal Study Supported By: F. Hoffmann-La Roche muscular atrophy (SMA) and two SMN2 gene copies. Background: SMA is a 005 severe, progressive, inherited disease that leads to loss of motor function and 5:57 p.m. – 6:00 p.m. is the leading genetic cause of mortality EMBARGOED FOR RELEASE UNTIL 12:01 in infants and toddlers. SMA is caused AM EST ON FRIDAY, APRIL 20, 2018 by reduced levels of SMN protein due to deletions or mutations of the survival Effect of fingolimod in pediatric MS: further of motor neuron 1 (SMN1) gene and insights from sensitivity, supportive and 91

EMERGING SCIENCE post-hoc analyses from PARADIGMS.

population. The Kaplan–Meier estimate of the percentage of patients without Kumaran Deiva, MD, PhD; Peter Huppke; 3M-CDP up to 2 years was higher in the Brenda Banwell, MD, FAAN; Tanuja Chitnis, fingolimod group (95.2%) compared with MD, FAAN; Jutta Gaertner, MD; Lauren the IFN β-1a group (84.7%) (p=0.015), with Krupp, MD, FAAN; Emmanuelle Waubant, a risk reduction in 3M-CDP of 77.2% (hazard MD, FAAN; Tracy Stites, PhD; Gregory ratio=0.23, p=0.007). 3M-CDP sustained Lewis Pearce; Martin Merschhemke until the last observation yielded similar results. Expanded disability status scale Objective: To further evaluate the effect (EDSS) measurements at different time of fingolimod versus interferon (IFN) points will be presented. Conclusions: β-1a in pediatric multiple sclerosis (MS), Fingolimod in pediatric MS was associated excluding IFN antibody-positive patients, in with consistent control of disease activity treatment-naïve patients, and on disability across sensitivity/supportive analyses, and progression up to 2 years. Background: benefits on disability progression were In PARADIGMS, a double-blind phase III observed over the treatment duration of up trial of 215 pediatric MS patients (age to 2 years. 10–<18 years), fingolimod administered up to 2 years significantly reduced both Study Supported By: Novartis the annualized relapse rate (ARR) (primary endpoint) and the rate of new/newly enlarged T2 (n/neT2) lesions (key secondary 006 endpoint) compared to IFN β-1a. Design/ 6:00 p.m. – 6:03 p.m. Methods: Predefined analyses of the endpoints were performed after excluding EMBARGOED FOR RELEASE UNTIL 12:01 AM EST ON FRIDAY, APRIL 20, 2018 patients in the IFN β-1a arm who were IFN neutralizing antibody (Nabs)-positive MRI and Relapse Results for ALKS 8700 in at study end (sensitivity analysis) and in Patients with Relapsing Remitting Multiple disease-modifying therapy (DMT)-naïve Sclerosis: 1-year Interim Results from the patients (supportive analysis). A post-hoc Phase 3 EVOLVE-MS-1 Study evaluation of 3-month confirmed disability progression (3M-CDP) was also conducted. Richard Leigh-Pemberton, MD; Robert Results: Excluding Nabs-positive IFN β-1a Naismith; Boris Kandinov; David Rezendes; patients (n=9) did not have any tangible Narinder Nangia; Maria Lopez-Bresnahan, impact on the primary and key secondary MD, PhD; Douglas Arnold, MD; Jerry results (81.5% ARR reduction and 47.6% Wolinsky, MD, FAAN reduction in n/neT2 lesions, both p<0.001, Objective: To report 1-year MRI and versus 81.9% and 52.6% in the overall relapse results for patients with relapsingpopulation, respectively). At baseline, remitting multiple sclerosis (RRMS) treated 63.3% of patients were treatment naïve. with ALKS 8700 (also known as BIIB098) The effect of fingolimod treatment in in EVOLVE-MS-1. Background: ALKS the DMT-naïve subpopulation (85.8% 8700 is a prodrug of monomethyl fumarate ARR reduction and 53.4% n/neT2 lesion (MMF), the active metabolite of dimethyl reduction versus IFN β-1a, both p<0.001) was also consistent with the overall patient fumarate (DMF). DMF is approved for 92 2018 AAN Annual Meeting On-site Guide

Study Supported By: Alkermes, Inc. Development program for ALKS 8700 now

supported under a collaboration agreement with Biogen

007 6:03 p.m. â&#x20AC;&#x201C; 6:06 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM EST ON FRIDAY, APRIL 20, 2018

Ezutromid significantly reduced muscle damage whilst maintaining utrophin in patients with Duchenne muscular dystrophy (DMD) after 24-weeks of treatment

EMERGING SCIENCE

relapsing forms of multiple sclerosis (RMS). ALKS 8700 is being developed as an oral disease-modifying therapy for RMS and is designed to treat MS with the same active metabolite as DMF but with potentially improved gastrointestinal tolerability. Two Phase 3 studies are currently evaluating ALKS 8700 in patients with RRMS: EVOLVEMS-1, a long-term safety and tolerability study of ALKS 8700, and EVOLVE-MS-2, a 5-week, head-to-head study comparing the gastrointestinal tolerability of ALKS 8700 and DMF. Design/Methods: EVOLVE-MS-1 is a multi-center, prospective, open-label, single-arm Phase 3 study to assess longterm safety, tolerability, and treatment effect of ALKS 8700 462 mg twice daily in approximately 900 patients with RRMS. Inclusion criteria: age 18-65 years with RRMS (McDonald criteria 2010) and EDSS 6.0. We present an exploratory interim report from November 2017 of annualized relapse rate (ARR) and MRI parameters. Results: ARR was 0.16 for the 570 patients (493.6 patient-years) evaluated during this interim analysis. Interim MRI results included 152 patients who completed MRI assessments at 1 year. Mean numbers (SD) of new/enlarging T2 lesions, gadoliniumenhancing (Gd+) lesions, and new T1hypointense lesions were 2.8 (5.9), 0.3 (1.1), and 1.8 (4.2), respectively. With ALKS 8700 treatment there was a significant reduction (p<0.0001) in the number of Gd+ lesions from baseline (mean 1.2 [SD 4.1]) to 1 year (0.3 [1.1]). Conclusions: ALKS 8700 is a novel, oral, prodrug of MMF in Phase 3 development for the treatment of RRMS. These preliminary findings suggest ALKS 8700 may be an effective oral treatment option for patients with RRMS.

Francesco Muntoni, MD; Gary Layton, MSc; Indranil Bhattacharya, PhD; Crystal Faelan, PhD; Anne C. Heatherington, PhD; David Roblin, MD, FRCp, FFPM, FMedSci; Jon Tinsley, PhD; Kay Davies, CBE, FRS, FMedSci Objective: To share results from interim analysis for ezutromid, a first-in-class utrophin modulator which has the potential to treat all patients with DMD Background: Utrophin is a naturally occurring protein that may act as a functional replacement for dystrophin. It is hypothesized that continuous expression in mature muscle fibers could modify the course of DMD (Tinsley et al, 1998). Design/Methods: PhaseOut DMD is a Phase 2 open-label study of ezutromid administered to 40 ambulatory patients with DMD. Primary endpoints (48 week) are MRS assessments. Key secondary endpoints are from muscle biopsy; to be collected at baseline (n=40) and week 24 (n=25) or 48 (n=15). Safety, pharmacokinetics and functional measures are monitored throughout. The interim analysis was planned to assess impact on muscle health, primarily by biopsy; mixed effect models were used to estimate, with 93

EMERGING SCIENCE 95% confidence intervals, the changes from baseline (least square means difference [LSMD]). Results: A statistically significant reduction in %fibres expressing developmental myosin (MHCd) was observed (from 11.37% to 8.76%, LSMD -2.62% CI, -4.33, -0.90); a relative reduction of 23%. Mean utrophin intensity was maintained and even increased (relative +7%) (0.370 to 0.396, LSMD 0.026 95% CI, -0.005, 0.058). MRS indicated an increase in mean fat fraction (vastus lateralis: from 14.7% to 18.5% n=37) but a decrease in relaxation time (T2) (soleus: from 31.85 to 30.99 msec, n=38). No patient lost ambulation and there were no meaningful decreases in functional performance (eg 6MWD: baseline 404m, 24 weeks: 395m, n=39). All patients achieved plasma levels sufficient to modulate utrophin. Ezutromid continues to be safe and well tolerated. Conclusions: Decreased MHCd, a marker of regeneration, indicates reduction in muscle damage. Utrophin levels were maintained and even increased which, with decreasing MHCd, provides evidence of target engagement. These results support the utrophin hypothesis and the potential for universal treatment for DMD. With PhaseOut DMD StudyGroup

008 6:06 p.m. â&#x20AC;&#x201C; 6:09 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM EST ON FRIDAY, APRIL 20, 2018

Efficacy, Safety, and Tolerability of Ubrogepant for the Acute Treatment of Migraine: Results from a Single Attack Phase II Study, ACHIEVE I Joel Trugman; Michell Finnegan; Richard Lipton, MD, FAAN; David Dodick, MD, 94 2018 AAN Annual Meeting On-site Guide

FAAN; Kaifeng Lu; Hassan Lakkis; Armin Szegedi Objective: To evaluate the efficacy, safety, and tolerability of ubrogepant (50mg, 100mg) versus placebo for the acute treatment of a single migraine attack. Background: Calcitonin gene-related peptide (CGRP) and its receptors are expressed in regions of the nervous system associated with migraine pathophysiology. Ubrogepant is a novel, oral CGRP receptor antagonist in development for the acute treatment of migraine. Design/Methods: Multicenter, randomized, double-blind, placebo-controlled, parallel-group, singleattack, Phase III study (NCT02828020; ACHIEVE I). Adult patients with a history of migraine (with/without aura) were randomized (1:1:1) to placebo, ubrogepant 50mg, or ubrogepant 100mg. Patients had up to 60 days to treat a single migraine attack of moderate/severe headache pain intensity. Co-primary efficacy endpoints were pain freedom 2 hours after initial dose and absence of the most bothersome migraine-associated symptom (MBS), identified at the time of the treated attack, 2 hours after initial dose. Safety and tolerability were evaluated. Results: 1672 patients were randomized, 1436 were in the safety population, and 1327 were included in the mITT efficacy analysis. Mean age was 40.7 years; majority Caucasian (82.4%) and female (87.5%). The MBS identified at the time of treatment were photophobia (56.4%), phonophobia (22.3%) and nausea (20.9%). At 2-hours post-initial dose, the percentage of ubrogepant-treated patients achieving pain freedom was significantly greater than those treated with placebo (50mg: 19.2%, p=0.0023; 100mg: 21.2%, p=0.0003, placebo: 11.8%). Similarly, the percentage of ubrogepant-treated

of efficacy and/or poor tolerability. It is therefore important to assess the safety and efficacy of erenumab in patients who have failed multiple therapies. Design/ Methods: LIBERTY (NCT03096834) was a 12-week, double-blind, randomized study. Patients (N=246) were randomized (1:1) to receive erenumab 140mg and placebo. The primary endpoint was the proportion of patients achieving ≥50% reduction in mean monthly migraine days (MMDs) during Weeks 9-12 (Month 3). Secondary endpoints included change from baseline to Month 3 in MMDs and monthly acute migrainespecific medication days (MSMDs) and Study Supported By: Allergan plc safety/tolerability. Results: At baseline, proportion of patients who failed 2, 3, and 4 prior PMTs were 38.6%, 37.8%, and 009 22.8%, respectively. The mean (SD) MMDs 6:09 p.m. – 6:12 p.m. and MSMDs were 9.3 (2.64) and 4.6 (2.89), respectively. At week 12, the proportion of EMBARGOED FOR RELEASE UNTIL 12:01 patients achieving ≥50% reduction in MMD AM EST ON FRIDAY, APRIL 20, 2018 was higher in those treated with erenumab Efficacy and safety of erenumab in episodic 140mg vs placebo (30.3% vs 13.7%; OR migraine patients with 2–4 prior preventive [95% CI]: 2.73 [1.43, 5.19]; p=0.002). At treatment failures: Results from the Phase week 12, there were greater reductions in 3b LIBERTY study MMDs and MSMDs with erenumab 140mg vs placebo (mean difference [95% CI] in Uwe Reuter; Peter Goadsby, MD, PhD; MMD: −1.61 [−2.70, −0.52]; p=0.004; mean Michel Lanteri-Minet, MD, Michel Ferrari, difference (95% CI) in MSMD: −1.73 [−2.46, MD, PhD; Shihua Wen; Jan Klatt −1.01]; p<0.001). Safety and tolerability profile of erenumab was comparable to Objective: To assess the efficacy and placebo. No patients in the erenumab safety of erenumab in patients with group discontinued due to adverse events. episodic migraine who have failed 2–4 Conclusions: These results confirm the prior preventive migraine treatments efficacy and safety of erenumab in this (PMTs). Background: Erenumab is a fully first dedicated study of a difficult to treat human monoclonal antibody that inhibits population with 2–4 prior preventive the canonical CGRP receptor. Clinical migraine treatment failures. studies have demonstrated the efficacy and safety of erenumab in patients with Study Supported By: Novartis Pharma AG, episodic and chronic migraine. Current Basel, Switzerland oral preventive therapies are associated with low adherence rates due to the lack

EMERGING SCIENCE

patients achieving absence of MBS was significantly greater than placebo (50mg: 38.6%, p=0.0023, 100mg: 37.7%, p=0.0023, placebo: 27.8%). The adverse event (AE) profile of ubrogepant was similar to placebo. The most common AEs within 48 hours of dosing were nausea, somnolence, and dry mouth, all with an incidence <5%. Conclusions: In the ACHIEVE I study, both co-primary efficacy endpoints were met with clinically meaningful effects on migraine headache pain and MBS. Ubrogepant was well-tolerated with no identified safety concerns.

EMERGING SCIENCE

EMERGING SCIENCE POSTER PRESENTATIONS P4.466 Poster Session IV, 11:30 a.m. – 7:00 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM EST ON FRIDAY, APRIL 20, 2018

AVXS-101 Gene Replacement Therapy for SMA Type 1: Pivotal Study (STR1VE) Update John W. Day, MD, PhD; Douglas Feltner, MD; Francis Ogrinc, PhD; Thomas Macek, PhD; Courtney Wells; Lynlee Muehring; James L’Italien, PhD; Jessica Cardenas, PhD; Douglas Sproule, MD; Sukumar Nagendran; Brian Kaspar, PhD; Jerry Mendell, MD, FAAN

serum aminotransferase soon after dosing that were attenuated by prednisolone. Design/Methods: STR1VE is a phase 3, multi-center (16 sites), open-label, singlearm, one-time-dose study in SMA1 patients SMN1 mutations, and 1–2 SMN2 copies). For the first 3 patients, a 4-week dosing interval allows review of safety data and of early signs of efficacy prior to dosing the next patient. The primary outcomes are achievement of independent sitting for 30 seconds at 18 months of age, and survival (avoidance of death or permanent ventilation) at 14 months of age. Results: As of Jan 30, 2018, 3 SMA1 patients with 2 SMN2 copies have been enrolled. Age at enrollment and symptom onset was 2.7 months (1.8– 4.3 months) and 1.0 months (0.5–2.0 months), respectively. The mean baseline CHOP-INTEND score was 24.3 (18–34). No patients required ventilatory or nutritional support. Conclusions: The AVXS-101 phase 3 pivotal study investigates the efficacy and safety of a one-time intravenous infusion of AVXS-101 SMNgene replacement in SMA1 patients. Updated patient data with follow-up will be presented.

Objective: STR1VE is a pivotal phase 3 study (NCT03306277) investigating efficacy and safety of a one-time intravenous infusion of AVXS-101, a potential SMN gene replacement therapy, in a minimum of 15 patients with Spinal Muscular Atrophy Type 1 (SMA1). We report the phase 3 clinical study design and baseline demographics. Background: SMA1 is a neurodegenerative disease leading to respiratory failure and early death. Patients fail to achieve motor milestones, and motor function declines, as measured by CHOPStudy Supported By: AveXis, Inc. INTEND. Phase 1 (NCT02122952) data demonstrated that AVXS-101 improved survival and motor function in SMA1 patients. CHOP-INTEND scores increased at 1 and 3 months compared with a decline in a historical cohort. Four patients experienced asymptomatic elevations in 96 2018 AAN Annual Meeting On-site Guide

to 53.9 in the three groups. During the 14-week treatment period, median percent changes in TS frequency were 13.1% in Poster Session IV, 11:30 a.m. – 7:00 p.m. placebo, -34.3% in ZX008 0.2 mg/kg/day EMBARGOED FOR RELEASE UNTIL 12:01 (p=0.031), and -70.1% in ZX008 0.8 mg/kg/ AM EST ON FRIDAY, APRIL 20, 2018 day (p<0.001). In addition to the effect of ZX008 0.8 mg/kg/day on CS, improvements Effect of ZX008 (Fenfluramine HCl Oral in myoclonic and absence seizures were Solution) on Total Seizures in Dravet also observed. ZX008 was generally well Syndrome Joseph Sullivan; Lieven Lagae; Kelly Knupp, tolerated. Conclusions: ZX008 may MD; Bradley Galer; Glenn Morrison; Arnold represent an important and effective new treatment option for patients with DS, with Gammaitoni; Gail Farfel improvement in several seizure types. Objective: To assess the effect of Study Supported By: Zogenix, Inc. ZX008 (fenfluramine) on total seizure (TS) frequency in patients with Dravet syndrome (DS). Background: DS is a P4.468 rare, severe, treatment-resistant epileptic encephalopathy. In a Phase 3, randomized, Poster Session IV, 11:30 a.m. – 7:00 p.m. double-blind, placebo-controlled trial, EMBARGOED FOR RELEASE UNTIL 12:01 ZX008 significantly reduced monthly AM EST ON FRIDAY, APRIL 20, 2018 convulsive seizure (CS) frequency (defined Transdermal Cannabidiol (CBD) Gel for the as tonic-clonic, tonic, atonic, clonic, and Treatment of Focal Epilepsy in Adults focal motor seizures). Here we present secondary analyses of the effect of ZX008 John A. Messenheimer, Jr., MD; Terence on TS frequency. Design/Methods: O’Brien, MD; Samuel Berkovic, MD, FRACP; Patients (2-18 years old) with a diagnosis Jacqueline French, MD, FAAN; Marcel of DS in whom CSs were not completely Bonn-Miller, PhD; Donna Gutterman, controlled by their current anti-epileptic PharmD drug regimen were enrolled. Following a 6-week baseline period, patients were Objective: Evaluate the safety and efficacy randomized 1:1:1 to placebo, ZX008 0.2 of ZYN002 (transdermal cannabidiol mg/kg/day, or ZX008 0.8 mg/kg/day [CBD] gel) as adjunctive therapy for (maximum dose 30 mg/day) and treated the treatment of adult focal seizures. for 14 weeks, including an initial 2-week Background: CBD can reduce seizures titration period. The number and type in pediatric patients, but data in adults of seizures were recorded daily in an are limited. Design/Methods: STAR 1 electronic diary by caregivers. Results: A was a phase 2A, randomized, doubletotal of 119 patients with DS enrolled in the blind, placebo-controlled study of ZYN002 study and were randomized to treatment administered BID for 12 weeks to adults (n=40, 0.8 mg/kg/day; n=39, 0.2 mg/kg/ with focal seizures. Patients were initially day; n=40, placebo). Mean subject age was randomized 1:1:1 to 195 mg or 390 mg CBD 9±4.7 years. During baseline, the median daily, or placebo. STAR 2 is the open-label monthly TS frequency ranged from 40.7

P4.467

EMERGING SCIENCE

EMERGING SCIENCE extension study for completers of STAR 1. In STAR 2, all patients started on 390 mg CBD daily. Results: 188 patients were initially randomized into STAR 1. After 12 weeks, the median reduction in focal seizures was 18.4% (195 mg CBD/day; n=63), 14.0% (390 mg CBD/day; n=62), and 8.7% (placebo; n=63). There were no statistically significant differences in efficacy between ZYN002 and placebo. 174 patients completed STAR 1 and 171 patients rolled into STAR 2. Seizure control was evaluated as a function of duration on ZYN002, regardless of initial randomization group or dose. Longer exposure to ZYN002 resulted in greater improvements in seizure frequency, with median percent change in seizures from -16.3% at 3 months (n=170), to -27.3% at 6 months (n=148), -50.2% at 9 months (n=98), and -58.0% at 12 months (n=70). ZYN002 was well tolerated, with excellent skin tolerability. The most common adverse events were upper respiratory tract infection (viral and bacterial; 16%), headache (11%), fatigue (7%), and laceration (5%). Conclusions: While change in seizure frequency was not significantly different between active and placebo during STAR 1, continued treatment with ZYN002 in STAR 2 appeared to result in improvements in seizure control, with clinically meaningful reductions observed by 6 months of treatment and maintained through 12 months. ZYN002 (administered BID) was well tolerated, with excellent patient compliance and acceptance. Study Supported By: Zynerba Pharmaceuticals, Inc.

P4.469 Poster Session IV, 11:30 a.m. â&#x20AC;&#x201C; 7:00 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM EST ON FRIDAY, APRIL 20, 2018

98 2018 AAN Annual Meeting On-site Guide

ZX008 (Fenfluramine HCL Oral Solution) in Dravet Syndrome: Effect on Convulsive Seizure Frequency in Subjects Who Failed Treatment with Stiripentol Prior to Study 1 Elaine Wirrell, MD, FAAN; Rima Nabbout; Linda Laux, MD; Joseph Sullivan; An-Sofie Schoonjans; Gail Farfel; Bradley Galer; Glenn Morrison; Arun Mistry; Arnold Gammaitoni Objective: To assess the effect of ZX008 on frequency of convulsive seizures (FCS) in a subset of Dravet syndrome (DS) subjects in a Phase 3 clinical trial (Study 1) who had previously been treated with stiripentol. For this analysis, subjects who had discontinued stiripentol prior to study entry were defined as failures. Background: Stiripentol is approved in Europe, Australia, Canada, and Japan (and available for compassionate use in the USA) for adjunctive treatment of patients with DS. Here we present a subgroup analysis of the effect of ZX008 on FCS in subjects who discontinued stiripentol prior to entry in Study 1 (N=119). Design/ Methods: Following a 6-week baseline period, subjects were randomized 1:1:1 to placebo (n=16), ZX008 0.2 mg/kg/day (n=20), or ZX008 0.8 mg/kg/day, maximum dose 30 mg/day (n=22) and treated for 14 weeks, including an initial 2-week titration period. Number and type of seizures were recorded daily in an electronic diary. Results: A total of 58 subjects met the criteria for this analysis with a mean age 9.7 years (range, 2-18). ZX008 0.8 mg/kg/day showed a 60.8% reduction in mean monthly FCS vs placebo (p=0.002). Seventy-three percent of subjects in the ZX008 0.8 mg/ kg/day group achieved>50% reduction in FCS (p=0.006) and 50% achieved >75% reduction in FCS (p=0.036). Longest median seizure-free intervals were 24.5 days (0.8 mg/kg/day, p=0.003), 18 days (0.2 mg/

Study Supported By: Zogenix

P4.470 Poster Session IV, 11:30 a.m. â&#x20AC;&#x201C; 7:00 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM EST ON FRIDAY, APRIL 20, 2018

with 100% bioavailability following iv administration, selectively and potently inhibits CGRP. Design/Methods: Adults with CM (ICDH-3 beta) were randomized (1:1:1) to eptinezumab 100 mg, 300 mg, or placebo. Infusions were administered on Day 0 and at Week 12. The primary endpoint was change from baseline in frequency of monthly migraine days (MMD) over Weeks 1-12. A key secondary endpoint was percentage of subjects with a migraine on Day 1 postinfusion. Another secondary endpoint was reduction from baseline in MMD over each month. Results: Efficacy analysis included 1072 subjects. Mean baseline MMD in 100-mg, 300-mg, and placebo groups were 16.1, 16.1, and 16.2, respectively. Mean reductions from baseline in MMD over Weeks 1-12 were -7.7 (p<0.0001) and -8.2 (p<0.0001) vs -5.6, respectively. Similar mean reductions from baseline in MMD were observed over monthly intervals: Weeks 1-4, -7.6 and -8.3 vs -5.3; Weeks 5-8, -8.1 and -8.5 vs -6.1; and Weeks 9-12, -7.7 and -8.2 vs -6.0. The average percent of subjects with a migraine on any given day during the baseline period in the 100-mg, 300-mg, and placebo groups was 57.5%, 57.4%, and 58.0%, respectively. The percent of subjects with a migraine on Day 1 postinfusion was 28.6% (-50.3% [p=0.0001]) and 27.8% (-51.6% [p<0.0001]) with eptinezumab 100 and 300 mg, respectively, vs 42.3% (-27.1%) with placebo. The safety profile was consistent with previous clinical trials of eptinezumab. Conclusions: A single infusion of eptinezumab significantly reduced MMD for 3 months in subjects with CM. The percentage of subjects with a migraine on Day 1 was reduced by approximately 50% following eptinezumab infusion.

EMERGING SCIENCE

kg/day, p=0.012), and 9 days (placebo). Compared with placebo, ZX008 0.8 mg/kg/ day-treated subjects were more likely to be rated much or very much improved by parents/caregivers (41% vs 6%, p=0.012) and investigators (64% vs 6%, p< 0.001). ZX008 was generally well tolerated. Conclusions: ZX008 provided robust improvement in FCS in subjects who had previously used stiripentol, the only approved treatment for seizures in DS. ZX008 may represent an effective new treatment option for these patients with DS.

Objective: Evaluate effects of eptinezumab on migraine activity from Day 1 post intravenous (iv) infusion through Weeks 4 and 12 in subjects with chronic migraine. Background: Calcitonin gene-related peptide (CGRP) plays an important role in migraine pathophysiology. Eptinezumab, a humanized, anti-CGRP monoclonal antibody Study Supported By: Alder

EMERGING SCIENCE BioPharmaceuticals, Inc., Bothell, WA, USA subjects. Mean baseline MMD in the 100mg, 300-mg, and placebo groups were 16.1, 16.1, and 16.2, respectively. Mean P4.471 reductions from baseline in MMD over Poster Session IV, 11:30 a.m. – 7:00 p.m. Weeks 1-12 were -7.7 (p< 0.0001) and -8.2 EMBARGOED FOR RELEASE UNTIL 12:01 (p< 0.0001) for eptinezumab 100 mg and AM EST ON FRIDAY, APRIL 20, 2018 300 mg, respectively, vs -5.6 for placebo. Eptinezumab Reduced Migraine Frequency Mean triptan/ergotamine medication days/month at baseline were 6.6, 6.7, and and Triptan/Ergotamine Use Over Weeks 1-12, and Improved HIT-6 Scores at Months 6.2 in the 100-mg, 300-mg, and placebo groups, respectively. Over Weeks 1-12, One and Three: Results From the Phase 3 mean triptan/ergotamine medication days/ PROMISE-2 Trial in Chronic Migraine month were 3.3 (-3.3 [p< 0.0001*]) and 3.2 Stephen D. Silberstein, MD, FAAN; Egilius (-3.5 [p< 0.0001]) vs 4.3 (-1.9), respectively. Mean HIT-6 baseline scores in the 100-mg, Spierings, MD, PhD; Gary Berman, MD; David Biondi, DO, FAAN; Jeff Smith; Suman 300-mg, and placebo groups were 65.0, 65.1, and 64.8, respectively. Mean HIT-6 Bhattacharya; Roger Cady score improvements from baseline were Objective: Evaluate the effects of -7.0and -8.6vs -4.7 over Weeks 1-4, and eptinezumab on migraine frequency and -6.2 (p=0.0011*) and -7.4 (p< 0.0001) vs -4.5 triptan/ergotamine use over Weeks 1-12, over Weeks 9-12. Conclusions: A single and on Headache Impact Test-6 (HIT-6) infusion of eptinezumab in subjects with scores over Weeks 1-4 and Weeks 9-12, CM significantly reduced mean MMD over in subjects with chronic migraine (CM). 3 months. This benefit was associated with Background: Calcitonin gene-related overall reductions of approximately 50% peptide (CGRP) plays an important role in in triptan/ergotamine use and meaningful migraine pathophysiology. Eptinezumab a improvements in HIT-6 scores. *Unadjusted. humanized, anti-CGRP monoclonal antibody Study Supported By: Alder with 100% bioavailability following BioPharmaceuticals, Inc., Bothell, WA, USA. intravenous administration, selectively and potently inhibits CGRP. Design/ Methods: Adults with CM (ICHD-3 beta) P4.472 were randomized (1:1:1) to eptinezumab Poster Session IV, 11:30 a.m. – 7:00 p.m. 100 mg, 300 mg, or placebo. Infusion was administered on Day 0 and at Week 12. EMBARGOED FOR RELEASE UNTIL 12:01 The primary endpoint was mean change AM EST ON FRIDAY, APRIL 20, 2018 from baseline in monthly migraine days Clinical Development of VX15/2503 Anti(MMD) over Weeks 1-12. Secondary Semaphorin 4D Antibody as a Potential endpoints included change in days of triptan/ergotamine use over Weeks 1-12 Treatment for Huntington’s Disease and HIT-6 score changes from baseline. Elizabeth Evans, PhD; Terry Fisher, PhD; Subjects completed HIT-6 questionnaires Maurce Zauderer; John Leonard; Danielle at baseline and at Weeks 4 and 12. Fisher; Leslie Balch; Alan Howell; Crystal Results: Efficacy analysis included 1072 100 2018 AAN Annual Meeting On-site Guide

Mallow; Ernest Smith, PhD; Andrew Feigin, MD

EMERGING SCIENCE

Objective: Evaluation of VX15/2503, a first-in-class antibody to Semaphorin 4D (SEMA4D), in a randomized double-blind, placebo-controlled phase 2 clinical trial (SIGNAL) enrolling late prodromal and early manifest HD subjects. Background: SEMA4D signaling through its receptor triggers activation of inflammatory glial cells, inhibits migration and differentiation of oligodendrocyte precursor cells, and disrupts endothelial tight junctions that maintain the blood-brain barrier (BBB). Chronic inflammation, neuronal degeneration, and disruption of the BBB are believed to play important roles in neuroinflammatory and neurodegenerative diseases. Antibody neutralization of SEMA4D ameliorates neurodegenerative processes in several preclinical models, including HD transgenic mice. Design/ Methods: The SIGNAL trial evaluates the safety, tolerability and efficacy of VX15/2503. Endpoints include clinical features of HD and imaging, including volumetric MRI, considered an early biomarker with prognostic significance for HD, and FDG-PET measures of glucose metabolism in prospectively defined brain regions of interest (ROI). Results: The recently completed first cohort in this first study of a biologic administered to HD subjects (n=36) demonstrated that rapid recruitment is feasible. No concerning safety signals were identified following up to 12 monthly IV administrations and a three-month safety follow-up. VX15/2503 treatment trended toward stabilization of disease-related reduction in MRI volume and favored VX15 over placebo in 24/31 ROI, especially among frontal and adjacent parietal lobes. FDG-PET imaging

also favored VX15 in all ROI, with median increase in FDG uptake from baseline of 8.6% (range: 0.5-20.4%) compared to placebo control and p-value <0.1 in 19/31 ROI, including 12/14 ROI within the frontal and parietal regions. Conclusions: Data from Cohort A suggests that treatment with VX15/2503 was well tolerated and appeared to prevent loss of brain volume and restore metabolic activity. These results informed the design of a larger cohort of subjects in this continuing study, in which additional clinical features of HD, including cognition and motor assessments, will be evaluated.

P4.473 Poster Session IV, 11:30 a.m. â&#x20AC;&#x201C; 7:00 p.m. EMBARGOED FOR RELEASE UNTIL 12:01 AM EST ON FRIDAY, APRIL 20, 2018

A Randomized Trial of Deferiprone for Pantothenate Kinase-Associated Neurodegeneration (on behalf of the TIRCON Group) Thomas H. Klopstock, MD Objective: To investigate whether treatment with the iron-chelating drug deferiprone (DFP) has benefit in patients with pantothenate kinase-associated neurodegeneration (PKAN), the most common form of neurodegeneration with brain iron accumulation (NBIA). Background: PKAN is a rare genetic disorder characterized by progressive dystonia and iron accumulation in the globus pallidus. Reduction of brain iron might slow the progression of symptoms. The iron chelator DFP can cross the blood-brain barrier and remove labile iron from neuronal cells. Design/Methods: Eighty-nine PKAN 101

EMERGING SCIENCE patients were randomized in a 2:1 ratio to receive either DFP or matching placebo for 18 months. Efficacy was assessed using the Barry-Albright Dystonia (BAD) scale, the Patient Global Impression of Improvement (PGI-I), and numerous tests of functional abilities and activities of daily living. Brain iron was measured at baseline and month 18 using MRI R2*. Results: After 18 months, MRI showed a sharp drop in brain iron the DFP group while the placebo group had virtually no change, for a treatment group difference of -35.6 Hz (p < 0.0001). In patients with atypical PKAN, a slowerprogressing form of the disease, DFPtreated patients worsened by 2.19 points less than placebo patients on the total BAD score (p=0.0187). In the intention-totreat analysis of all patients, however, this group difference did not reach significance with DFP-treated patients worsening by 1.51 points less than the placebo group (p=0.0761). No significant differences were seen on other efficacy measures, but there was a pattern suggesting an effect for deferiprone on the majority of measures. With regard to safety, deferiprone was well tolerated. Conclusions: Patients with PKAN who received DFP for 18 months showed a significant decrease in brain iron and a trend suggesting slower progression of symptoms as compared to patients who received placebo.

for Symptomatic Relief of Hand Tremor in Essential Tremor Rajesh Pahwa, MD, FAAN; Monique Giroux, MD; Jill Ostrem, MD; Rohit Dhall, MD; Pinky Agarwal, MD, FAAN; Ryder Gwinn, MD; Dhira Khosla, DO; Kelly Lyons, PhD; Paula Chidester, MS; Erika Ross, PhD; Scott Delp, PhD

Objective: We evaluated the safety and efficacy of a non-invasive neuromodulation therapy for hand tremors in essential tremor (ET) using a custom stimulation pattern tuned to interrupt each patientâ&#x20AC;&#x2122;s tremulous signal in both acute and at-home settings. Background: Although the precise mechanisms of ET are uncertain, it is thought to be caused by tremulous activity within a central tremor network. There is myriad clinical evidence supporting invasive neuromodulation of deep brain structures within this network in ET patients. Few studies have investigated the effect of noninvasive neuromodulation of the connecting peripheral nerve inputs to this network in tremor. Design/Methods: In the acute study, 77 subjects were randomized to receive either peripheral nerve treatment or sham stimulation of the tremor dominant hand. Tremor was evaluated before and after a single stimulation session. For the chronic study, 61 subjects were randomized to treatment, sham, or standard-of-care. Study Supported By: European Commission, Subjects underwent a minimum of two the US FDA, and ApoPharma Inc., Canada. sessions each day throughout the study. Results: The acute study demonstrated that the therapy was safe and produced P4.474 significant improvements compared to sham in the physician-rated Tremor Research Poster Session IV, 11:30 a.m. â&#x20AC;&#x201C; 7:00 p.m. Group Essential Tremor Rating Assessment EMBARGOED FOR RELEASE UNTIL 12:01 Scale (TETRAS) dominant upper limb AM EST ON FRIDAY, APRIL 20, 2018 scores (p=0.017), and in patient-rated Bain Non-Invasive Peripheral Nerve Stimulation and Findley activities of daily living (ADL) 102 2018 AAN Annual Meeting On-site Guide

103

EMERGING SCIENCE

Background: Natalizumab, approved for 300 mg intravenous every-4-weeks dosing, is associated with PML risk. Prior studies have been inconclusive regarding EID’s impact on PML risk. The US REMS program (TOUCH) offers the largest data source that can inform on PML risk in patients on EID. Design/Methods: Investigators developed SID and EID definitions and finalized the statistical analysis plan while blinded to PML events. Average dosing intervals (ADIs) were ≥3 to 5 to ≤12 weeks for EID. The primary analysis assessed ADI in the last 18 months of infusion history. The secondary analysis identified any prolonged period of EID at any time in the infusion history. The tertiary analysis assessed ADI over the full infusion history. Only anti-JC virus antibody positive (JCV Ab+) patients with dosing Study Supported By: Cala Health, Inc. intervals ≥3 to ≤12 weeks were included. EID and SID PML hazard ratios (HRs) were compared using adjusted Cox regression P4.475 models and Kaplan-Meier estimates. Poster Session IV, 11:30 a.m. – 7:00 p.m. Results: Analyses included 13,132 SID and 1988 EID patients (primary), 15,424 EMBARGOED FOR RELEASE UNTIL 12:01 SID and 3331 EID patients (secondary), and AM EST ON FRIDAY, APRIL 20, 2018 23,168 SID and 815 EID patients (tertiary). In Natalizumab extended interval dosing (EID) primary analyses, ADI (days) was 30 for SID is associated with a significant reduction in and 37 for EID; median exposure (months) progressive multifocal leukoencephalopathy was 44 for SID and 59 for EID. Most EID (PML) risk compared with standard interval patients had >2 years SID treatment prior dosing (SID) in the TOUCH® Prescribing to EID. The PML HR (95% confidence Program interval) was 0.06 (0.01-0.22; P<0.001) for primary and 0.12 (0.05-0.29; P<0.001) Lana Zhovtis Ryerson, MD; John Foley, for secondary analyses (both in favor of MD; Ih Chang; Ilya Kister, MD, FAAN; EID); no EID PML cases were observed in Gary Cutter, PhD; Ryan Metzger, PhD; tertiary analyses (Kaplan-Meier log-rank Judith Goldberg; Xiaochun Li; Evan Riddle, test P=0.02). Conclusions: In JCV Ab+ PhD; Karen Smirnakis; Bei Yu; Zheng Ren; patients, natalizumab EID is associated Chistophe Hotermans, MD, PhD; Pei-Ran with a clinically and statistically significant Ho; Nolan Campbell reduction in PML risk as compared with SID. As TOUCH does not collect effectiveness Objective: To determine whether data, further studies are needed. natalizumab EID is associated with reduced PML risk compared with SID. Study Supported By: Biogen scores (p = 0.001). No significant adverse events were reported, 3% of subjects experienced mild adverse events (skin redness, irritation) that spontaneously resolved without intervention. In the chronic study, baseline tremor characteristics, including tremor frequency (5.3 Hz +/-; 1.1 Hz), were identified in the kinematic data as well as tremor characteristics and response over the course of the study. Conclusions: These randomized controlled studies suggest that non-invasive peripheral neuromodulation may offer meaningful symptomatic relief from hand tremor in ET with a favorable side effect profile compared to other available therapies, and that at-home monitoring may provide key insights into evaluating and treating tremor.

EMERGING SCIENCE Results: Median age at diagnosis was 33 (21–52) years. Median time between symptom onset and AHSCT was 9 (2–58) months. Median pre-treatment Expanded P4.477 Disability Status Scale (EDSS) score was 6.5 (1.5–9.5). Median follow up was 30 Poster Session IV, 11:30 a.m. – 7:00 p.m. (6–118) months. Median EDSS score at EMBARGOED FOR RELEASE UNTIL 12:01 the last follow up was 2.0 (0–6.5). Median AM EST ON FRIDAY, APRIL 20, 2018 improvement of EDSS scores was 2.0 (0–8) (p<0.05, Wilcoxon signed-rank test). None Autologous Haematopoietic Stem Cell Transplantation in Treatment Naïve Patients had any clinical relapse following AHSCT. Three patients had new T2 lesions with with ‘Aggressive’ Multiple Sclerosis or without gadolinium enhancement at Joyutpal Das, MBBS; John Snowden; Mark the first six month follow up MRI, but no Freedman, MD, FAAN; Sona Mistry; Simon further new or enhancing lesions were observed in any subsequent scans. Routine Bell, MB, ChB, MRCP; Azza Ismail, PhD, toxicities were observed with no treatment MBBS, MRCP; Helen Jessop; Marjorie related mortality. Conclusions: AHSCT Bowman; Ricardo Sarccardi; Chiara Innocenti; Harold Atkins; Joachim Burman; was safe and highly effective in inducing rapid and sustain remission in this cohort Basil Sharrack, MD, PhD, FAAN and was associated with a significant Objective: To assess the safety and improvement of their level of disability. efficacy of autologous haematopoietic stem AHSCT should be considered as first line cell transplantation (AHSCT) in treatment therapy in patients with ‘aggressive’ MS. naïve patients with ‘aggressive’ multiple 1. Snowden et al. Haematopoietic SCT in sclerosis (MS). Background: AHSCT is a severe autoimmune diseases: updated very effective treatment in patients with guidelines of European Group for Blood and highly active relapsing remitting MS who Marrow Transplantation. Bone Marrow failed to respond to standard disease Transplantation 2012Jun;47(6):770-90 modifying therapies (DMTs). International guidelines advocate its use in treatment naïve patients with ‘aggressive’ MS (1). P4.478 Design/Methods: A total of 19 patients: Poster Session IV, 11:30 a.m. – 7:00 p.m. 7 from Sheffield (UK), 7 from Uppsala (Sweden), 4 from Ottawa (Canada) and EMBARGOED FOR RELEASE UNTIL 12:01 1 from Florence(Italy) with ‘aggressive’ AM EST ON FRIDAY, APRIL 20, 2018 MS received AHSCT between May 2004 B Cell Targeted Treatment in Myasthenia and May 2017. None received standard Gravis (BeatMG) - A Phase 2 Trial of DMTs before AHSCT. BEAM (carmustine, Rituximab in Myasthenia Gravis: Topline etoposide, cytarabine, melphalan) with antithymocyte globulin (ATG), Richard J. Nowak, MD; Christopher Coffey, cyclophosphamide with ATG or combination PhD; Jonathan Goldstein, MD; Mazen of cyclophosphamide, ATG and busulphan Dimachkie, MD, FAAN; Michael Benatar, were used as conditioning regimens. MBChB, DPhil, FAAN; Safawa Huq; Brenda

P4.476 Withdrawn

104 2018 AAN Annual Meeting On-site Guide

Pearson; Jon Yankey; Liz Uribe; Laura Herbelin; Kevin O’Connor; Robin Conwit, MD, FAAN; John Kissel, MD, FAAN; David Hafler, MD, FAAN; Merit Cudkowicz, MD, MSc; Richard Barohn, MD, FAAN

105

EMERGING SCIENCE

day. Participants were randomized 1:1 to receive a two-cycle rituximab regimen (375 mg/m2 IV weekly x 4 weeks, repeated at Week 24) versus matching placebo, and included additional strata based on baseline immunotherapy regimen. The Objective: The specific primary objective study duration was 52 weeks, and enrolled of the BeatMG study is to determine a total of 52 participants. A forced steroid whether rituximab is a safe and beneficial taper began at Week 8, and was guided by therapeutic for myasthenia gravis (MG) that predefined criteria. The primary outcome warrants further study in an efficacy trial. was a measure of steroid sparing effect, Background: MG is an antibody-mediated defined as the proportion of participants autoimmune disorder characterized by achieving a ≥75% reduction in mean daily fatigable muscle weakness. Despite prednisone dose in the 4 weeks prior to available therapies, some patients week 52 and with clinical improvement or continue to have uncontrolled disease or no significant worsening. Safety evaluations intolerable adverse effects. Autoreactive included adverse events, vital signs, B cells appear to play an important role and laboratory assessments. Secondary in the immunopathogenesis of MG and outcomes determined whether there was would seem appropriate for targeted a trend toward clinical benefit as defined drug therapy investigation. Additionally, by an improvement in MG-specific clinical encouraging preliminary findings with assessments: Myasthenia Gravis Composite rituximab provided the rationale for this (MGC) and Quantitative Myasthenia Gravis trial. Design/Methods: We conducted (QMG) scores, among others. Results: Final a randomized, double-blind, placeboresults from the study will be presented. controlled, multicenter phase 2 clinical trial Conclusions: Conclusions to be discussed. utilizing a futility analysis for the primary Study Supported By: The study was outcome. Participants 21-90 years of age, with confirmed acetylcholine receptor supported by grant U01NS084495 from (AChR) antibody positive generalized MG the National Institute of Neurological (Myasthenia Gravis Foundation of America Disorders and Stroke (NINDS) with drug/ Class II-IV) were eligible for enrollment if placebo provided by Genentech through an they were on ≥15 mg of prednisone per investigator-initiated trial agreement.

EMERGING SCIENCE CLINICAL TRIALS PLENARY SESSION

Tuesday, April 24, 2018, 9:15 a.m. – 11:30 a.m.

EMBARGOED FOR RELEASE UNTIL 12:01 AM EST ON FRIDAY, APRIL 20, 2018

A double-blind placebo-controlled study to evaluate the safety and efficacy of FcRn-antagonist ARGX-113 (efgartigimod) in generalized myasthenia gravis James F. Howard, Jr., MD, FAAN; Vera Bril, MD; Renato Mantegazza, MD; Andrzef Szczudlik, MD; Said Beydoun, MD, FAAN; Francisco Javier Rodriguez De Rivera Garrido, PhD, MBBS; Mariarosa Rottoli; Fredrik Piehl, MD, PhD; Philip Van Damme; Tuan Vu; Peter Ulrichts; Katrien Verschueren; Antonio Guglietta; Hans de Haard; Nicolas Leupin; Jan Verschuuren, MD, PhD Objective: To evaluate the safety and efficacy of ARGX-113 (efgartigimod) for the treatment of generalized MG. Background: Myasthenia gravis (MG) is an autoimmune disease driven by IgG autoantibodies targeting the neuromuscular junction hence leading to muscle weakness. ARGX-113 is an Fc fragment antagonizing the IgG salvage receptor FcRn thereby accelerating the degradation of IgGs and reducing their serum levels. This effect may be beneficial in IgG-driven autoimmune diseases such as MG. Design/Methods: A phase 2 randomized, double-blind, placebo-controlled, multicenter study was conducted in 24 patients with generalized MG (gMG). Primary objective of the study

106 2018 AAN Annual Meeting On-site Guide

was to evaluate the safety and tolerability of ARGX-113 and secondary objectives included an efficacy analysis using four established clinical scales (MG-ADL, QMG, MGC and MG-QoL-15r). Adult anti-AChR+ gMG patients with MG-ADL ≥ 5 were enrolled. Patients were randomized 1:1 to receive four once-weekly infusions of 10 mg/kg ARGX-113 or placebo and were monitored 8 additional weeks after last treatment. Results: ARGX-113 was well tolerated in all patients, with most adverse events characterized as mild and deemed unrelated to the study drug. No serious or severe adverse events were reported. Treatment with ARGX-113 resulted in rapid and strong clinical improvement over placebo lasting for the entire duration of the study as measured by all four efficacy scales (MG-ADL, QMG, MGC and MG-QoL15r). More specifically, 75% of patients treated with ARGX-113 had a clinically meaningful improvement in MG-ADL scores (≥2-point reduction from baseline) for a period of at least 6 consecutive weeks versus 25% of placebo patients (p = 0.0391). All patients in the treatment arm showed a rapid and deep reduction of their total IgG levels and disease improvement correlated with reduction in pathogenic IgG levels. Conclusions: These results validate ARGX-113 as a potential novel therapeutic option for gMG patients and warrant further clinical evaluation. Study Supported By: Argenx BVBA

CLINICAL TRIALS PLENARY SESSION

Tuesday, April 24, 2018, 9:15 a.m. – 11:30 a.m.

EMBARGOED FOR RELEASE UNTIL 12:01 AM EST ON FRIDAY, APRIL 20, 2018

107

EMERGING SCIENCE

baseline MMD in the 100-mg, 300-mg, and placebo groups were 16.1, 16.1, and 16.2, respectively. Reductions from baseline in A Phase 3, Randomized, Double-blind, MMD over Weeks 1-12 were greater with Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab for the eptinezumab 100 mg (-7.7 [p<0.0001]) and Preventive Treatment of Chronic Migraine: 300 mg (-8.2 [p=0.0001]) vs placebo (-5.6). Significantly more subjects achieved ≥75% Results of the PROMISE-2 (Prevention of reduction in MMD over Weeks 1-12 with Migraine via Intravenous Eptinezumab eptinezumab 100 mg (26.7% [p=0.0001]) Safety and Efficacy 2) Trial and 300 mg (33.1% [p<0.0001]) vs placebo (15.0%). The ≥75% reductions in MMD over Richard B. Lipton, MD, FAAN; Joel Saper, MD, FAAN; Messoud Ashina; David Biondi, Weeks 1-4 were similar. Results favored eptinezumab for ≥50% reduction in MMD DO, FAAN; Suman Bhattacharya; Joe over Weeks 1-12: 100 mg (57.6% [p<0.0001]) Hirman; Barbara Schaeffler; Roger Cady and 300 mg (61.4% [p<0.0001]) vs placebo Objective: Evaluate the efficacy and (39.3%). The percentage of subjects with safety of intravenous (iv) eptinezumab for migraine on Day 1 postinfusion was reduced preventive treatment of chronic migraine from baseline by 50.3% (p=0.0001) for 100 (CM). Background: Calcitonin gene-related mg and 51.6% (p<0.0001) for 300 mg vs peptide (CGRP) plays an important role in 27.1% for placebo. The safety profile was migraine pathophysiology. Eptinezumab, consistent with previous clinical trials of a humanized, anti-CGRP monoclonal eptinezumab. Conclusions: In subjects antibody with 100% bioavailability with CM, a single dose of eptinezumab 100 following iv administration, selectively mg and 300 mg significantly reduced MMD and potently inhibits CGRP. Design/ for 12 weeks. Significant benefits occurred Methods: Adults with CM (ICHD-3 beta) on the first day postinfusion and were and were randomized (1:1:1) to eptinezumab sustained for 3 months. 100 mg, 300 mg, or placebo. Infusion Study Supported By: Alder was administered on Day 0 and at Week BioPharmaceuticals, Inc., Bothell, WA, USA. 12. The primary endpoint was change from baseline in monthly migraine days (MMD) over Weeks 1-12. Key secondary endpoints included ≥75% reduction in MMD over Weeks 1-12 and Weeks 1-4, ≥50% reduction in MMD over Weeks 1-12, and percentage of subjects with migraine on Day 1 postinfusion. Results: Efficacy analysis included 1072 subjects. Mean

FREE Water Bottles! Visit the Live Well Experiential Learning Area in the Kentia Foyer to pick up your free water bottle!

Sponsored by:

In Multiple

Sclerosis

Find Out Why

109

In Multiple Sclerosis

Grey Matter pathology is widespread, progressive, and correlated with disability1-3 FIND OUT MORE

BOOTH

932 References: 1. Van de Pavert SHP, Muhlert N, Sethi V, et al. DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime? J Neurol Neurosurg Psychiatry. 2016;87(5):461-467. 2. Fisher E, Lee J-C, Nakmura K, Rudick RA. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol. 2008;64(3):255-265. 3. Hulst HE, Geurts JJG. Gray matter imaging in multiple sclerosis: what have we learned? BMC Neurol. 2011;11:153-164. ÂŠ 2018 Celgene Corporation All rights reserved. 03/18 USII-CELG180053

Alzheimer’s/Other Dementias

Exhibitors as of March 2, 2018

928 Advanced Brain Monitoring 1003 Mayo Medical Laboratories 1258 PsychoGenics Inc. 1570 Johns Hopkins University Press 2035 Medscape Neurology Autism 922 MNG Laboratories Biotechnology

EXHIBITOR BY TOPIC

323 GE Healthcare 419 Sensonics International 504 Mylan Inc. 547 Houston Methodist 603 Lilly 635 EUROIMMUN 729 Allergan Medical Affairs 763 Inova Medical Group 829 COGNISION 859 Penn State Health 908 PHARNEXT 924 King-Devick technologies, inc. 928 Advanced Brain Monitoring 958 Spectrum Health Clinical Neurosciences 1003 Mayo Medical Laboratories 1004 EMS Biomedical 1113 CorTechs Labs 1123 Abbvie 1133 Allergan 1157 Practical Neurology 1208 NEUROLOGY REVIEWS 1212 CNS Vital Signs 1256 Saint Luke’s Marion Bloch Neuroscience Institute 1258 PsychoGenics Inc. 1309 Biogen SMA Commercial 1315 Biogen MS Commercial 1367 Alzheimer’s Association 1375 University of Florida Health 1411 Biogen Medical 1471 AFTD and FTD Disorders Regsitry 1568 LBDA 1570 Johns Hopkins University Press 2035 Medscape Neurology 2131 ProtoKinetics Gait Analysis Walkways

Anxiety and Depression

503 Alexion Pharmacueticals 635 EUROIMMUN 1019 Great Lakes NeuroTechnologies 1111 Catalyst Pharmaceuticals 1112 McKesson Specialty Health 1118 KRONUS, Inc. 1247 Amgen/Novartis 1316 NINDS CDE Project 1755 electroCore, LLC Child Neurology 335 Ipsen Biopharmaceuticals, Inc. 435 Greenwich Biosciences, Inc. 453 PTC Therapeutics 617 Invitae 658 Providence St Joseph Health 712 BioMarin Pharmaceutical 759 Prevea Health 803 Philips EGI 907 Variantyx Inc. 922 MNG Laboratories 924 King-Devick technologies, inc. 947 NIHON KOHDEN AMERICA, INC. 1015 Pfizer 1023 CADWELL INDUSTRIES, INC. 1111 Catalyst Pharmaceuticals 1113 CorTechs Labs 111

EXHIBITOR BY TOPIC 1213 MULTIGON INDUSTRIES,INC. 1312 National Institute of Neurological Disorders & Stroke 1403 Upsher-Smith Laboratories, LLC 1463 Neurovirtual 1503 Medtronic 1572 Glut1 Deficiency Foundation 1576 International Essential Tremor Foundation 1767 Aurora Health Care Chronic Pain/Neuropathic Pain 317 Abbott 511 Elsevier 603 Lilly 648 KabaFusion 660 PeaceHealth 923 Corinthian Reference Lab 1003 Mayo Medical Laboratories 1476 National Headache Foundation Dystonias 335 Ipsen Biopharmaceuticals, Inc. 703 Adamas Pharma 712 BioMarin Pharmaceutical 729 Allergan Medical Affairs 922 MNG Laboratories 1133 Allergan 1377 Defeat MSA & MSA Awareness Shoe 1503 Medtronic 1572 Glut1 Deficiency Foundation 1773 Dystonia Medical Research Foundation Electronic Health Records 634 DynaMed Plus/EBSCO Health 2228 Photo-Stat Electronics 112 2018 AAN Annual Meeting On-site Guide

652 EyeTech Digital Systesm 1019 Great Lakes NeuroTechnologies 2133 Liftware Epilepsy 351 LivaNova 429 SK life science 435 Greenwich Biosciences, Inc. 504 Mylan Inc. 509 Mount Sinai Health System 617 Invitae 712 BioMarin Pharmaceutical 757 Carolinas HealthCare System 761 The Ohio State University Department of Neurology 803 Philips EGI 823 Clinical Neurology News.Com 858 Ochsner Health System 859 Penn State Health 922 MNG Laboratories 947 NIHON KOHDEN AMERICA, INC. 1004 EMS Biomedical 1023 CADWELL INDUSTRIES, INC. 1113 CorTechs Labs 1157 Practical Neurology 1208 NEUROLOGY REVIEWS 1256 Saint Luke’s Marion Bloch Neuroscience Institute 1258 PsychoGenics Inc. 1375 University of Florida Health 1403 Upsher-Smith Laboratories, LLC 1463 Neurovirtual 1472 Riverside Healthcare 1474 Epilepsy Foundation 1570 Johns Hopkins University Press 1572 Glut1 Deficiency Foundation 1574 Managing Epilepsy Well Network 1662 University of Utah Health - Clinical Neurosciences Center

A commitment to patients. A passion for progress. A culture of compassion.

Neurology with spirit Helping to fulfill our human health care (hhc) mission

Visit us at Booth 1715 to learn more about Eisai Neurology or visit NeurologyWithSpirit.com to learn more about Eisai Neurology.

113

EXHIBITOR BY TOPIC 1715 Eisai Inc. 1823 Sunovion PD 1833 Sunovion 2015 Zeto 2023 Sunovion Med Affairs Fibromyalgia 923 Corinthian Reference Lab General Neurology 311 Merz Neurosciences 317 Abbott 347 Ceribell, Inc. 405 Senso Medical Labs 419 Sensonics International 429 SK life science 463 Southern Ohio Medical Center 503 Alexion Pharmacueticals 504 Mylan Inc. 511 Elsevier 518 National ALS Registry 563 Southeast Health 608 BriovaRx Infusion Services 623 Alnylam Pharmaceuticals, Inc. 635 EUROIMMUN 648 KabaFusion 658 Providence St Joseph Health 660 PeaceHealth 703 Adamas Pharma 757 Carolinas HealthCare System 759 Prevea Health 761 The Ohio State University Department of Neurology 763 Inova Medical Group 823 Clinical Neurology News.Com 829 COGNISION 858 Ochsner Health System 859 Penn State Health 114 2018 AAN Annual Meeting On-site Guide

906 RMS Medical Products 907 Variantyx Inc. 958 Spectrum Health Clinical Neurosciences 1023 CADWELL INDUSTRIES, INC. 1026 EAN - European Academy of Neurology 1035 Bayer 1111 Catalyst Pharmaceuticals 1208 NEUROLOGY REVIEWS 1268 California Rehabilitation Institute 1312 National Institute of Neurological Disorders & Stroke 1377 Defeat MSA & MSA Awareness Shoe 1463 Neurovirtual 1472 Riverside Healthcare 1503 Medtronic 1567 Yuma Regional Medical Center 1573 OhioHealth 1576 International Essential Tremor Foundation 1666 Cambridge University Press 1672 International Parkinson and Movement Disorder Society (MDS) 1767 Aurora Health Care 1823 Sunovion PD 1833 Sunovion 1866 Bellin Health 1917 US WorldMeds 2003 Natus Neurology 2015 Zeto 2023 Sunovion Med Affairs 2118 The JAMA Network 2133 Liftware 2139 Neuro Kinetics, Inc. 2202 RosmanSearch, Inc.

Headache/Migraine

Exhibitors as of March 2, 2018

646 American Heart/American Stroke Association 1476 National Headache Foundation 2228 Photo-Stat Imaging 323 GE Healthcare 511 Elsevier 652 EyeTech Digital Systesm 803 Philips EGI 928 Advanced Brain Monitoring 1113 CorTechs Labs 1213 MULTIGON INDUSTRIES,INC. 1477 DENT Neuroscience Research Center (DNRC) 2228 Photo-Stat

EXHIBITOR BY TOPIC

504 Mylan Inc. 509 Mount Sinai Health System 523 Promius Pharma 603 Lilly 629 Alder Biopharmaceuticals Inc. 716 eNeura, Inc. 729 Allergan Medical Affairs 761 The Ohio State University Department of Neurology 763 Inova Medical Group 858 Ochsner Health System 958 Spectrum Health Clinical Neurosciences 1013 American Headache Society 1026 EAN - European Academy of Neurology 1117 CEFALY Technology 1133 Allergan 1203 Impax Laboratories, Inc. 1208 NEUROLOGY REVIEWS 1247 Amgen/Novartis 1403 Upsher-Smith Laboratories, LLC 1447 Teva CNS 1472 Riverside Healthcare 1476 National Headache Foundation 1477 DENT Neuroscience Research Center (DNRC) 1563 Akeso Health Sciences, LLC 1662 University of Utah Health - Clinical Neurosciences Center 1755 electroCore, LLC 1767 Aurora Health Care 1963 Acorda Therapeutics, Inc 2047 Acorda Therapeutics, Inc. 2129 Health Monitor Network

Health Information Management

Medical Equipment 317 Abbott 347 Ceribell, Inc. 419 Sensonics International 638 Rimed USA, Inc. 716 eNeura, Inc. 738 Micromedical Technologies, Inc. 803 Philips EGI 829 COGNISION 906 RMS Medical Products 947 NIHON KOHDEN AMERICA, INC. 1004 EMS Biomedical 2131 ProtoKinetics Gait Analysis Walkways 2139 Neuro Kinetics, Inc. Multiple Sclerosis 329 Actelion Pharmaceuticals Ltd 423 MEDDAY PHARMACEUTICALS 430 Saol Therapeutics 115

EXHIBITOR BY TOPIC 504 Mylan Inc. 509 Mount Sinai Health System 511 Elsevier 648 KabaFusion 658 Providence St Joseph Health 761 The Ohio State University Department of Neurology 859 Penn State Health 905 MS Care Connect 924 King-Devick technologies, inc. 932 Celgene Corporation 958 Spectrum Health Clinical Neurosciences 1003 Mayo Medical Laboratories 1035 Bayer 1112 McKesson Specialty Health 1113 CorTechs Labs 1123 Abbvie 1157 Practical Neurology 1212 CNS Vital Signs 1256 Saint Luke’s Marion Bloch Neuroscience Institute 1309 Biogen SMA Commercial 1315 Biogen MS Commercial 1375 University of Florida Health 1411 Biogen Medical 1447 Teva CNS 1566 Multiple Sclerosis Foundation 1674 MotherToBaby 1676 ACTRIMS 1802 Genentech, A Member of the Roche Group 1847 EMD Serono, Inc. 1963 Acorda Therapeutics, Inc 2047 Acorda Therapeutics, Inc. 2131 ProtoKinetics Gait Analysis Walkways

116 2018 AAN Annual Meeting On-site Guide

Muscular Dystrophy 335 453 763 922 1003 1202

Ipsen Biopharmaceuticals, Inc. PTC Therapeutics Inova Medical Group MNG Laboratories Mayo Medical Laboratories AveXis, Inc.

Neuromuscular 311 Merz Neurosciences 430 Saol Therapeutics 453 PTC Therapeutics 503 Alexion Pharmacueticals 547 Houston Methodist 617 Invitae 623 Alnylam Pharmaceuticals, Inc. 648 KabaFusion 703 Adamas Pharma 735 Strongbridge Biopharma 761 The Ohio State University Department of Neurology 846 CSL Behring 858 Ochsner Health System 908 PHARNEXT 922 MNG Laboratories 923 Corinthian Reference Lab 1015 Pfizer 1019 Great Lakes NeuroTechnologies 1023 CADWELL INDUSTRIES, INC. 1111 Catalyst Pharmaceuticals 1118 KRONUS, Inc. 1268 California Rehabilitation Institute 1309 Biogen SMA Commercial 1315 Biogen MS Commercial 1411 Biogen Medical 1572 Glut1 Deficiency Foundation 1662 University of Utah Health - Clinical Neurosciences Center 1767 Aurora Health Care

1917 US WorldMeds 2139 Neuro Kinetics, Inc. Non-Profit 463 518 557 561 563 646

Pain and Palliative Care 660 PeaceHealth 923 Corinthian Reference Lab 1570 Johns Hopkins University Press

Exhibitors as of March 2, 2018

317 Abbott 323 GE Healthcare 419 Sensonics International 424 SpeechVive 504 Mylan Inc. 509 Mount Sinai Health System 529 Boston Scientific 547 Houston Methodist 635 EUROIMMUN 908 PHARNEXT 924 King-Devick technologies, inc. 928 Advanced Brain Monitoring 1003 Mayo Medical Laboratories 1019 Great Lakes NeuroTechnologies 1123 Abbvie 1157 Practical Neurology 1203 Impax Laboratories, Inc. 1212 CNS Vital Signs 1256 Saint Luke’s Marion Bloch Neuroscience Institute 1258 PsychoGenics Inc. 1309 Biogen SMA Commercial 1312 National Institute of Neurological Disorders & Stroke 1315 Biogen MS Commercial 1375 University of Florida Health 1377 Defeat MSA & MSA Awareness Shoe 1411 Biogen Medical 1447 Teva CNS 1503 Medtronic 1523 AbbVie, Inc. 1568 LBDA 1570 Johns Hopkins University Press 1662 University of Utah Health - Clinical Neurosciences Center 1672 International Parkinson and Movement Disorder Society (MDS)

EXHIBITOR BY TOPIC

Southern Ohio Medical Center National ALS Registry Intermountain Healthcare Gundersen Health System Southeast Health American Heart/American Stroke Association 734 Mayo Clinic 962 OSF HealthCare Illinois Neurological Institute 1006 Child Neurology Foundation 1026 EAN - European Academy of Neurology 1367 Alzheimer’s Association 1468 THE GUTHY-JACKSON CHARITABLE FOUNDATION 1471 AFTD and FTD Disorders Regsitry 1474 Epilepsy Foundation 1568 LBDA 1572 Glut1 Deficiency Foundation 1573 OhioHealth 1576 International Essential Tremor Foundation 1666 Cambridge University Press 1771 The Neurocritical Care Society 1866 Bellin Health 2118 The JAMA Network 2228 Photo-Stat

Parkinson’s Disease

117

EXHIBITOR BY TOPIC 1747 1917 1963 2047 2131

ACADIA Pharmaceuticals Inc. US WorldMeds Acorda Therapeutics, Inc Acorda Therapeutics, Inc. ProtoKinetics Gait Analysis Walkways 2133 Liftware Pharmaceutical 419 Sensonics International 429 SK life science 430 Saol Therapeutics 435 Greenwich Biosciences, Inc. 447 Lundbeck 503 Alexion Pharmacueticals 512 US Bioservices 523 Promius Pharma 608 BriovaRx Infusion Services 712 BioMarin Pharmaceutical 729 Allergan Medical Affairs 735 Strongbridge Biopharma 846 CSL Behring 908 PHARNEXT 932 Celgene Corporation 1022 Neurocrine Biosciences, Inc. 1111 Catalyst Pharmaceuticals 1133 Allergan 1247 Amgen/Novartis 1367 Alzheimer’s Association 1802 Genentech, A Member of the Roche Group 1823 Sunovion PD 1833 Sunovion 1847 EMD Serono, Inc. 1867 Eris Lifesciences LTD 2023 Sunovion Med Affairs

118 2018 AAN Annual Meeting On-site Guide

Practice/Policy 662 1112 1208 1477

Neurology Career Center McKesson Specialty Health NEUROLOGY REVIEWS DENT Neuroscience Research Center (DNRC) 1672 International Parkinson and Movement Disorder Society (MDS) 2113 Frontiers 2228 Photo-Stat

Publisher 511 Elsevier 634 DynaMed Plus/EBSCO Health 646 American Heart/American Stroke Association 823 Clinical Neurology News.Com 929 PracticeLink 1666 Cambridge University Press 1723 Wolters Kluwer 2013 McGraw-Hill Education 2105 Wiley 2109 DEMOS MEDICAL 2112 MedLink Neurology 2113 Frontiers 2117 Oxford University Press 2118 The JAMA Network 2129 Health Monitor Network 2208 Springer Recruiter 502 CompHealth 551 Staff Care, Inc. 552 Legacy Health Careers 557 Intermountain Healthcare 561 Gundersen Health System 562 Community Health Systems 563 Southeast Health

Restless Legs Syndrome 547 Houston Methodist Sleep Disorders 928 947 1004 1023 1258 1377

Advanced Brain Monitoring NIHON KOHDEN AMERICA, INC. EMS Biomedical CADWELL INDUSTRIES, INC. PsychoGenics Inc. Defeat MSA & MSA Awareness Shoe 1463 Neurovirtual 2015 Zeto

Exhibitors as of March 2, 2018

Sports and Concussion 738 Micromedical Technologies, Inc. 829 COGNISION 1019 Great Lakes NeuroTechnologies 1212 CNS Vital Signs 1375 University of Florida Health 2015 Zeto 2139 Neuro Kinetics, Inc. Stroke 311 Merz Neurosciences 424 SpeechVive 430 Saol Therapeutics 509 Mount Sinai Health System 547 Houston Methodist 638 Rimed USA, Inc. 658 Providence St Joseph Health 759 Prevea Health 761 The Ohio State University Department of Neurology 763 Inova Medical Group 803 Philips EGI 858 Ochsner Health System 859 Penn State Health 958 Spectrum Health Clinical Neurosciences 1004 EMS Biomedical 1157 Practical Neurology 1213 MULTIGON INDUSTRIES,INC. 1256 Saint Luke’s Marion Bloch Neuroscience Institute 1268 California Rehabilitation Institute 1309 Biogen SMA Commercial 1312 National Institute of Neurological Disorders & Stroke 1315 Biogen MS Commercial 1375 University of Florida Health 1411 Biogen Medical

EXHIBITOR BY TOPIC

613 Weatherby Healthcare 656 HCA 662 Neurology Career Center 757 Carolinas HealthCare System 759 Prevea Health 856 University of Utah Health Department of Neurology 860 Spartanburg Regional Healthcare System 863 Kaiser Permanente - Permanente Medical Groups 929 PracticeLink 958 Spectrum Health Clinical Neurosciences 962 OSF HealthCare Illinois Neurological Institute 1028 LocumTenens.com 1116 Jackson & Coker 1210 Hayes Locums 1472 Riverside Healthcare 1767 Aurora Health Care 1866 Bellin Health 2113 Frontiers

119

EXHIBITOR BY TOPIC 1463 Neurovirtual 1472 Riverside Healthcare 1503 Medtronic 1573 OhioHealth 1662 University of Utah Health - Clinical Neurosciences Center 1769 Society of Vascular and Interventional Neurology 2015 Zeto 2035 Medscape Neurology 2131 ProtoKinetics Gait Analysis Walkways Tourette Syndrome 1022 Neurocrine Biosciences, Inc. Traumatic Brain Injury 347 Ceribell, Inc. 424 SpeechVive 430 Saol Therapeutics 638 Rimed USA, Inc. 738 Micromedical Technologies, Inc. 829 COGNISION 924 King-Devick technologies, inc. 1113 CorTechs Labs 1212 CNS Vital Signs 1213 MULTIGON INDUSTRIES,INC. 1268 California Rehabilitation Institute 1312 National Institute of Neurological Disorders & Stroke 1474 Epilepsy Foundation 2131 ProtoKinetics Gait Analysis Walkways 2139 Neuro Kinetics, Inc. Unlisted Area of Focus 463 Southern Ohio Medical Center 518 National ALS Registry 634 DynaMed Plus/EBSCO Health 120 2018 AAN Annual Meeting On-site Guide

635 EUROIMMUN 648 KabaFusion 662 Neurology Career Center 712 BioMarin Pharmaceutical 716 eNeura, Inc. 735 Strongbridge Biopharma 809 UBS Financial Services 906 RMS Medical Products 907 Variantyx Inc. 1022 Neurocrine Biosciences, Inc. 1109 RDL Reference Laboratory 1114 United Council for Neurologic Subspecialties 1118 KRONUS, Inc. 1217 Quest Diagnostics 1377 Defeat MSA & MSA Awareness Shoe 1471 AFTD and FTD Disorders Regsitry 1477 DENT Neuroscience Research Center (DNRC) Organization Classification 463 Southern Ohio Medical Center 561 Gundersen Health System 660 PeaceHealth 759 Prevea Health 856 University of Utah Health Department of Neurology 859 Penn State Health 860 Spartanburg Regional Healthcare System 962 OSF HealthCare Illinois Neurological Institute 1268 California Rehabilitation Institute 1567 Yuma Regional Medical Center 1569 Northwell Health

1662 University of Utah Health - Clinical Neurosciences Center 1767 Aurora Health Care 1866 Bellin Health Hospital Medical Device/Medical Software

Non-Profit 557 561 734 763 962

Intermountain Healthcare Gundersen Health System Mayo Clinic Inova Medical Group OSF HealthCare Illinois Neurological Institute 1006 Child Neurology Foundation 1013 American Headache Society 1468 THE GUTHY-JACKSON CHARITABLE FOUNDATION 1472 Riverside Healthcare 1567 Yuma Regional Medical Center

Exhibitors as of March 2, 2018

Other 635 EUROIMMUN 652 EyeTech Digital Systesm 809 UBS Financial Services 907 Variantyx Inc. 1258 PsychoGenics Inc. 1262 Hawaiian Moon 1316 NINDS CDE Project 1563 Akeso Health Sciences, LLC

EXHIBITOR BY TOPIC

347 Ceribell, Inc. 405 Senso Medical Labs 419 Sensonics International 529 Boston Scientific 637 Novocure Inc. 803 Philips EGI 829 COGNISION 905 MS Care Connect 906 RMS Medical Products 928 Advanced Brain Monitoring 1004 EMS Biomedical 1019 Great Lakes NeuroTechnologies 1023 CADWELL INDUSTRIES, INC. 1212 CNS Vital Signs 1503 Medtronic 1755 electroCore, LLC 2015 Zeto 2139 Neuro Kinetics, Inc. 2228 Photo-Stat

1569 Northwell Health 1572 Glut1 Deficiency Foundation 1576 International Essential Tremor Foundation 1769 Society of Vascular and Interventional Neurology 1771 The Neurocritical Care Society 1866 Bellin Health

Pharmaceutical 329 Actelion Pharmaceuticals Ltd 426 Retrophin 429 SK life science 523 Promius Pharma 703 Adamas Pharma 712 BioMarin Pharmaceutical 735 Strongbridge Biopharma 846 CSL Behring 908 PHARNEXT 1123 Abbvie 1202 AveXis, Inc. 1247 Amgen/Novartis 1867 Eris Lifesciences LTD

121

EXHIBITOR BY TOPIC Publisher 511 Elsevier 1157 Practical Neurology 1208 NEUROLOGY REVIEWS 1570 Johns Hopkins University Press Recruiter 613 Weatherby Healthcare 862 Vituity 962 OSF HealthCare Illinois Neurological Institute 1028 LocumTenens.com 1567 Yuma Regional Medical Center

VISIT US AT BOOTH #1202 TO LEARN MORE ABOUT GRT

GENE REPLACEMENT THERAPY:

A GENETIC EVOLUTION from Mendel’s work based in nature to notable advancements in medicine We’ve come a long way since Mendel first laid the foundation of genetics—today, gene replacement therapy (GRT) is being investigated as a therapeutic approach that may have the potential to treat monogenic diseases at their source.1,2

References:1. Gayon J. From Mendel to epigenetics: history of genetics. C R Biol. 2016;339(7-8):225-230. 2. Naldini L. Gene therapy returns to centre stage. Nature. 2015;526(7573):351-360. © 2018 AveXis, Inc. All Rights Reserved. US-UNB-18-0040 04/18

EXHIBITOR BY NUMBER Booth Number Exhibitor

Exhibitors as of March 2, 2018

EXHIBITOR BY BOOTH NUMBER

311 Merz Neurosciences 317 Abbott 323 GE Healthcare 329 Actelion Pharmaceuticals Ltd 335 Ipsen Biopharmaceuticals, Inc. 347 Ceribell, Inc. 351 LivaNova 405 Senso Medical Labs 413 Corinthian Health Services, Inc. 417 Jari Electrode Supply 419 Sensonics International 422 Aspen Medical Products 423 MEDDAY PHARMACEUTICALS 424 SpeechVive 426 Retrophin 429 SK life science 430 Saol Therapeutics 435 Greenwich Biosciences, Inc. 447 Lundbeck 453 PTC Therapeutics 461 Allegheny Health Network 463 Southern Ohio Medical Center 502 CompHealth 503 Alexion Pharmacueticals 504 Mylan Inc. 509 Mount Sinai Health System 511 Elsevier 512 US Bioservices 514 MVAP Medical Supplies Inc. 516 Compumedics Neuroscan 518 National ALS Registry 523 Promius Pharma 529 Boston Scientific 547 Houston Methodist 551 Staff Care, Inc. 552 Legacy Health Careers

557 Intermountain Healthcare 559 Tower Health 560 Baptist Health Medical Group (Kentucky) 561 Gundersen Health System 562 Community Health Systems 563 Southeast Health 603 Lilly 608 BriovaRx Infusion Services 612 Cogstate Healthcare 613 Weatherby Healthcare 615 QMENTA 617 Invitae 619 Healix Infusion Therapy 623 Alnylam Pharmaceuticals, Inc. 629 Alder Biopharmaceuticals Inc. 634 DynaMed Plus/EBSCO Health 635 EUROIMMUN 636 IGeneX, Inc. 637 Novocure Inc. 638 Rimed USA, Inc. 646 American Heart/American Stroke Association 648 KabaFusion 652 EyeTech Digital Systesm 656 HCA 658 Providence St Joseph Health 660 PeaceHealth 662 Neurology Career Center 703 Adamas Pharma 707 Ionis Pharmaceuticals 712 BioMarin Pharmaceutical 716 eNeura, Inc. 729 Allergan Medical Affairs 734 Mayo Clinic 735 Strongbridge Biopharma 738 Micromedical Technologies, Inc. 757 Carolinas HealthCare System 123

EXHIBITOR BY NUMBER 759 Prevea Health 761 The Ohio State University Department of Neurology 763 Inova Medical Group 803 Philips EGI 807 General Sleep 809 UBS Financial Services 823 Clinical Neurology News.Com 825 Quadrant Biosciences 827 Neuro Central 829 COGNISION 846 CSL Behring 847 Supernus Pharmaceuticals, Inc. 856 University of Utah Health Department of Neurology 858 Ochsner Health System 859 Penn State Health 860 Spartanburg Regional Healthcare System 861 Tallahassee Memorial HealthCare 862 Vituity 863 Kaiser Permanente - Permanente Medical Groups 902 Biohaven Pharmaceuticals 903 APDM Wearable Technologies 905 MS Care Connect 906 RMS Medical Products 907 Variantyx Inc. 908 PHARNEXT 922 MNG Laboratories 923 Corinthian Reference Lab 924 King-Devick technologies, inc. 926 Every Body Fitness 927 Neurocrine Biosciences 928 Advanced Brain Monitoring 929 PracticeLink 932 Celgene Corporation 947 NIHON KOHDEN AMERICA, INC. 953 Sanofi Genzyme 124 2018 AAN Annual Meeting On-site Guide

958 Spectrum Health Clinical Neurosciences 959 Supernus Pharmaceuticals, Inc. 960 Parkview Health 962 OSF HealthCare Illinois Neurological Institute 1002 CortiCare 1003 Mayo Medical Laboratories 1004 EMS Biomedical 1006 Child Neurology Foundation 1008 Tekscan, Inc. 1013 American Headache Society 1015 Pfizer 1019 Great Lakes NeuroTechnologies 1022 Neurocrine Biosciences, Inc. 1023 CADWELL INDUSTRIES, INC. 1026 EAN - European Academy of Neurology 1028 LocumTenens.com 1029 Mitsubishi Tanabe Pharma America Medical Affairs 1035 Bayer 1109 RDL Reference Laboratory 1111 Catalyst Pharmaceuticals 1112 McKesson Specialty Health 1113 CorTechs Labs 1114 United Council for Neurologic Subspecialties 1116 Jackson & Coker 1117 CEFALY Technology 1118 KRONUS, Inc. 1123 Abbvie 1133 Allergan 1146 Sanofi Genzyme 1157 Practical Neurology 1159 Aquestive Therapeutics 1202 AveXis, Inc. 1203 Impax Laboratories, Inc. 1208 NEUROLOGY REVIEWS

Exhibitors as of March 2, 2018

1473 Benign Essential Blepharospasm Research Foundation, Inc. 1474 Epilepsy Foundation 1476 National Headache Foundation 1477 DENT Neuroscience Research Center (DNRC) 1503 Medtronic 1523 AbbVie, Inc. 1562 Piramal Critical Care 1563 Akeso Health Sciences, LLC 1566 Multiple Sclerosis Foundation 1567 Yuma Regional Medical Center 1568 LBDA 1569 Northwell Health 1570 Johns Hopkins University Press 1572 Glut1 Deficiency Foundation 1573 OhioHealth 1574 Managing Epilepsy Well Network 1575 Decode Duchenne/Parent Project Muscular Dystrophy 1576 International Essential Tremor Foundation 1577 Children’s Hospital Los Angeles 1662 University of Utah Health - Clinical Neurosciences Center 1666 Cambridge University Press 1672 International Parkinson and Movement Disorder Society (MDS) 1674 MotherToBaby 1676 ACTRIMS 1715 Eisai Inc. 1723 Wolters Kluwer 1747 ACADIA Pharmaceuticals Inc. 1755 electroCore, LLC 1767 Aurora Health Care 1769 Society of Vascular and Interventional Neurology 1771 The Neurocritical Care Society 1773 Dystonia Medical Research Foundation

EXHIBITOR BY BOOTH NUMBER

1210 Hayes Locums 1212 CNS Vital Signs 1213 MULTIGON INDUSTRIES,INC. 1215 World Congress of Neurology 1217 Quest Diagnostics 1247 Amgen/Novartis 1256 Saint Luke’s Marion Bloch Neuroscience Institute 1258 PsychoGenics Inc. 1260 Abreos Biosciences 1261 Teva CNS 1262 Hawaiian Moon 1267 RAPID SENSORY CLEANWHEEL 1268 California Rehabilitation Institute 1309 Biogen SMA Commercial 1312 National Institute of Neurological Disorders & Stroke 1315 Biogen MS Commercial 1316 NINDS CDE Project 1318 American Board of Psychiatry and Neurology 1322 Mitsubishi Tanabe Pharma America 1331 Novartis Pharmaceuticals 1367 Alzheimer’s Association 1373 The Michael J. Fox Foundation for Parkinson’s Research 1375 University of Florida Health 1377 Defeat MSA & MSA Awareness Shoe 1403 Upsher-Smith Laboratories, LLC 1411 Biogen Medical 1447 Teva CNS 1463 Neurovirtual 1466 University of Southern California 1468 THE GUTHY-JACKSON CHARITABLE FOUNDATION 1469 Moebius Syndrome Foundation 1471 AFTD and FTD Disorders Regsitry 1472 Riverside Healthcare

125

1802 Genentech, A Member of the Roche Group 1823 Sunovion PD 1833 Sunovion 1847 EMD Serono, Inc. 1857 Sarepta Therapeutics 1866 Bellin Health 1867 Eris Lifesciences LTD 1868 The Myositis Association 1870 California Parkinson’s Disease Registry 1872 Interior Health 1917 US WorldMeds 1963 Acorda Therapeutics, Inc 2003 Natus Neurology 2013 McGraw-Hill Education 2015 Zeto 2019 US WorldMeds 2023 Sunovion Med Affairs 2035 Medscape Neurology 2047 Acorda Therapeutics, Inc. 2103 Neurology Advisor 2105 Wiley 2109 DEMOS MEDICAL 2112 MedLink Neurology 2113 Frontiers 2117 Oxford University Press 2118 The JAMA Network 2129 Health Monitor Network 2131 ProtoKinetics Gait Analysis Walkways 2133 Liftware 2137 Coram / CVS Specialty infusion services 2139 Neuro Kinetics, Inc. 2202 RosmanSearch, Inc. 2208 Springer 2219 Kedrion Biopharma Inc. 2228 Photo-Stat 126 2018 AAN Annual Meeting On-site Guide

VISIT US AT

BOOTH #447 DISCOVER

A FORCE

FOR REDUCTION Please visit Booth #447 for full Prescribing Information, including Boxed Warning for risks from concomitant use with opioids.

PA TIE N

ATE REPUTAT RPOR ION CO OF PH

#1 OVERALL

MA AR

IEW TV

#1 IN ALL SEVEN INDICATORS

LUNDBECK

U.S. EDITION

TOP RANKING IN 2015 & 2016

• Most effective patient-centered strategy • Best record on patient safety • Best high-quality information to patients • Most useful high-quality products • Best record of transparency with stakeholders • Most integrity • Best relationships with patient groups

Thank You

2O18 Industry Roundtable Members* The American Academy of Neurology and the Industry Roundtable collaborate on opportunities to support neurology and serve patients with neurologic disease.

$50,000

$40,000

Acorda Therapeutics Greenwich Biosciences, Inc. IPSEN Biopharmaceuticals, Inc.

$25,000

Abbott Adamas Pharmaceuticals, Inc. Allergan Alnylam Pharmaceuticals, Inc. AveXis, Inc. Eisai Inc. GE Healthcare Medtronic Neurocrine Biosciences Sarepta Therapeutics UCB Inc.

$10,000

CSL Behring Ionis Pharmaceuticals

*commitments as of March 12, 2018

PARKINSON’S DISEASE-RELATED HALLUCINATIONS AND DELUSIONS DISTORT WHAT IS REAL1

H ELP R E S TOR E R E A LIT Y W ITH N U PL A ZI D 2,3 NUPLAZID® (pimavanserin) remarkably reduces the frequency and/or severity of Parkinson’s disease psychosis with no impact on motor function2,3

Experience the virtual reality world of patients with Parkinson’s disease psychosis at Booth #1747.

Indication NUPLAZID is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. Important Safety Information for NUPLAZID (pimavanserin) 17-mg Tablets WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIARELATED PSYCHOSIS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. NUPLAZID is not approved for the treatment of patients with dementia-related psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis. Contraindication: NUPLAZID is contraindicated in patients with a history of a hypersensitivity reaction to pimavanserin or any of its components. Rash, urticaria, and reactions consistent with angioedema (e.g., tongue swelling, circumoral edema, throat tightness, and dyspnea) have been reported.

QT Interval Prolongation: NUPLAZID prolongs the QT interval. The use of NUPLAZID should be avoided in patients with known QT prolongation or in combination with other drugs known to prolong QT interval including Class 1A antiarrhythmics or Class 3 antiarrhythmics, certain antipsychotic medications, and certain antibiotics NUPLAZID should also be avoided in patients with a history of cardiac arrhythmias, as well as other circumstances that may increase the risk of the occurrence of torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and presence of congenital prolongation of the QT interval. Adverse Reactions: The most common adverse reactions (≥2% for NUPLAZID and greater than placebo) were peripheral edema (7% vs 2%), nausea (7% vs 4%), confusional state (6% vs 3%), hallucination (5% vs 3%), constipation (4% vs 3%), and gait disturbance (2% vs <1%).

Drug Interactions: Strong CYP3A4 inhibitors (eg, ketoconazole) increase NUPLAZID concentrations. Reduce the NUPLAZID dose by one-half. Strong CYP3A4 inducers may reduce NUPLAZID exposure, monitor for reduced efficacy. Increase in NUPLAZID dosage may be needed. Pregnancy: Use of NUPLAZID in pregnant women has not been evaluated and should therefore be used in pregnancy only if the potential benefit justifies the potential risk to the mother and fetus. Pediatric Use: Safety and efficacy have not been established in pediatric patients. Dosage and Administration Recommended dose: 34 mg per day, taken orally as two 17-mg tablets once daily, without titration.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You can also call ACADIA Pharmaceuticals Inc. at 1-844-4ACADIA (1-844-422-2342). References: 1. Ravina B, Marder K, Fernandez HH, et al. Diagnostic criteria for psychosis in Parkinson’s disease: report of an NINDS, NIMH work group. Mov Disord. 2007;22(8):1061-1068. 2. NUPLAZID® (pimavanserin) prescribing information, ACADIA. 3. Cummings J, Isaacson S, Mills R, et al. Pimavanserin for patients with Parkinson’s disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet. 2014;383(9916):533-540.

S:10.875”

NUPLAZID® (pimavanserin) tablets, for oral use. Rx only Brief Summary: This information is not comprehensive. Visit www.NUPLAZIDhcp.com to obtain the FDA-approved product labeling or call 1-844-422-2342.

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIARELATED PSYCHOSIS • Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. • NUPLAZID is not approved for the treatment of patients with dementiarelated psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis. 1 INDICATIONS AND USAGE NUPLAZID is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. 2 DOSAGE AND ADMINISTRATION The recommended dose of NUPLAZID is 34 mg, taken orally as two 17-mg strength tablets once daily, without titration.

psychosis unrelated to the hallucinations and delusions associated with Parkinson’s disease psychosis. QT Interval Prolongation NUPLAZID prolongs the QT interval. The use of NUPLAZID should be avoided in patients with known QT prolongation or in combination with other drugs known to prolong QT interval including Class 1A antiarrhythmics (e.g., quinidine, procainamide) or Class 3 antiarrhythmics (e.g., amiodarone, sotalol), certain antipsychotic medications (e.g., ziprasidone, chlorpromazine, thioridazine), and certain antibiotics (e.g., gatifloxacin, moxifloxacin). NUPLAZID should also be avoided in patients with a history of cardiac arrhythmias, as well as other circumstances that may increase the risk of the occurrence of torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and the presence of congenital prolongation of the QT interval. 6 ADVERSE REACTIONS The following serious adverse reactions are discussed elsewhere in the labeling: • Increased Mortality in Elderly Patients with Dementia-Related Psychosis • QT Interval Prolongation Clinical Trial Experience The clinical trial database for NUPLAZID consists of over 1200 subjects and patients exposed to one or more doses of NUPLAZID.

4 CONTRAINDICATIONS Contraindicated in patients with a history of a hypersensitivity reaction to pimavanserin or any of its components. Rash, urticaria, and reactions consistent with angioedema (e.g., tongue swelling, circumoral edema, throat tightness, and dyspnea) have been reported.

Adverse Reactions (≥2% and >Placebo)

5 WARNINGS AND PRECAUTIONS Increased Mortality in Elderly Patients with Dementia-Related Psychosis Antipsychotic drugs increase the all-cause risk of death in elderly patients with dementia-related psychosis. Analyses of 17 dementia-related psychosis placebo-controlled trials (modal duration of 10 weeks and largely in patients taking atypical antipsychotic drugs) revealed a risk of death in the drug-treated patients of between 1.6- to 1.7-times that in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in placebo-treated patients. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. NUPLAZID is not approved for the treatment of patients with dementia related NUPL18CDNY4232_BS_16_25_x_10_875_MAR2018_r7.indd 1

Adverse reactions that occurred in 6-week, placebocontrolled studies and that were reported at an incidence of ≥2% and >placebo are presented in the following table.

Preferred Term

NUPLAZID 34 mg N = 202

Placebo N = 231

Nausea

Peripheral edema

Confusional state

Hallucination

Constipation

Gait disturbance

<1%

Postmarketing Experience The following adverse reactions have been identified during postapproval use of NUPLAZID. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. These reactions include somnolence, rash, urticaria, and reactions consistent with angioedema (e.g., tongue swelling, circumoral edema, throat tightness, and dyspnea). 3/16/18 2:32 PM

S:16.25”

• Coadministration with Strong CYP3A4 Inhibitors The recommended dose of NUPLAZID when coadministered with strong CYP3A4 inhibitors (e.g., ketoconazole) is 17 mg, taken orally as one tablet once daily. • Coadministration with Strong CYP3A4 Inducers Monitor patients for reduced efficacy if NUPLAZID is used concomitantly with strong CYP3A4 inducers; an increase in NUPLAZID dosage may be needed.

S:10.875”

7 DRUG INTERACTIONS QT Interval Prolongation Concomitant use of drugs that prolong the QT interval may add to the QT effects of NUPLAZID and increase the risk of cardiac arrhythmia. Avoid the use of NUPLAZID in combination with other drugs known to prolong QT interval. Strong CYP3A4 Inhibitors Concomitant use of NUPLAZID with a strong CYP3A4 inhibitor increases pimavanserin exposure. If NUPLAZID is used with a strong CYP3A4 inhibitor, reduce the dosage of NUPLAZID. Strong CYP3A4 Inducers Concomitant use of a strong CYP3A4 inducer may reduce pimavanserin exposure resulting in a potential decrease in efficacy. Patients should be monitored for reduced efficacy and an increase in dosage may be needed if NUPLAZID is used concomitantly with strong CYP3A4 inducers.

Lactation There is no information regarding the presence of pimavanserin in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for NUPLAZID and any potential adverse effects on the breastfed infant from NUPLAZID or from the underlying maternal condition. Pediatric Use Safety and effectiveness of NUPLAZID have not been established in pediatric patients. Geriatric Use No dose adjustment is required for elderly patients. Parkinson’s disease is a disorder occurring primarily in individuals over 55 years of age. The mean age of patients enrolled in the 6-week clinical studies with NUPLAZID was 71 years, with 49% 65-75 years old and 31% >75 years old. In the pooled population of patients enrolled in 6-week, placebo-controlled studies (N=614), 27% had MMSE scores from 21 to 24 compared to 73% with scores ≥25. No clinically meaningful differences in safety or effectiveness were noted between these two groups. Renal Impairment No dosage adjustment for NUPLAZID is needed in NUPL18CDNY4232_BS_16_25_x_10_875_MAR2018_r7.indd 2

Hepatic Impairment No dosage adjustment for NUPLAZID is recommended in patients with hepatic impairment based on the exposure differences observed in patients with and without hepatic impairment in a hepatic impairment study. 9 DRUG ABUSE AND DEPENDENCE Controlled Substance NUPLAZID is not a controlled substance. Abuse NUPLAZID has not been systematically studied in humans for its potential for abuse, tolerance, or physical dependence. While short-term, placebocontrolled and long-term, open-label clinical trials did not reveal increases in drug-seeking behavior, the limited experience from the clinical trials do not predict the extent to which a CNS-active drug will be misused, diverted, and/or abused once marketed. 10 OVERDOSAGE Human Experience The pre-marketing clinical trials involving NUPLAZID in approximately 1200 subjects and patients do not provide information regarding symptoms with overdose. In healthy subject studies, dose limiting nausea and vomiting were observed. Management of Overdose There are no known specific antidotes for NUPLAZID. In managing overdose, cardiovascular monitoring should commence immediately and should include continuous ECG monitoring to detect possible arrhythmias. If antiarrhythmic therapy is administered, disopyramide, procainamide, and quinidine should not be used, as they have the potential for QT-prolonging effects that might be additive to those of NUPLAZID. Consider the long plasma half-life of pimavanserin (about 57 hours) and the possibility of multiple drug involvement. 17 PATIENT COUNSELING INFORMATION Concomitant Medication Advise patients to inform their healthcare providers if there are any changes to their current prescription or over-the-counter medications, since there is a potential for drug interactions. CAUTION: Federal law prohibits dispensing without prescription. Distributed by ACADIA Pharmaceuticals Inc. San Diego, CA 92130 NUPLAZID® is a trademark of ACADIA Pharmaceuticals Inc. © 2018 ACADIA Pharmaceuticals Inc. All rights reserved. 03/18 NU-1128 3/16/18 2:32 PM

S:16.25”

8 USE IN SPECIFIC POPULATIONS Pregnancy There are no data on NUPLAZID use in pregnant women that would allow assessment of the drugassociated risk of major congenital malformations or miscarriage. In animal reproduction studies, no adverse developmental effects were seen when pimavanserin was administered orally to rats or rabbits during the period of organogenesis at doses up to 10- or 12-times the maximum recommended human dose (MRHD) of 34 mg/day, respectively. Administration of pimavanserin to pregnant rats during pregnancy and lactation resulted in maternal toxicity and lower pup survival and body weight at doses which are 2-times the MRHD of 34 mg/day.

patients with mild to severe renal impairment or end stage renal disease (ESRD); however, increased exposure (Cmax and AUC) to NUPLAZID occurred in patients with severe renal impairment (CrCL <30 mL/ min, Cockcroft-Gault) in a renal impairment study. NUPLAZID should be used with caution in patients with severe renal impairment and end stage renal disease. In a renal impairment study, dialysis did not appear to significantly affect the concentrations of NUPLAZID.

EXHIBITOR DESCRIPTIONS Abbott Booth

317

6300 Bee Caves Rd. Bldg. 2 Suite 100 Austin, TX 78746 sjm.com

At Abbott, we’re committed to helping you live your best possible life through the power of health. For more than 125 years, we’ve brought new products and technologies to the world ‑ in nutrition, diagnostics, medical devices and branded generic pharmaceuticals ‑ that create more possibilities for more people at all stages of life. Today, 94,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.

pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.

New

Abreos Biosciences Booth

1260

2223 Avenida de la Playa Suite 206 La Jolla, CA 92037 abreos.com

ACADIA Pharmaceuticals Inc.

Abbvie Booth

Booth

1123

1 North Waukegan Rd North Chicago, IL 60064 abbvie.com

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries.

AbbVie, Inc.

Booth

1523

1 North Waukegan Rd North Chicago, IL 60045 abbvie.com

AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established

134 2018 AAN Annual Meeting On-site Guide

1747

3611 Valley Centre Drive Suite 300 San Diego, CA 92130 acadia-pharm.com

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders. Visit Booth No. 489 to learn more.

New

Acorda Therapeutics, Inc Booth

1963

420 Saw Mill River Road Ardsley, NY 10502 acorda.com

Acorda Therapeutics is a 22 year old biotechnology company based in Westchester County, New York. The Company's mission is to develop therapies that will restore function and improve the lives of people with neurological disorders. Acorda has a pipeline of neurological therapies addressing a range of disorders, including Parkinson's disease, migraine and multiple sclerosis. Acorda markets three FDA-approved therapies, including AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg.

New Exhibitor

New

Acorda Therapeutics, Inc. Booth

2047

420 Saw Mill River Road Ardsley, NY 10502 acorda.com

Actelion Pharmaceuticals Ltd

329 ACTRIMS Booth

1676

Gewerbestrasse 16 Allschwil, Switzerland 4123 actelion.com

22 N. Carroll Street Suite 300 Madison, WI 53703 actrims.org

The Americas Committee for Treatment & Research in Multiple Sclerosis (ACTRIMS™) provides leadership in the field of multiple sclerosis and other demyelinating diseases. ACTRIMS invites researchers, clinicians, residents, students, postdoctoral fellows and patient advocates for MS to attend ACTRIMS Forum 2019 on February 28-March 2, 2019 in Dallas, TX at the Hilton Anatole. Visit www. actrims.org/forum2019 for additional information.

Adamas Pharma Booth

703

1900 Powell Street Emeryville, CA 94608 adamaspharma.com

At Adamas Pharmaceuticals, Inc., we believe in the power of medicines derived from a deep understanding of time-dependent biology. We strive to create medicines with therapeutic profiles that match the pattern of disease to drive a more significant and durable clinical effect.

Advanced Brain Monitoring Booth

928

2237 Faraday ave Suite 100 carlsbad, CA 92008

advancedbrainmonitoring.com

New Booth

New

Advanced Brain Monitoring is a neuro-diagnostics device company specializing in the acquisition and analysis of awake and sleep EEG, and in the development of EEG-based biomarkers. Our products are used in clinical trials and in clinical practice to interpret brain function as it relates to early stage neuro-degeneration and chronic diseases. Our seven FDA-cleared systems have been used on over 1.5 mm patients worldwide, and earned the GHP 2016 Most Innovative Medical Device Company award.

AFTD and FTD Disorders Regsitry Booth

1471

EXHIBITORS BY NAME

Exhibit Hall Passport Destination

Radnor Station, 290 King of Prussia Road Bldg 2, Suite 320 Radnor, PA 19087 theaftd.org

AFTD strives to improve the quality of life of people affected by FTD. We fund competitive grant programs including FTD Biomarkers and TreatFTD, and provide education and support to families living with FTD disorders. The FTD Disorders Registry was founded by AFTD and The Bluefield Project. The Registry is open to persons diagnosed with an FTD disorder, their caregivers, family members and friends in the US and Canada. Registry data will be used to support research studies and clinical trials.

135

EXHIBITOR DESCRIPTIONS New

Akeso Health Sciences, LLC Booth

1563

4607 Lakeview Cyn #561 Westlake Village, CA 91361 migrelief.com

MigreLief by Akeso Health Sciences is a very effective multi-patented natural supplement targeting the nutritional needs of migraine sufferers. The product line includes Original MigreLief for men, women and children 12 and older, MigreLief + M for menstrual migraine sufferers, Children's MigreLief for children ages 2-11 and MigreLief NOW which is taken for on the spot, fast acting, nutritional support for on-going headaches and migraines.

Alder Biopharmaceuticals Inc. Booth

629

6515 Grand Teton Plaza Ste 241 Madison, WI 53719 alderbio.com

Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies. Alder’s lead pivotal-stage product candidate, eptinezumab, is being evaluated for migraine prevention. Eptinezumab is a monoclonal antibody that inhibits calcitonin gene-related peptide (CGRP), a protein active in mediating the initiation of migraine. For more information, please visit http:// www.alderbio.com.

Alexion Pharmacueticals Booth

503

100 College St New Haven, CT 06510 alexion.com

Alexion is a global biopharmaceutical company focused on life-transforming therapies for patients with devastating, rare diseases. Alexion developed the first and only approved complement inhibitor for PNH & aHUS. The Company is strengthening and broadening its complement

136 2018 AAN Annual Meeting On-site Guide

portfolio, including evaluating complement inhibition in additional ultra-rare disorders. Alexion's metabolic franchise includes two highly innovative enzyme replacement therapies for two ultra-rare, life-threatening disorders.

New

Allegheny Health Network Booth

461 Allergan Booth

1133

232 West 25th Street Erie, PA 16544 ahn.org

2525 Dupont Drive Irvine, CA 92612 allergan.com

Allergan plc (NYSE: AGN), is a bold, global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. For more information, visit Allergan's website at https://www.Allergan.com.

Allergan Medical Affairs Booth

729

2525 Dupont Drive Irvine, CA 92612 allergan.com

INDUSTRY THERAPEUTIC UPDATE FROM EMD SERONO

Join us in the EMD Serono Medical Booth, #1847, to help us construct the neuroimmunology model in

Iâ&#x20AC;&#x2122;M BALANCING MS APRIL 22-25, 2018

EVOLVING PERSPECTIVES AND INNOVATIONS IN MULTIPLE SCLEROSIS 7:00 - 10:00 pm WEDNESDAY, April 25, 2018 Platinum Ballroom JW Marriott Los Angeles

JOIN US IN THE EMD SERONO MEDICAL BOOTH, #1847, AT THE AAN ANNUAL MEETING FOR

SaGE ON THE STaGE Aging and the immune system: What does it mean for patients with Multiple Sclerosis? Monday, April 23, 2018 at 1:00 pm – 1:20 pm pT Wednesday, April 25, 2018 at 12:00 pm – 12:20

Sibyl Wray, MD Hope Neurology Knoxville, TN

A lymphocyte review: Everything you wanted to know in 12 minutes Monday, April 23, 2018 at 12:00 pm – 12:20 pm pT Wednesday, April 25, 2018 at 1:00 pm – 1:20 pm pT Bruce Hughes, MD Dir., Ruan MS Center Mercy Ruan Neurology Clinic & Research Center Assoc. Prof., Neurology Des Moines Univ. College of Medicine Des Moines, IA

Immune reconstitution: Aiming to rebalance the immune repertoire in Multiple Sclerosis Industry Therapeutic Update from EMD Serono will take place at the Platinum Ballroom located on the 2nd floor at the JW Marriott JW Marriott Los Angeles L.A. LIVE 900 West Olympic Boulevard Los Angeles, California 90015 USA EMD Serono has the pleasure to invite you to their Industry Therapeutic Update event, entitled Evolving Perspectives and Innovations in Multiple Sclerosis. A welcome dinner will be served at 7:00 pm followed by the presentation. THIS MEETING IS NOT AN EVENT OF THE AAN ANNUAL MEETING. THIS MEETING IS NOT A CME PROGRAM NOR WILL CME CREDITS BE GIVEN FOR ATTENDANCE.

Sunday, April 22, 2018 at 12:00 pm – 12:20 pm pT Tuesday, April 24, 2018 at 1:00 pm – 1:20 pm pT Le Hua, MD Samson Chair for MS Research Dir., Mellen Program for MS Lou Ruvo Center for Brain Health Asst. Prof. of Medicine, Cleveland Clinic Lerner College of Medicine Las Vegas, NV

Pregnancy: Significance, outcomes and considerations in Multiple Sclerosis patients Sunday, April 22, 2018 at 1:00 pm – 1:20 pm pT Tuesday, April 24, 2018 at 12:00 pm – 12:20 pm pT Lori Travis, MD Neurologist Clinical Asst. Prof., Neurology Univ. of AZ College Of Medicine Phoenix, AZ EMD Serono is a business of Merck KGaA, Darmstadt, Germany. © 2018 EMD Serono, Inc. All rights reserved. US/NPR/0218/0037(2)

New Exhibitor

Alnylam Pharmaceuticals, Inc. Booth

623

300 Third Street Cambridge, MA 02142 alnylam.com

Alzheimer’s Association Booth

1367

225 North Michigan Avenue 17th Floor Chicago, IL 60601 alz.org

The Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research. The Association hosts the annual Alzheimer's Association International Conference™ (AAIC™), bringing the world's leading dementia scientists together to share the latest research. Visit our booth to learn more about AAIC 2018, the International Research Grant Program™, the Association's membership society (ISTAART), TrialMatch™, and patient and caregiver resources.

American Board of Psychiatry and Neurology Booth

1318

2150 E. Lake Cook Rd. Ste. 900 Buffalo Grove, IL 60089 abpn.com

The American Board of Psychiatry and Neurology serves the public interest and the professions of psychiatry and neurology by promoting excellence in practice through its certification and maintenance of certification processes. ABPN also oversees the certification process for physicians seeking certification in child and adolescent psychiatry.

American Headache Society Booth

1013

19 Mantua Rd Mt Royal, NJ 08061

americanheadachesociety.org

The American Headache Society™(AHS) is the professional organization for the study and management of headache and face pain. AHS activities include an annual scientific meeting, a comprehensive headache symposium, regional symposia for neurologists and family practice physicians, and publication of the journal Headache. AHS established the American Migraine Foundation to raise awareness about migraine and related disorders and raise funds to establish the American Registry for Migraine Research.

American Heart/American Stroke Association Booth

646

7272 Greenville Ave Dallas, TX 75231 myamericanheart.org

Visit the AHA booth to receive information on AHA scientific conferences. AHA/ASA professional membership, scientific publications, AHA's Focus on Quality Program, patient education, Connected Heart Health and much more. Learn how you can join more than 30,000 professional members and receive more benefits than ever!

EXHIBITORS BY NAME

Alnylam is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of patients who have limited or inadequate treatment options. RNAi therapeutics represent a powerful, clinicallyvalidated approach for the treatment of a wide range of debilitating diseases.

Exhibit Hall Passport Destination

Amgen/Novartis Booth

1247

One Amgen Center Drive Thousand Oaks, CA 91320 amgen.com

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

139

EXHIBITOR DESCRIPTIONS AveXis, Inc.

New

APDM Wearable Technologies Booth

903

2828 SW Corbett Avenue Portland, OR 98665 apdm.com

New

Aquestive Therapeutics Booth

1159

30 Technology Dr. Warren, NJ 07059 aquestive.com

Booth

1202

We are breaking barriers. AveXis is a clinicalstage gene therapy company relentlessly focused on bringing gene therapy out of the lab and into the clinical setting for patients and families devastated by rare and orphan neurological genetic diseases. For more information, please visit AveXis.com.

Baptist Health Medical Group (Kentucky) Booth

560

New

2275 Half Day Road Suite 200 Bannockburn, IL 60015 avexis.com

2701 Eastpoint Parkway Louisville, KY

Aspen Medical Products Booth

422

6481 Oak Canyon Irvine, CA 92618 aspenmp.com

Aurora Health Care Booth

1767

3000 W Montana Street Milwaukee, WI 53215 aurora.org/doctor

Aurora Health Care is the largest health system in Wisconsin with service areas extending to Northeastern Illinois. Our integrated delivery model allows our physicians to support their patients, connect with colleagues and offer state-of-the-art, top-tier quality care. For more information about our neurology opportunities, please call Jeanette Krimmer at 414-389-2634, email Jeanette.krimmer@aurora.org or visit our website at aurora.org/doctor.

Bayer

Booth

1035

100 Bayer Blvd. Whippany, NJ 07981 bayer.com

Bayer has been committed to supporting people with multiple sclerosis (MS) for more than 25 years. Since 1995, our robust patient support programs and services have made a difference in patients' lives. As we continue our collaboration with the MS community, we remain committed to building on our shared history of progress. To learn more about our innovative support tools and resources, please visit Booth #1035.

Bellin Health Booth

1866

744 S Webster Ave Green Bay, WI 54301 bellin.org

Green Bay, WI is known for the Packers & offers an ideal setting for working, living & raising a family. It is also home to Bellin Health, a fast

140 2018 AAN Annual Meeting On-site Guide

New Exhibitor growing, innovative network of hospitals, physicians, & clinics throughout Northeastern WI & Upper MI. We are a 220 bed hospital recognized by Consumer Reports as the #1 hospital in the nation for patient safety. Our vision is that the people in our region will be the healthiest in the nation. Consider joining our Neuro Team & help us reach our vision!

Biogen Medical

1411

225 Binney Street Cambridge, MA 02142 biogen.com

One of the pioneers in biotechnology, Biogen today has the leading portfolio of medicines to treat (MS), has the first and only approved treatment for spinal muscular atrophy (SMA) and is at the forefront of research into new medicines for neurological and neurodegenerative conditions. Led by world-class research and development, Biogen uses novel science and leading-edge technologies to create, commercialize, and manufacture transformative therapies for patients with few or no options.

Biogen SMA Commercial

Biogen MS Commercial

Booth

1315

New

Biohaven Pharmaceuticals Booth

902

1309

225 Binney Street Cambridge, MA 02142 biogen.com

234 Church Street New Haven, CT 06510 biohavenpharma.com

BioMarin Pharmaceutical Booth

712 Booth

133 Boston Post Road Weston, MA 02127 biogen.com

105 Digital Drive Novato, CA 94949 biomarin.com

EXHIBITORS BY NAME

Booth

Exhibit Hall Passport Destination

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Approved products include the first and only medications for PKU and LEMS, and the first and only enzyme replacement therapies for MPS I, MPS VI and Morquio A syndrome. Visit www.BMRN.com to learn more.

141

EXHIBITOR DESCRIPTIONS Boston Scientific Booth

529

25155 Rye Canyon Loop Valencia, CA 91355 bostonscientific.com/dbs

Boston Scientific is a worldwide developer and manufacturer of medical devices whose products are used in a broad range of interventional medical specialties. As an innovation leader in Neuromodulation and implantable Deep Brain Stimulation Technology, Boston Scientific is committed to transforming lives through innovative medical solutions that improve the health of patients.

BriovaRx Infusion Services Booth

608

15529 College Blvd Lenexa, KS 66219 briovarxinfusion.com

BriovaRx Infusion Services is a home infusion care provider serving patients across the U.S. with a national network of pharmacies. We specialize in Immune globulin (IgG), Parenteral Nutrition (PN), Anti-infectives, Hydration, Biologics and other specialty infusions. Our comprehensive services include specially trained on-staff nurses and pharmacists, around-the-clock clinical support, reimbursement specialists and on-going patient education for safety and comfort.

CADWELL INDUSTRIES, INC. Booth

1023

909 N. Kellogg Street Kennewick, WA 99336 cadwell.com

Cadwell enables cutting-edge neurodiagnostics. We’re excited to unveil the Apollo™ Ambulatory and In-Hospital EEG solution, (510(k) pending). Sentinel™ Monitoring for ICU and EMU allows you to monitor multiple patients at once from one computer, control cameras, enter events, review EEG and receive notifications. We’re also excited to share our new EMG software Sierra™ 3.1 with fully integrated ultrasound options. Visit us to see these innovative solutions. We are helping you help others.

142 2018 AAN Annual Meeting On-site Guide

New

California Parkinson’s Disease Registry Booth

1870

1631 Alhambra Blvd Suite 200 Sacramento, CA 95816

https://www.cdph.ca.gov/Programs/ CCDPHP/DCDIC/CDSRB/Pages/ Program-Landing2.aspx

New

California Rehabilitation Institute Booth

1268

2070 Century Park East Los Angeles, CA 90067 californiarehabinstitute.com

A partnership of Cedars-Sinai, UCLA Health, and Select Medical, California Rehabilitation Institute has 138 all-private-rooms and provides advanced acute inpatient care to patients recovering from a stroke, neuromuscular illness, brain injury, spinal cord injury, cancer, and other medical conditions. Our physician-led teams are committed to bringing patients to their highest level of functional ability and giving them the best opportunity to optimize their quality of life.

Cambridge University Press Booth

1666

1 Liberty Plaza New York, NY 10006 cambridge.org/us/academic

Cambridge’s publishing in books and journals combines state-of-the-art content with the highest standards of scholarship, writing and production. Visit our stand to browse new titles, available at a 20% discount, and to pick up sample issues of our journals. Visit our website to see everything we do: www.cambridge.org/us/ academic.

New Exhibitor Cape Fear Valley Health Booth

1475

101 Robeson Street Suite 303 Fayetteville, NC 28301 capefearvalley.com

Cape Fear Valley is a 916-bed, 8-hospital regional health system, the 8 th largest in North Carolina, with more than 1 million inpatient and outpatients annually. A private not-for-profit organization with 7,000 employees and 850 physicians.

Booth

757

4135 South Stream Blvd Suite 300 Charlotte, NC 28217

Carolinas HealthCare System, one of the nation's leading and most innovative healthcare organizations, provides a full spectrum of healthcare and wellness throughout the Carolinas. Our Neurosciences Institute of Neurology, leads in advanced neurological care with treatment, research, rehabilitation and specialty programs. We provide a level of expertise unmatched in the region. Our programs lead nationally in the development of quality improvement and clinical outcomes in the neurosciences.

Catalyst Pharmaceuticals Booth

1111

355 Alhambra Circle Suite 1250 Coral Gable, FL 33134 catalystpharma.com

Catalyst Pharmaceutical's mission is to develop therapies for rare neuro/neuromuscular diseases such as Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndromes (CMS), MuSK Myasthenia Gravis, and Infantile Spasms. Our lead candidate is amifampridine phosphate with an ongoing PIII trial for CMS adult & pediatric patients (enrolling), a PIII trial for MuSK-MG (enrolling), and a planned NDA submission in early 2018 as well as a POC study for Spinal Muscular Atrophy (SMA).

CEFALY Technology Booth

1117

187 Danbury Road Wilton, CT cefaly.us

CEFALY Technology has developed unique medical devices for the acute and preventive treatments of migraine. The first Cefaly device received FDA approval in March 2014. The company's mission is to develop non-invasive, drug-free, neurological medical treatments. In addition to Cefaly devices for migraine treatments, the company is leading research on medical devices to treat coma, epilepsy and fibromyalgia.

Celgene Corporation

Booth

932

86 Morris Avenue Summit, NJ 07901 celgene.com

Celgene Corporation (Nasdaq:CELG) is a global biopharmaceutical company that is helping healthcare providers turn incurable cancers into chronic, manageable diseases, as well as manage serious inflammatory conditions through innovative therapies. This dedication to medical progress goes hand-in-hand with our industryleading patient support and access programs. Together, these aspects form the core of our commitment to patients worldwide. For more information, visit www.celgene.com

EXHIBITORS BY NAME

Carolinas HealthCare System

Exhibit Hall Passport Destination

143

EXHIBITOR DESCRIPTIONS Clinical Neurology News.Com

New

Ceribell, Inc. Booth

347

2483 Old Middlefield Way Suite 120 Mountain View, CA 94043 ceribell.com

Ceribell is focused on making electroencephalography (EEG) widely accessible, more efficient, and more cost-effective to improve the diagnosis and treatment of patients at risk for seizures. The Ceribell EEG System can be set up by any healthcare provider within 6 minutes and offers a proprietary Brain Stethoscope function that dramatically simplifies interpretation of EEG results by converting brainwaves to sound so seizures can be detected by listening to the brain.

New

Booth

823

ClinicalNeurologyNews.com is a trusted source for independent news and views for neurologists since early 2005. The content has been crafted with your needs in mind–featuring the latest medical and subspecialty news, thought leader commentary, conference coverage, CME, practice management, and so much more. Twice a week, we email the NEXUS, an eNewsletter, with the latest neurology news and developments.

CNS Vital Signs Booth

1212

Child Neurology Foundation Booth

1006

201 Chicago Avenue Suite 200 Minneapolis, MN 55415 childneurologyfoundation.org

Child Neurology Foundation (CNF) serves as a collaborative center of education and support for caregivers and their children with neurologic conditions. CNF is committed to building a community of partners that navigates the path of disease diagnosis, treatment and management together, so that children and their families achieve the highest quality of care, and the highest quality of life.

New

Children’s Hospital Los Angeles Booth

1577

4650 W SUNSET BLVD. #138 LOS ANGELES, CA 90027 chla.org

144 2018 AAN Annual Meeting On-site Guide

7 Century Drive Suite 302 Parsippany, NJ 07054 clinicalneurologynews.com

598 Airport Blvd. Suite 1400 Morrisville, NC 27560 cnsvs.com

CNS Vital Signs is a world leader in computerizedneurocognitive assessment tools. Baseline, evaluate and track the status and disease progression of your patients. Used by over 12,000 clinicians and researchers in 52 countries! Available in over 50 languages. Come by our exhibit or go to www.cnsvs.com for a free trial.

COGNISION Booth

829

1044 E Chestnut St. Louisville, KY 40204 cognision.com

COGNISION™ is the first easy-to-use, FDA cleared, cloud-powered cognitive assessment system to evaluate patients with neurological disorders, such as dementia and TBI. By measuring the electrical activity in the brain directly responsible for information processing, COGNISION™ can accurate assess cognitive function. COGNISION™ provides objective measures, is practical to implement and has an attractive revenue model.

Are your patients asking about cannabis? How does cannabis work? What are the differences between the products out there?

Find answers and explore the science at the

CannabinoidClinical.com Booth #435

CannabinoidClinical.com is sponsored by Greenwich Biosciences, Inc., a GW Pharmaceuticals plc company. This site is not intended to provide medical advice or to suggest that any product mentioned is safe or efficacious for any disease or condition. This website is intended for a US audience. ÂŠ2018 Greenwich Biosciences, Inc. All rights reserved.

THE POTENTIAL TO

TRANSFORM the treatment of

hATTR amyloidosis

ON THE HORIZON FROM ALNYLAM The landscape of hereditary ATTR (hATTR) amyloidosis is changing, and Alnylam is leading the way. Alnylam is pursuing a potential new class of medicines for patients and their families, based on Nobel Prize–winning science, to address hATTR amyloidosis and other genetic disorders that have limited treatment options. For the latest news and updates, sign up at hATTRupdates.com

New Exhibitor

New

Cogstate Healthcare Booth

612

745 Atlantic Avenue Boston, MA 02111 cogstate.com/healthcare

Community Health Systems Booth

Community Health Systems, Inc. is one of the nation's leading operators of general acute care hospitals. The organization's affiliates own, operate or lease approximately 127 + hospitals in 20 states with approximately 30,000 licensed beds. Affiliated hospitals are dedicated to providing quality healthcare for local residents and contribute to the economic development of their communities.

Coram / CVS Specialty infusion services Booth

2137

CVS Specialty and Coram provide compassionate, high-quality infusion care to patients where they live, work or travel. Local teams from more than 90 locations throughout the country offer the highest level of personalized care, education and support. With nearly 1,200 skilled clinicians and more than 30 years of experience, Coram CVS Specialty Infusion Services leads the industry with commitment from the heart. The company has achieved a 96 percent patient satisfaction rating for seven years.

New

Corinthian Health Services, Inc. Booth

CompHealth Booth

502

7259 S Bingham Junction Blvd Midvale, UT 84047 comphealth.com

Founded in 1979, CompHealth is the largest locum tenens staffing agency in the United States. CompHealth also specializes in temporary and permanent allied healthcare staffing. CompHealth is part of the CHG Healthcare Services family of companies, which is recognized on FORTUNE magazine’s list of 100 Best Companies to Work For. www.comphealth.com

Compumedics Neuroscan Booth

516

5015 West WT Harris Blvd Suite E Charlotte, NC 28269 neuroscan.com

555 17th St Suite 1500 Denver, CO 80202-3900 coramhc.com

413

509 coyote rd Southlake, TX 76092 corinthianhealth.com

Corinthian Reference Lab Booth

923

6201 Southwest Blvd Benbrook, TX 76132 corinthianreferencelab.com

EXHIBITORS BY NAME

562

4000 Meridian Blvd Franklin, TN 37067-6325 chsmedcareers.com

Exhibit Hall Passport Destination

CRL is a commercial diagnostic laboratory specializing in neurological disease detection. We specialize in epidermal nerve fiber density (ENFD) testing. ENFD testing offers patients objective evidence of a neuropathy which can hopefully lead to a more accurate diagnosis. Please contact Greg Davenport with questions or to receive additional information: 480-330-3684.

147

EXHIBITOR DESCRIPTIONS CorTechs Labs Booth

1113

4690 Executive Dr., Sye 250 San Diego, CA 92121 cortechslabs.com

CorTechs Labs develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making volumetric analysis of MRI images of the human brain a routine part of clinical practice. Our cutting-edge imaging analysis tools provide physicians a convenient way to quantify brain structures and compare results to age- and gender-matched norms, helping assess neurological issues, such as dementia, epilepsy, MS, and brain trauma.

New

CortiCare Booth

1002

2237 Faraday Avenue Suite 120 Carlsbad, CA 92008 corticare.com

New

CSL Behring Booth

846

1020 1st Avenue King of Prussia, PA 19406 cslbehring.com

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients' needs using the latest technologies to develop and deliver innovative biotherapies used to treat serious and rare conditions such as neurological and coagulation disorders, primary immune deficiencies, hereditary angioedema and inherited respiratory disease. CSL Behring's products are used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn.

148 2018 AAN Annual Meeting On-site Guide

New

Decode Duchenne/Parent Project Muscular Dystrophy Booth

1575

401 Hackensack Ave 9th Floor Hack, NJ 07601 parentprojectmd.org

Defeat MSA & MSA Awareness Shoe Booth

1377

9935-D Rea Road Charlotte, NC 28277 defeatmsa.org

Staffed entirely by volunteers, Defeat MSA is an inclusive US based 501(c)(3) public charity that aspires to balance efforts to support patients, educate medical professionals, raise public awareness and nurture promising clinical research. The MSA Awareness Shoe is a tool for spreading awareness, increasing support for MSA patients and fighting MSA in the public sphere. The Shoe’s globetrotting journey is undertaken in memory of all those that have died due to MSA and in support of all those still fighting Multiple System Atrophy!

DEMOS MEDICAL Booth

2109

11 W 42ND STREET NEW YORK, NY 07304 demosmedical.com

For more than 25 years, Demos Medical Publishing has served the information needs of medical professionals. We publish high-quality books and digital products for physicians and other healthcare providers, and have established an international reputation for excellence in our core areas of neurology, physical medicine and rehabilitation, pathology, and oncology.

New Exhibitor DENT Neuroscience Research Center (DNRC) Booth

1477

3980 Sheridan Drive Suite B Amherst, NY 14223 dentinstitute.com

DENT Is the largest out-patient neurologic center in the United States. We are currently offering fellowship opportunities for 2017-18-19 in the fields of Neuroimaging (2), Headache (1), NeuroOncology (1), Neuro-Otology (1).

Booth

634

10 Estes Street Ipswich, MA 01938 dynamed.com

DynaMed Plus™ is the next-generation clinical information resource that optimizes speed to answer for the busy clinician. Evidence-based content is written by a world-class team of physicians who synthesize the evidence and provide objective analysis to help clinicians in their daily practice.

EAN - European Academy of Neurology

Booth

1026

The EAN-European Academy of Neurology brings together European neurologists. The membership, 47 European national neurological societies and > 800 individuals, represents > 21K neurologists. EAN has ongoing educational programmes, grants, teaching courses and online learning tools. Regional Teaching Courses are organised in Eastern Europe and Sub-Saharan Africa. A shared EAN/AAN membership agreement is active since January 1st, 2016 3rd EAN congress - Amsterdam, The Netherlands June 24-27, 2017.

Eisai Inc. Booth

1715

Dystonia Medical Research Foundation Booth

1773

1 E. Wacker Drive Suite 2810 Chicago, IL 60601 dystonia-foundation.org

The mission of the Dystonia Medical Research Foundation (DMRF) is to advance research for more treatments and ultimately a cure, to promote awareness and education, and to support the needs and well being of affected individuals and families.

Breitegasse 4-7 Vienna, 1070 ean.org

100 Tice Blvd Woodcliff Lake, NJ 07677 us.eisai.com

As the U.S. pharmaceutical subsidiary of Tokyobased Eisai Co., Ltd., we are a fully integrated pharmaceutical business with discovery, clinical, and marketing capabilities. Our key areas of focus include oncology and neurology (dementia-related diseases and neurodegenerative diseases). To learn more about Eisai Inc., please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn.

EXHIBITORS BY NAME

DynaMed Plus/EBSCO Health

Exhibit Hall Passport Destination

electroCore, LLC Booth

1755

150 Allen Rd. Suite 201 Basking Ridge, NJ 07920 electroCore.com

electroCore, LLC is a U.S.-based commercialstage bioelectronic medicine company dedicated to improving patient outcomes through its

149

EXHIBITOR DESCRIPTIONS proprietary self-administered, non-invasive vagus nerve stimulation (nVNS) therapy for the treatment of multiple conditions in neurology, metabolic disorders and rheumatology. The company's first commercialized product, gammaCore, is FDA-cleared for the acute treatment of pain associated with migraine and episodic cluster headache in adults.

Elsevier

New

EMS Biomedical Booth

1004

Jochingergasse 1 Korneuburg, 2100 emsbiomed.com

Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity.

EMS Biomedical is a European (Vienna based) manufacturer of Diagnostic solutions in the fields of Neurophysiology, PSG and EIT and at AAN we are presenting our world leading Sienna Ultimate System offering 32, 64 and 128 channel solutions for LTM EEG, Ambulatory EEG, Routine EEG and PSG with WiFi/LAN connectivity. Sienna Ultimate has a unique range of changeable headboxes allowing different applications with the same Amplifier. Award winning design, high specification now available in the US

EMD Serono, Inc.

eNeura, Inc.

Booth

511

Booth

1847

1600 John. F Kennedy Boulevard Suite 1800 Philadelphia, PA 19103 elsevier.com

One Technology Place Rockland, MA 02370 emdserono.com

EMD Serono is the North America biopharma business of Merck KGaA, Darmstadt, Germany - a leading science and technology company focused exclusively on specialty care. For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. EMD Serono has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in oncology, immuno-oncology and immunology.

150 2018 AAN Annual Meeting On-site Guide

Booth

716

715 N. Pastoria Ave. Sunnyvale, CA 94085 eneura.com

eNeura Inc., a privately-held medical technology company, is pioneering the use of portable, noninvasive transcranial magnetic stimulation (TMS) devices for treatment of migraine. Prescribed by physicians but designed for patient use, the sTMS mini™ is the first truly portable, convenient TMS product that will allow migraine patients to administer treatment as needed‑at home, in the office, or on the go. The sTMS mini is indicated for the acute and prophylactic treatment of migraine.

New Exhibitor Epilepsy Foundation Booth

1474

8301 Professional Place East Suite 200 Landover, MD 20785 epilepsy.com

The Epilepsy Foundation is your unwavering ally on your journey with epilepsy and seizures. The Foundation is a community-based, family-led organization dedicated to improving the lives of all people impacted by seizures.

7th Floor Commerce 4 Prahlad Nager , Nr Shell Petrol Pump Ahmedabad, Gujarat 380015 eris.co.in

Eris is one of the fastest growing companies within the chronic and acute categories of the Indian branded formulations market. Eris focuses on developing, manufacturing and marketing products for lifestyle related disorders such as: cardiovascular,antiofdiabetes vitamins and Neurology. Eris focus on diseases that are chronic in nature and treated by super specialist and specialist doctors. Eris is the youngest in the top 25 companies in the branded formulations segment with 192 regtd. products.

EUROIMMUN Booth

635

Every Body Fitness Booth

926

6216 E. Pacific Coast Hwy #26 Long Beach, CA 90803 ebfitnessonline.com

New

Seekamp 31 Luebeck, 23560 euroimmun.com

EUROIMMUN offers a comprehensive range of multiparametric tests for anti-neural autoantibodies, encompassing over 35 defined specificities. Autoantibody detection can establish a diagnosis of autoimmune encephalitis, paraneoplastic syndrome or neuromyelitis optica spectrum disorders and clarify symptoms such as memory deficits, psychosis and seizures. EUROIMMUN also offers assays for neurodegeneration biomarkers, e.g. in Alzheimer's disease, and for pathogen-specific antibodies affecting the CNS.

Booth

652

1128 E. Greenway St. Suite 1 Mesa, AZ 85203 eyetechds.com

EyeTech debuts world's first high speed diagnostic VR headset with integrated eye tracking technology capturing 16000 data points per sec. In collaboration with aerospace medicine and vestibular research scientists, EyeTech also introduces OCATofthe latest science able to quantify cognitive performance and detect cognitive impairment. This technology is now being embedded into to medical diagnostic solutions for neurological testing, pharmaceutical performance and disease progression monitoring.

Frontiers Booth

2113

Avenue du Tribunal Federal 34 3rd Floor LAUSANNE, Vaud 1005 frontiersin.org

EXHIBITORS BY NAME

Eris Lifesciences LTD

1867

New

EyeTech Digital Systesm

New Booth

Exhibit Hall Passport Destination

Frontiers is an award-winning Open Science platform and leadingopen-access scholarly publisher.Ourmission is to make high-quality, peer-reviewedresearch articles rapidly and freely available to everybody in the world, thereby accelerating scientific and technological innovation, societal progress and economic growth. For more information, visit www.frontiersin.org

151

EXHIBITOR DESCRIPTIONS GE Healthcare Booth

323

100 Results Way Marlborough, MA 01752 gehealthcare.com

GE Healthcare provides transformational medical technologies & services to meet the demand for increased access, enhanced quality & more affordable healthcare around the world. GE works on things that matter - great people & technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring & diagnostics to drug discovery, biopharm manufacturing technologies & performance improvement, GE Healthcare helps medical professionals deliver great healthcare to patients.

Genentech, A Member of the Roche Group

Booth

1802

1 DNA Way South San Francisco, CA 94080 gene.com

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 35 years. At Genentech, we use human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or lifethreatening medical conditions. Today, we are among the world’s leading biotech companies, with multiple products on the market and a promising development pipeline.

New

General Sleep Booth

807

26250 Euclid Ave Suite 709 Cleveland, OH 44132 generalsleep.com

152 2018 AAN Annual Meeting On-site Guide

Glut1 Deficiency Foundation Booth

1572

PO Box 737 Owingsville, KY 40360 G1DFoundation.org

The Glut1 Deficiency Foundation is a nonprofit family organization dedicated to improving the lives of those in the G1D community through its mission of increased awareness, improved education, advocacy for patients and families, and support and funding for research.

Great Lakes NeuroTechnologies Booth

1019

10055 Sweet Valley Dr. Suite 1 Cleveland, OH 44125 GLNeuroTech.com

Great Lakes NeuroTech focuses on wearable sensors, mobile apps, and web applications to capture objective measures for clinical trials and patient care. Kinesia technology provides objective Parkinson's monitoring for clinical trials, patient care, and programming deep brain stimulation: http://glneurotech.com/kinesia/ . BioRadio technology provides wearable, wireless tech for capturing cardiorespiratory measures for clinical trials: https://glneurotech.com/bioradio/

Greenwich Biosciences, Inc. Booth

435

3777 Sweat Creek Run Marietta, GA 30062 greenwichbiosciences.com

Our strategy is to be the world leader in the field of cannabinoid science. We focus on the research, development and commercialization of cannabinoid molecules as novel pharmaceutical therapies. Our lead product candidate, Epidiolex (CBD), is currently in Phase 3 trials in Dravet Syndrome, Lennox Gastaut Syndrome, Infantile Spasms, and to treat the seizures associated with Tuberous Sclerosis Complex.

New Exhibitor Gundersen Health System Booth

561

1900 South Ave. La Crosse, WI 54601 gundersenhealth.org/ medcareers

Hawaiian Moon Booth

1262

321 S. Missouri Ave Clearwater, FL 33756 aloecream.biz

Say Goodbye to Dry Skin with Hawaiian Moon Organic Aloe Cream!

Hayes Locums Booth

1210

6700 N. Andrews Avenue Suite 600 Fort Lauderdale, FL 33309 hayeslocums.com

Our mission is to provide dependable and trustworthy placement services on a temporary and permanent basis to both physicians and healthcare institutions nationwide. We have a network of physicians who are interested in short and long-term locum tenens assignments, as well as permanent placement. Getting you placed at the right assignment is just the beginning of our first-class service. Our goal is to focus on your needs, so you can take care of the needs of your patients.

HCA

Booth

656

2000 HealthPark Drive Brentwood, TN 37027 practicewithus.com

HCA owns and operates over 170 hospitals across the United States, which makes us one of the nation's leading providers of healthcare services. We believe exceptional patient outcomes only come through a dedicated community of care, placing our physicians at the forefront.

New

Healix Infusion Therapy Booth

619

14140 SW Freeway Suite 400 Sugar Land, TX 77478

Health Monitor Network Booth

2129

135 Chestnut Ridge Rd 2nd Floor Montvale, NJ 07645 healthmonitornetwork.com

Health Monitor Network™ is the nation's leading patient engagement company (40+ million patients and 360,000+ physicians). Our mission is to facilitate dialogue between patients and healthcare professionals through the quality, independence of our content, and the strength of 30+ exclusive strategic relationships with healthcare associations and advocacy organizations, including AAN, MSSA, AANP, AAPA and various state associations. Please see how we enhance the patient experience at Booth# 2129.

EXHIBITORS BY NAME

Gundersen Health System, based in La Crosse, WI, invites you to join us in our mission to deliver excellence in patient care, education, and research, and to improve health in the communities we serve. We are a physician-led, teaching hospital, employing over 500 medical staff. Located along the upper Mississippi River, La Crosse and surrounding communities offer unparalleled natural beauty. Fine arts and performing arts, great restaurants, and good schools make this a great place to live!

Exhibit Hall Passport Destination

153

EXHIBITOR DESCRIPTIONS Houston Methodist Booth

547

6565 Fannin St Houston, TX 77030 houstonmethodist.org

Consistently recognized by U.S. News & World Report as one of the best hospitals for neurological and neurosurgical care, the Houston Methodist Neurological Institute is a pioneer in the neurosciences, providing exceptional patient care, groundbreaking research and renowned academic programs. Through integration of neurological specialties, Houston Methodist treats the most complex neurological disorders while providing personalized care from diagnosis to rehabilitation.

795 SAN ANTONIO RD PALO ALTO, CA 94303 igenex.com

Impax Laboratories, Inc. Booth

1203

31047 Genstar Road Hayward, CA 94544 impaxlabs.com

Impax Specialty Pharma is a branded product division of Impax Laboratories™, Inc. Impax Specialty Pharma is focused on targeting significant unmet needs, with a primary focus on developing treatments for neurological disorders.

Inova Neuroscience and Spine Institute

763

Booth

1872

557

505 Doyle Avenue Kelowna, BC V1Y0C5 physicianjobs.interiorhealth. ca

3130 Fairview Park Dr. Falls Church, VA 22042 inova.org/inovaneuroscience-institute

Inova Neuroscience and Spine Institute is a regional leader in the diagnosis, treatment and research of complex neurological conditions involving the brain, spine and nervous system.

154 2018 AAN Annual Meeting On-site Guide

36 South State St. 21st floor Salt Lake City, UT 84111 Physicianjobsintermountain.org

Visit Intermountain Healthcare to learn about exciting physician job opportunities. Intermountain Healthcare is a Utah-based nonprofit system of 22 hospitals, 185 clinics, a Medical Group (1,400+ employed physicians), a health-plan division (Select Health), and other health services. Intermountain is recognized as a leader in clinical quality improvement and efficient healthcare delivery. https://intermountainhealthcare.org/, https:// Physicianjobsintermountain.org

International Essential Tremor Foundation Booth

New Booth

Interior Health

Booth

IGeneX, Inc.

636

New

Intermountain Healthcare

New Booth

Our highly trained and nationally recognized physicians treat a wide range of conditions, including neurotrauma, spine conditions, epilepsy, movement disorders, brain and spinal tumors, memory disorders and stroke and cerebrovascular disease.

1576

11111 W. 95th St. Suite 260 Overland Park, KS 66214 essentialtremor.org

The International Essential Tremor Foundation provides hope to the essential tremor (ET) community worldwide through awareness, education, support, and research. Founded in 1988 as a 501(c)3 non-profit membership organization, the IETF consists of patients, physicians, educators, health care workers, parents, relatives, friends and volunteers.

How long will it take you to unlock the possibilities

Test your Knowledge Booth 1261 April 22-25 Los Angeles

EXPERIENCE PRESENTED BY

Teva Pharmaceuticals is committed to advancing migraine science and education.

Welcome to The Migraine Prevention Challenge!

Join the Experience

You’re about to enter a hotel room where your vacation is about to start. Or is it? You will need to work together with your team to find clues, solve puzzles and try to overcome a migraine attack. We only have a few simple guidelines: If something is glued, screwed or stapled together, it’s supposed to be that way. There’s no solution to this game that involves breaking things.

Booth 1261 April 22-25 Los Angeles

You can use your cell phones inside if you like! Google, texting and phoning a friend are all absolutely allowed. Teamwork is paramount to winning! You’re all working together to solve this game, so if you find something, share it with everyone else. Remember, you’re being timed. The better you work together, the faster you can escape! One door will remain unlocked at all times. If you would like to exit the room before the game has concluded, please ask the room attendant. Each team will have five minutes to attempt their escape. Have fun, and good luck — you’ll need it! By entering the Migraine Prevention Challenge room, you assume the risk of playing the game and agree to release Teva Pharmaceuticals USA, Inc., its affiliates, officers, employees and agents from any liability connected with the Migraine Prevention Challenge game.

New Exhibitor

International Parkinson and Movement Disorder Society (MDS) Booth

1672

555 East Wells Street Suite 1100 Milwaukee, WI 53202 movementdisorders.org

Invitae Booth

617

1400 16th Street San Francisco, CA 94103 invitae.com

Invitae's mission is to bring genetic information into mainstream medical practice to improve healthcare for everyone. We offer clinically validated, affordable genetic testing for neurology, pediatric, metabolic, cardiology, oncology and more.

New

Ionis Pharmaceuticals Booth

707

2855 Gazelle Court Carlsbad, CA 92010 ionispharma.com

Ipsen Biopharmaceuticals, Inc. Booth

335

106 Allen Road 3rd Floor Basking Ridge, NJ 07920 ipsenus.com/

Ipsen Biopharmaceuticals, Inc. is the US affiliate of Ipsen, a global specialty-driven pharmaceutical group. At Ipsen Biopharmaceuticals, we focus our resources, investments, and energy on discovering, developing, and commercializing new therapeutic options for oncologic, neurologic, and endocrine diseases. For more information on Ipsen in North America, please visit www. ipsenus.com or www.ipsen.ca

Jackson & Coker Booth

1116

3000 Old Alabama Road Suite 119-608 Alpharetta, GA 30022 jacksoncoker.com

Jackson & Coker, among the most wellrecognized healthcare staffing firms in the United States, is dedicated to uniting top locum tenens physicians and advanced practitioners with the medical facilities that need them, ensuring patients have access to life-saving care in their own communities. Jackson & Coker is ranked as a Best Staffing Firm to Work For by Staffing Industry Analysts. At Jackson & Coker,”We focus on you of the patient's true hero.” For more information, visit JacksonCoker.com.

EXHIBITORS BY NAME

The International Parkinson and Movement Disorder Society (MDS) is a professional society bringing together over 7,500 clinicians, scientists, and other healthcare professionals who are interested in Parkinson’s disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic movement disorders, and abnormalities in muscle tone and motor control. MDS provides professionals with a variety of educational and networking opportunities across the globe, among many online resources.

Exhibit Hall Passport Destination

Jari Electrode Supply Booth

417

380 Tomkins Court Gilroy, CA 95023

157

EXHIBITOR DESCRIPTIONS New

Johns Hopkins University Press Booth

1570

2715 North Charles Street Baltimore, MD 21218 jhupbooks.press.jhu.edu

Johns Hopkins University Press is an awardwinning publisher of journals, books, and electronic media with more than 300+ book/ ebook titles in health and wellness aimed at educating consumers, including market-leading works devoted to Dementia, Parkinson's Disease, Epilepsy, and other core areas in neurology.

KabaFusion Booth

648

17777 Center Court Dr N Ste 550 Cerritos, CA 90703-9337 kabafusion.com

KabaFusion is a pharmacist-owned, patientfocused team of professionals with extensive experience in home infusion and specialty infusion therapy. Services are provided from our seven specialty pharmacies located in CA, TX, NJ, MA, IL, FL and PA, serving over 30 states across the country. Our pharmacists, nurses, and reimbursement specialists work as a team to provide your patient with compassionate, efficient, and reliable care.

Kaiser Permanente - Permanente Medical Groups Booth

863

393 East Walnut Street Pasadena, CA 91188 physiciancareers.kp.org

Within the Permanente Medical Groups, physicians find recognition, stability, opportunity, and independence. Driven by the needs of our members and built on a platform in which medical decisions are made by physicians, each of our locations is able to self-manage the resources necessary for the delivery of excellent patient care. Beyond the practice of medicine, our physicians are provided with many personal and professional opportunities.

158 2018 AAN Annual Meeting On-site Guide 158

New

Kedrion Biopharma Inc. Booth

2219

400 Kelby Street 16th Floor Fort Lee, NJ 07024 gammaked.com

King-Devick technologies, inc. Booth

924

2 Mid America Plaza suite #110 Oakbrook Terrace, IL 60181 kingdevicktest.com

King-Devick Technologies, Inc. offers a broad set of evidence-based solutions utilizing integrated technology for concussion management and indicators of neurological function. King-Devick products have been scientifically validated in more than 110 recent peer reviewed articles published in elite medical journals related to concussion management, reading solutions, Alzheimer's disease, hypoxia, multiple sclerosis, Parkinson's disease, sleep disorders, extreme sleep deprivation and ALS.

KRONUS, Inc. Booth

1118

170 S. Seneca Springs Way Ste 105 Star, ID 83669 kronus.com

For more than 30 years, KRONUS has served as a leading provider of specialized immunoassay test kits to medical professionals at the world's most respected research and clinical laboratory facilities. The Company will be presenting information on its neuroimmunology-related test kits. Please take a few moments to visit our informative exhibit at booth number 1118 and learn more about our unique and innovative product line.

New Exhibitor LBDA

Booth

1568

912 Killian Hill Rd Lilburn, GA 30047 lbda.org

The Lewy Body Dementia Association (LBDA) is a 501(c)(3) nonprofit organization dedicated to raising awareness of the Lewy body dementias (LBD), supporting people with LBD, their families and caregivers and promoting scientific advances. The Association’s purposes are charitable, educational, and scientific.

Booth

552

1120 NW 20th Ave Ste 111 Portland, OR 97209 legacyhealth.org

At Legacy Health, we do what is right ‑ for our employees, our patients, our communities and our world. That means helping people get healthy and stay that way. It also means encouraging medical professionals to set a higher standard. Tending to the little things that help patients heal, to meet the needs of those we serve. At Legacy, our fundamental responsibility is to improve the wellness of everyone we touch, empower people to live healthier lives, and to create a legacy that truly lives on.

Liftware Booth

2133

1600 Amphitheatre Parkway Mountain View, CA 94043 liftware.com

We are a group of scientists and engineers working to develop assistive technologies for people with essential tremor, Parkinson's disease, spinal cord injury, cerebral palsy, and other motion disorders. Seeing the experiences of our friends and family motivated us to create Liftware products focused on improving overall quality of life and independence for those with mobility impairments. Liftware joined Google Life Sciences in 2014, which became Verily in 2015.

Lilly

Booth

603

Lilly Corporate Center Indianapolis, IN 46285 lilly.com

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities.

LivaNova Booth

351

100 Cyberonics Blvd. Houston, TX 77058 vnstherapy.com

LivaNova PLC is a global medical technology company built on nearly five decades of experience and a commitment to improve the lives of patients worldwide. LivaNova's advanced technologies and breakthrough treatments provide meaningful solutions for patients, healthcare professionals and healthcare systems across three business franchises: Cardiac Surgery, Neuromodulation and Cardiac Rhythm Management. LivaNova PLC is proud to sponsor AAN and advance the wellbeing of those living with epilepsy.

EXHIBITORS BY NAME

Legacy Health Careers

Exhibit Hall Passport Destination

159

EXHIBITOR DESCRIPTIONS LocumTenens.com Booth

1028

2655 Northwinds Parkway Alpharetta, GA 30009 locumtenens.com

Founded in 1995, LocumTenens.com is a fullservice staffing firm serving physicians, advanced practice professionals and healthcare facilities looking to solve employment shortages. Operator of the largest online job board for the locums industry, LocumTenens.com provides job-seeking providers direct access to thousands of jobs, in all specialties, posted directly by facilities and agencies nationwide.

447

Booth

734

Mayo Medical Laboratories

1003 Six Parkway North Deerfield, IL 60015 lundbeckus.com

Lundbeck, a global pharmaceutical company based in Denmark and founded in 1915, strives for global leadership in psychiatry and neurology by improving the lives of patients. One of the world's leading companies specializing in brain disorders, Lundbeck is focused on innovating treatments for depression, schizophrenia, Parkinson's disease and Alzheimer's disease.

Booth

1574

One Medical Center Drive Lebanon, NH 03766 ManagingEpilepsyWell.org

The Managing Epilepsy Well (MEW) Network is a team of people who care about the health of people with epilepsy. MEW Network members come from U.S. universities, community-based organizations and the Centers for Disease Control and Prevention (CDC). As a non-profit entity, we work together to promote epilepsy selfmanagement research and improve the quality of life for people with epilepsy.

160 2018 AAN Annual Meeting On-site Guide

3050 Superior Drive NW Rochester, MN 55905 MayoMedicalLaboratories.com

Mayo Medical Laboratories is a global reference laboratory operating within Mayo Clinic's Department of Laboratory Medicine and Pathology. Our comprehensive neurology testing menu, as well as the expertise of Mayo Clinic neurologists, lab directors and genetic counselors, provides the detailed clinical information to diagnose and treat hundreds of neurological conditions.

McGraw-Hill Education Booth

Managing Epilepsy Well Network

200 First Street SW BioBusiness 8 Rochester, MN 55905 mayoclinic.org

Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. The Referring Provider Office is a resource for all providers outside of Mayo Clinic, whether you are getting in touch with Mayo for the first time or have an ongoing relationship with us and our providers. We want to collaborate with you!

Booth

Lundbeck

Booth

Mayo Clinic

2013

2 Penn Plaza 9th Floor New York, NY 10121 mcgrawhillmedical.com

McGraw-Hill Education is a premier publisher of medical print and electronic media including Adams & Victor's Principles of Neurology and the Neurology Collection on AccessMedicine™.

New Exhibitor McKesson Specialty Health Booth

1112

123 Mission Street San Francisco, CA 94105 mckessonspecialtyhealth.com

Medscape Neurology Booth

2035

Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME.

Medtronic Booth

MEDDAY PHARMACEUTICALS Booth

423

24-26 rue de la pepinire PARIS, 75008 medday-pharma

MedDay addresses areas of unmet need in neurological and psychiatric diseases through the brain metabolism. This approach relies on unique clinical and pharmaceutical development expertise in the field of rare inborn errors of metabolism.

MedLink Neurology Booth

2112

10393 San Diego Mission Road Suite 120 San Diego, CA 92108 medlink.com

Thousands of neurologists worldwide rely on MedLink™ Neurology to quickly find authoritative, current answers to their clinical questions, as well as to earn free CME credits with routine use. Whether clinician, scientist, or member of industry, ask us how you can benefit by connecting with this select community. Visit us in Publishers’ Row and sign up for 30 days of free access to MedLink Neurology.

825 8th Avenue New York, NY 10019 medscape.com/neurology

1503

710 Medtronic Pkwy Minneapolis, MN 554325603 medtronic.com

Through innovation and collaboration, Medtronic improves the lives and health of millions of people each year. Visit our booth #1503 for information on our treatments for Parkinson's disease, essential tremor, normal pressure hydrocephalus and large vessel occlusion ischemic stroke. In addition, see how medical technology can help you manage patients with cryptogenic stroke.

Merz Neurosciences Booth

311

6501 Six Forks Rd. Raleigh, NC 27615 merzusa.com

EXHIBITORS BY NAME

McKesson Specialty Health is the leading provider of specialty pharmaceutical distribution services and practice management solutions to neurology offices. We deliver innovative drug therapies and offer support services that help practices grow revenue and profitability, control drug costs and capture operational efficiencies. Our neurology specialist team will work directly with you to ensure your practice's success.

Exhibit Hall Passport Destination

Merz Neurosciences is dedicated to delivering a better total experience to patients and physicians in neurosciences. We strive to deliver meaningful treatment options and a better patient experience in order to meet the needs of each person we serve. Merz Neurosciences is an important contributor to the U.S. neurosciences space, offering a well-balanced product portfolio that includes the neurotoxin Xeomin™ (incobotulinumtoxinA) and the anticholinergic Cuvposa™ (glycopyrrolate) Oral Solution.

161

EXHIBITOR DESCRIPTIONS Micromedical Technologies, Inc. Booth

738

10 Kemp Drive Chatham, IL 62629 micromedical.com

Micromedical by Interacoustics leads the industry by providing state of the art turnkey Balance Centers to clinicians whose patient populations include those with vestibular or neurological disorders, traumatic brain injury or individuals who are pursuing balance enhancement.

Mitsubishi Tanabe Pharma America

MNG Laboratories Booth

922

5424 Glenridge Dr. Atlanta, GA 30342 mnglabs.com

MNG Laboratories is an internationally recognized clinical diagnostic leader specializing in neurogenetic and complex biochemical testing. With over 15 years of neurogenetic experience, and powered by a culture of discovery and advancement, MNG Laboratories delivers results that make a difference for patients and their families.

New

Moebius Syndrome Foundation Booth

Booth

1322

525 Washington Blvd Suite 400 Jersey City, NJ 07310 mt-pharma.co.jp/e/index.php

Mitsubishi Tanabe Pharma America Medical Affairs

Booth

1029

525 Washington Blvd Suite 400 Jersey City, NJ 07310 mt-pharma-america.com/

1469

PO Box 147 Pilot Grove, MO 65276 moebiussyndrome.org

MotherToBaby Booth

1674

7910 Frost St. Suite 370 San Diego, CA 92123 mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists (OTIS), provides evidence-based information about medications and other exposures during pregnancy and lactation. MotherToBaby Pregnancy Studies conducted by OTIS is evaluating effects to the fetus from Multiple Sclerosis and the safety of medications used to treat MS during pregnancy.

Mount Sinai Health System Booth

509

One Gustave L. Levy Place New York, NY 10029 mountsinaihealth.org/ patient-care/neurology

Icahn School of Medicine at Mount Sinai Department of Neurology The Estelle and Daniel Maggin Department of Neurology at

162 2018 AAN Annual Meeting On-site Guide

New Exhibitor the Icahn School of Medicine at Mount Sinai in New York City has over a 100-year history, with an international reputation for excellence across inpatient and outpatient neurological subspecialties. Directed by Barbara G. Vickrey, MD, MPH, the department continues to advance clinical care, academic training, and elucidate the underlying mechanisms of neurological disease.

MS Care Connect Booth

905

MS Care Connect Mobile App and Web-based dashboard This free, comprehensive tool supports you and your staff by providing the ability to: *Quickly view your patients' PRO survey results to enhance conversations and support shared treatment decisions *Track your patients' progress between office visits *Compare your patient, or entire practice, against national, or other, populations *Filter data based on a number of variables, including diagnosis, disease severity, and patient demographics

MULTIGON INDUSTRIES,INC. Booth

1213

525 Executive Boulevard Elmsford, NY 10523 multigon.com

Multigon Industries 1213 is exhibiting its NEXGEN Digital Transcranial Doppler (TCD) Ultrasound with unique Robotic Headband for Long-term monitoring. The Robotic Headband locks on to the signal and maintains it despite patient or headband movement. Other functions include emboli monitoring , PFO’s,Vasomotor reactivity, integrated optional capnostat, management of vasospasm. 5 CPT codes can be utilized. Optional Integrated ICM+ and Finapress beat to beat blood pressure for autonomic testing.

Multiple Sclerosis Foundation Booth

1566

6520 North Andrews Ave Fort Lauderdale, FL 33309 msfocus.org

The Multiple Sclerosis Foundation, known in the MS community as MS Focus, is a nonprofit organization focused on providing free services that address the critical needs of people with MS and their families, helping them maintain the best quality of life. The symptoms of MS may increase in severity over time. This presents many challenges families must face. MS Focus is here to provide the support, education, and assistance needed to adapt to these challenging circumstances.

New

MVAP Medical Supplies Inc. Booth

514 Mylan Inc. Booth

504

1415 Lawrence Drive Newbury Park, CA 91320

1000 Mylan Blvd Canonsburg, PA 15317 mylan.com

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Our mission is to provide the world's 7 billion people access to high quality medicine. We offer a growing portfolio of more than 1,400 generic pharmaceuticals and several brand medications in approximately 165 countries and territories.

EXHIBITORS BY NAME

370 E 9th Ave, Suite 111 Salt Lake City, UT 84103 mscareconnect.com

Exhibit Hall Passport Destination

National ALS Registry Booth

518

MS F-57 Atlanta, GA 30341 cdc.gov/als

The main goals of the congressionally mandated National ALS Registry are to better describe the incidence and prevalence of ALS, examine risk factors such as environmental and occupational factors, and characterize the demographics

163

EXHIBITOR DESCRIPTIONS of persons living with ALS. The National ALS Registry recently launched the National ALS Biorepository to further expand ALS research into areas such as genetics, biomarkers, and environmental toxicants.

National Headache Foundation Booth

1476

820 N. Orleans St. Suite 201 Chicago, IL 60610 headaches.org

The National Headache Foundation's mission is”To cure headache, and end its pain and suffering.” Its vision is”A World Without Headache.” It is the premier educational and informational resource for those with headache, health care providers, and the public. It publishes the quarterly magazine, HeadWise™ and the monthly e-newsletter, NHF News to Know. For information or a list of physicians in a geographical area who treat headache, visit www.headaches.org, or call 1-888-NHF-5552.

National Institute of Neurological Disorders & Stroke Booth

1312

31 Center Dr., MSC 2540 Building 31, Room 8A07 Bethesda, MD 20892-2540 ninds.nih.gov

The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, provides members of the American Academy of Neurology with information on available research support and offers free publications for patients and their families on a wide variety of neurological disorders. Members of the NINDS staff will be available at the exhibit booth to assist you. Printed material is available.

Natus Neurology Booth

2003

3150 Pleasant View Road Middleton, WI 53562 natus.com

Natus Neuro provides leading solutions for the neurodiagnostic, neurosurgery, and neurocritical care markets. Neurodiagnostic solutions enhance the diagnosis and monitoring of various

164 2018 AAN Annual Meeting On-site Guide

neurological conditions such as epilepsy, sleep disorders, and neuromuscular diseases. Neurosurgery and neurocritical care solutions limit uncertainty with advanced fluid drainage, shunts and intracranial pressure monitoring systems.

Neuro Central Booth

827

Future Medicine Unitec London , UK N3 1QB neurology-central.com

Neuro Central is a free online hub that bridges the gap between neuroscience and neurology, supporting synergistic progression through collaboration and learning. Designed for researchers and clinicians, and endorsed by an expanding board of Expert Panel members from across the globe, we keep you up to date with the latest news, interviews, opinions, podcasts and more, plus peer-reviewed articles from our partnered journals.

New

Neuro Kinetics, Inc. Booth

2139

128 Gamma Dr. Pittsburgh, PA 15238 neuro-kinetics.com

Neuro Kinetics, Inc., the world leader in clinical eye tracking and non-invasive neuro-functional diagnostic testing, has the Science to See™ neuro-functional biomarkers invisible to the naked eye. Products include the portable, objective, and precise I-PAS™ for oculomotor, vestibular & reaction time testing, and other I-Portal™ systems. Thirty-plus years of leading edge science is enabling NKI to expand beyond vestibular markets to new areas in mTBI, concussion, ophthalmology, and neurology.

Neurocrine Biosciences Booth

927

12780 El Camino Real San Diego, CA 92130 neurocrine.com

New Exhibitor Neurocrine Biosciences, Inc.

Neurovirtual

1022

1463

Booth

12780 El Camino Real San Diego, CA 92130 neurocrine.com

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals utilizing our novel R&D platform. Neurocrine’s efforts are focused on conditions with high unmet medical needs, specifically in neurological and endocrine based diseases and disorders.

Booth

2103

275 7th Avenue 10th floor New York, NY 10001 neurologyadvisor.com

Neurology Career Center Booth

662

201 Chicago Ave Minneapolis, MN 55415 AAN.com/careers

The AAN’s Neurology Career Center is the world’s largest neurology-specific career resource. Search over 500 open neurology positions nationwide. Create a Job Alert to receive notication when new positions of interest are posted. Download articles on career topics. AAN Junior members can access the Salary Calculator tool. A variety of advertising options exist for employers including online, print and e-mail options.

NEUROLOGY REVIEWS Booth

1208

7 Century Drive Suite 302 Parsippany, NJ 07054 neurologyreviews.com

NEUROLOGY REVIEWS is a clinical news publication with articles and timely department features that keep neurologists, primary care physicians, and other healthcare professionals informed of the latest news affecting their practice. NEUROLOGY REVIEWS covers major medical conferences and monitors the peer review literature to report the latest research findings.

Booth

3300 W. Commercial Blvd. Suite 100 Fort Lauderdale, FL 3309 neurovirtual.com

At Neurovirtual, we specialize in the development, manufacturing, and marketing of premium-quality diagnostic devices used in the fields of Neurology and Sleep Medicine. Our mission is to provide the latest technology at a fair price. Our corporate culture promotes quality, innovation, and a people-first approach to every facet of the ownership experience, with round-the-clock access to live help and software solutions that evolve with you.

NIHON KOHDEN AMERICA, INC. Booth

947

15353 Barranca Parkway Irvine, CA 92618 us.nihonkohden.com

Nihon Kohden is the leading manufacturer, developer and supplier of instrumentation and services for Epilepsy Monitoring, Electroencephalography, Ambulatory and OCST Recording, Polysomnography, Electromyography, Evoked Potentials, Intra-operative and cEEG ICU monitoring. Nihon Kohden's products offer the flexibility and expandability needed to meet the changing demands of today's neurodiagnostic field.

EXHIBITORS BY NAME

Neurology Advisor

Exhibit Hall Passport Destination

New

NINDS CDE Project Booth

1316

401 N Washington Street Suite 700 Rockville, MD 20850 emmes.com

Although the term, contract research organization, is often used to describe our industry, we consider ourselves a clinical research collaborator. We work side-by-side with leading researchers to tackle challenges that have an impact on public health throughout the world.

165

EXHIBITOR DESCRIPTIONS Ochsner Health System

New

Northwell Health Booth

1569

600 Community Drive Manhasset, NY 11030 northwell.edu

ABOUT NORTHWELL HEALTH As New York State's largest health care provider and private employer with 23 hospitals and more than 600 outpatient locations throughout the Metro New York area and beyond, Northwell Health serves over 11 million people. Northwell is the major teaching affiliate of the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Come visit us at Booth 1569 to learn more about Northwell Health and the department of Neurology.

Novartis Pharmaceuticals

Booth

1331

One Health Plaza East Hanover, NJ 07936

Novocure Inc. Booth

637

195 Commerce Way Portsmouth, NH 03801 novocure.com

Novocure is a Jersey Isle oncology company pioneering a novel therapy for solid tumors called TTFields. Novocure's US operations are based in Portsmouth, NH and New York, NY. Additionally, the company has offices in Germany, Switzerland, and Japan and a research center in Haifa, Israel. For additional information about the company, please visit www.novocure.com or follow us at www.twitter.com/novocure.

166 2018 AAN Annual Meeting On-site Guide

Booth

858

1514 Jefferson Hwy. New Orleans, LA 70121 ochsner.org

The Ochsner Neuroscience Institute earns national and regional recognition as a leader in providing quality neuroscience services. Our multidisciplinary team offers the latest diagnostic and therapeutic options and is actively recruiting BC/BE Neurologists to join its group of 36 neurologists. We are a Top 25 Neuroscience Center in the latest US News & World Report rankings. Ochsner is Louisiana's largest non-profit, academic, healthcare system, employing more than 1,200 physicians.

OhioHealth Booth

1573

180 E. Broad St. Columbus, OH 43215 ohiohealth.com

OhioHealth is home to one of the nation's largest comprehensive neuroscience programs. The $321 million OhioHealth Neuroscience Center features an unmatched range of care such as inpatient and outpatient treatment, neurodiagnostics, interventional procedures, clinical trials, surgery and education. Riverside Methodist is also certified by The Joint Commission as a Comprehensive Stroke Center, and was ranked a 2016-2017”Best Hospital” for neurology and neurosurgery by U.S. News & World Report.

New

OSF HealthCare Illinois Neurological Institute Booth

962

1420 W Pioneer Parkway Peoria, IL 61615 osfcareers.org

Experience the difference of a Mission-driven culture. Everyone who works at OSF HealthCare is a Mission Partner working together to serve our patients which the greatest care and love. OSF HealthCare, owned and operated by The Sisters of the Third Order of St. Francis, Peoria, Illinois,

New Exhibitor includes OSF Healthcare System consisting of 13 hospitals and medical centers and two colleges of nursing. Join our dynamic health care team!

Oxford University Press Booth

2117

198 Madison Avenue New York, NC 10016 global.oup.com

New

Parkview Health Booth

960

3942 New Vision Drive Fort Wayne, IN 46845 parkview.com

PeaceHealth Booth

660

1115 SE 164th Ave. Vancouver, WA 98683 peacehealth.org

PeaceHealth, based in Vancouver, WA., is a not-for-profit Catholic health system offering care to communities in Washington, Oregon, and Alaska. PeaceHealth has approximately 16,000 caregivers, a multi-specialty medical group practice with more than 900 providers, 10 medical centers and 70+ clinics serving both urban and rural communities throughout the Northwest. To learn more about PeaceHealth, please visit our homepage peacehealth.org/providercareers.

New

Penn State Health Booth

859

MC A595, Post Office Box 855 90 Hope Drive Hershey, PA 17033 pennstatehealth.org

Penn State Health is a multi-hospital health system serving patients and communities across central Pennsylvania. The system includes Penn State Health St. Joseph Medical Center in Reading, Pa., Penn State Health Milton S. Hershey Medical Center, Penn State Children's Hospital, Penn State Cancer Institute, and Penn State Health Rehabilitation Hospital (jointly owned), based in Hershey, Pa., as well as more than 1,300 physicians and direct care providers at 78 medical office locations.

Pfizer

Booth

1015

235 East 42nd Street New York, NY 10017 pfizer.com

At Pfizer, one of the world’s premier innovative biopharmaceutical companies, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

EXHIBITORS BY NAME

Oxford University Press is proud to publish some of the world’s premier books, journals, and online resources in Neurology. Visit our booth for discounts on new and classic titles and free journal samples. www.oup.com/us

Exhibit Hall Passport Destination

New

PHARNEXT Booth

908

11 rue des peupliers Issy les moulineaux, 92130 pharnext.com

Pharnext is an advanced clinical-stage biopharmaceutical developing novel therapeutics targeting severe neurodegenerative diseases rare or common - that currently lack curative and/ or disease modifying treatments. The company was founded in 2007 by renowned scientists and entrepreneurs including Pr Daniel Cohen, a pioneer in modern genomics.

167

EXHIBITOR DESCRIPTIONS Practical Neurology

New

Philips EGI Booth

803

3721 Valley Centre Drive, Suite 500 San Diego, CA 92130 egi.com/

EGI is now a part of Philips, combining EGI's expertise in dense array EEG-based brain imaging and personalized neuromodulation with Philips' expertise in diagnostic imaging, image-guided therapy, and health informatics. Visit our booth to see our electrical source imaging (ESI) solution and to discuss published studies investigating the use of HD EEG and HD ESI for epilepsy presurgical planning.

New

Photo-Stat Booth

2228

120 S BRIERY RD IRVING, TX 75060-2117 photostat.org

Photo-Stat is a leader in release of information services that enable medical facilities to reduce their costs, limit physicians liabilities and increase employee productivity. Our HIPAA compliant services are fully automated and have received recognition of being HITRUST Certified. All medical records processed are scrutinized for accuracy before being delivered securely to authorized medical record requestors including patients for continuing care purposes.

New

Piramal Critical Care Booth

1562

268 Brodhead Road Bethlehem, PA 18017 piramalcriticalcare.com

168 2018 AAN Annual Meeting On-site Guide

Booth

1157

1008 Upper Gulph Rd Ste 200 Wayne, PA 19087-2700 practicalneurology.com

Practical Neurology™ is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. We currently print 9 times a year and have a circulation of over 18,000 physicians.

PracticeLink Booth

929

415 2nd Avenue Hinton, WV 25951 PracticeLink.com

Physicians searching for their first or next practice rely on PracticeLink‑The Career Advancement Resource for Physicians. PracticeLink helps physicians find the practice opportunities that best suit their personal and professional needs, and provides helpful career development and job-search information. Find your next practice on PracticeLink.com

Prevea Health Booth

759

2710 Executive Drive Green Bay, WI 54307 prevea.com

PREVEA HEALTH, a physician owned & led multispecialty group is at AAN seeking Neurologists (Adult, Pediatric & Interventional) to join our group. Prevea offers physicians a voice in their practice and recognizes the importance of Work/ Life balance. Our unique partnership with (6) Hospital Sisters Health System hospitals, based in Northeastern and Western Wisconsin, is one of a kind. Come visit our booth at AAN or contact Becky @ 608-290-2362 to learn more about our outstanding organization.

New Exhibitor

New

Promius Pharma Booth

523

107 College Road East Princeton, NJ 08540 promiuspharma.com

ProtoKinetics Gait Analysis Walkways Booth

2131

60 Garlor Drive Havertown, PA 19083 protokinetics.com

Postural control, dynamic balance, and transitional gait performance [starting, turning, braking] are critical components to quantify in clinical practice; the PKMAS Primary Gait Screen (PGS) is a unique protocol that addresses these transitional movements in a single test (typically performed in less than one minute) that requires no editing and is easy to administer. Data are available immediately. Key gait metrics include efficiency, symmetry, and speed. Over 29 clinical sites and counting...

Providence St Joseph Health Booth

658

800 Fifth Ave Suite 700 Seattle, WA 98104 htprovidence.org/ providerjobs

practice providers each year into its network of hospitals, medical groups and private practice partners in Alaska, California, Montana, Oregon and Washington. Providence is affiliated with Swedish Health Services, Pacific Medical Centers, Kadlec and other like-minded not-forprofit groups, expanding our reach even further.

New

PsychoGenics Inc. Booth

1258

215 College Road Paramus, NJ 07652 psychogenics.com

PsychoGenics, is a leading provider of preclinical CNS capabilities offering behavioral testing, electrophysiology, EEG, histology and microdialysis, along with a variety of transgenic mouse models for dozens of neurodegenerative and psychiatric disorders. PsychoGenics has also pioneered the translation of rodent behavioral responses into robust, high-throughput, high content phenotyping and drug discovery.

New

PTC Therapeutics Booth

453

100 Corporate Court South Planfield, NJ 07080 ptcbio.com

PTC Therapeutics is a global biopharmaceutical company focused on the discovery, development and commercialization of novel orally administered drugs that target RNA mechanisms affecting protein production. It is PTC's mission to bring new therapies to patients affected by rare and neglected diseases such as cystic fibrosis and Duchenne muscular dystrophy. For more information please visit www.ptcbio.com.

EXHIBITORS BY NAME

Promius Pharma designs personal and practical health care solutions for people. Through robust dialogue with patients and HCPs, we try to address the most important unmet needs by creating tailored solutions to help people better manage disease. Promius Pharma is working on numerous R&D programs with the hope of introducing therapies to help people with medical conditions. For more information about how we are putting patients first, visit http:// promiuspharma.com/

Exhibit Hall Passport Destination

Providence Health & Services, rated among the most integrated health systems in the nation, recruits over 1,000 physicians and advanced

169

EXHIBITOR DESCRIPTIONS RDL Reference Laboratory

New

QMENTA Booth

615

Booth

241 A Street Suite 300 Boston, MA 02210 qmenta.com

New

Quadrant Biosciences Booth

825

505 Irving Avenue Suite 3100AB Syracuse, NY 13210 quadrantbiosciences.com

1109

RDL Reference Laboratory is a full service, autoimmune CLIA approved laboratory providing exclusive, quality assays for the practicing and academic Neurologist. We offer the most extensive Myositis Antibody Panel (MyoMarker 3) and uniquely offer Anti-HMGCR Ab for statin-induced myonecrosis, and Anti-cN-1A Ab for sIBM. RDL also performs innumerable autoimmune disease assays.

New

Retrophin Booth

Quest Diagnostics Booth

1217

3 Giralda Farms Madison, NJ 07940 athenadiagnostics.com

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. We serve half of the physicians and hospitals in the United States. QuestDiagnostics.com.

New

RAPID SENSORY CLEANWHEEL Booth

1267

2419 Habor Blvd., Unit 126 Ventura, CA 93001 cleanwheel.com

170 2018 AAN Annual Meeting On-site Guide

10755 Venice Blvd Los Angeles, CA 90034 rdlinc.com

426

3721 Valley Centre Drive Suite 200 San Diego, CA 92130 retrophin.com

Retrophin is a biopharmaceutical company dedicated to delivering life-changing therapies to people living with rare diseases who have few, if any, treatment options.

Rimed USA, Inc. Booth

638

11-11 44th Drive Long Island City Suite G New York, NY 11101 rimed.com

Rimed has been leading the Transcranial Doppler (TCD) system market for over 30 years. TCD is an invaluable examination, allows real-time monitoring of cerebral blood flow velocities. Our products help clinicians improve patient care in over 100 countries, with over 5,000 installations in Stroke, Neurocritical Care, Neurology, Neurosurgery departments.

New Exhibitor

Riverside Healthcare Booth

1472

350 N. Wall St. Kankakee, IL 60914 riversidehealthcare.org

Riverside Medical Center/ Riverside Neurosciences Institute is a Five-star recipient for Treatment of Stroke for 8 years in a row (2010-2017) Our commitment to providing patients with quality services is well-recognized. Our multidisciplinary team approach offers the latest diagnostic and therapeutic options and we are recruiting BC/BE Neurologists to join our Riverside Medical Group (RMG). Riverside Healthcare is a non-profit, fully integrated healthcare system located in IL.

New

RMS Medical Products Booth

906

24 Carpenter Rd Chester, NY 10918 rmsmedicalproducts.com

RMS Medical Products designs, manufactures and markets proprietary, innovative medical devices in compliance with the FDA and international regulatory and quality systems management. Products include FREEDOM™ Syringe Infusion Systems and accessories, RMS HIgH-Flo Subcutaneous Safety Needle Sets™, RMS Precision Flow Rate Tubing™ and RES-QVAC™ Portable Medical Suction System. https://www.rmsmedpro.com.

EXHIBITORS BY NAME

New

Exhibit Hall Passport Destination

EXHIBITOR DESCRIPTIONS RosmanSearch, Inc. Booth

2202

30799 Pinetree Rd, Ste 250 Pepper Pike, OH 44122 rosmansearch.com

RosmanSearch is a Neurosurgery, Neurology and APP recruitment firm. We place quality providers with quality practices nationwide. We are the only search firm with dedicated teams specializing in neuroscience. Our mission is to be the best, the most expert, and the one that is known for quality‑every time!

Saint Luke’s Marion Bloch Neuroscience Institute Booth

1256

901 East 104th Street Kansas City, MO 64063 saintlukeshealthsystem.org

Saint Luke’s Marion Bloch Neuroscience Institute has neuroscience experts who help patients with the most complex brain and spine disorders in the Greater Kansas City area. Our specialists include, a nationally recognized stroke team, a Level 4 Comprehensive Epilepsy Center, neurologists who treat the full range of neurological conditions, subspecialty-trained neurosurgeons, pioneers in cochlear implants, and a clinical team that participates in clinical research trails.

Sanofi Genzyme

Booth

1146

500 Kendall Street Cambridge, MA 02142

Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated

172 2018 AAN Annual Meeting On-site Guide

to discovering and advancing new therapies, providing hope to patients and their families around the world.

Sanofi Genzyme

Booth

953

500 Kendall Street Cambridge, MA 02142

Saol Therapeutics Booth

430

1000 Holcomb Woods Parkway Suite 270 Roswell, GA 30076 saolrx.com

Saol Therapeutics (pronounced”Sail”)is a privately held specialty pharmaceutical company focused on providing therapies to patients with rare diseases.The company currently markets a therapy for the treatment of severe spasticity and has a strategic growth emphasis on the neurologic therapeutic area. For more information, visit www.saolrx.com.

EXHIBITOR DESCRIPTIONS SK life science

New

Sarepta Therapeutics Booth

1857

215 First St Cambridge, MA 02142 sarepta.com

New

Senso Medical Labs Booth

405

265 Franklin St. Suite 1702 Boston, MA 02110 sensomedical.com

Inventing a breakthrough neuroscience technology is just the first step in a long, complicated process in bringing it to market as a viable neuroproduct. SensoMedical is the only company in the world who provides all the necessary expertise under one roof including neurology, electrophysiology, and designing active implants.

Booth

429

SK life science, a subsidiary of SK biopharmaceuticals, has focused its efforts on research and development in CNS disorders since 1993. We are a part of SK Group, a global conglomerate and the second largest company in Korea. In the US, we are transitioning from a clinical-stage company to a fully-integrated pharmaceutical organization. SK life science has two CNS products in late stage development.

New

Society of Vascular and Interventional Neurology Booth

1769

Sensonics International Booth

419

125 White Horse Pike Haddon Heights, NJ 08035 smelltest.com

Sensonics, Inc. provides the medical, scientific and industrial communities with the best smell and taste tests for assessing chemosensory function. The Smell Identification Test™ is the most widely used quantitative olfactory test in the world.

22-10 Route 208 South Fair Lawn, NJ 75028 SKLifeScienceInc.com

5841 Cedar Lake Road Suite 110 Minneapolis, MN 55416 svin.org

The Society of Vascular and Interventional Neurology is an international medical society whose mission is to represent the advancement of interventional neurology as a field with the ultimate goal of improving clinical care and outcomes of patients with stroke and cerebrovascular diseases.

Southeast Health Booth

563

1701 Lacey Street Cape Girardeau, MO 63701 sehealth.org

At SoutheastHEALTH, the region's premier healthcare system in Southeast Missouri, our patients receive excellent care of the highest quality, close to home. Within our network are more than 50 care locations in 14 communities,

174 2018 AAN Annual Meeting On-site Guide

EXHIBITOR DESCRIPTIONS including hospitals, primary and specialty care clinics representing over 30 clinical specialties and extending care for patients in a four-state area. Southeast Hospital in Cape Girardeau has been a trusted health care resource in the community for nearly 100 years.

Southern Ohio Medical Center

463

1805 27th Street Portsmouth, OH 45662 somc.org

New

Spartanburg Regional Healthcare System Booth

860

101 E Wood Street Spartanburg, SC 29303 spartanburgregional.com

Spartanburg Regional, a 540-bed Level 1 Trauma Center, is seeking neurologist to join an expanding neurology program. Our needs are in the inpatient and outpatient setting. The Neurohospitalist will work a 7 on, 7 off schedule; 7am of 7p with no call responsibilities. They will be responsible for rounding, admissions, and consults, as well as handling all neurological emergencies. Must be currently licensed to practice in the state of South Carolina and be board certified in Neurology.

Spectrum Health Clinical Neurosciences Booth

958

SpeechVive Booth

New Booth

Health Medical Group; and Priority Health, a 725,000-member health plan. Spectrum Health is West Michigan's largest employer with 25,500 employees.

333 Bridge Street NW 4th Floor, Suite 410 Grand Rapids, MI 49504 spectrumhealth.org

Spectrum Health is a not-for-profit health system, based in West Michigan, offering a full continuum of care needs. Spectrum Health is comprised of 12 hospitals;180 ambulatory and service sites; 1,600 employed physicians and advanced practice providers including members of the Spectrum

176 2018 AAN Annual Meeting On-site Guide

424

30177 Weisshorn Cir. Pine, CO 80470 speechvive.com

SpeechVive, giving people with Parkinson's a voice! SpeechVive is a behind the ear smart device which helps people with Parkinson's disease speak more loudly and communicate more effectively. The SpeechVive device is supported by over 5 years of clinical data which demonstrated SpeechVive to be effective in improving volume, articulation, and speech rate in 90% of the people participating in two multi-site clinical trials.

Springer Booth

2208

233 Spring Street New York, NY 10013 springernature.com

Springer Nature is one of the world's leading global research, educational and professional publishers, home to an array of respected and trusted brands providing quality content through a range of innovative products and services. Springer Nature is the world's largest academic book publisher and numbers almost 13,000 staff in over 50 countries. www.springernature.com

Staff Care, Inc. Booth

551

8840 Cypress Waters Blvd, Suite 300 Dallas, TX 75019 staffcare.com

Staff Care is an AMN Healthcare company that provides locum tenens recruitment and staffing services. We match physicians, as well as other healthcare professionals, including dentists, CRNAs, nurse practitioners and physician assistants, with all types of medical facilities and healthcare organizations.

New Exhibitor Strongbridge Biopharma Booth

735

900 Northbrook Drive Suite 200 Trevose, PA 19053 strongbridgebio.com

and medicine to help people with serious medical conditions. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological, and respiratory conditions. Additional information can be found on the Company's website: www.sunovion.com. Connect with us @Sunovion.

Sunovion PD Booth

1823

Sunovion Booth

1833

84 Waterford Dr Marlborough, MA 017527010 sunovion.com

Sunovion is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological, and respiratory conditions. Additional information can be found on the Company's website: www.sunovion.com. Connect with us @Sunovion.

Sunovion Med Affairs Booth

2023

84 Waterford Dr Marlborough, MA 017527010 sunovion.com

Sunovion is a global biopharmaceutical company focused on the innovative application of science

84 Waterford Dr Marlborough, MA 017527010 sunovion.com

Supernus Pharmaceuticals, Inc.

EXHIBITORS BY NAME

Strongbridge Biopharma is a global commercialstage biopharmaceutical company focused on therapies for rare diseases. Strongbridge has the only FDA-approved treatment for hyperkalemic, hypokalemic, and related variants of Primary Periodic Paralysis (PPP). PPP is a group of rare hereditary disorders that causes potentially severe episodes of muscle weakness and/or paralysis.

Exhibit Hall Passport Destination

Booth

959

Rockville, MD 20850 supernus.com

With more than 20 years of experience, Supernus is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) disorders. We are developing differentiated products by leveraging our proprietary and inlicensed technologies. We use such technologies to discover and develop novel uses for known drug compounds and to enhance their therapeutic benefits.

177

New Exhibitor Supernus Pharmaceuticals, Inc.

Booth

847

Rockville, MD 20850 supernus.com

1300 Miccosukee Road Tallahassee, FL 32308 tmh.org

New

1008

307 West First St. South Boston, MA 02127 tekscan.com

Teva CNS

Booth

1261

1447

9715 Jacob Lane Lees Summit, MO 64086 tevausa.com/CNS.aspx

Teva CNS provides a total approach to disease management, offering sustainable, indispensable medicines and patient support services that improve outcomes in conditions affecting the central nervous system. Our mission is one of leadership in neuroscience, pain management, and neuropsychiatry, through the quality of our products and people, and our focus on patients.

THE GUTHY-JACKSON CHARITABLE FOUNDATION Booth

Tekscan, Inc. Booth

Booth

1468

4653 Carmel Mountain Rd Suite 308 # 517 San Diego, CA 92130 guthyjacksonfoundation.org

The Guthy-Jackson Charitable Foundation is dedicated to funding research in the search to understand the pathophysiology and biochemistry of Neuromyelitis Optica (NMO) Spectrum Disease. Our Foundation is passionate in its support of providing opportunities to develop programs for prevention, clinical treatments, and an eventual cure for this rare and often misunderstood disease.

EXHIBITORS BY NAME

Tallahassee Memorial HealthCare

861

medicines and patient support services that improve outcomes in conditions affecting the central nervous system. Our mission is one of leadership in neuroscience, pain management, and neuropsychiatry, through the quality of our products and people, and our focus on patients.

Teva CNS

Booth

Exhibit Hall Passport Destination

Teva CNS provides a total approach to disease management, offering sustainable, indispensable

179

EXHIBITOR DESCRIPTIONS The JAMA Network Booth

2118

330 N. Wabash Avenue Suite 39300 Chicago, IL 60611 jamanetwork.com

Building on a tradition of editorial excellence, the JAMA Network brings JAMA together with eleven specialty journals to offer enhanced access to the research, reviews, and opinions shaping the future of medicine. JAMA Network Open, a new open access, general medical journal, will launch in early 2018.

The Michael J. Fox Foundation for Parkinson’s Research Booth

1373

Grand Central Station PO Box 4777 New York, NY 10163 michaeljfox.org

The Ohio State University Department of Neurology Booth

761

395 W. 12th Ave., 7th Floor Columbus, OH 43210 medicalcenter.osu.edu

The Ohio State University Neurological Institute brings together 200 researchers and clinicians collaborating together in neurology, neurosurgery, physical medicine and rehabilitation, psychiatry, psychology, anesthesia and neuroscience research to create better methods of prevention, detection and treatment for patients with brain and spine conditions. Through this unique model, Ohio State Medical Center is poised to be at the forefront of neurological patient care and neuroscience research.

New

Tower Health The Myositis Association Booth

1868

1737 King Street Alexandria, VA 22314

Booth

559

420 South 5th Avenue West Reading, PA 19611 towerhealth.org

New

UBS Financial Services

New

Booth

The Neurocritical Care Society Booth

1771

330 N Wabash Ave Suite 2000 Chicago, IL 60611 neurocriticalcare.org

The Neurocritical Care Society (NCS) is a multidisciplinary, international organization whose mission is to improve health care and outcomes for patients with life-threatening neurological illnesses. With a worldwide membership of health care providers, the NCS is dedicated to promoting quality patient care, professional collaboration, research, training and advocacy.

180 2018 AAN Annual Meeting On-site Guide

809

131 S Rodeo Drive Suite 300 Beverly Hills, CA 90212 .ubs.com/fa/robertlevin

Robert Levin is a former Wall Street pharmaceuticals analyst and board-certified physician. He directs a wealth management advisory practice at UBS, focusing on the financial needs of physicians and health care executives. His clients trust him as their primary resource to navigate through the complexities of the financial world.

New Exhibitor United Council for Neurologic Subspecialties Booth

1114

201 Chicago Ave Minneapolis, MN 55415 ucns.org

University of Florida Health Booth

1375

1329 SW 16th Street Third Floor Gainesville, FL 32610 ufhealth.org

The University of Florida Department of Neurology strives to create, disseminate and clinically apply neurological knowledge to benefit regional, national and global populations. Our missions are to provide compassionate, skilled and innovative healthcare of the highest quality; to educate and train dedicated, and skilled physician leaders of the future and to perform programmatic cutting-edge research that improves the understanding of origins or pathophysiology of neurological diseases.

New

University of Southern California Booth

1466

3711 BALDWIN ST UNIT 605, LOS ANGELES, CA 90031 usc.edu/

University of Utah Health Clinical Neurosciences Center Booth

1662

175 North Medical Drive 5th Floor Salt Lake City, UT 84132 medicine.utah.edu/ neurology/

At U of U Health, we strive to create customized treatment plans for patients and to promote awareness and education in sharing prevention practices through community events. Working with the School of Medicine departments of neurology, neurosurgery, and radiology, we have a team committed to teaching a new generation of medical providers, seeking tomorrow's answers to today's medical mysteries through research and healing those individuals currently fighting life's greatest medical challenges.

University of Utah Health Department of Neurology Booth

856

175 N. Medical Drive SLC, UT 84132 medicine.utah.edu/neurology

The Department of Neurology at the University of Utah has a long tradition of excellence in clinical care, education, and translational and clinical research. Our subspecialists provide expert diagnosis and treatment for all disorders affecting the brain, spinal cord, nerves, and muscles. We have highly regarded residency and subspecialty fellowship programs that allow interdisciplinary collaboration with several departments such as neurosurgery, neuroradiology, pediatrics, and rehabilitation.

EXHIBITORS BY NAME

UCNS is a nonprofit organization founded in 2003 by the AAN, AUPN, ANA, CNS, and PCN to accredit fellowship training programs and certify physicians in emerging neurologic subspecialties. UCNS has accredited over 175 fellowship programs and certified over 2,650 physicians. Visit the booth to learn more about UCNS and neurologic subspecialty accreditation and certification.

Exhibit Hall Passport Destination

Upsher-Smith Laboratories, LLC Booth

1403

6701 Evenstad Dr. Maple Grove, MN 55369 upsher-smith.com

Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company that has strived to deliver quality, affordable generic medications for nearly a century. In June 2017, Upsher-Smith

181

EXHIBITOR DESCRIPTIONS was acquired by Sawai Pharmaceutical Co., Ltd., a large publicly traded generics company in Japan that shares a similar philosophy of always putting patients first. For more information, visit www. upsher-smith.com.

US Bioservices Booth

512

3101 Gaylord Parkway Frisco, TX 75034 usbioservices.com/

Providing trusted support for over 20 years, US Bioservices is AmerisourceBergen's specialty pharmacy offering nationwide dispensing and home infusion nursing services. Our comprehensive approach improves the patient experience while increasing transparency and collaboration with the practice. Focused on clinical integration, we partner with physicians to help patients realize the best outcomes.

US WorldMeds Booth

2019

4441 Springdale Rd Louisville, KY 40241 usworldmeds.com

US WorldMeds Booth

1917

4441 Springdale Rd Louisville, KY 40241 usworldmeds.com

New

Variantyx Inc. Booth

907

1671 Worcester Rd Suite 300 Framingham, MA 01701 variantyx.com

Variantyx provides Variantyx Unity™ - a whole genome sequencing (WGS) based test for diagnosis of rare inherited disorders. We also enable hospitals and labs to profitably expand

182 2018 AAN Annual Meeting On-site Guide

their test menu with validated genomic diagnostic solutions using our Genomic Intelligence™ platform for simplified NGS data analysis, interpretation and clinical reporting.

New Vituity Booth

862

2100 Powell St Suite 900 Emeryville, CA 94608 vituity.com/careers

As a physician-owned and managed organization driven by a partnership culture, Vituity understands the importance of transparency, accountability, and collaboration needed to achieve common goals. We use our collective expertise to develop new pathways to better care with the future in mind. Since 1975 we have offered joyful, rewarding career opportunities. We have practice sites across the country, comprehensive systems of support, and education opportunities for career growth. Visit vituity.com/ careers to learn more.

New

Weatherby Healthcare Booth

613

6451 N Federal Hwy Fort Lauderdale, FL 33308 weatherbyhealthcare.com

Since 1995, Weatherby Healthcare has established itself as an expert in locum tenens staffing for physicians, physician assistants, and nurse practitioners. The company employs nearly 600 employees committed to filling locum tenens assignments in large-scale healthcare networks, hospitals, and clinics nationwide. Learn more at weatherbyhealthcare.com.

New Exhibitor Wiley

Booth

2105

101 Station Landing Suite 300 Medford, MA 02155

Wolters Kluwer Booth

1723

Two Commerce Sq 2001 Market Street Philadelphia, PA 19103 lww.com

Wolters Kluwer Health is a global provider of information, business intelligence and pointof-care solutions for the healthcare industry . Brands include Lippincott Williams & Wilkins, a leading international publisher of medical books, electronic media and journals and the official publisher of American Academy of Neurology. We proudly offer specialized publications and software for physicians, nurses, students and clinicians. Please visit booth #1723 to browse our comprehensive product line.

World Congress of Neurology Booth

1215

Chester House, Fulham Green, 81-83 Fulham High Street London SW6 3JA United Kingdom www.wfneurology.org

neurology and participate in active discussions and cutting‐edge lectures by the world’s top scientists and neurologists. Submit an abstract before May 7, 2019. Save on registration fees before August 6, 2019.

Yuma Regional Medical Center Booth

1567

2400 S. Avenue A Yuma, AZ 85364 yumaregional.org

Amazing opportunity for an employed outpatient GENERAL Neurology position in a growing community of 200k year-round residents, where we are joined by an additional 100K during our mild 70 degree winters. Yuma Regional Medical Center (YRMC), a 406 bed top-in-technology facility, is the only acute care hospital of its size within a 170 mile radius and provides almost all modalities of care. Sunny Yuma, Arizona sits on the edge of the Colorado River and borders San Diego, CA and Phoenix, AZ.

New Zeto

Booth

2015

2336 Park Ave Santa Clara, CA 95050 zeto-inc.com

Zeto is changing the way Routine EEG is done at hospitals. Fast, convenient, medical-grade EEG - is what we do. Our product is a patent pending, zero-prep, easy to wear headset with dry electrodes backed by a cloud platform that offers instant upload, tools for analysis and live viewing from any location. Zeto also makes EEG available to facilities that currently do not have access to it.

EXHIBITORS BY NAME

Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments, and individuals increase the academic and professional impact of their work.

Exhibit Hall Passport Destination

The XXIV World Congress of Neurology (WCN 2019) will take place in Dubai, United Arab Emirates on October 26 – 31 2019, hosted by the Emirates Neurology Society. This year's theme will be "Accelerating the pace of change". Be up to date on the all the advances in scientific and clinical

183

Thank You

2O18 Annual Meeting Supporters* The American Academy of Neurology (AAN) thanks the following companies, foundations, and organizations for their demonstrated vision, commitment, and strong support of programs which find answers and improve lives through neurologic education and research. Abbott Industry Therapeutic Update Abbvie, Inc. C136 Multiple Sclerosis Therapy: Disease-modifying Treatment I Door Drop Insert On-site Exhibit Hall Passport Meeting Suites Acadia Pharmaceuticals C52 Nonmotor Manifestations of Parkinson’s Disease II On-site Exhibit Guide Advertising

Celgene Corporation Amgen/Novartis Pharmaceuticals Corporation 5K Run/1K Walk for Brain Research 5K Run/1K Walk for Brain Research AANextra Advertising Brain Health Fair Platinum Sponsorship Door Drop Bag Sponsorship Exhibit Hall Charging Hubs Exhibit Hall Buzz Café Exhibit Hall Buzz Cafes Exhibit Hall Charging Hub Exhibit Hall Park Benches Exhibit Hall Digital Billboard Cell Phone Charging Locker Exhibit Hall Opening Luncheon Industry Therapeutic Updates Exhibit Hall Networking Reception Leadership University: Exhibit Hall Pillar Marketing C7 Women in Leadership Onsite Exhibit Guide Advertising

AveXis, Inc. 5K Run/1K Walk for Brain Research AANextra Advertising Acorda Therapeutics Inc. Door Drop Insert Exhibit Hall Passport Exhibit Hall Charging Lounge On-site Exhibit Guide Advertising Exhibit Hall Table Top Graphics Adamas Pharmaceuticals Onsite Exhibit Guide Advertising 5K Run/1K Walk for Brain Research Opening Party Platinum Sponsor AANextra Advertising Biogen Door Drop Insert 5K Run/1K Walk for Brain Research Exhibit Hall Footprints AANextra Advertising Exhibit Hall Table Top Graphics Annual Meeting Water Bottles Industry Therapeutic Update Door Drop Insert On-site Exhibit Guide Advertising Exhibit Hall Aisle Carpet Allergan Exhibit Hall Door Decals Diversity Leadership Program Exhibit Hall Entrance Graphics Palatucci Advocacy Leadership Forum Exhibit Hall Passport Transforming Leadership Program Exhibit Hall Pillar Marketing Women Leading in Neurology Fellows Scholarship Fund Industry Therapeutic Updates The Allergan Foundation Onsite Exhibit Guide Advertising Enhanced Resident Leadership Program Resident Scholarship Fund Medical Student Diversity Program Science Program Advertising Alnylam Pharmaceuticals Blick Art Supplies Onsite Exhibit Guide Advertising Innovation Hub in Kind Donation Industry Therapeutic Update On-site Exhibit Guide Advertising

Boston Scientific Onsite Exhibit Guide Advertising Cadwell Industries, Inc. C17 Neurophysiologic Intraoperative Monitoring Skills Workshop

CSL Behring Exhibit Hall Footprints Exhibit Hall Passport Industry Therapeutic Update Eisai Inc. AANextra Advertising Door Drop Insert Exhibit Hall Passport Onsite Exhibit Guide Advertising C172 Clinical Epilepsy I: Basics EMD Serono, Inc. 5K Run/1K Walk for Brain Research Door Drop Insert Exhibit Hall Footprints Exhibit Hall Passport Exhibit Hall Presentation Stage Industry Therapeutic Update Onsite Exhibit Guide Advertising Genentech, A Member of the Roche Group 5K Run/1K Walk for Brain Research AANextra Advertising Cell Phone Charging Station Drop Drop Inserts Exhibit Hall Pillar Marketing Exhibit Hall Street Posts Exhibit Hall Table Top Graphics Industry Therapeutic Update Onsite Exhibit Guide Advertising

Supernus Pharmaceuticals Inc. 5K Run/1K Walk for Brain Research Brain Health Fair Silver Sponsor Door Drop Inserts Novartis Pharmaceuticals Corporation Exhibit Hall Charging Lounge 5K Run/1K Walk for Brain Research Grifols USA Exhibit Hall Passport Exhibit Hall Charging Hubs C225 Neuromuscular Junction Onsite Exhibit Guide Advertising Disorders I: Myasthenia Gravis, Ocular, Exhibit Hall Buzz Cafes and MuSK Myasthenia Teva CNS Exhibit Hall Park Benches Door Drop Insert Exhibit Hall Table Top Graphics Health Monitor Network Exhibit Hall Passport Industry Therapeutic Updates Exhibit Hall Passport Industry Therapeutic Updates Leadership University: Ionis Pharmaceuticals C7 Women in Leadership Onsite Exhibit Guide Advertising Industry Therapeutic Update Science Program NeuroPace Lundbeck LLC Shuttle Bus WiFi Access C234 Epilepsy Skills Workshop: Focus 5K Walk/1K Run for Brain Research on Treatment UCB, Inc. AANextra Advertising Diversity Leadership Program Samsung Ultrasound Cell Phone Charging Locker Palatucci Advocacy Leadership Forum C209 Clinical Usefulness of Botulinum Fellows Scholarship Fund Toxin for Spasticity Skills Workshop Upsher-Smith Laboratories Inc. Exhibit Hall Pillar Marketing Sanofi Genzyme Exhibit Hall Passport Leadership University: C45 Being a Door Drop Insert Resilient Leader: How Do You Lead US WorldMeds the Change? Industry Therapeutic Updates Brain Health Fair Silver Sponsor Leadership University: C105 Onsite Exhibit Guide Advertising C159 Clinical Uses of Botulinum Toxin Mentoring…Growing the Next Emerging Leaders Program for Dystonia Skills Workshop Generation of Neurologist Women Leading in Neurology Welch Allyn Onsite Exhibit Guide Advertising C83 Neuro-ophthalmology and Sarepta Therapeutics Resident Scholarship Fund Neurovestibular Exam Lab Skills Workshop Industry Therapeutic Update Science Program Greenwich Biosciences Exhibit Hall Passport Onsite Exhibit Guide Advertising Industry Therapeutic Update

Neurocrine Biosciences AANextra Advertising Door Drop Insert

MagVenture, Inc. C17 Neurophysiologic Intraoperative Monitoring Skills Workshop

SEI Healthcare AANextra Advertising

Medtronic C229 Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders Mitsubishi Tanabe Pharma America Door Drop Insert Exhibit Hall Pillar Marketing Industry Therapeutic Update Onsite Exhibit Guide Advertising

SK life science, a subsidiary of SK biopharmaceuticals Door Drop Insert Exhibit Hall Passport Onsite Exhibit Guide Advertising

Sunovion Pharmaceuticals Inc. 5K Run/1K Walk for Brain Research Annual Meeting Hotel Key Cards & Sleeves Annual Meeting Mobile App Brain Health Fair Silver Sponsor Natus Neuro Cell Phone Charging Station C17 Neurophysiologic Intraoperative Door Drop Inserts Monitoring Skills Workshop Exhibit Hall Passport C119 EMG Skills Workshop: Basic Exhibit Hall Table Top Graphics C209 Clinical Usefulness of Botulinum Exhibit Hall Way Finding Map Toxin for Spasticity Skills Workshop Science Program C234 Epilepsy Skills Workshop: Focus on Treatment

Wolters Kluwer Health, publisher of the AAN publications: Neurology ®, Neurology ® Clinical Practice, Neurology ® Neuroimmunology & Neuroinflammation, Neurology ® Genetics, Continuum®, Neurology Today ®, and Brain & Life™. Annual Meeting Book Bags Brain Health Fair Book Bags Convention Center WiFi Access Exhibit Hall Passport

*commitments as of March 5, 2018

2018 AWARD RECIPIENTS

he research we celebrate, with the recipients below, has generated paradigm-changing discoveries in epilepsy, fundamental insights in multiple sclerosis, and pioneering breakthroughs in pain, to name a few of the transformative advances conceived by these luminaries. We honor those researchers and pay tribute to all those who play a role in the search for cures for brain disease, from mentors to colleagues to those just starting out on their journey. The American Academy of Neurology thanks the American Brain Foundation for its philanthropic support of American Academy of Neurology’s awards program.

ALLIANCE AWARDS: FOUNDERS

Sponsored by the American Academy of Neurology and endowed by the former American Academy of Neurology Alliance.

Recipient: Ezequiel Gleichgerrcht, MD

Thank You Statement: None of this would be possible without the support from my research mentor, Dr. Leonardo Bonilha. His guidance and encouragement have continued to ignite my research interests throughout residency. His bright mind and kindness are both humbling and inspiring.

Why the Recipient Was Chosen: Dr. Gleichgerrcht’s work applies state-of-the-art neuroimaging analysis techniques, founded upon pathobiologic principles, to improve prognostic capabilities beyond current clinical standards/ impressions in the treatment of patients undergoing epilepsy surgery for medication-refractory epilepsy. His masterful application of high-level analytics not only demonstrates a scientific aptitude for formulating and addressing a clinically relevant scientific question, but also provides a meaningful contribution to the clinical field of epileptology, supporting clinical decision making and defining potential biomarkers for early intervention and/or prevention. In sum, his findings accurately predict surgical outcomes based on network influence in the ipsilateral temporal lobe, based on graph theory analyses of an individual’s diffusion tensor imaging-based connectome.

ALLIANCE AWARDS: S. WEIR MITCHELL

Sponsored by the American Academy of Neurology and endowed by the former American Academy of Neurology Alliance.

Recipient: Eric C. Landsness, MD, PhD Thank You Statement: My co-author on this manuscript, Lindsey Brier, deserves equal credit and it was through our combined efforts that this project came to fruition.

Why the Recipient Was Chosen: Dr. Landsness embodies the essence of a resident clinician scientist. His study builds upon an early career of scientific inquiry by applying newly acquired, sophisticated techniques and statistical methods to derive confirmatory information

186 2018 AAN Annual Meeting On-site Guide

about sleep neurophysiology with high spatial and temporal resolution. Measuring realtime cortical slow-wave propagation through in vivo imaging of calcium-based neuronal activity correlated to electroencephalography he demonstrates one of the key underlying neurophysiologic phenomena of sleep - antero-posterior propagation of slow wave activity -, while also providing inroads to translational applications in humans.

AMERICAN ACADEMY OF NEUROLOGY PRESIDENT’S AWARD This award is given by the American Academy of Neurology President for outstanding service to the AAN and the profession of neurology.

Recipient: Lisa M. Shulman, MD, FAAN, Baltimore, MD T hank You Statement: Why do thousands of AAN members donate their time to serve the Academy? Opportunities to work on major issues confronting neurology draw many of us. But less acknowledged is what we gain— unanticipated new skills of communication, governance, and leadership. Thank you for this award— it’s a genuine pleasure and privilege.

AWARDS

Why the Recipient Was Chosen: Since 1991, Lisa M. Shulman, MD, FAAN, has worked tirelessly to further the AAN’s mission, serving as an exemplary Board member and steward of AAN finances; helping guide us in many committees; championing patient education and measurements; and supporting the American Brain Foundation’s strategic plan—always with enthusiasm and energy. She has served on the AAN Board of Directors from 2007-17 as a member, Secretary, and Treasurer.

AMERICAN BRAIN FOUNDATION BOARD CHAIR’S AWARD Sponsored by the American Brain Foundation.

Recipient: Richard P. Essey, San Francisco, CA Thank You Statement: It is an honor to be recognized by the American Brain Foundation for my work to defeat ALS. I created The Sheila Essey Award in honor of my wife Sheila with the goal of encouraging and recognizing scientific research towards new advancements in treatment and ultimately, towards finding a cure. I am proud that, since its inception, remarkable work has been done, advancing progress and giving hope to patients and caregivers. Why the Recipient Was Chosen: For his leadership in philanthropy, establishing the Sheila Essey Award for Research in ALS.

187

2018 AWARD RECIPIENTS ASSOCIATION OF INDIAN NEUROLOGISTS IN AMERICA (AINA) LIFETIME ACHIEVEMENT AWARD Sponsored by the American Brain Foundation.

Recipient: Vinay Chaudhry, MD, MBA, CPE, FRCP, FAAN, Baltimore, MD Thank You Statement: I am deeply honored and grateful to receive this honor from an organization that I admire.

Why the Recipient Was Chosen: Chaudhry is professor of neurology at the Johns Hopkins University School of Medicine where he is the co-director of EMG laboratory and was Vice‑Chair of Clinical Affairs and Director of the Neurology Outpatient Center. He is internationally recognized as a clinician, teacher, researcher, and a leader in field of neuromuscular medicine and electrophysiology. Dr. Chaudhry’s areas of research include Wallerian degeneration in human nerves, multifocal motor neuropathy, toxic neuropathies, and electrophysiological aspects of neuromuscular diseases. Dr. Chaudhry has over 130 publications and has participated in numerous clinical trials in motor neuron disease, peripheral neuropathies, myasthenia gravis, and myotonic muscular dystrophy. He has been on the editorial board of muscle nerve, neurologist, and science. He has served on the board of directors of AAN and American Board of Electrodiagnostic Medicine. Dr. Chaudhry was the chair of Neuromuscular section of AAN (2001-05), and it was under his leadership that Neuromuscular Medicine Board was created. Dr. Chaudhry was President of the AINA from 2001-2003 and President of Aiimsonians of America (2002-4), his alumni group, which also awarded him with a distinguished alumnus award in 2006.

AWARD FOR CREATIVE EXPRESSION OF HUMAN VALUES IN NEUROLOGY This award is sponsored by the Ethics, Law, and Humanities Committee, a joint committee of the American Academy of Neurology, the American Neurological Association, and the Child Neurology Society.

Recipient: Madaline B. Harrison, MD, Charlottesville, VA Thank You Statement: I am grateful for this award and the opportunity to acknowledge my mentors. Thanks to Fred Wooten, MD, who taught me neurology and about being with patients and to Dan Becker, MD, MFA, for his encouragement and editor’s eye. Thanks also to the Taos Writing Retreat and my writing group. Why The Recipient Was Chosen: The Creative Expression Award recognizes the artistic expression of human values in neurology. Dr. Harrison’s essay, The 9 o’clock patient, elegantly expresses her keen understanding of her patients–not only their medical conditions, but also their relationships and the other sources of meaning in their lives.

188 2018 AAN Annual Meeting On-site Guide

A.B. BAKER AWARD FOR LIFETIME ACHIEVEMENT IN NEUROLOGIC EDUCATION

Funded by an endowment created by matching funds from the A.B. Baker Family Trust and Novartis Pharmaceuticals

Recipient: Steven Galetta, MD, FAAN New York, New York Thank You Statement: Thank very much for this honor, but I’m not foolish enough to regard it as an individual one. It would be no fun if it happened that way. Learning and teaching is a two way street and in its most perfect form the distinction is blurred. So, I share this award with all the trainees, colleagues, and mentors that I had the pleasure to cross paths with. I’m very grateful to be their representative. Why The Recipient Was Chosen: Dr. Galetta is a devoted and exceptional leader with an impressive impact on neurology education. He has had a prolific career which includes being the recipient of multiple teaching awards.

AWARDS

SIDNEY CARTER AWARD IN CHILD NEUROLOGY Recipient: Richard S. Finkel, MD Nemours Children’s Hospital Orlando, FL Title: Spinal Muscular Atrophy Is a Treatable Neurodegenerative Disease

189

2018 AWARD RECIPIENTS CLERKSHIP COORDINATOR RECOGNITION AWARD Recipients: Maryam Shakir, MPH, Miami, FL Thank You Statement: I would like to extend my sincerest gratitude to the AAN for choosing me as a recipient of the Clerkship Coordinator Recognition Award. I am delighted to be acknowledged by the faculty and students I have had the pleasure to work with.

Janet Lopez, Chicago, IL Thank You Statement: I am honored to receive this award from the AAN. I would like to thank Dr. Madhu Soni, and the Neurology faculty and residents at Rush University Medical Center. Their passion for neurology and dedication to teaching inspires me to work hard to make the clerkship a wonderful educational experience for our students. Why the Recipients Were Chosen: The two coordinators chosen serve an essential function in medical student education. They are being recognized for their dedication, creativity, and innovation in their role which is crucial in ensuring the future of Neurology.

CLERKSHIP DIRECTOR TEACHING AWARD Recipient:â&#x20AC;&#x201A; Rachel Marie E. Salas, MD, FAAN Baltimore, MD Thank You Statement: Itâ&#x20AC;&#x2122;s an honor to be recognized among the educators in neurology and a privilege to collaborate and work with other peers and trainees within the AAN. I mainly want to thank Dr. Charlene Gamaldo for her mentorship and Dr. Justin McArthur for his leadership and support. I am also thankful to be so supported by the educational leaders at Johns Hopkins as well. Lastly, I want to thank my family for all their support and love. Why the Recipient Was Chosen: Dr. Salas is a dedicated educator who devotes considerable time and energy to her role. She has dedicated herself to neurology education and to creating not only future generations of neurologists but also teaching neurology to students choosing other disciplines.

190 2018 AAN Annual Meeting On-site Guide

COMMITMENT TO CURES AWARD Sponsored by the American Brain Foundation.

Recipient: DeMaurice Smith, Executive Director, NFL Players Association, Washington, DC Thank You Statement: I am grateful to the American Brain Foundation for this honor and I am thrilled to accept it on behalf of all of our player leadership, staff and everyone who has worked tirelessly and relentlessly in the pursuit of improving the lives of athletes everywhere. Why the Recipient Was Chosen: For his leadership in promoting research in athlete brain health and concussion protocols in professional football.

GEORGE C. COTZIAS LECTURE Recipient: Tallie Z. Baram, MD, PhD University of CA-Irvine, Irvine, CA

AWARDS

Title: How Early- Life Experiences Sculpt Your Brain: From Molecules to Circuits

DREIFUSS-PENRY EPILEPSY AWARD

Sponsored by the American Academy of Neurology and endowed by members of the American Academy of Neurology Epilepsy Section; Abbott Laboratories, Inc.; Cephalon, Inc.; Cyberonics, Inc.; Elan Pharmaceuticals, Inc.; GlaxoSmithKline; Novartis Neuroscience; Ortho-McNeil Neurologics; Pfizer Inc; Shire US, Inc; and UCB Pharma.

Recipient:â&#x20AC;&#x201A; Kathryn A. Davis, MD, MS, FAES Thank You Statement: I would like to thank my dedicated mentors, Drs. John Detre, Brian Litt, Frances Jensen, Hal Blumenfeld, and Ravinder Reddy. I thank my trainees and colleagues for their hard work and passion, and our patients for their dedication.

Why the Recipient Was Chosen: We are very pleased to announce the selection of Kathyn Admakiak Davis, M.D., M.S.T.R. for the Dreifuss-Penry Epilepsy Award. Dr. Davis obtained her medical degree from Yale University. Thereafter, all of her subsequent training and experience has been at the University of Pennsylvania where she is an assistant professor in the department of neurology. Her academic career has been utilized the tools of invasive neurophysiology and neuroimaging to better localize epileptic networks in patients with medically-refractory epilepsy. She has authored 40 papers, demonstrating significant and focused contributions to the field and she is also the recipient of a K23 award.

191

2018 AWARD RECIPIENTS JOHN DYSTEL PRIZE FOR MULTIPLE SCLEROSIS RESEARCH

Sponsored by the American Academy of Neurology and National Multiple Sclerosis Society and made possible through a special contribution from the John Dystel Multiple Sclerosis Research Fund at the National Multiple Sclerosis Society.

Recipient: Frederik Barkhof, MD, Phd Thank You Statement: My work was inspired by Ian McDonald, Donald Paty, Jacob Valk and Otto Hommes. I am indebted to many collaborators including David Miller, Henry McFarland, Chris Polman and Alan Thompson and the MAGNIMS network. I am grateful to all my PhD students and current colleagues in Amsterdam and London. Why the Recipient Was Chosen: Dr. Barkhof’s work has played a pivotal role in establishing the role of magnetic resonance imaging in all aspects of multiple sclerosis including diagnosis, treatment response, and disease progression. His many seminal contributions include the establishment of MRI diagnostic criteria, the recognition of cortical lesions, the importance of spinal cord imaging as well as key insights into the pathological changes underlying MRI signals. It is hard to overstate the tremendous impact that Dr. Barkhof’s insights have had and will continue to have in advancing multiple sclerosis clinical translational research. He epitomizes the qualities the Dystel Prize is intended to recognize, namely work that has influenced the way we think about multiple sclerosis.

SHEILA ESSEY AWARD: AN AWARD FOR ALS RESEARCH

Sponsored by the American Academy of Neurology, the American Brain Foundation and the ALS Association and supported through the philanthropy of the Essey Family and the ALS Association.

Recipient: Timothy M. Miller, MD, PhD Thank You Statement: I have been privileged to work with outstanding mentors throughout my career. I am extremely grateful to my PhD Mentor, Dr. Eugene Johnson, Neuromuscular Fellowship Mentor, Dr. Richard Olney, Postdoctoral Research Mentor, Dr. Don Cleveland, and Clinical Research Mentor, Dr. Merit Cudkowicz. Why the Recipient Was Chosen: Dr. Timothy Miller receives the Sheila Essey Award for his pioneering work in bringing antisense oligonucleotide (ASO) therapeutics in ALS forward from the laboratory to the clinic. Dr. Miller is a physician-scientist who played key roles in testing ASO’s targeting SOD1 in ALS transgenic mice, studying the pharmacodynamics of ASOs in non-human primates, and performing the first-in-man trial of ASOs targeting SOD1 in SOD1-mutant patients. The work in ALS has been critical in bringing the whole field of ASO therapeutics forward in human neurogenetic diseases. Dr. Miller is also working on SOD1 protein kinetics, natural history of C9orf72-related ALS, and the role of micro-RNAs in ALS.

192 2018 AAN Annual Meeting On-site Guide

FRANK A. RUBINO AWARD FOR EXCELLENCE IN CLINICAL NEUROLOGY TEACHING

The award is funded by an endowment created by matching funds from the Mayo Clinic Frank A. Rubino fund.

Recipient: Barbara S. Giesser, MD, FAAN, Los Angeles, CA Thank You Statement: Recognition from peers is an honor and a privilege. Receiving this recognition for doing what you love is sheer joy. I am indebted to Dr. Alon Avidan for crafting a most elegant nomination on my behalf, and I am profoundly grateful to the AAN for honoring me in this fashion.

NORMAN GESCHWIND PRIZE IN BEHAVIORAL NEUROLOGY Sponsored by the American Academy of Neurology and endowed through Dr. Geschwind’s family, friends, and colleagues; Pfizer Inc; and the Society for Behavioral and Cognitive Neurology.

Recipient: Zachary A. Miller, MD

AWARDS

Thank You Statement: None of this would have been possible without the generosity of our patients and their dedication to research, the guidance and support of Drs. Maria Luisa Gorno-Tempini and Bruce Miller of the UCSF Memory and Aging Center, and of course my friends and family who always believed in me. Why the Recipient Was Chosen: Dr. Miller was selected as the 2018 recipient of the Normal Geschwind Prize in Behavioral Neurology as a result of his excellence in research that extends the work started by Professor Geschwind. Dr Miller’s accomplishments suggest he has a bright future in the field.

WAYNE A. HENING SLEEP MEDICINE INVESTIGATOR AWARD Sponsored by the American Academy of Neurology and endowed by UCB, Inc., Lilly USA, Elite Home Medical & Respiratory, Inc., Raleigh Neurology Associates, and friends of Dr. Wayne A. Hening.

Recipient: Yo-El Ju, MD, MSCI Thank You Statement: I am grateful to Brian Sommerville, neurologist and husband, for supporting and challenging me to pursue interesting questions. I thank my mentor David Holtzman, for sparking my interest in this research topic and continuing support. I am indebted to many colleagues: Brendan Lucey, John Zempel, Sharon Ooms, and many others. Why the Recipient Was Chosen: Dr. Ju is a highly creative researcher with a significant track record evaluating the mechanism of sleep disorders in patients with neurodegenerative diseases. She has conducted novel research highlighting the mechanism of sleep disruption in Alzheimer’s disease, particularly identifying that disruption of slow wave sleep selectively increases CSF A?. Her innovative skills as an exemplary young sleep investigator fulfils the mission bestowed by this Award.

193

2018 AWARD RECIPIENTS INTERNATIONAL SCHOLARSHIP AWARD Sponsored by the American Academy of Neurology. Recipients:

Dr. Zemen Tadesse Abu, Addis Ababa, Ethiopia Thank You Statement: I would like to thank you the AAN for giving me this opportunity. I also would like to thank my mentors, Dr. Vineeta Singh and Dr. Yared Mamushet, who encouraged and helped me present my cases.

Dr. Vafa Alakbarzade, Plymouth, United Kingdom Thank You Statement: I am sincerely grateful to my supervisors who provided invaluable guidance throughout my project. It would have been impossible without encouragement and support of my mother.

Dr. Fabiola De Marchi, Novara, Italy Thank You Statement: Iâ&#x20AC;&#x2122;m grateful for the opportunity that you are offering to me. I want to thank my mentor Dr. Letizia Mazzini for the support and for inspiring me in clinical and research activities.

Dr. Federico Eberbach, Buenos Aires, Argentina Thank You Statement: Thanks to my collaborators Dr. Bruno and Dr. Chavez for making this study possible. To my mentor and co-author, Dr. Sebastian Ameriso, for his supervision in each step of the work. Finally I want to thank my family and especially my parents, for their constant support and confidence in me.

Dr. Arunmozhimaran Elavarasi, New Delhi, India Thank You Statement: The success of this study is a result of the work of my mentor, guides and teachers and colleagues. To my family and friends who were there with me during the course of my life at AIIMS, New Delhi Thank you!!!

194 2018 AAN Annual Meeting On-site Guide

Dr. Nada Abdelhameed Elsaid, Mansoura, Egypt Thank You Statement: It is an honor to be recognized by the AAN for the International Scholarship Award. I am really excited to gain this enormous experience. Thank you so much.

Dr. Clare Angeli Enriquez, Manila, Phillipines Thank You Statement: I am eternally grateful to my family and loved ones, who inspire me to be the best that I can be. To my consultants, who spent their time and efforts to guide me in my training. And lastly to my patientsâ&#x20AC;&#x201D;the greatest teachers I have ever had.

Dr. Kaushik Gowthaman, Chennai, India

AWARDS

Thank You Statement: It is a great honor for me to receive this International Scholarship Award from AAN. My gratitude to all my mentors, professors and colleagues of Madras Institute of Neurology and to my family for their support.

Dr. Chiseko Ikenaga, Tokyo, Japan Thank You Statement: I am grateful to the AAN for selecting me as a recipient of this award. Without support from my mentors and family, I could not have performed the work. With gratitude for the AAN and them, I would like to make further efforts for the progress of the research.

Dr. Mariano Marrodan, Buenos Aires, Argentina Thank You Statement: Thanks to my wife, my family, friends and co-authors, without whom the success of this work would not have been possible. Especially my mentors and co-authors, Dr. Sebastian Ameriso and Dr. Jorge Correale, for their trust, support and permanent teaching from the first moment of my training.

195

2018 AWARD RECIPIENTS Dr. Sankaranarayanan Muthukani, Tamilnadu, India Thank You Statement: I would like to immensely thank Prof. Kameshwar Prasad, Prof. Ajay Garg, Dr. Leve Joseph Devarajan, Dr. Parthiban and my wife Dr. Poornima for their constant support throughout the study and Prof. M.B.Singh for motivating me . I am indebted to my mentors Prof.R.Lakshmi Narasimhan and Prof. S.Meenakshi-Sundaram, Madurai.

Dr. Divya M. Radhakrishnan, New Delhi, India Thank You Statement: I am thankful to God, teachers, friends and my family for being my pillars of strength. I owe my gratitude to my mentors at AIIMSNew Delhi for their unwavering support and guidance.

Dr. Gerard Raimon M. Saranza, Manila, Phillipines Thank You Statement: The International Scholarship Award has made my dream of attending the AAN Annual Meeting a reality. It has also given me the opportunity to present our genetic study on X-linked Dystonia Parkinsonism (DYT3), with the hope of raising awareness on an international platform the need for further studies and support for this neurodegenerative disorder endemic to the Philippines.

Dr. Elison Sarapura, Lima, Peru Thank You Statement: The success of this work is due tosupport of Neurogenetics Research Center team at Instituto Nacional de Ciencias Neurologicas, Lima, Peru. To my mentor and co-author Dr. Mario Cornejo-Olivas, for your constant support and advice that allow me to improve day to day.

Dr. Marianna Spatola, Barcelona, Spain Thank You Statement: I thank my mentor, Josep Dalmau, for guiding me in this challenging project, Myrna Rosenfeld, for her constructive criticism and help, and my colleagues for their loving support. A great thanks to the Academy for giving me the opportunity to present my work at such a renowned international meeting.

196 2018 AAN Annual Meeting On-site Guide

Dr. Irina Sharinova, Moscow, Russia Thank You Statement: I would like to express my deepest gratitude to the American Academy of Neurology for the opportunity to present my research at the AAN Annual Meeting 2018. My deep appreciation also goes to my mentors and co-authors Prof. Shevelev and Kalenova MD, PhD, my colleagues and my dearest family.

Dr. Chen-chen Tan, Qingdao, China Thank You Statement: I would like to acknowledge with deep gratitude the assistance and guidance given to me by my tutor Professor Lan Tan and Professor JinTai Yu. I wish to take this opportunity to thank my family, friends and colleagues.

Dr. Joseph Kamtchum Tatuene, Blantyre, Malawi

AWARDS

Thank You Statement: I am grateful for this wonderful occasion to interact with the vibrant AAN community. I hope it will pave the way for new, strong, and lifelong friendships and collaborations. I thank the Lord, my family, my colleagues and friends, and my mentors their amazing support.

Dr. Jiangtao Zhang, Beijing, China Thank You Statement: Thank the AAN and I am so honored to win the prestigious International Scholarship Award. I would like to acknowledge my mentors, Pro. Yicheng Zhu and Jun Ni, for the unwavering support and encouragement, both in scientific career and in life. Many researchers and participants contributed to our Shunyi study, and I will always appreciate that. This work would not be successful without my family and friends.

197

2018 AWARD RECIPIENTS Dr. Susanna M. Zuurbier, Amsterdam, The Netherlands Thank You Statement: I am sincerely honored to have been selected as the recipient of the Fellow Scholarship for the AAN Meeting. I would like to thank my colleagues from Amsterdam, and all collaborators of our International Cerebral Venous Thrombosis Consortium.

Why the Recipients Were Chosen: The International Subcommittee is responsible for evaluating the applicants for the International Scholarship Award. The objective of the award is to provide eligible international candidates the opportunity to attend and participate in the Annual Meeting by providing up to $2,500 in reimbursement toward expenses. The awards are given to citizens of a nation outside the US and Canada who are 36 years of age or younger (unless a reasonable case can be made for why someone older should still be considered). Twenty total awards are distributed, five are given based on the quality of abstract submitted, and 10 awards are given based on quality of abstract as well as other criteria such as personal need and country of origin, with emphasis given to applicants from developing countries. This year we received 61 eligible applicants from around the world.

MITCHELL B. MAX AWARD FOR NEUROPATHIC PAIN

Sponsored by the American Academy of Neurology and endowed by the United States Cancer Pain Relief Committee, the Mayday Fund, and friends of Dr. Mitchell Max.

Recipient: David M. Simpson, MD, FAAN

Thank You Statement: I would like to thank my Neurology Chairs at Cornell, Fred Plum and Jerome Posner; mentors at Harvard Medical School Clinical Neurophysiology Labs, Robert Young and Baghwan Shahani; colleagues in neuropathic pain including Robert Dworkin and Justin McArthur.

Why the Recipient Was Chosen: Dr. Simpson’s pioneering research and clinical work in the area of neuropathic pain has led to much needed therapeutic options for patients with neuropathy. We honor him for his invaluable contribution to neuroscience.

LAWRENCE C. MCHENRY AWARD: AN AWARD FOR THE HISTORY OF NEUROLOGY Sponsored by the American Academy of Neurology.

Recipient: Bart TH Lutters, BSc Thank You Statement: I am very honored with this award. I am passionate about the history of the neurosciences and it feels great that my efforts in this area are appreciated by the international neurological community.

Why the Recipient Was Chosen: Dr. Lutters’ historical scholarship marks and commemorates the 100th year of the description of encephalitis lethargica by Dr. Constantin von Economo. Through this work, Dr. Lutters’ commemorates Dr. von Economo’s role in correlating

198 2018 AAN Annual Meeting On-site Guide

neurologic symptoms to structure. The story is concisely and crisply written, demonstrating a clear progression of neurologic thought over the 19th and 20th centuries that was driven by descriptions of this mysterious illness, paving the way for the neuroanatomic localization of arousal, parkinsonism, and psychiatric behaviors.

MEDICAL STUDENT ESSAY AWARD - EXTENDED NEUROSCIENCE AWARD

Sponsored by the American Academy of Neurology. Award not given for 2018

MEDICAL STUDENT ESSAY AWARD - G. MILTON SHY AWARD Sponsored by the American Academy of Neurology.

Recipient: Benjamin D. Wissel

Thank You Statement: I thank Dr. Alberto Espay for his research mentorship and the neurologists across nine centers worldwide who came together for this project. Lastly, I am thankful to the patients whose data were included in this study. May their legacy benefit others who will fill their shoes in the future.

AWARDS

Why the Recipient Was Chosen: Mr. Wissell submitted a very strong paper investigating the features of Parkinson’s disease that associate with functional neurological findings. The essay identified many correlates in patients with PD and coexisting functional neurological disorders, including higher levels of dyskinesia, depression/anxiety, and levodopa equivalent. The study also suggested that preexisting psychiatric disorders and family history of PD were more prevalent in these patients. The experimental approach and data analyses were excellent, and thus overall, the paper was a worthy recipient of the G. Milton Shy Award.

MEDICAL STUDENT ESSAY AWARD - ROLAND P. MACKAY AWARD Sponsored by the American Academy of Neurology.

Recipient: Yi Tong Thank You Statement: I thank Dr. Chenjie Xia for her continued mentorship and support.

Why the Recipient Was Chosen: Ms. Tong’s essay provided an outstanding historical perspective on the concept of brain death through time. The essay was very well written and full of many details from a broad array of references, making it an ideal choice for the Roland P. Mackay award.

199

2018 AWARD RECIPIENTS MEDICAL STUDENT ESSAY AWARD - SAUL R. KOREY AWARD Sponsored by the American Academy of Neurology.

Recipient: Kirsten Martin Thank You Statement: Dr. Gleeson, MD, and Dr. Gregor, PhD gave me a unique opportunity to contribute to a gene discovery project and provided insight into performing clinical research. Having supportive and ambitious mentors enhanced to my learning and enjoyment of the project and increased my interest in incorporating research into my future career. Why the Recipient Was Chosen: Ms. Martin submitted an interesting project investigating the phenotype and genotype correlation for pediatric structural brain defects. The study utilized a population sample of over 2,200 consanguineous partnerships and identified novel genes that demonstrated phenotypic similarity in subjects with these neurodevelopment defects.The essay was well written and deserving of the Saul R. Korey Award.

MOVEMENT DISORDERS RESEARCH AWARD

Sponsored by the American Academy of Neurology, the Parkinson’s Foundation, and the American Academy of Neurology Movement Disorders Section and endowed by the Parkinson’s Foundation.

Recipient: Irene Litvan, MD, FAAN Thank You Statement: There have been many colleagues who have influenced and advised me throughout my career, but I would like to acknowledge in particular Prof. Yves Agid, from the Salpetriere, France and Jordan Grafman, from Northwestern University, who bolstered my creativity and collaborated with me at the beginning of my research career. Why the Recipient Was Chosen: Dr. Litvan has a long and distinguished academic career in movement disorders research. She contributed to the clinical and pathological characterization of atypical parkinsonisms, particularly disorders featuring aggregation of tau or alpha-synuclein, including progressive supranuclear palsy (PSP), corticobasal ganglionic degeneration (CBD), Pick’s disease and multiple system atrophy (MSA). Dr. Litvan has also contributed to the experimental therapeutics of these disorders, especially PSP and provided international leadership in shaping the field.

200 2018 AAN Annual Meeting On-site Guide

NEURO-ONCOLOGY INVESTIGATOR AWARD

Sponsored by the American Academy of Neurology and supported by friends of Dr. Jerome Posner.

Recipient:â&#x20AC;&#x201A; Milan G. Chheda, MD Thank You Statement: Michael Diamond and Jeremy Rich are close collaborators. I received superb scientific training from William Hahn, Ingo Mellinghoff, and David Sabatini. Tracy Batchelor, Patrick Wen, and Lisa DeAngelis were models throughout my training for their excellence in clinical investigation and their compassionate care of patients. Why the Recipient Was Chosen: Dr. Chheda was chosen among an esteemed group of candidates in recognition of his laboratory work on how glioma stem cells resist therapy and contribute to tumor growth, his recent discoveries with regard to Zika virus and its potential to target glioblastoma propagating cells, and most importantly for his potential as a young investigator who will continue to make contributions that advance the understanding of glioblastoma biology and improve treatment options for patients as he transitions from an early-stage to advanced-stage physician scientist

AWARDS

NEURO-ONCOLOGY SCIENTIFIC AWARD

Sponsored by the American Academy of Neurology and supported by friends of Dr. WK Alfred Yung.

Recipient:â&#x20AC;&#x201A; Scott R. Plotkin, MD, PhD Thank You Statement: I am deeply indebted to the caring mentors who have guided me throughout my career, including Drs. Abba Kastin, Bill Banks, Mia MacCollin, and Tracy Batchelor. I have also benefited from the unwavering support of my Chiefs, Drs. Anne Young and Merit Cudkowicz. Finally, a heartfelt thanks to my neuro-oncology colleagues. Why the Recipient Was Chosen: A senior clinician investigator widely recognized for expertise in neurofibromatoses and related syndromes, Dr. Plotkin is dedicated to understanding the way in which typically syndromic and rare tumors symptomatically affect patients, and by collaborating with laboratory scientists to design and conduct clinical trials of novel therapies aimed at improving neurologic function. This has included seminal findings with regard to improvement in hearing among patients with NF2 and vestibular schwannomas following treatment with bevacizumab.

201

2018 AWARD RECIPIENTS NEUROLOGY® RESIDENT & FELLOW SECTION WRITING AWARD Recipients:

Sheena Chew, MD,

Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Ivana Vodopivec, MD, PhD

Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

Aaron L. Berkowitz, MD, PhD

Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

Thank You Statement for all Recipients: We are truly honored to receive the 2018 Neurology® Resident & Fellow Writing Award, which serves as a reminder of how privileged we are to learn and teach neurology through interactions with our patients. Why the Recipients Were Chosen: The award winning Clinical Reasoning’ paper by is the report of a case of Stiff Person Syndrome with anti-GAD antibodies. The authors skillfully utilized the unique, Clinical Reasoning’ format to emphasize the differential diagnosis and challenge the reader to consider the physical exam and diagnostic testing options at every step of the evaluation.

NEUROENDOCRINE RESEARCH AWARD

Sponsored by the American Academy of Neurology and supported by friends of Dr. Andrew Herzog.

Recipient: Ellen Mowry, MD, FAAN Thank You Statement: I am extremely grateful to my mentors, many of whom are AAN members, for their dedication to me and hope that I can do the same for trainees so as to pave the way for more breakthroughs for people with MS.

202 2018 AAN Annual Meeting On-site Guide

Why the Recipient Was Chosen: The cause of multiple sclerosis (MS) is unknown. For some time, it has been known that people with low levels of vitamin D are at highest risk for MS. Dr. Mowry has paved the way for determining why low vitamin D might contribute to the immune activation that is seen in MS, as well as determining whether vitamin D supplementation, and at what level, can be therapeutic in people with MS by preventing relapses. She has continued her exploration of how metabolic dysregulation, strongly related to neuroendocrine function, influences the disease and is conducting pilot trials to intervene upon the metabolism to assess the possibility of improving outcomes for this patient population.

NEUROSCIENCE RESEARCH PRIZE Funded by the American Academy of Neurology.

Recipients:â&#x20AC;&#x201A; Alex Remnitz Thank You Statement: I would like to thank my mentors, Dr. Grosell and Dr. Heuer from RSMAS at UM, who allowed me to create my own project and provided me with all of the help, support, encouragement, and materials I needed to do so. I am grateful for the experience they offered me.

AWARDS

Jackie Stochel Thank You Statement: I would like everyone who contributed to my project! I could not conduct amazing research without my amazing mentors (Dr. Patric Stanton and Dr. Linnea Vose). I am also so grateful to my research teachers (Mr. Michael Blueglass, Ms. Rachel Koenigstein, and Mr. Dominic Guazzo) for their guidance and dedication.

Sarah Hoffman Thank You Statement: My mentor, Dr. Norris, my lab head, Dr. Strickland, and all members of my lab welcomed me into their neurobiology laboratory and aided me in research design and execution. My research teachers, Mr. Piccirillo and Ms. Holmes, and my family and friends supported and encouraged me through the scientific process. Why the Recipients Were Chosen: Our committee had a spirited discussion after detailed reading and analysis of our submissions. This yearâ&#x20AC;&#x2122;s Neuroscience Research Prize winners have produced outstanding scientific work, especially for their age. These young students demonstrated amazing intellectual curiosity and depth of knowledge. We are fortunate to have them share their research with us and hopeful that this will mark the beginning of a long and dedicated career in the neurosciences.

203

2018 AWARD RECIPIENTS CHILD NEUROLOGY NEUROSCIENCE RESEARCH PRIZE

Sponsored by the American Academy of Neurology and the Child Neurology Society.

Amy Shteyman Thank You Statement: I would like to thank my mentor Dr. Joy Hirsch at Yale University’s Brain Function Laboratory, the members of the Brain Function Laboratory, Mr. Schorn and Ms. Schust my high school science research teachers for helping me with my project, and my family.

Why the Recipient Was Chosen: Our committee had a spirited discussion after detailed reading and analysis of our submissions. This year’s Neuroscience Research Prize winners have produced outstanding scientific work, especially for their age. These young students demonstrated amazing intellectual curiosity and depth of knowledge. We are fortunate to have them share their research with us and hopeful that this will mark the beginning of a long and dedicated career in the neurosciences.

MICHAEL S. PESSIN STROKE LEADERSHIP PRIZE

Sponsored by the American Academy of Neurology and endowed by Dr. Pessin’s family, friends, and colleagues.

Recipient: Glen Jickling, MD, MSc, FRCP(C) Thank You Statement: Thank you to Dr Frank Sharp for his mentorship and guidance in my career.

Why the Recipient Was Chosen: Dr. Jickling’s research exemplifies the best of clinical and translational stroke research: innovative, cutting edge, patient-oriented, and mechanistically sound. His work on developing state-of-the-art biomarkers for stroke diagnosis, etiology, and prognosis has the potential to transform practice and improve stroke care. Even at this relatively early stage in his career, he has also served as a mentor to many trainees.

PUBLIC LEADERSHIP IN NEUROLOGY AWARD Sponsored by the American Brain Foundation.

Recipient: Temple Grandin, Ph.D., Fort Collins, CO Thank You Statement: I am honored to receive the Public Leadership in Neurology Award from the American Brain Foundation. It is paramount that the skills that people with autism bring to the table be nurtured for their benefit and society’s. Some people with autism have exceptional skills in math, art or music.

Why The Recipient Was Chosen: For her leadership and advocacy for autistic people. She is one of the first individuals on the autism spectrum to publicly share insights from her personal experience of autism.

204 2018 AAN Annual Meeting On-site Guide

MRIDHA SPIRIT OF NEUROLOGY HUMANITARIAN AWARD

Sponsored by the American Brain Foundation and funded through the philanthropy of Dr. and Mrs. Mridha.

Aaron L. Berkowitz, MD, PhD Boston, MA Thank You Statement: I am honored to receive this award, and grateful to the American Brain Foundation and Dr. Mridha for creating this new award. I am grateful to my extraordinary colleagues in Haiti at Partners In Health/Zanmi Lasante, whom I have worked with and learned from for the past five years in our efforts to develop neurologic care and education in rural Haiti. Why The Recipient Was Chosen: Recognized for his humanitarian work to develop neurological care and education in rural Haiti.

PRESIDENTIAL LECTURE Francis S. Collins, MD, PhD Director of National Institutes of Health, Bethesda, MD

AWARDS

Title: California Dreaming: BRAIN and Precision Medicine in 2018

POTAMKIN PRIZE FOR RESEARCH IN PICK’S, ALZHEIMER’S, AND RELATED DISEASES

Sponsored by the American Academy of Neurology and the American Brain Foundation and funded through the philanthropy of the Potamkin family.

Recipient: David A. Bennett, MD Thank You Statement: I thank my research mentor, Denis Evans, the entire Rush Alzheimer’s Disease Center, and my colleagues Bob Wilson, Julie Schneider, and Phil DeJager. Most importantly, I thank Stacy Powell-Bennett, my best friend and wife, without whose support, encouragement, counsel, understanding, patience and love, this would not be possible. Why the Recipient Was Chosen: Dr. David Bennett, MD, is a neurologist at Rush who leads their Alzheimer Center as well as major epidemiological studies into causes of dementia. His multidisciplinary team has been one of the leaders of understanding what causes dementia, studying a population of elderly individuals in Chicago and dissecting what part is Alzheimer’s, what part is stroke, what part is depression, and so forth. He has assembled a great team for these studies and has also collected biosamples and, ultimately, autopsies to inform genetics and other -omics studies, both at Rush and, by sharing of specimens and data, by scientists around the world. It’s made a huge impact – both because the work is fantastic, and because the culture of sharing information has such a spectacularly positive impact.

205

2018 AWARD RECIPIENTS PROGRAM COORDINATOR RECOGNITION AWARD Recipients:

Silviya H. M. Eaton, MBA, MA, C-TAGME, Boston, MA Thank You Statement: I would like to thank the Brigham and Womenâ&#x20AC;&#x2122;s Hospital/Massachusetts General Hospital/Harvard Medical School Neurology Residency leadership for their inspiration and support: Drs. Cho, Prasad, and Milligan; department chairs: Drs. Cudkowicz and Samuels; directors: Ms. Kotarski and Mr. Lynch; our fellows, residents, and program directors; my fellow administrators (especially, Ms. Armstrong); the AAN (specifically, Ms. Jacques and Ms. Persaud); Ms. Sagar, and my family.

Frances Clark, BS, C-TAGME, Dayton, OH Thank You Statement: I am honored to be a recipient of the American Academy of Neurology Program Coordinator Recognition Award. I am deeply grateful for the residents and all involved in our program at the Wright State University Boonshoft School of Medicine. They have allowed me the opportunity to make a difference.

PROGRAM DIRECTOR RECOGNITION AWARD Recipients:

Lyell K. Jones Jr, MD, FAAN, Rochester, MN Thank You Statement: Working with the neurology residents at the Mayo Clinic has been the singular honor of my career. I am grateful to them, our faculty, and my friends and colleagues at the AAN who make our academic mission possible.

Raymond Price, MD, Philadelphia, PA Thank You Statement: I am extremely honored to receive the 2018 AAN Program Director Recognition Award. When I chose a career in neurology, my goal was to be a neurology residency program director. I consider myself incredibly fortunate to have this position and participate in the training of so many outstanding neurologists.

206 2018 AAN Annual Meeting On-site Guide

CAREER DEVELOPMENT AWARD Funded by the American Academy of Neurology.

Recipient: Aasef Shaikh, PhD, MD, Case Western Reserve University

AWARDS

Thank You Statement: The topic of the current proposal, investigation of motion perception function in Parkinson’s disease is critical and timely. This project is special as it combines two cutting edge and unique technologies. One is the study of motion perception and effect of electrical neuromodulation (deep brain stimulation) using one of the world’s best motion delivery systems with six degrees of freedom. Second is the opportunity to apply the state-of-art, quantitative tissue activation computational models to understand effects of deep brain stimulation on motion perception. My previous research training allowed me to achieve expertise in the neurophysiology of balance. The proposed project and the American Academy of Neurology Career Development Award will provide a chance to learn the theoretical aspects of neural engineering and computational neuroscience of deep brain stimulation. At the end of this specialized training I will develop a unique niche expertise in vestibular and eye movement function, the interaction of deep brain stimulation with vestibular and balance mechanisms, as well neural engineering and computational neuroscience to understand function implications of electrical tissue activation with deep brain stimulation. I feel honored and fortunate to get selected for this prestigious research funding.

CLINICAL RESEARCH TRAINING SCHOLARSHIP (FORMERLY FELLOWSHIP) Funded by the American Academy of Neurology.

Recipients: Christopher Benjamin, PhD, Yale New Haven Medical Center Thank You Statement: I’m extremely grateful to the AAN for this award! Without this award and my mentor Lawrence Hirsch, MD, I simply could not complete this work, which is vital for our field. Patients who have epilepsy want to stop their seizures, and neurosurgery offers great hope for a cure but also anxiety about risks. My goal is to give our patients simple statements about the risks and benefits of surgery, so that they can understand what their life is likely to look like after surgery and make well-informed decisions about their care. This award will bring me closer to that goal.

Matthew Bevers, PhD, MD, Brigham Women’s Hospital/ Harvard University Thank You Statement: It is a great honor to receive the AAN Clinical Research Training Scholarship. The AAN has a long tradition of supporting new investigators, and many of the doctors and scientists I admire were supported by the AAN early in their careers. It feels wonderful to be able to follow in their footsteps. I truly believe that this award will kick-start my research and allow us to move towards improving the lives of survivors of stroke and intracerebral hemorrhage.

207

2018 AWARD RECIPIENTS Peter Kang, MD, Washington University Thank You Statement: It is a true honor and privilege to be a recipient of the American Academy of Neurology and American Brain Foundation Clinical Research Training Scholarship. This award will allow me to continue my work and further my development as a junior clinical investigator. I am grateful for this opportunity and thank all the donors for funding this important program.

CLINICAL RESEARCH TRAINING SCHOLARSHIP IN ALS Funded by the American Brain Foundation and the ALS Association.

Recipient:â&#x20AC;&#x201A; Peter Creigh, MD, University of Rochester Thank You Statement: I am grateful and honored to receive this award from The ALS Association, American Brain Foundation and American Academy of Neurology. This award will allow me to grow as a clinician-researcher for a disease that is in desperate need for improved treatments. It will help create a role for telemedicine in ALS research, improving access to research participation. I am excited and feel fortunate to help patients and families affected by this devastating disease.

CLINICAL RESEARCH TRAINING SCHOLARSHIP IN DEMENTIA WITH LEWY BODIES Funded by the American Brain Foundation, and The Mary E. Groff Charitable Trust.

Recipient:â&#x20AC;&#x201A; Bhavana Patel, MD, University of Florida College of Medicine Thank You Statement: It is a great honor to be the recipient of this award. I have aspired to be a clinical researcher with the commitment of making a difference in the lives of my patients and in the population affected by neurodegenerative diseases. Early in my training, after developing an interest in movement disorders, I quickly learned about the limited knowledge that exists in clinical care access and outcomes in patients with DLB. I believe in order to improve care, we must first identify the current state of affairs. This study was developed to serve that purpose. This award will broaden our knowledge in the care of patients with DLB and be an avenue for future strategies to improve access and outcomes.

208 2018 AAN Annual Meeting On-site Guide

CLINICAL RESEARCH TRAINING SCHOLARSHIP IN MULTIPLE SCLEROSIS Supported by Genzyme and the American Academy of Neurology.

Recipient: Giulia Fadda, MD, University of Pennsylvania Thank You Statement: I am extremely honored and proud to have been selected as a recipient of such a prestigious award. This support fosters my motivation in pursuing a career bridging clinical neurology and research as I am committed to make the best use of this great opportunity.

CLINICAL RESEARCH TRAINING SCHOLARSHIP IN MUSCULAR DYSTROPHY

Funded by the American Brain Foundation and the Muscular Dystrophy Association.

Recipient: Katharine Nicholson, MD, Massachusetts General Hospital, Brigham, Harvard

CLINICAL RESEARCH TRAINING SCHOLARSHIP IN NEUROMUSCULAR DISEASE Funded by the American Brain Foundation, and the Muscle Study Group.

Recipient: Davut Pehlivan, MD, Baylor College of Medicine Thank You Statement: I am extremely humbled to receive this award; this is my first competitive AAN award/grant. As a junior physician scientist early in my career, this award will allow me to obtain preliminary data and apply for a larger NINDS/NIH grant. I believe this funding will have a significant impact on my research career.

209

AWARDS

Thank You Statement: I am honored to receive the AAN Clinical Training Scholarship in Muscular Dystrophy for my project investigating the ‚“Early Markers of Disease in C9ORF72 ALS.”I strongly believe we are on the horizon of advancing our understanding of genetically-mediated ALS. I view my work as a partnership with patients and families affected by inherited forms of ALS, and am grateful for their support and generosity with research participation. I sincerely thank my mentors — Dr. Merit Cudkowicz, Dr. James Berry, Dr. Nazem Atassi, Dr. Timothy Miller, and Dr. Leonard Petrucelli— whose support has fostered my early clinical research career in familial ALS and continues to inspire me every day.

2018 AWARD RECIPIENTS CLINICAL RESEARCH TRAINING SCHOLARSHIP IN PARKINSON’S DISEASE

Supported by Lundbeck in collaboration with the American Academy of Neurrology.

Recipient: Krithi Irmady, MD, PhD, Rockefeller University Thank You Statement: I am grateful to the AAN for awarding me with the Clinical Research Training Scholarship in Parkinson’s disease. This award provides crucial support and encouragement in my early career as a physician scientist. I am immensely appreciative of my research mentor Dr. Robert Darnell and the Rockefeller University Scholar’s program leadership Dr. Barry Coller and Dr. Sarah Schlesinger. I would also like to thank Dr. Un Kang, Dr. Stanley Fahn and Dr. Oren Levy at Columbia University Medical Center for their strong clinical mentorship. I am hopeful that with the support provided by the AAN, I can make meaningful progress in advancing our knowledge of Parkinson’s disease, which can potentially translate into the development of new treatments.

CLINICAL RESEARCH TRAINING SCHOLARSHIP IN TOURETTE SYNDROME Funded by the American Brain Foundation and the Tourette Association of America.

Recipient: Wissam Georges Deeb, MD, University of Florida College of Medicine Thank You Statement: I finished my medical studies in Lebanon and decided to the come to the United States for a better opportunity to learn and train in neurology. The movement disorders fellowship at the University of Florida taught me the importance of patient-centered interdisciplinary care. This comprehensive patient care model relies on excellent clinical skills and on advancing knowledge through research. Through this experience, I got to appreciate the importance of the clinician-researcher in improving the current and the future care of patients with neurologic conditions. I feel quite honored to receive this award from the American Academy of Neurology. It will provide me with the needed monetary and time support to develop my clinician-research career in Tourette syndrome. This award will afford me, a junior faculty and recent graduate from fellowship, the opportunity for mentorship and training needed to become an independent investigator.

NEUROSCIENCE RESEARCH TRAINING SCHOLARSHIP Funded by the American Academy of Neurology.

Recipients: Marianna Spatola, MD, Ragon Institute of MGH, MIT and Harvard Thank You Statement: It is a privilege and honor to receive the Neuroscience Research Training Scholarship from the American Academy of Neurology. This award represents recognition of my work that would not have been possible without the guidance of my mentors and the help and support of my colleagues, friends and family. I look forward with enthusiasm to starting this new challenging project. I want to again thank the AAN for this unique opportunity to continue my professional development as a clinician and scientist.

210 2018 AAN Annual Meeting On-site Guide

Brett McCray, MD, PhD, Johns Hopkins University Thank You Statement: When I first learned that I had received the Neuroscience Research Training Scholarship award, I was excited that our work had been recognized as being important and worthwhile. I was also extremely grateful because the award will help me to dedicate the necessary time and energy required to fulfill the goals of this project. The support from the award will also help me to get the additional scientific training that I will need to eventually start my own laboratory focused on furthering the understanding and treatment of different forms of peripheral neuropathy. Andrew Findlay, MD, Washington University Thank You Statement: I am extremely honored and grateful for this prestigious opportunity provided by the AAN. My family and my amazing mentors, Tahseen Mozaffar, Kevin Flanigan, Alan Pestronk, and Chris Weihl, have been inspirational and empowering. I cannot thank them enough. I would also like to acknowledge the Neuromuscular Department at Washington University Saint Louis for their ongoing support.

AWARDS

PRACTICE RESEARCH TRAINING SCHOLARSHIP (FORMERLY FELLOWSHIP) Funded by the American Academy of Neurology.

Recipient: Archana Patel, MD, Children’s Hospital Boston Thank You Statement: I am very honored and thrilled to receive this award. My research interests have always been broadly public health based in neurological conditions, with a specific focus on improving pediatric epilepsy care for children in low resource regions—and while global health neurology has been emerging in recent years, this career path remains a fairly new and developing one. Therefore, to have this type of research funded by the AAN is something I am very excited about, not only on a personal level for this project, but for the recognition of global health neurology research in general.

SUSAN S. SPENCER CLINICAL RESEARCH TRAINING SCHOLARSHIP (FORMERLY FELLOWSHIP)

Funded by the American Brain Foundation, the American Epilepsy Society, and the Epilepsy Foundation.

Recipient: Hiroki Nariai, MD, UCLA Medical Center Thank You Statement: I feel very privileged to receive this award. My career goal is to conduct clinical research in epilepsy and advance understanding and treatment of patients with epilepsy. This award will give me precious opportunity to focus on clinical research on epilepsy as a new investigator. It is very difficult to secure time and funding for research in this era, so I really appreciate the generous support.

211

2018 AWARD RECIPIENTS CLINICIAN SCIENTIST DEVELOPMENT AWARD IN INTERVENTIONAL NEUROLOGY

Funded the American Brain Foundation and the Society of Vascular and Interventional Neurology.

Recipient:â&#x20AC;&#x201A; Sunil A. Sheth, MD, McGovern Medical School at The University of Texas Health Science Center Thank You Statement: Receiving the AAN/SVIN/ABF award at this early stage in my career is an absolute honor. The support and prestige that comes with this award will allow me work towards accomplishing wh at I have always wanted to do, identifying ways to improve the lives of patients suffering from stroke.

MCKNIGHT CLINICAL TRANSLATIONAL RESEARCH SCHOLARSHIP IN COGNITIVE AGING AND AGE-RELATED MEMORY LOSS

Funded by the McKnight Brain Research Foundation through the American Brain Foundation, and the American Academy of Neurology.

Recipients: Brice McConnell, PhD, MD, University of Colorado Denver School of Medicine Thank You Statement: I am delighted and very honored to have been selected for this award.

Kimberly Albert, PhD, Vanderbilt University Medical Center Thank You Statement: I am very honored and excited to receive this award. I look forward to the interesting work this award will support in developing remote cognitive assessment strategies and a better understanding of the role of attention in memory complaints associated with aging.

212 2018 AAN Annual Meeting On-site Guide

SAFETY AND QUALITY AWARD

Sponsored by the American Academy of Neurology.

Recipient: Lily Grossmann, MD, Boston, MA Thank You Statement: Thank you for recognizing the work of the interdisciplinary Neurology team at Boston Children’s Hospital in their efforts to improve both patient and parent experience of undergoing multiple diagnostic evaluations by coordinating sedation for MRI and lumbar puncture. We will continue to strive for high-quality, patient-centered care. Why the Recipient Was Chosen: Dr. Grossmann, is being recognized for her work to improve patient experience for children requiring a lumbar puncture (LP) and MRI for evaluation of their pediatric neurological condition. Through a partnership of the neurology and anesthesia departments, a protocol was developed for continuous anesthesia for MRI and LP tests to be done sequentially. Over the course of the project, the protocol was found to be feasible, costeffective, safe, and less burdensome for patients and their families.

Recipient: Yi Li, MD, PhD, Worcester, MA

AWARDS

Thank You Statement: Thank you for recognizing our work of ultrasound guided lumbar puncture, with the aim to decrease the discomfort of the patients and to improve the success rate. We are grateful to all the patients, neurology residents and faculty who are involved in this patient-centered project in University of Massachusetts Medical School. It is a great pleasure to contribute to improvements in patient comfort and safety, and we look forward to continuing to do so. Why the Recipient Was Chosen: Dr.Li, PhD, is being recognized for her project implementing an ultrasound guided lumbar puncture learning module for neurology residents that includes a 1-hour didactic presentation with a 30-minute practice session. Residents that have completed the module have shown to have a higher success rate, shorter procedure duration, and lower complaints of pain.

Recipient: Michael Robers, MD, Phoenix, AZ Thank You Statement: Thank you to the AAN for recognizing our efforts to improve the time it takes to respond to results of send out laboratory results. We intend to use the positive results and response to our project to spur even more improvement in this area. We would like to also thank the faculty and mentors at Barrow Neurological Institute who continue to support resident driven interventions to continuously improve our patient care. Why the Recipient Was Chosen: Dr. Robers is accepting on behalf of the senior members of his resident class at Barrow Neurological Institute. Their efforts to improve physician acknowledgement of lab results in a timely manner were successful. By leveraging the electronic medical record, physician response rate went from 36% to 93% and the average time between a reported result and physician acknowledgement went down by 66%.

213

2018 AWARD RECIPIENTS Recipient: Mauricio Villamar, MD, Lexington, KY Thank You Statement: Optimizing the timely identification and treatment of patients with status epilepticus can have a critical impact on their outcomes. Thank you to the University of Kentucky Department of Neurology, and particularly to Dr. Meriem Bensalem-Owen, for their ongoing support of my research and for constantly striving to provide exceptional patient care. Why the Recipient Was Chosen: Dr. Villamar is being recognized for his work on improving the rapid identification and treatment of patients with status epilepticus (SE). A novel SE alert protocol resulted in rapid notification of key team members including the general neurology resident, the pharmacist, the neurointensivist on call, as well as the rapid response team.

IRWIN SCHATZ AWARD FOR AUTONOMIC DISORDERS

Sponsored by the American Academy of Neurology and endowed by Lundbeck, Inc.

Recipient: David S. Goldstein, MD, PhD Thank You Statement: Irwin J. (Irv) Kopin was my scientific father. Courtney Holmes ran our catecholamine lab for more than a quarter century and unerringly pointed me to the truth. Patients are a key scientific resource, and I remember and especially acknowledge those who donated tissues after death, for the benefit of humanity. Why the Recipient Was Chosen: Dr. Goldstein was selected based on both his lifetime achievements and contributions to the field of autonomic disorders as well as for his ongoing dedication to research and education. His curriculum vitae outlines an extraordinarily distinguished career with many unique contributions to the field. Dr. Goldstein is a true pioneer in autonomic disorders and has special expertise in clinical catecholamine neurochemistry and sympathetic neuroimaging. He has made key contributions to our understanding of autonomic failure, especially in Parkinson’s disease, multiple system atrophy, and pure autonomic failure. He has trained many specialists in the field, has lectured extensively to patients and clinicians alike and wrote a book (which he generously offer free of charge online to everyone interested, again patient or provider) to foster better understanding and better care for patients with autonomic disorders.

BRUCE S. SCHOENBERG INTERNATIONAL AWARD IN NEUROEPIDEMIOLOGY

Sponsored by the American Academy of Neurology and endowed by GlaxoSmithKline, Inc.

Recipient: Fred Sarfo, MD, PhD Thank You Statement: Special thanks to Prof. Bruce Ovbiagele, my mentor; Prof. Opare-Sem, Prof. Richard Phillips, Prof. George Bedu-Addo, Prof. Mayowa Owolabi, Dr. Albert Akpalu, and Prof. Carolyn Jenkins. A big thank you to my wife, Maame and my son, Jason.

214 2018 AAN Annual Meeting On-site Guide

Why the Recipient Was Chosen: Dr. Fred Sarfo’s highly promising study employing novel m-Health technology and nurse-led approaches for improvement of secondary stroke prevention benefits an understudied problem in the underserved context of Ghana, and reflects his overall impressive career trajectory of performing high-impact and public health relevant work in a resource-restricted setting. The work has the potential to transform stroke care delivery in Ghana, and more broadly in resource-limited settings, and could potentially be transformative for public health in Sub Saharan Africa.

SLEEP SCIENCE AWARD

Sponsored by the American Academy of Neurology and the American Academy of Neurology Sleep Section and endowed by Cephalon, Inc.

Recipient: Bradley F. Boeve, MD Thank You Statement: I thank many colleagues - particularly Dr. Michael Silber who has been my mentor in sleep medicine for the past 20+ years.

AWARDS

Why the Recipient Was Chosen: Over the last two decades Dr. Boeve has been a pioneer in the field of sleep and neurodegenerative disorders, in particular helping to confirm the link between REM sleep Behavior Disorder and alpha-synuclein pathology. The scope of his discoveries range from basic brainstem neuroanatomy to developing and validating practical tools used by clinical neurologists. Currently, his research is helping to lead the way in the development of disease modifying therapies with the ultimate goal of curing disorders such as Dementia with Lewy Bodies and Parkinson’s disease.

JON STOLK AWARD IN MOVEMENT DISORDERS FOR YOUNG INVESTIGATORS Sponsored by the American Academy of Neurology and endowed by Kyowa Pharmaceutical, Inc., Lineberry Research, Quintiles, Dr. Dennis Gillings, and VelaPharma.

Recipient: Nandakumar Narayanan, MD, PhD Thank You Statement: I’d like to acknowledge my perspicacious scientific and clinical mentors, particularly Dr. Ralph DiLeone (Yale), Dr. Robert Rodnitzky (Iowa), and Dr. George Richerson (Iowa). In addition, I’d like to thank my colleagues at the University of Iowa and the incredible research team we’ve built. Why the Recipient Was Chosen: Dr. Narayanan’s laboratory focuses on dopamine receptors and motor timing, with the goal of understanding the brain circuitry involved in Parkinson disease-related cognitive dysfunction. In his short career, he has already made important contributions to the field that have been published in leading neuroscience journals and he has been awarded numerous grants from the National Institutes for Health and other organizations. Dr. Narayanan is a rising star in the movement disorders field and has dedicated his research and clinical efforts to tackling the pervasive challenge of cognitive decline in Parkinson disease.

215

2018 AWARD RECIPIENTS H. RICHARD TYLER AWARD

Sponsored by the American Academy of Neurology and the American Academy of Neurology History Section

Recipient: Andrew J. Solomon, MD, Burlington, VT Thank You Statement: I am honored to receive the 2018 H. Richard Tyler Award from the American Academy of Neurology. I would like acknowledge the leadership of the AAN, and especially the late Rick Tyler, MD, Professor of Neurology emeritus at Harvard Medical School, for supporting this exceptional opportunity to access an incomparable historical collection of neurology and neuroscience materials. Why The Recipient Was Chosen: Dr. Solomon was chosen to receive the 2018 H. Richard Tyler Award based on his proposal to use the texts in the collection to examine clinical descriptions of multiple sclerosis in 19th and early 20th century with an emphasis on diagnosis and differential diagnosis. He has hypothesized that studying the approach to the diagnosis of MS during this time, before the incorporation of paraclinical evidence, may still have value for current diagnosis.

KENNETH M. VISTE JR., MD, PATIENT ADVOCATE OF THE YEAR AWARD

Sponsored by the American Academy of Neurology and endowed by gifts from Dr. Viste’s colleagues, friends and patients.

Recipient: Oleg Chernyshev, MD, PhD T hank You Statement: It is a true honor to receive the prestigious Kenneth M. Viste, Jr., MD, Patient Advocate of the Year Award from the American Academy of Neurology. I am so grateful that life has granted me this unique, rewarding opportunity to be an effective advocate for my patients and to be a positive influence in their lives. I strongly believe that our sustained efforts can make a difference not only in individual patient health, but also in community health regardless of the political climate. So, let’s get involved, stay involved, and make difference! Why the Recipient Was Chosen: Dr. Chernyshev has demonstrated a sustained dedication and commitment to his patients and the community at large. Practicing in the heart of the US Stroke Belt, he has been the driving force behind the development of a stroke center at LSU Health Sciences Center in Shreveport, LA. His compassion and relentless drive to be on the front lines of fighting stroke has earned him the nickname Dr. Stroke by his patients. He embodies all the selfless and genuine qualities of the Kenneth M. Viste Jr., MD, Patient Advocate of the Year.

216 2018 AAN Annual Meeting On-site Guide

ROBERT WARTENBERG LECTURE Recipient: Lisa M. DeAngelis, MD, FAAN Memorial Sloan-Kettering Cancer Center, New York, NY Title: Neuro-oncology: How Cancer and the Nervous System Interact

HAROLD WOLFF-JOHN GRAHAM AWARD: AN AWARD FOR HEADACHE/FACIAL PAIN RESEARCH Sponsored by the American Academy of Neurology and endowed by Endo Pharmaceuticals.

Recipient: William R. Renthal, MD, PhD

Why the Recipient Was Chosen: As the 2018 recipient of the Harold Wolff-John Graham Award, the committee has selected William Renthal, MD, PhD, an Instructor in the Department of Neurobiology at Harvard Medical School and the Director of Headache Research at the John Graham Headache Center at Brigham and Women’s Hospital. Dr. Renthal’s abstract details an innovative area of translational research using single-cell RNA sequencing to identify unique gene expression patterns within individual trigeminal ganglion cell types, with the ultimate goal of investigating the role of these genes in CGRP+ neuronal function and migraine pathophysiology. With a new 5-year NIH K08 Career Development Award, and a resume including 27 original research articles and five reviews, Dr. Renthal is on track to make substantial contributions to the field of migraine.

217

AWARDS

Thank You Statement: I would like to acknowledge my mentors, Michael Greenberg and Clifford Woolf, for generously supporting my research and career development, my John Graham Headache Center colleagues for building an amazing environment for advancing headache medicine, and the International Headache Academy for inspiring me and the next generation of headache researchers.

2018 ANNUAL MEETING ATTENDEES Aaen, Gregory Aamodt, Whitley Abad, Ajay Abadal, Grant Abbasi, Saad Abbassi, Puya Abbatemarco, Justin Abbott, Sabra, MD, PhD Abboud, Hesham Abboud, Halim Abd Wahab, Wasan Abdallah, Amir, MBCHB Abdelkader, Ahmed, MD, PhD Abdella, Hayder Abdelmalek, Sandy Abdelmessih, Mourad Abdelmonheim, Nader Abdelnassier, Maged Abdelrehim, Mohamed Abdo, Christopher Abdou, Ashraf Abdou Hassan, Ahmed Hassan Abdullaev, Bekhzod Abdullah, Namir, MD, PhD Abdulrasoul, Abdullah, MD, MBBS Abedin, Laleh Abend, Nicholas Abendroth, Francena Abernethy, David, MB, ChB, FRACP Abhyankar, Rahul Abiad, Renee Abid, Muhamed, MD, MBBS Abijay, Joseph Albert Abokhamis, Ahmad Aboseif, Albert, MS3 (medical student) Abou Fayssal, Nada Aboud, Talal

Aboulmaaty, Ali Abourjaily, Heather Abraham, Justin, MBA Abramowski, Jannicke Abramson, Scott Abrantes-Pais, Fatima Abreu, Pedro, MD Absar, Nicole Abu, Zemen Abu Shama, Ahmed, MD Abualela, Hanadi Abu-Esheh, Baha, FAHS Abulaban, Ahmad Abusrair, Ali Acevedo, Jose Acharya, Jayant, MD, DM Achi Arteaga, Jimmy Achiron, Anat, MD, PhD, FAAN Achtnichts, Lutz Ackerman, Daniel Ackermans, Nathalie Acosta, Julian Acosta, Juan Acosta, Lealani Acosta Martinez, Dionisio Acuna, Patrick Adamczak, Richard Adamczyk-Sowa, Monika, MD Adamolekun, Bola Adams, Elizabeth Adams, Angela Adams, Kristin Adams, David Adams, Irene Adams, Lori Adams, Lori, BS Adams, Robert, MBA Adams, Sue, BSc Adamu, Sheila, MBChB

218 2018 AAN Annual Meeting On-site Guide

Adcock, Amanda Addington, James Addis, Alberto Adeli, Gholam Adelman, Philip Adil, Malik Adler, Charles, MD, PhD, FAAN Adler, Margaret Adoni, Tarso Adstamongkonkul, Dusit Aerra, Ashwitha, M.Pharm Aerts, Cecile Afkhamnejad, Elahhe, BA, MA Afonso, Livia Afra, Pegah Afreen, Ehad Afridi, Shazia, PhD FRCP Afshari, Mitra, MPH Afzal, Umair Afzal, Muhammad Furqan Agabi, Osigwe Agadi, Jagadish Agafonova, Nataliya Agan, Kadriye Agarwal, Puja, PhD, MBA Agarwal, Shashank, MD, MBBS Agarwal, Tijil Agarwal, Rajul Agarwal, Pinky, MD, FAAN Agarwal, Sachin, MD,MPH Agarwal, Saloni Agarwal, Kriti Agarwal, Shreya, BA Aggarwal, Rajiv Agha, Ahmed Aghaei-Lasboo, Anahita Aghajan, Yasmin Agnese, Wendy Agonafer, Makeda

Aino, Hiroshi Airas, Laura, MD, PhD Ait Tihyaty, Maria Aita, John Aiyagari, Venkatesh, MD Ajiboye, Norman, MD Ajroud-Driss, Senda Akamatsu, Masao Akbar, Umer Akbari, Yama, MD, PhD Akbaripanahi, Sepideh Akcali, Aylin, MD Akfirat, Gokhan Akhtar, Shahrzad Akins, Sarah Akkineni, Keerthana Akman, Orhan Akman Demir, Firdevs Gulsen, MD Aksamit, Allen, MD, FAAN Aksoy, Durdane, MD Aktas, Orhan Al Abbasi, Ziad Al Balla, Saleh Al Ghamdi, Fouad Al Hussona, Mariam Al Jerdi, Salman Al Kawi, Zuheir, MD, FAAN Al Kawi, Ammar, MD, FAAN Al Khathaami, Ali Al Otaibi, Majid Al Rizaiza, Adeeb Al Said, Youssef Al Saman, Abdulaziz Al Sawaf, Abdullah Al Shehri, Ali Al Sheikhly, Abdulmuttaleb, MD, FAAN Al Soufi Al Sukkary, Ziad Al Sultan, Abdulaziz

Ala, Thomas Alabdali, Majed Alabdi, Zainab Alabdulraheem, Najayeb Alabi, Peter, MBBS, FMCP Alabkal, Jarrah Aladeen, Traci Alafifi, Tariq ALAJBEGOVIC, AZRA Alakbarzade, Vafa, PhD Alalawi, Zainab Alam, Mohammad Alam, Tariq Alam, Sardar Muhammad Alam, Rina, FRACP, MBBS Alam, Fidaul Alameda, Gustavo Alampur, Uma Alamri, Abdullah Alapatt, Paul, MD, MBBS Al-Araji, Sarmad, MBChB MRCP Al-Araji, Adnan Alario, Joseph Alawadhi, Abdulla Alawi, Aws Alawi, Sadaga Al-Awwad, Ahmad Alazwary, Nail Albala, Bruce Albalawi, Miad Albanese, Gustavo, MD Albanese, Maria, Dr Albaradei, Omnya Albassam, Fahad AlBassami, Afnan Albers, Gregory, MD Albert, Dara Albert, Guillermo, MD, FAAN Albert, Kimberly

219

2018 ANNUAL MEETING ATTENDEES

Agopian, Eliz Agosta, Federica Agrawal, Punit Agrawal, Sanket, MBA, MPH Aguera Morales, Eduardo Aguilar, Rina Aguilar, Luis Carlos Aguirre Castaneda, Claudio Aguirre Hernandez, Clara, MD Agunias, Jhaphet, MD Ahad, Antwan Ahadi, Sahar Ahdab-Barmada, Mamdouha Ahdidan, Jamila Ahern, Kevin Ahlawat, Aditi Ahluwalia, Ranbir Ahluwalia-Singh, Brij, MD, FAAN Ahmad, Arsalan Ahmad, Tazeen, BS Ahmed, Aiesha Ahmed, Iftekhar, MD, PC, FAAN Ahmed, Kazi Gias Uddin, MD, MBBS Ahmed, Munazza Ahmed, Sheikh Ahmed, Ammar, PhD, MBBS, FRCP,Lond Ahmed, Samar Ahmed, Wamda Ahn, Andrew, MD, PhD Ahrendtsen, Kate Ahrens, Stephanie Ahsan, Nusrat Ahuja, Ashim Ahuruonye, Ndubuisi Aiba, Ikuko Aich, Josef Ailey, Stephanie, BS

2018 ANNUAL MEETING ATTENDEES Alberts, Mark Albilali, Abdulrazaq Albrecht, Philipp, PD MD Albuja, Ana Al-Bustani, Najwa, FRCPC Alcalay, Roy Alcaraz, Leah, MD Alchaki, Abdul Rahman Aldawehi, Ashah Aldhukair, Hisham AlDosary, Rana Aleem, Mohamed Ibrahim Alegria, Dylan, MD, MS Alemany, Ramon, MD Alencar, Jessica Alessi, Anthony, MD, FAAN Alexander, Nicole Alexander, David Alexander, Joshua, DO, MPH Alexander, Jessica Alexander, Monica, MA Alexandrov, Andrei, MD Alexan-Shirabad, Richard Alexopoulos, Harry Alfaify, Omar Alfano, Lindsay, DPT Alford, Alison Alfradique-Dunham, Isabel Algarni, Musleh Alghamdi, Abdulaziz Algom, Avi Alhadid, Kenda Alhamaid, Fawaz Alhamdan, Omar Al-Hamdan, Nourah Al-hameed, Majed Alhammad, Reem Alharbi, Samar, MD, MBBS Al-Harbi, Talal

Alhashmi, Sajad Naseer Alhazzani, Adel Ali Alhijab, Mohammed Alhomosh, Alaaedin Ali, Abdulrahman Ali, Fuad-al Ali, Mohammad Ali, Musab Ali, Naif, MD, MBBS Ali, Zeeshan Ali, Syed, MD Ali, Imran, MD, FAAN Ali, Ishaq Ali, Mumtaz Ali, Syed Ali, Ashhar Ali, Sameer Ali, Uzma, MD, MBBS Ali, Ismael Ali, Noore Ali, Fizzah Ali Ahmad Mohammad, Ahmad Ali Pacha, Lamia Alikhani, Katayoun Alilender, Malle Aljaafari, Danah Aljammaz, Ahmed Al-Janabi, Omar, MBChB, MS Al-Jarki, Namareq Al-Jughaiman, Umar Al-Jumah, Mohammed, MD, MBBS Alkaitis, Damanhuri, MD, FAAN Alkhaldi, Modhi Alkhoujah, Mohammad Allali, Gilles, MD, PhD Allam, Gregory Alldredge, Brett Allegri, Ricardo, MD

220 2018 AAN Annual Meeting On-site Guide

Allen, Arthur Allen, Christopher Allen, Jeffrey Allendorfer, Jane Allen-Jouaibi, Tristin Allen-Philbey, Kimberley, MSc Allien, Stephanie Allison, Tyler Al-Louzi, Omar, MD Al-Lozi, Muhammad, MD Al-Lubdan, Reem, MD, MBBS Alluri, Jagga Almejally, Mousa Almomen, Momen Almsaddi, Malaz Al-Mubarak, Ali Almullahassan, Ameer Almuntaser, Samar, Mbbs, ABP, MRCPCH Almutlaq, Ahmad Alomar, Majed Alonso-Jimenez, Alicia Alonso-Labori, Ernesto Alotaibi, Hessa Alotaibi, Naser Alotibi, Hessah Alp, Filiz Alpert, Jack, MD, FAAN Alqadi, Khalid Alqahtani, Amirah Alqahtany, Abrar Al-Qureshi, Shireen, MD, FRCP, FAAN Alrajeh, Saad Alrasheed, Khalid Alrasheed, Abdulrahman Alrefai, Ali Alrohimi, Anas AlRuwaili, Raed Alsallom, Faisal

Alvim, Marina Aly, Hazem, MD, PhD Alyahya, Mossaed Alyazidi, Ghalia AlYouha, Dalal Alzagatiti, Bassam Alzahrani, Abdulaziz Alzahrani, Sultan Alzahrany, Majed Amajuoyi, Uche Aman, Muhammad, MD, MBBS Amann, Peter Amara, Amy, MD PhD Amaral, Caroline Amaral, Eliane Amatniek, Joan Amato, Anthony, MD, FAAN Amato, Maria Pia Amayo, Erastus, MD, FAAN Ambe, Solomon, MBBS Ambulkar, Swapnil, MBA Amer, Wael Ameri Shahrabi, Abdol Ameur el Khedoud, Wahiba Amezcua, Lilyana, MD Amick, Amy Amigo Jorrin, Maria del Campo Amin, Hitha, MD, MBBS Amin, Nessim Amin, Anik Aminian, Abdolkarim Aminoff, Michael, MD, DSc, FAAN Amir, Darwin Amirova, Samira Amjad, Fahd Amlie-Lefond, Catherine, MD Ammah, Deidre Ammerman, Diane, PharmaD

Ammoury, Nazih Amodeo, Katherine Amodeo, Lauren Amos, Edwin Ampapa, Radek Amrutkar, Chaitanya Anadani, Mohammad Anagnastou, Evdokia, MD Anagnos, Sylvia Anagnos, Angela Anand, Amar Anand, Bhupinder Anand, Samyuktha Ananda, Rajee Anandan, Charenya Anandaram, Sanjay Anang, Julius Ancane, Gunta Andelova, Michaela Ander, Tracy Andersen, Peter Munch Andersen, Henning, Proffessor Anderson, Collin Anderson, Haley Anderson, Noriko, MD Anderson, Eric, MD, PhD Anderson, Aaron Anderson, C, MD, FAAN Anderson, Christopher, MD, MMSc Anderson, Elise Anderson, Garrett Anderson, Wayne, MD, FAAN, FAHS Anderson, Julie Anderson, Karen Anderson, Kim, DVM Anderson, Jan, Pharm.D. Anderson, Austen, MBS Andersson, Ellen Christina

221

2018 ANNUAL MEETING ATTENDEES

Alseoudi, Sarab Alshaar, Mohammed Alamin ALSHAHRANI, ASHWAQ AlShahrani, Mohammed Alshaikh, Jumana Al-Shamaa, Sarmad, MBChB Alshamai, Crystal Al-Sharoqi, Isa, MRCP, MD Alshehri, Ali Mohammed Al-Shehri, Ebtesam Alshikho, Mohamad J. Alshimemeri, Sohaila Al-Shorafat, Duha Alsibai, Ahmad Alsinaidi, Omar Alskaini, Mohammed Altalib, Hamada Alter, Aliza Alter, Katharine, MD Altier, Matthew Altieri, Carlos Altikes Hazzan, Mario Altintas, Ayse, MD Altmann, Markus Altunrende, Burcu Aluclu, Ufuk, MD Alumin Osman, Ebtisam, MD Alvarado Arias, Alexis Alvarenga, Marcos, MD Alvarez, Enrique, MD, PhD Alvarez, Maria Alvarez, Carolina Alvarez, Lubia Alvarez, Valeria Alvaro, Anthony, FRACP, MBBS Alves, Monique Alves, Veruska Alves Pinheiro, Candida, MD Alvi, Muhammad

2018 ANNUAL MEETING ATTENDEES Andrade, Helen Andreozzi, Erica, PhD Andriuta, Daniela Androdias, Geraldine Andruska, Kristin, MD, PhD Anello, Mimma Angelini, Corrado Angell, Suzanne Anidi, Chioma, BA Anilkumar, Arayamparambil Ani-Osheku, Ifeyinwa Anlacan, Michelle, MD Annan, Isaac Annocaro, Claudia Ansari, Saeed Ansari, Tasjeel Ansari, Abu, MD, MBBS Ansari, Hossein, MD, FAAN Ansari, Rahila Ansari, Pireh, BSc Anseeuw, Brian Ansevin, Carl Ansevin, Carl, MD, FAAN Antelmi, Elena Antezana Camacho, Gary Antinew, Jeremias Antonino, Ilia, PharmD Antony, Arun Antuono, Piero, MD, FAAN Anwar, Tayyba Anwer, Sanam Anzalone, Susan Anzardi Vidal, Javier, MD Ao, Dong-Hui Apostolos Pereira, Samira Luisa Apostolova, Liana, MD, FAAN Appel, Joan, PA-C,CCRC Appel, Stanley, MD, FAAN Apple, Stephen

Aradine, Elizabeth Araqui, Houssaini Araujo, Abelardo, MSc Araujo, Alexandra, MD,PhD Araujo, Igor Araujo, Lindsey Araujo, Mauro Araujo, Roberto Arbatti, Lakshmi Arbuckle, Lisa Arce Gaspar, Victor Hugo Arcot Desai, Sharanya Ardakani, Rumyar Ardito, Bonaventura, MD Arditti, Inbal Aref, Hany Arenas Sanchez, Marcela Ares Luque, Adrian Arezki, Mohamed Argoff, Charles Arhebamen, Ebinehita, MPH Arias Gomez, Manuel, MD Aritonang, Freddy Armangue, Thais, MD Armanious, Mark Armon, Carmel, MD, FAAN Armstrong, Melissa, MD, MSc, FAAN Armstrong, Jennifer, MD, MPH Armstrong, Michelle, MAED, CTAGME Arnan, Martinson, MD Arneson, Erik, BS Arnett, Kenya, BA Arnold, Alexander Arnold, Douglas Arnold, William Arnold, Natalie Arnone, Vincent Aron, Carey, DVM

222 2018 AAN Annual Meeting On-site Guide

Arons, Magali Arouca, Eustaquio Arredondo, Kristen Arrieta Cetina, Adriana Arsalan, Nazeem Arsiwalla, Mehreen Arumaithurai, Kogul Arun, Priti Arvanitakis, Zoe, MD, MS, FAAN Arya, Divya Arya, Kapil Aryal, Nirmala Aryal Pandit, Aashrayata Asato, Miya, MD Asawavichienjinda, Thanin, MD, PhD Asbury, Charles Asenbaum-Nan, Susanne, PhD Asgari, Nasrin Asgharnejad, Mahnaz Ashaye, Tomi Ashcraft, Elizabeth Ashikian, Nazely Ashina, Sait Ashleigh, Theophania, BHSc Ashley, Kristin Ashley, Kevin, BS Ashman, Eric, MD, FAAN Aslam, Sana Assadi, Rami-james Assal, Frederic Ata, Ahmad Atalay, Yahya Atanga, Pascal Atassi, Nazem Athauda, Dilan, MBBS, PhD Athwal, Gurleen Atkins, Edward Atri, Alireza, MD, PhD

Azab, Ahmed Azam, Sarah, DO, 2019 Azeem, Muhammad Azevedo, Christina, MPH Azevedo, Paula Azimi Saeen, Amirreza Azodi, Shila Azzi Nogueira, Deborah Ba, Fang Baang, Hae Young Baba-Ahmed, Nassima Babcock, Lauren, MS Babikian, Viken, MD, FAAN Baca, Christine Bacharach, Rae Bacile, Elizabeth Bacsi, Ann, MBBS(BSc), RACP Bader-Weder, Silvia Badhwar-Parasher, Shruti Badjatia, Neeraj, MD Badsi, Douniazade Badve, Monica Baechler, Andrea Baehring, Joachim, MD, DSc Baek, William Baena, Mateus Baer, Taryn, MABS Baeta, Alex Baez, Alejandra, MD Bagert, Bridget, MD, MPH Baggaley, Susan Baglin, Ally Bahntge, Michael Bahouth, Mona Baig, Fahd Baik, Minyoul Bailey, Charles Bajaj, Nikesh Bajaj, Richa, DMD

Bajaj, Tushar Bajenaru, Ovidiu, MD, PhD Bajenaru, Ovidiu-Lucian Bajwa, Samar Bajwa, Zahid Bakdache, Fabien Baker, Nancy Baker, Darren Baker-Newsholme, Beverly Bakshi, Rohit, MD, FAAN Bakst, Isaac Balart, Mireya Balas, Calaneet Balashov, Konstantin, MD, PhD, FAAN Balbuena-Root, Melissa Balcer, Laura, MD, MSCE, FAAN Balci, Belgin Petek, PhD Balcom, Erin, BSc Baldassari, Laura, MD, MHS Baldinger, Esther Baldus, Jamie Baldwin, Kelly, MD Balgobin, Bhumika Baliguas, Beverly Balish, Marshall, MD, PhD Ballen Caceres, Justo Balnyte, Renata, MD Baloh, Robert, MD, FAAN Baltogiannis, Christos Bamaga, Ahmed Khamis Bana, Mario, MD Banakar, Basavaraj Banales, Jose Luis Banar, Bronislava Bandari, Savitra Bandyopadhyay, Sankar, MD, FAAN Banisadr, Ghazal Bankole, Idowu, MD, FMCP

223

2018 ANNUAL MEETING ATTENDEES

Attal, Nadine, MD, PhD Attarian, Hrayr Attaripour, Sanaz Atteyah, Daniah Attie, Kenneth Aubuchon, Adam Auclair, Greg, MSc Audia, Hannah Auerbach, Sanford, MD, FAAN Augustine, Erika, MD, FAAN Aul, Edward Ault, Jennifer, DO, PhD, PT Aurora, Sheena, MD Austin, Sara, MD, FAAN Austin, Catherine Avanesian, Agnesa Avendano, Francisco Javier Avery, Robert, DO Avidan, Alon, MD, MPH, FAAN Avila, David Avila, Mirla Avila, Robin Avila-Ornelas, Jose Avitzur, Orly, MD, MBA, FAAN Awad, Ibrahim, BSC, MBA Awais, Ozaire Awe, Leah, MS, MBA Awosika, Oluwole, MD Ayala, Martin Aybek, Selma Aydemir, Aynur, MD Aydinturk, Ilknur, MD Ayeni, Oluwasheyi Ayer, Gretchen, MS Ayoub, Omar Ayoub, Maya, Ed.M. Ayub, Neishay Ayub, Zahra Ayyaswamy, Mohan

2018 ANNUAL MEETING ATTENDEES Banks, Matthew Banks, Diana Banks, Gordon, MD, PhD, FAAN Banks, Sarah Banks, Samantha Bansal, Vikas Bansal, Gagan Banwell, Brenda, MD, FAAN Bar Dov, Ayelet Bar Zohar, Danny Baraban, Elizabeth, PhD, MPH Barak, Yoram Barako, Tristan Baram, Tallie, MD, PhD Baranello, Giovanni Barbano, Richard, MD, PhD, FAAN Barbato, Luigi Barbe, Michael, MD Barber, Elizabeth Barber Lindquist, Susan Barberis Martinez, Patricia Barbosa, Marcelo Barboza, Andres, MD Barca, Emanuele Barcinas, Tanya Barclay, Terry Bardon, Jan Barfield, Jason Barghouthi, Tamara Bargnes, Vincent Barinagarrementeria, Fernando, MD, FAAN Barkhof, Frederik Barkhuizen, Melinda Barmore, Ryan Barnes, J., MBA Barnes, Stephanie Barnes, David Barnes, Janel

Barnett Tapia, Carolina Barohn, Richard, MD, FAAN Baroncini, Damiano, MD Barone, Leonardo Bar-Or, Amit, MD, FRCPC Barr, Donald Barr, Lorraine Barratt, Diana, MD, MPH, FAAN Barreira, Amilton Barrell, Kelsey Barrentine, Lori, MS, PAC Barrera, Jasmine, MSPH Barreras, Paula Barreto, Carlos Barreto, Amilcar, MR Barreto-Montalvo, Juan, MD, FAAN Barrett, Douglas, MD, FAAN Barrett, Kevin Barrett, Shannon, MS, CGC Barry, Brian Barsottini, Orlando, MD, PhD Barth, Jay Bartleson, J. D., MD, FAAN Bartok, Gabor Bartolini, Luca Barton, Brandon, MS Barton, Edward Bartonik, Jan Bartosik-Psujek, Halina Bartt, Russell, MD, FAAN Baruca, Mateja Basaia, Silvia Basal, Eati Bashir, Ferhad Bashir, Hassaan Bashmakov, Anna, MS Basile, Patricia, MD Basilio, Carlos, MD

224 2018 AAN Annual Meeting On-site Guide

Baskin, Jonathan Basoff, Daniel Bassons, Rocio, MD Bastos, Lilian Basu, Roshni Basumatary, Lakshya Batara, Julette Batchelor, Tracy, MD, MPH Bateman, James Bates, Brandy Bates, Vernice Bates, Deneb, ND Bath, Kiran Batish, Sat Dev Batista da Silva, Elizabeth Battal, Cemal, MD Battistini, Matthew Baumann, Robert, MD, FAAN Baumer, Fiona, MD Baumgart, Andrea Baumhefner, Robert, MD, FAAN Baute, Vanessa Bautista, Alyssa Baxter, Laura Bayode, Andrew BAYRAK, AYSE OYTUN Bazaldua Avila, Hector Noe Bazan, Tracy Beaber, Brandon Beals, Chan Bearden, David Beary, Jonathan Beato-Abreu, Maritza Beaudin, Marie Beaudry, Michel Beaver, Bahar Beavin, Jill Beba, Kanita Bebin, Martina, MPA

Benard, Shawna Benatar, Michael, MBChB, DPhil, FAAN Benavente, Amy Benavides, David, MD, PhD Benavides, Valeriane Benbadis, Selim, MD, FAAN Benbow, Jen Bencherchali, Abderrahmane Bendahan, Nathaniel Bendarraz, Abdelkarim Bender, William Bender, Andreas Bender, Ulrich Bendhaou, Karim Bendok, Bernard, MD Benedict, Steven, MD Benedict, Ralph Benesh, Frank Benesh, Janet, BSMT Benesova, Yvonne Benezra, David Benhatzel, Christopher, MS Benish, Sarah, MD, FAAN Benjamin, Christopher, PhD Benjamin, Eugene, MD, FAAN Bennett, David, MD Bennett, Frank Bennett, Alix Bennett, Bucky Benninger, David Benova, Barbora Benrabah, Rabah, PhD Bensaidane, Reda, MD, MSc Bensken, Wyatt Benson, Rachael Benson, Lynn, Medical Student Bentley, Ruth Benzadon-Cohen, Aaron, MD, FAAN

Bera, Rakesh Beran, Roy Berbesque, Philippe Bercury Russell, Kathryn Berdia, Ajay Berens, LeAnn Berentsen, Thomas Berger, Alan Berger, Itai Berger, Melvin, MD, PhD Bergethon, Peter Bergey, Gregory, MD, FAAN Berghoff, Martin Bergmann, Arnfin Bergmann, Lars Bergsland, Niels Berini, Sarah Berk, Julie Berkovich, Regina, MD, PhD Berkowitz, Aaron, MD, PhD Berman, Stephen Berman, Brian, MD,MS Berman, Jennifer Berman, Robert, MD Bermperian, Kyriakos Bernal Rodriguez, Raquel Fatima Bernard, Jacqueline, MD, FAAN Bernardo, Danilo Bernardo, Katrina Berner, Natalie Bernes, Saunder Bernhardt, Nechama Bernhardt, Lydia, BA Bernheimer, James Bernitsas, Evanthia Bernstein, Rebecca Berrens-Peijnenburg, Marianne Berruecos, Steve, RCP Berry, Lisa

225

2018 ANNUAL MEETING ATTENDEES

Bechtold, Cliff Beck, Sabih, MBS Beck, Simon Becker, Taj Becker, Daniel Becker, Meredith Becker, Kimberly, Pharm.D. Beckmann, Yesim, MD Bede, Peter Bedi, Gurdesh, MD, FAAN Beecham, Gary Beesen, Ayshe Bega, Danny Begelman, Susan Beheshti, Nima, MPH Behrens, Bing Behymer, Tyler, BS Beinlich, Axel, MD Bekele-Arcuri, Zewditu Belachew, Shibeshih Belagaje, Samir, MD, FAAN Belenguer Benavides, Antonio, MD Bell, Jeremiah Bell, Karen Bell, Lynne, MD, PhD Bell, Josh Bell, Amy Bellafiore, Peter Bellantonio, Paolo, MD Bellows, Steven Belman, Anita, MD, FAAN Belter, Lisa, MPH Beltran, Dario, MD, FAAN Beltran, Janet Beltran, Joel Ben Menachem, Elinor Benameur, Karima Ben-Amor, Ali-Frederic

2018 ANNUAL MEETING ATTENDEES Berry, Leanne, BA (Bachelor of Arts) Berthaud, Jimmy Bertoldi, Roger Bertolon, Laura Silvina Bertolotto, Antonio, PhD Bertram, Edward, MD, FAAN Besbris, Jessica Beshara, Simon Besharat, Amir Bessho, Tomoko Best, Brian Bestoso, Jose, MD Betjemann, John, MD Bette, Sagari Bettelheim, Ruth Betting, Luiz Bever, Christopher, MD, MBA, FAAN Bevers, Matthew, MD Beversdorf, David, MD, FAAN Bevevino Tomcik, Colleen Beydoun, Said, MD, FAAN Beyer, Richard Beynon, Vanessa Bezerra, Jose Bezerra, Daniel Bhadola, Shivkumar, BA Bhagavan, Seetha Bhalla, Sonam Bhan, Saurabh, PAC Bhandari, Nilesh, MD, MBBS Bhanu, Kesavamurthy Bhanushali, Minal Bhargava, Pavan Bhaskaran, Muthu Bhatia, Ankush Bhatia, Kunal Bhatia, Kailash, MD, FAAN Bhatia, Nisha

Bhatnagar, Rajesh Bhatt, Rujuta, MD Bhatt, Jaydeep Bhatt, Amar Bhattacharjee, Pritorthi, M Pharm Bhattacharya, Anup Bhattacharya, Joydip Bhattacharya, Pratik, MD,MPH Bhattacharya, Susanta, MD, MBBS Bhattacharyya, Shamik, MD Bhatti, Danish Bhawsar, Nilaya Bhoi, Kamala, MD, MBBS Bhole, Rohini Bhullar, Narinder Biagioni, Milton Bialik, Brenton Biary, Nabil, MD, FAAN Bichuetti, Denis Bickel, Jennifer, MD, FAAN Bidollari, Ilda Bieber, David Bielawski, Martin Bielekova, Bibiana, MD, FAAN Biemiller, Rachel Biesiada, Izabela Bigaud, Marc Biggerstaff, Sara Bilala, Saurabh, MD, MBBS Bildosola, Alejandro, MD Bilici, Nadir Biliciler, Suur, MD Biller, Tara, ARNP, FNP-BC Biller, Jose, MD, FAAN, FACP, FAHA Billinghurst, Lori Bilodeau, Philippe-Antoine Bindner, Robert

226 2018 AAN Annual Meeting On-site Guide

Biniwale, Avanti, MD, MBBS Biondi, David, DO, FAAN Biotti, Damien, MD Biousse, Valerie Biplob, Roy, MD, MBBS Birch, Torrey, MD Birday, Erkingul, MD Birdie, Scott Birk, Harvinder Birlea, Laur Marius Birnboim, Ronnie Bischof, Felix, PD MD Bischoff, Keri, M.Ed Bischoff, Christian Ludger Bischofs, Stefan, MD Bisecco, Alvino, MD Bismuth, Daniella Bissig, David Bissonnette, Stephanie Biswakumar, Balaram, MD, DM, Dsc Biswal, Debabrat Biswas, Siddhartha, DM, MD, MBBS Bite, Anna Bitsch, Andreas Bitter, Johannes Bjornevik, Kjetil, MD, PhD Blaabjerg, Morten Blacher, Matias Black, Rebekah Blackburn, Kyle, MD Blaettler, Thomas Blaiss, Cory Blakeley, Jaishri, MD Blanche, Jorge Blandford, Jill Blank, Leah Blas-Boria, David Blasco de Nova, Daniel

Boggaram, Bhagya Bogoje Raspopovic, Andrijana, MD Bogoslovsky, Tanya Bohlega, Saeed, MD, FAAN Bohnen, Nicolaas, MD, PhD, FAAN Boisseaux, Pascale, MD Boivin, Joseph, PharmD, RPh Bojarski, Lauren Bojedla, Sundeep Bokhari, Hammad Bokkala-Pinninti, Shaila Bokkerink, Harm Bolano Del Vecchio, Diana Bolanos Merida, Hector, MD, FAAN Boller, Francois, MD, PhD, FAAN Bolton, Stephanie Bolton, Monica Bondareff, William Bonek, Robert, MD Bongiovanni, Dana, MPH Bonilha, Leonardo, MD, PhD Bonnel, Laurence Bonner, Wes, BS Bonni, Azad, MD, PhD Bonte, Johan Boonchai, Tiplada Borak, Peter Borazanci, Aimee Borchert, Leona Borire, Adeniyi Borkar, Raksha Bormann, Anja Boroojerdi, Babak Boroujerdi, Amin Borriello, Giovanna, MD Boruchow, Scott Borucki, Sally

Bosch, Mauricio, MD Bosch, Michael Boschert Shafaatian, Ursula Bose, Gauruv Bose, Shelley Bosnjak Pasic, Marija, MD Bossano, Fernando Bossolasco, Michela Botefur, Ingolf Carl, MD Both, Matthias Boubour, Alexandra BOUCHENAK KHELLADI, Djaouad Boucher, Thierry Bouges, Abdulrahman Bough, Matthew Bouhassira, Didier, MD, PhD Bouhia, Amal Boukarrou, Latifa Boukhari, Mokhtar Boundy, Karyn Bourdette, Dennis, MD, FAAN Bourgeois, Philip Bourque, Richard Bourre, Bertrand Bourscheid, Raeann Boutros, Raja Boutros, Gamal Boutros, Dina Bouvier, Deborah Bouvy, Willem, MD, PhD BOUZENADA, Hichem Bove, Riley Bowen, Theodore Bower, James, MD, MSc, FAAN Bowers, Joe Bowes, Ryan Bowling, Allen, MD, PhD Bowling, Susana

227

2018 ANNUAL MEETING ATTENDEES

Blasczyk, Ludovico Blattner, Matthew Blauw, Hylke, MD, PhD Blazejewska-Hyzorek, Beata Blech, Benzion Bleck, Thomas, MD, FAAN Bledsoe, Ian Bloch, Sana, MD, FAAN Block, Haley Block, Gilbert, MD, PhD Block, Valerie, DPTSc Blodau, Andreas Blom, Kristina Blowes, Christopher Blueglass, Michael Bluett, Brent Blum, David, MS Blumberga, Sanita Blume, Gregory Blume, Heidi, MD, MPH Blume Rice, Shannon Blumenfeld, Andrew, MD Boak, Lauren Board, Thomas Bobzean, Samara Boccardo, Alejandro, MD Boden-Albala, Bernadette, MPH Bodensteiner, John, MD, FAAN Bodhinathan, Karthik Bodhit, Aakash Bodkin, Cynthia Boehme, Amelia Boes, Christopher, MD, FAAN Boesen, Magnus Spangsberg Boessen, Carmen Boeve, Bradley Boffa, Michael Boffa, Laura, MD Bogdanovich, Sasha

2018 ANNUAL MEETING ATTENDEES Boxer, Adam, MD, PhD Boyanova, Neli Boyanpally, Anusha Boyce, Matthew Boyd, John Boyer, Stacey Boyko, Matthew Boyle, Richard, FRACP Boynton, Li Boz, Cavit, MD Bozinov, Nina Bozoki, Andrea, MD, FAAN Bozorg, Ali Bracken, Eric Bradford, Jennifer Bradley, Walter, DM, FRCP, FAAN Bradshaw, Michael, MD Bradshaw, Deborah, MD, FAAN Bragg, Cristopher Bragin, Ilya Brancato, Michael Brand, Patricio Brandabur, Melanie Brandel, Michael, BA Brandes, David, MD, FAAN Brand-Schieber, Elimor Brandstadter, Rachel Brandt, Carla Branger, Pierre Branson, Chantale Brashear, Allison, MD, MBA, FAAN Braun, Michael Braund, Victoria Braune, Stefan, PhD MD Bravo, Pablo Brazda, Pavel, MBA Brazeau, Serge Breningstall, Galen, MD, FAAN

Brennan, Benjamin Brennan, K.C., MD, FAAN Brennan, Ryan Brennan Tsang, Tommy, BS Brenner, Robert Brenowitz, Willa, MPH Brenton, James Bresas, Alejandra Breville, Gautier Brew, Bruce, MD, DSc FAAN Brey, Robin, MD, FAAN Brickell, Kiri Bridgman, Peter Brieva Ruiz, Luis, MD Bril, Vera Brilla, Roland, MD, MPH Brillante, Raquel, DNP, MSN Brillantes, Jason Brin, Mitchell, MD, FAAN Brinar, Vesna, MD Briscoe, Jessica, MBS Brisson, Jean-Denis Bristol, Adam Brito, Claudio Britton, Jeffrey, MD, FAAN Britton, Carolyn Britton, Heather Britze, Josefine Brix, Ulrike Broadley, Simon Brochet, Bruno, PhD Brock, Charles Brockmeier, Bernd, MD Brod, Staley Brodbeck, Robbin Broderick, Matthew, MD Broderick, Joseph, MD, FAAN Brody, David, MD, PhD Broessner, Gregor

228 2018 AAN Annual Meeting On-site Guide

Bromberg, Mark, MD, PhD, FAAN Bromley, Steven, MD, FAAN Bronstein, Yuri Bronstein, Sandra Bronte-Stewart, Helen, MD, MSE, FAAN Brooks, Benjamin Brooks, Joseph Bruno Brooks, Leah Brooks-Kayal, Amy, MD, FAAN Brown, Ethan Brown, Robert, MD, FAAN Brown, Devin, MD Brown, Anthony Brown, E. Alexandra Brown, Kevin Brown, Kristin Brown, Emery Brown, Arleen Brown, Marie Brown, Adam Brown, Amy Brown, Andrew Brown, Christopher Browner, Nina Brownlee, Wallace, MBChB, FRACP Bruce, Beau Brueck, Wolfgang Bruera, Osvaldo Carlos jesus Bruhnding, Aubree Bruijn, Lucie, PhD, MBA Bruining, Kersti, MD, FAAN Brum, Marisa Brunelli, Brian Brunet, Francis Brunner, Angela, PhD Bruns, Marla, MD, PhD Brunson, Greg

Burian, Cosette Burka, Tekalign Burke, Matthew Burkey, Adam Burneo, Jorge, MD, MSPH, FAAN Burnett, Margaret Burnham, Jane, MD, PhD Burns, Richard Burnstine, Thomas Burrus, Tamika Bursaw, Andrew Burton, Jodie Buse, Dawn Buser, Adam Bushnaq, Saji Bushnell, Cheryl, MD, MHS Busis, Neil, MD, FAAN Busl, Katharina, MD, MS Busse, Gregory Bussiere, Sylvain, MSc Pharm Busza, Ania, MD, PhD Butala, Nitin Butkovic Soldo, Silva, MD Butler, Ernest, MD,PhD,FRACP Butt, Reema, MD Butt, Tanya, MPH Buttari, Fabio, Dr Butterfield, Russell, MD PhD BS Buttmann, Mathias, MD Butts, Donna, RN, NP Butts, Cherie Buyan Dent, Laura, MD, PhD Buyukturkoglu, Korhan Byrd, Erica Byrne, Richard Byrne, Paul Bzdyra, Piotr Cabatingan, Mark

Cabral, Norberto Cabreira, Veronica Cabrera, Jose Cabrera, Juan Cacciaguerra, Laura Caceres, Fernando Cachero, Teresa Cacho Diaz, Bernardo Cacic, Kelsey Cadavid, Diego, MD, FAAN Cadiou, Francois, MBA, MSc Cady, Ryan, MS Caekebeke, Johan Caffaro, Maria Cagniart, Kendra Cahill, Hugh Cahill, Jonathan Cahill, Catherine CAKAR, FILINTA Cakciri, Genci Calabresi, Peter, MD, FAAN Calabria, Samuel Calder, Christopher, MD, PhD Caldera, Manjula Calderon Rios, Maria Del Rosario Calderwood, David Calil da Silveira, Victor Caliskan, Zeynep Calkwood, Jonathan Call, Rebecca Callaghan, Brian Callahan, Michael Calle Lemos, Juan Fernando Callegari, Peter Caller, Tracie Callister, Marcus Calvo Vildoso, Christian, MD Calvoso, Roberta

2018 ANNUAL MEETING ATTENDEES

Brusil, Olga Brys, Miroslaw, MD, PhD Brzosko, Barbara Brzozowski, Lawrence Bubrick, Ellen, MD Buccafusca, Maria, Dr Bucello, Sebastiano, MD Buchbjerg, Jeppe Buchhalter, Jeffrey, MD, FAAN Buck, Laura Bucklan, Julia Buckland, Wendy Buckle, Guy, MD Buckler, Sharon Buckley, Terra Budhram, Adrian Budson, Andrew Bueno, Priscila Buettner, Christian Buffels, Regine Buford, Rhonda Buggia, Micheal Bulka, Helena Bullinger, Ann Bunting-Perry, Lisette, PhD, RN Burba, Jennifer, MD Burba, Alonzo Burbank, Emma Burbano, Lisseth Burch, Jaclyn Burdette, David Burdick, Daniel Bureau, Britta Burela, Nikolina Burford, Matthew Burger, Kathleen Burgos, Adrian Burgos, Marcos, MD Burgos-Vega, Carolina

229

2018 ANNUAL MEETING ATTENDEES Calzado Rivas, Maria Elena Camargo Villarreal, Walter Mario Camerlingo, Sebastian, MD Cameron, Lauren Cameron, Michelle Cammarota, Angel Campagnolo, Denise Campbell, Joel Campbell, Bob Campbell, Jamie Campbell, Nolan Campellone, Joseph, MD, FAAN Campos, Sheila Canbaz Kabay, Sibel, MD Candler, Shawn Canham, Luke, MBBS, Bsc (Hons), MR Canizares Ledo, Emmanuel Cannard, Kevin, MD, FAAN Cannistraro, Rocco Cannon, Victoria Cantillon, Marc, MD, FAAN Cantone, Catherine Cantor, Charles Cantu, David Capal, Jamie Caparo, Cesar Cape, Charles, MD,FAAN Capela, Carlos Capobianco, David, MD, FAAN Capobianco, Marco Alfonso, MD Capocelli, Kelley Capone, Patrick, MD, PhD, FAAN Caputo, Domenico, MD Caraballo-Cartagena, Sonia, MD Carabenciov, Ivan, MD

Carandang, Raphael Cardenas, Javier, MD Cardenas, Simon Cardenas Castillo, Ylec Cardoso, Maria Joao Carey, Peter Carey, Bridget Cargnelutti, Daniela, Dr Carlin, Jeanette Carlini, Daniela Carlson, Aaron Carlson, Chad Carlson, Dawn Michelle Carlson, Brian Carne, Ross, FRACP Carneiro, Andre, MBA Carnes, Tarah Carod Artal, Javier Carolus, Keith Carosella, Maria Carra, Adriana, MD Carrasco, Sira Carrasco Solino, Felix Carreno, Nicolas Carreon, Danielle, MPH Carrera, Joseph Carrillo-Nunez, Ignacio, MD, FAAN Carroll, Jeanne Carroll, William, MBBS, MD, FRACP, FRC Carroll Bullock, Andrea Carter, Jonathan Carter, Julie Carter, Sophie, BSc (Hons) Carter-Kappus, Cindy, APRN CCNS-P Caruso, Joe Carvalho, Larissa Carvalho, Diego, MD

230 2018 AAN Annual Meeting On-site Guide

Carvalho, Flavio Carvalho, Valerio Carvalho Neto, Euripedes Carver, Alan, MD Casallas Vanegas, Adriana Casanovas Ortega, Marta, Bsc Casas-Parera, Ignacio, MD, PhD, FAAN Casci, Ian Cascino, Terrence, MD, FAAN Cascino, Gregory, MD, FAAN Case, Celeste Case, Ryan Caselli, Richard, MD, FAAN Casez, Olivier, PhD Cash, Tiyonnoh Casserly, Courtney Casstevens, Cristina Castellanos, Yulexi Castilho Pelloso, Fernando Castillo, Pablo, MD, FAAN Castillo, Vilma Castillo Trivino, Tamara, MD Castillo-Torres, Sergio Castrillo-Viguera, Carmen Castro, Diana Castro, Angel Castro, Luiz Castro, Cristian Castro Borrero, Wanda Castro-suarez, Sheila Castruita Flores, Miguel David Catalan, Pascual Catalano, Louis, MD, FAAN Caunca, Michelle Cavalier, Steven, MD, FAAN Cavanagh, Julien Cavazos, Jose, MD,PhD, FAAN Ceballos, Jeanne

Chalmer, Thor Ameri Chamanadjian, Christopher Chamberlain, Mike Chambers, Anthony Chambers, Leslie, MSPH Chan, Jason, MD, PhD Chan, Calvin, MbChB Chan, Jillian Chan, Justine Chan, Ka Yee Clara Chan, Lik Hang Tommy, MD Chan, Adrian Chan, Bernard Chan, Jacqueline, MD, PhD, FAAN Chan, Koon Ho, MD, MBBS Chan, Hiu Fai Chan, Chiu Yee Leonard Chan Smyth, Nathan Chand, Pratap, MD, FRCP, FAAN Chandak, Rahul Chandar, Krishan, MB Chandel, Shammy, MSC Chandok, Arun Chandos, Brandon Chandra, Shivika Chandrashekhar, Swathy Chandy, John, MBBS, MS, MBA Chaney, Kimberly Chang, Jacky, BS Chang, Yoonkyung Chang, Ellen Chang, Rui Chang, Timothy, MD, PhD Chang, Celia Chang, Fen-Lei, MD, PhD Chang, Jason Chang, Li-Hsin Chang, Ming-hong

Chang, Vivide Chang, Andrew D, MS Chang, Florence Ching-Fen, FRACP Chansakul, Chakorn Chao, Hsiao-Tuan Chaparala, Sonja Chaplick, Jayne Chapman, Sherita Chappell, Amy Chapp-Jumbo, Emmanuel, BMedSc, FWACP, FACP Charbonneau, Marie-eve Charbonneau, Brigitte Charlafti, Ilias, MSc Charles, Andrew, MD Charlesworth, Jennifer, MSc. Charlson, Robert Charvet, Leigh Chase, Marie Chatamra, Krai Chatterjee, Apratim Chatterjee, Jahnavi Chaturvedi, Seemant, MD, FAAN, FAHA Chau, Siu Kwan Chris, MBChB Chaudhary, Nilesh, MD, MBBS Chaudhry, Farrukh Chaudhry, Vinay, MD, FAAN Chaudhry, Nadeem Chaudhry, Yash Chauhan, Varun, MD Chaurasia, Rameshwar Chaves, Margarita Chavin, Jeffrey Chavolla, Cristina Chayasirisobhon, Sirichai, MD, FAAN Cheah, Chun Fai Cheema, Zahid, MD, FAAN

231

2018 ANNUAL MEETING ATTENDEES

Ceccaldi, Mathieu, PhD Cedrolla, Carlos, MD Cee, Marketa Cejas, Diana Celebisoy, Nese Cenarro Campos, Jose Maria, PharmD Centanaro, Gabriel Cepek, Lukas Ceponiene, Rita, MD, PhD Cerdan-Trevino, Mario Ceriani, Claire Ceronie, Bryan Cerqueira, Joao Cervantes-Arslanian, Anna Marisa, MD CERVELLATI, Matteo Cervera Alvarez, Alvaro Cesar, Paul-Henri Cespedes, Jorge Cetin, Sezgin Cha, Jang-Ho, MD, PhD Cha, Choon Cha, Yoon-Hee Chacon, Marcus Chade, Anabel Chade, Noelia, MD Chadha, Savi Chae, Jin Chae, Ryan CHAHIDI, Abderrahmane, MRrici, PhDst Chahin, Nizar Chai, Nu Chakhava, George CHAKRABORTY, PROSENJIT, MD, MBBS Chaku, Shilpa Chalaupka, Flavio Chalissery, Albi

2018 ANNUAL MEETING ATTENDEES Chehebar, Daniel Cheilakos, Grigorios Chelimsky, Thomas, MD, FAAN Chemmanam, Thomas, FRACP, DM Chen, Yen-chung Chen, Benson, MBChB Chen, Chun-Yu, MD, PhD Chen, Yu-Ting Chen, Denise Chen, Edward Chen, Jessie Chen, Patrick Chen, Wei-Liang Chen, Kimberly Chen, Daniel Chen, Hsiong Chen, Linda Chen, Robert, MD, MBBChir Chen, Henry Chen, Marcus Chen, Michelle Chen, Vincent Chen, Lan Chen, Jack, PharmD BCPS CGP Chen, Karen Chen, C. Chen, Bing Yu, MD, CM Chen, Jason, BS Chen, Timothy Cheng, Jia Zhen Cheng, Eric, MD, MS, FAAN Cheng, Jocelyn Cheng, Brian Cheng, Hailong Cheng, Sunfa Cheng, Nan, BS Cherchi, Marcello, MD, PhD, FAAN Cherian, Rejo

Cherian, Laurel Chernick, Dustin, B.S. Cherninkova-Gopina, Silviya Chernyak, Alexander, MS Chernyshev, Oleg, MD, PhD Chertcoff, Anibal Cherukuda Vishnu Na, Soumya, DM Chesak, David Cheshire, William, MD, FAAN Chester, Jennifer, FNP Chetkovich, Dane, MD, PhD Cheung, Shauna Cheung, Pak Kin Cheung, Tyler Cheung, Kit Yan Chez, Michael, MD, FAAN Chhabria, Nisha Chheda, Milan, MD Chia, Nicholas Chiang, Chia-Chun Chiang, Tsing-Yun, MD,FAAN Chiang, Sharon Chiarello, Lauren Chibane, Imane Chibber, Yogya, Master of Technology Chichkova, Rossitza Chidambaram, Shobha Chieia, Marco Chien, Hsin, MD, PhD Chilakamarri, Priyanka Chileuitt, Abraham Chin, Jerome, MD, PhD, MPH, FAAN Chin, Peter Chin, Richard Chin, Russell Chinedu-Anunaso, Nkeiruka Chinnadurai, Somasundaram

232 2018 AAN Annual Meeting On-site Guide

Chintamani, Rohit Chinthaparthi, Sireesha Chio, Adriano, MD, FAAN Chiodo, Louis Chiong, Winston Chiota-McCollum, Nicole Chiriboga, Claudia Chitlangia, Alissa Chitnis, Tanuja, MD, FAAN Chitnis, Shilpa, MD, PhD, FAAN, FANA Chitsantikul, Prin Chiu, Annie, MD Chiveri, Luca Riccardo, MD Chivukula, Pardh Cho, Tracey, MD, FAAN Cho, Inwha Cho, Young Cho, Eun Bin Cho, Kyung Chodosh, Joshua Choe, Meeryo Choi, Myunghan Choi, Jennifer Choi, Ellie Choi, Dae, MPH Choi, Young-Chul Choi, Jessica Chokhawala, Himanshu Cholfin, Jeremy, MD, PhD Chong, Yao Feng Chopra, Amit Chorbadzhieva, Elena Chou, Sherry, MD Chou, Denise Choudhary, Saher Choudhary, Shahid Choudhury, Parichita Choudhury, Debasish, MD, MBBS

Cichowski, Andrew, MD CICIARELLI, MARCELO Ciechanski, Patrick Cimino, Marcus, MBA Cimprichova, Andrea Cioroiu, Comana Claassen, Daniel Claassen, Jan, MD, PhD Clamp, Debra Clardy, Stacey, MD, PhD Clark, Heather Clark, Karen Clark, Kathleen Clark, Lukas Clark, Frances, BS, C-TAGME Clarke, Teryn Clark-Imperial, Lisa Clavelou, Pierre, PhD Claverie, Santiago, MD Clay, Ariel Clayton, Stephen Clayton, Ashley, MA Cleeremans, Bruce Cleland, James Clerico, Marinella, MD Clifford, David, MD, FAAN Clifford, Megan Cline, Martha Cline, Gary Clinton, Mary Ellen Cloughsey, Timothy Coastes, Matthew Cobia, Miles Cochran, Keith Cochran, Maggie Cockroft, Bettina Coco, Christine Codling, Amanda, BS Coerver, Katherine, MD, PhD

Coetzee, Timothy Coffee, Elizabeth Coffey, Christopher Coffman, Keith Cohan, Stanley, MD, PhD Cohen, Devon Cohen, Bruce, MD, FAAN Cohen, Jeffrey, MD Cohen, Alan, MD, FAAN Cohen, Jeffrey, MD, FAAN Cohen, Mikael, MD Cohen, Ron Cohen, Stanley, MD, FAAN Cohen, Abigail Coiteux, Yvonne Colamarino, Renato Cole, Bradley Cole, Dorothee Cole, Lauran, BScH Cole, Sydni Coleman, Erin R M Coleman, Juliana Collas, David Collecutt, Barry, BMS Colletta, Kalea Colley, Jessica Collier, Ann Marie Colliez, Florence Collins, Hunter Collins, John Collins, Francis, MD, PhD Colman, Thomas, MS Colon, Angela Colon-Lopez, Milagros Colorado, Hector Colpitts, Tracey Colston, Benjamin Colten, Sridevi Comella, Cynthia, MD, FAAN

2018 ANNUAL MEETING ATTENDEES

Choudhury, Faisal, BS, MS Chourasia, Nitish Chow, Frances Chow, Felicia, MD Chow, Matthew Chow, William Chowdhury, Arif Chowdhury, Nahian Chowdhury, Sanjida Chowdhury Johnson, Ann, BA, C-TAGME Chrisman, Christina Christensen, Caitlin Christensen, April Christensen, Angelene Christiana, Andrew Christine, Chadwick Christnovich, Anthony Christy, Alison, MD, PhD Chroni, Dafni Chu, Stacy Chu, Ching-Chiang, MD, PhD Chu, Peiyun Chu, Teresa Chua, Yuan Kit Christopher Chuang, Dennis, MD, PhD Chuang, Rosalind Chun, Michael Chung, Sun Ju Chung, A. Maria Chung, Chun Pong Chung, David Chung, Luke Chuquilin Arista, Miguel Chwalisz, Bart Chyrchel-Paszkiewicz, Urszula Ciafaloni, Emma, MD, FAAN Ciasulli, Elia Ciccarelli, Olga, FRCP

233

2018 ANNUAL MEETING ATTENDEES Comer, Adam Comi, Giancarlo, PhD Comi, Giacomo Comiter, Henry Comtois, Jacynthe Conde, Bernardo, MD Condello, Jill Condes Diez Martinez, Diego, MD Condon, Christina Conforti, Erodida, DNP Congleton, Jon Conidi, Francis, DO,MS Connolly, Anne, MD, FAAN Connors, Robert Consing, Kirsten Nicole Consky, Earl Conti, Maria, MD Conway, Brittani Conway, Devon Conway, Charlie, PhD Conwit, Robin, MD, FAAN Cook, Tara Cook, Melissa, MD Cook, Glen Cook, Lisa Cook, Brian, MBA Cook, Karin, MA Cook, Kendall Cook, Calli, FNP-C Cooley, S Cooper, Christa Cooper, Dana Cooper, Kathryn Cooper, Gregory, MD, PhD Cooper, Christine Coorg, Rohini Copeland, Dane Copeland, Brian

Copeland, Kelly Copello, Miguel, MD Coppola, Mariano, MD Coquery, Christine Corbett, Alastair Corbin, Conor Corbin, Ann, DHSc, MS Corboy, John, MD, FAAN Corbridge, Sarah Corcoran, Sean Cordani, Claudio Cordeiro, Barbara Cordero, Adolfo Cordioli, Cinzia, MD Cordoba, Marta, MD Coric, Vlad, MD Cormier, Justine Cornblath, Wayne, MD, FAAN Cornejo Olivas, Mario Cornelissen, Christian Coronado, Paola Correa, Eber, MD Correa Neto, Ylmar Correale, Jorge Correia, Filipe Correll, Cynthia Corry, Lauren Cort, Mark, BA Cortelekoglu, Tansel, PhD Cortez, Melissa, DO Cortez-Garcia, Eduardo Corti, Stefania Cortoni Calia, Leandro Corvasce, Stefano, MD Cosentino, Carlos, MD, FAAN Coslett, H., MD, FAAN Costa, Andreia Costa Achaval, Veronica, MD Costa Arpin, Eva

234 2018 AAN Annual Meeting On-site Guide

Costa Pereira, Fernanda Costantino, Cristina Costelloe, Lisa, PhD Costigan, Michele Cottrell, David Couch, James, MD, PhD, FAAN Couchenour, Rachel, PharmD Coughlin, David Coulter, Ian Couraud, Benjamin, MD Courtney, Ardith Cox, Benjamin Cox, Jacqueline Coyle, John Coyle, Patricia, MD, FAAN Cragin, Douglas Cramer, Steven, MD, FAAN Cramer, Joyce, BS Crandall, David Crandell, Allie, PharmD,RPh Craner, Matthew Crank, Kerri Cravanas, Brian Craveiro, Licinio, MD Cree, Bruce, MD, PhD, MCR, FAAN Creed, Andrew Creigh, Peter Crenshaw, Marjorie Crepeau, Amy, MD Crespo, Ernesto, MD Creutzfeldt, Claire Crimmins, Dennis Criscione, Emanuele Crispino, Matias Cristancho, Ana, MD Cronin, Carolyn, MD,PhD Cronin, Christina, B.A. Cronin, Simon

Curiel, Michael Curran, Terrie Currens, Lauryn Currier, Nicolas Curry, Michael Cutfield, Nicholas Cutsforth-Gregory, Jeremy Cutter, Gary Cuzzone, Louis Cvengrosova, Anna Cykowski, Matthew Czap, Alexandra Czeisler, Barry, MD, MS D' Ambrosio, Alessandro, MD Dâ&#x20AC;&#x2122;Souza, Yohan Da Nobrega, Paulo Da Silva, Soraya Dababneh, Dina Dabbagh, Omar, MD, FAAN Dabbous, Omar, MD, MPH Dabir, Aman Dabiri-Zanjani, Samira Dable, Habib Dabrowski, Edward Dafe, Charles, MD, MSc, MRCP (UK) F Daffner, Kirk, MD, FAAN Daghistani, Rawan Dahab, Mohammad Magdy Dahab, Mostafa Mohammed Moh Dahan, Benjamin Dahan, Dina Dahbour, Said, MD, FAAN Dahlke, Frank Dai, Chi Daiga, David Daizadeh, Nadia Dakka, Youssef, MD, FAAN Dalakas, Marinos, MD, FAAN

Dale, Elizabeth Dale, Marian Daley, Aaron Dalla Stella, Carlos, MD Dalmau, Josep, MD, PhD, FAAN Dalton, Stephanie Daly, Elizabeth Daly, Farrah, MD, MBA Dam, Thuy-Tien Damasceno, Alfredo Damasceno, Carlos Augusto D'Amico, Emanuele, MD Damin, Antonio, MD, PhD Dammerman, Ryan Damodaram, Srikanth Danesi, Mustapha Dangayach, Neha, MD Dangond, Fernando, MD, FAAN Daniel, Jacob, MBBS, MD, DM Daniello, Kate Danon, Moris, MD, FAAN Danoun, Omar Danzi, Yael Dao, Jasmin Daoudi, Smail Darah, Mike, MHSA Daras, Mariza Darazi, Michel Darbonne, Carol, BS, CCRC Darby, Adam Darby, Ryan Darki, Leila Darrah, Shannon, BA Darras, Basil Darrow, Kelly, FNPC Darwich, Chadi Darwin, Priscilla Darwish, Sonja Darya, Kauroon

235

2018 ANNUAL MEETING ATTENDEES

Cronin, Donna Croop, Robert, MD Cross, Cassandra Cross, Matt Crossley, Kate Crossley, Alexander Crotty, Grace Crouse, Sandra Crum-Bailey, Jennifer Crump, Nicholas, FRACP Crumrine, Patricia, MD, FAAN Crutchfield, Kevin, MD Cruz, Martha Cruz, Ana Cruz-Flores, Salvador, MD, FAAN Csajaghy, Diane Csikos, Janos Cuadros Rey, Maria, MD Cuasay, Edna Cuascut Lassus, Fernando Cuberos, Ely, Bachelors of Science Cubo Delgado, Esther Cucca, Alberto Cuchanski, Mathieu Cuchanski, Alyssa-Rae Cudkowicz, Merit, MD, MSC Cuebas, Juan CUEVA CUEVA, ORLANDO Culbert, Summer Culler, George Cummings, Christopher Cunha, Natalia Cunningham, Ed Cupler, Edward, MD, FAAN Curatolo, Luis, MD Curbelo, Maria Curfman, David Curfman, Thomas

2018 ANNUAL MEETING ATTENDEES Das, Joyutpal Das, Asha, MD, FAAN Das, Ashis, MD, MBBS Das, Rohit, MD, FAAN Das, Chandi, MD, FRACP Das, Abhijit, BS Dasari, Ravi Dashti, Eman, MSc Dashtipour, Khashayar, MD, PhD Dastagir, Akram Dasyam, Sreedhar, MD, MBBS Datta, Neil Datta, Proleta Datta, Shaetu, MD Datwani, Akash Davalos, Ernesto Dave, Ajal Dave, Hina Dave, Prafull Dave, Sachin David, Shany Davidovic, Goran Davids, Daniel, M.Biotech Davis, Douglas Davis, Johnathan Davis, Kathryn, MD Davis, Lloyd Davis, Aaron Davis, Lauren, MSEd Davison, William, MD, FAAN Davuluri, Sreenadha Davydovskaia, Maria Dawit, Sara Dawson, Andrew Dawson, Katherine Dawson, Kirstin, BA Day, Gregory, MD, MSc Day, John, MD, PhD Dayal, Viswas, FRACP

Dayalu, Praveen, MD Dayananthan, Ashok Dayaw, Maria De aguirre, Maria De Almeida Afonso, Cristiane De Boer, Lisa De Boisvilliers, Stephen De Bruin, Marjolein de Buyl, Olivier, MD De Cuffa, Anderson de Erausquin, Gabriel, MD, PhD, MSc De Groot, Diandra De Groot, John De Havenon, Adam, MD De Jager, Philip, MD, PhD De Klippel, Nina De la Meilleure, Gino De Lamar Del Risco, RenÃ© De Las Casas, Jorge, MD De Leon, Anne, BS De Leon Benedetti, Andres, MD De Lima, Marianne De Lorenzo, Filippo, Mr De Los Reyes, Emily, MD De Luca, Gabriele, MD,PhD De Marchi, Fabiola De Oliveira, Tales De Oliveira, Fabricio, MD, PhD, BBA, MS De Prevoisin, Gilles, BS De Seze, Jerome, MD De Sousa, Eduardo, MD, FAAN De Vecino, Maria Dean, Shannon DeAngelis, Lisa, MD, FAAN Deare, Nathalie Dearlove, Joanna, MPH Deck, Gina Decker, Jenna

236 2018 AAN Annual Meeting On-site Guide

Decoo, Danny Deeb, Wissam Deegan, Chad Deep, Aman DeFeo, Jan, RD Defer, Gilles Degirmenci, Suleyman, PhD Deglincerti, Alessia DeGrauw, Ton Deik Acosta Madiedo, Andres, MSEd Deisenhammer, Florian, PhD Dejthevaporn, Charungthai DeKosky, Steven, MD, FAAN Del Brutto, Victor Del Brutto, Oscar, MD, FAAN Delahaie, Vincent DeLange, Justin Deleon, Jessica Deleu, Dirk, MD, PhD, FAAN,FRCP Delgado, Jessie Delgado-Escueta, Antonio, MD, FAAN Delgado-Garcia, Guillermo Deligtisch, Amanda Deline, Christopher Deliran, Shahrzad Dellinger, Debra Delman, David Delplanche, Curtis Delva, Aline Demaerschalk, Bart, MD, MSc, FRCPC Demanuele, Charmaine Demattos, Natasha Demey, Ignacio, MD, PhD Demir, Caner Feyzi DEMIR, GOKSEMIN Demirkaya, Seref

Dexter, Donn, MD, FAAN Deykin, Aaron DeYoung, Linda D'Haeseleer, Miguel Dhahi, Ahmed Dhakal, Lakshmi, FRACP Dhaliwal, Harinder, MD Dham, Bhavpreet Dhamija, Radhika Dhruv, Parth Di Battista, Eliane Di Capua Sacoto, Daniela Di Julio, Thomas Di Lorenzo, Rodica Di Napoli, Lucia, MD Di Paolo, Diana Diab, Diaa Diamond, Mark Diarbaquirli, Walter, MD Dias, Diego, MD Diaz, Frank, MD, PhD Diaz, Monica Diaz, Luis Diaz, Christina Diaz, Natalie Diaz, Eridiz Diaz, Ricardo Diaz Campos, Marcos Diaz Lorente, Maria, MD Diaz Ortiz, Maria Diaz Rojas, Maria Diaz Sanchez, Maria Diaz-Arrastia, Ramon, MD, PhD, FAAN Dib, Hussein DiCapua, Daniel Dick, Herman Dickendesher, Travis Dickens, Deanna

Dickerson, Bradford, MD Dickerson, Aisha Dickey, Trisha Dickinson, Carolyn Didion, Jacob Diede, Hans Erich Diederich, Nico Diekstra, Frank Diep, Lien Diestro, Jose Danilo Dietiker, Cameron Dietrich, Jorg, MD, PhD Dighe, Gaurav Digre, Kathleen, MD, FAAN Dike, Nnamdi Dillon, Michael Dilly, Keith Dimachkie, Mazen, MD, FAAN DiMauro, Salvatore, MD Dimitrov, Dimitar Dimitrova, Alexandra, MA, MCR Dimitrova, Rozalina, MD, MPH Dimyan, Sherif Din, Moeen Din, Farah, BSc Dincer, Imren, PM Ding, Joy Dinis Marques, Vanessa Diniz, Barbara Diniz, Denise, MD Dinkin, Marc, MD Diot, Eric Direnfeld, Lorne DiSano, Michael Dive, Dominique Divirgilio, Gabriella Dix, Amy Dixit, Neel Dixit, Shanker, MD, FAAN

237

2018 ANNUAL MEETING ATTENDEES

Demitrack, Mark Demko, Nadine, BSc, MSc DeMoor, Carl Denier, Christian, PhD Deniz, Irem, MM Dennison, David DePaepe, Audrey Depew, Jessica Depoortere, Paul-Henri, MD Deramo, Mariana Derani, Talal, MD Dergalust, Sunita Derissen, Wolfgang Derissen, Mara Derwin, Rebecca Desai, Aaron, MD, MBBS Desai, Dhaval Desai, Neeja Desai, Bhupat Deschamps, Lisa Deseati, Fernando, MD Desjardins, Lusine DeSouza, Bryan, MD, FAAN DeStefano, Katherine Desveaux, Lorna Detke, Holland, PhD Detrich, Terry, MD, FAAN Deutschlander, Angela Devadittiya, Chaya Devarapalli, Sandeep Devere, Ronald, MD, FAAN Devere, Todd Devereaux, Michael, MD, FAAN Devi, Sarala Dewan, Ramita, B.S. Dewanto, Georgius, MD, FAAN Dewey, Jeffrey, MD DeWitt, L DeWitt, Jan

2018 ANNUAL MEETING ATTENDEES Dixon, Laura Djani, Kamalia Djebari, Fouzia Djebbari, Radia, PhD Dlugos, Dennis, MD Do, An Hong Do, Mary Anhthu Doak, Karen Doan, Victor Dobbs, Bryan, BS Dobi, Drini Dobos, Eniko Ilona Doctorovich, Eduardo Daniel Dodek, Mike Dodenhoff, Kristen Dodick, David, MD, FAAN Dodig, Dubravka Dodson, Katherine, RN, NP Doepel, Colby Dogu, Okan Doheim, Mohamed Fahmy, Medical student Doherty, Christine, Bachelor of Science Dolan, Celeste Dolev, Mark Dolia, Jaydevsinh Dolnikova-Smith, Jana, MBA Domanico, Natalie Domigan, Courtney Domingo, Kristine Domingo, Carmina Domingos, Joao Domke, Renate Sylke Domoto-Reilly, Kimiko Donahue, Kathleen, Bachelor of Science Donaldson, Deirdre Donath, Vladimir, CSc., Doc.

Dong, Susan, BHSc (Bachelor's of Science) Donlea, Jeffrey, PhD Donley, Elizabeth, JD, MBA, MS Donnelly, Gina, BS D'onofrio, Hector Donovan, Daniel, MD, PhD Donovan, Joanne, MD, PhD Doody, Rachelle Dooneief, George Dorangrichia, Cathy, BS Dorfman, Leslie Dorman, James, MD, FAAN Dorriz, Parshaw Dorsch, Andrew Dortch, Richard Dos Santos, Gutemberg Augusto Dos Santos, Jean-Claude Dos Santos, Ana Cristina, Fellow Dossa, Paul Dotor Garcia-Soto, Julio, MD Doty, Richard, PhD, FAAN Doudican, Benjamin, Bachelors of Science Dougherty, Michelle Doughty, Christopher Douglas, Preston, MD Douglas, Vanja, MD Douglass, Shirley, PMP Doumic, Javier, MD Dourau, Solange Dove, Kristi Dover, Marcia Dowling, Ewa Downey, Carrie Downey, Josh Downie, Jonathan Downing, Brett, MEng

238 2018 AAN Annual Meeting On-site Guide

Doyle, Michael Doyle, Carly, BA Dr. Hermann, Andras Dr. Lovas, Gabor Dr. Simo, Magdolna Draconi, Crys Drane, Debbie Drapier, Sophie Drappa, Jorn Drazkowski, Joseph, MD, FAAN Dredla, Brynn Drees, Cornelia, MD Drelles, Annie, MPH Drislane, Frank, MD, FAAN Driver-Dunckley, Erika Drobnis, Adam Droege, Marcus, PhD, MBA Droker, Brian Drulovic, Jelena Drum, John Drummond, Patrick D'Souza, Marcel, MD D'Souza, Terence, MD, FAAN Du, Cheng Duarte Caron, Fernando Dubey, Divyanshu Dubinsky, Richard, MD, FAAN, MPH Dubois, Sharon DuBois, Craig Dubow, Elizabeth Dubuisson, Nicolas Duda, Julian Duda, John, MD Duda, Petra, MD, PhD Duddy, Martin Dudman, Jennifer Duel, Gina Dueland, Aud Nome, MD, PhD

Dweik, Mahmoud Dworetzky, Barbara, MD, FAAN Dwyer, Chris Dwyer, Brigid Dwyer, Michael, MD, PhD Dy, Marisela Dyck, P. James B., MD, FAAN Dyck, Andrew Dyes, Mary Kay Dygert, Levi Dymm, Braydon Dzhafarova, Narmina, MD DO Dzhenkova, Dimitrichka Dzimiera, Alexandra East, Joshua, BS Eaton, Silviya, MBA, MA Eberbach, Federico Ebrahim, Senan, AB Ecker, Kenneth Eckert, Svetlana Ecklund, Dixie Eckstein, Christopher Edberg, Dale Edelbrock, Ryan Edgar, Ellen Edinger, Lara Edlow, Brian, MD Edmonds, Harvey, MD, FAAN Edwards, Megan Edwards, Jonathan, MD Edwards, John Edwards, Keith, MD, FAAN Edwards, James Edwards, Michael Efendi, Husnu, MD Effat, Ahmed Efuni, Evgeny, B.S. Eggenberger, Eric, DO, FAAN Egger, Carsten

Eggers, Carsten Eguia del Rio, Pablo, MD Ehrlich, Debra Eichinger, Katy, PT, DPT, NCS EIDELSTEIN, YAKI Eischeid, Alex Eizaguirre, Maria, MD Ekeh, Bertha Ekici, Rifat Ekladious, Adel, MRCP Eklund, Kelsey Eko Purwata, Thomas, MD, PhD, FAAN Ekuta, Victor, B.A. El Ayoubi, Nabil El Feki, Amro El Hayek, Paula El Hokayem, Jimmy El Husseini, Nada El Jamal, Sleiman El Khoury, Ramy El Kouzi, Ahmad El Nabil, Lobna El Serafy, Omar Elahi, Ali Elahi, Fanny Elahi, Hafiz Elaskary, Ahmed ELASKARY, Ahmed Elavarasi, Arunmozhimaran Elbalalesy, Naser Elble, Rodger, MD, PhD, FAAN Elble, Suzanne, MA Elbrecht, Ellen Eldrige, Jason, MD Elfont, Robert, MD,PhD Elgallab, Janet Elhusseiny, Hebatalla Elias-Hamp, Birte

239

2018 ANNUAL MEETING ATTENDEES

Duff, David Duffy, Alexandra Dugas, Michel Duhart, Dan Dujari, Shefali Dujmovic Basuroski, Irena, MD, PhD Duker, Andrew Dukic, Stefan, MSc Dulac, Emmanuel Duman ilki, Canan Dumitrascu, Oana Dumlao, Melanie Dunaway Young, Sally, DPT Dunbar, Erin Duncan, Charles Dunham, Steven Dunlap, Shariff Dunn, Jeffrey, MD, FAAN Dunn, Timothy Dunn, Renee Dunn-Pirio, Anastasie Dunuwille, Janavi, FRACP Duong, William Duque, Aristides Duque, Lissette Durafourt, Bryce Duran Ferreras, Eduardo Durand, Jorge Durand-Dubief, Francoise, PhD Durif, Franck, MD, PhD During, Emmanuel Durocher, Andre Durojaye, Samuel Duron, Reyna M. Dutaret, Claudine Dutra, Aurelio Dutta, Tara Dutton, Carolyn

2018 ANNUAL MEETING ATTENDEES Elicabe, Daniel Eliezer, Katz Elizondo-Muniz, Jose Hector Elkhider, Hisham Elkins, Elizabeth, BA, MS Ellajosyula, Ratnavalli, MD, DM Ellenbeck, Thomas Ellington, Kent Elliott, Kathryn Ellis, Steven Ellis, Ronald, MD, PhD, FAAN Ellis, James Elm, Jordan Elmaki, Soha El-Menshawi, Ibrahim Elmore, Todd, MD, FAAN El-Moslimany, Halima El-Nazer, Rasheda El-Sadi, Farah Elsaid, Nada El-Said, Refaat El-Salem, Khalid, MD, FAAN Elsbernd, Paul, MS Elseidy, Ehab Ahmed Shawky Ah Elserafi, Tamer Elsheikh, Bakri El-Sherif, Mohammed Elsherifi, Saad Elshetihy, Ahmed Elumalai, Senthilkumar, MD, MBBS Emmanuele, Valentina, MD, PhD EMRE, UFUK Emsalem, Ahmed Enayetallah, Ahmed, PhD, MBBS Engel, Emily England, Kathy, NP England, John, MD, FAAN

English, Stephen Engstrom, John, MD, FAAN Enlow, NicholasOD Ennist, David Enriquez, Guillermo Enriquez, Romeo, MD Enriquez, Clare Angeli, MD ENTAKLI, Jonathan Entunc, Tolga Enzinger, Christian Epiney, Jean-Benoit Epner, Susan Eraksoy, Mefkure Erdemir, Gozde Erdos, Robert, Mgr., MBA Erfan, Jessica, PA-C Erickson, Jay Eriksen, Erik Eryilmaz Kirali, Aysegul, BUM Escamilla, Juan Esch, Megan Escolar, Diana, MD, FAAN Escutin, Rodolfo Eskenazi, Jaime Eskenazi Markewitz, Jonathan, MD Esmaeili, Behnaz Esnaashari, Nasrin Esnard, Enrique Espay, Alberto, MD, FAAN Esper, Gregory, MD, MBA, FAAN Esper, Christine Esposito, Sabrina, MD Essad, Kate, MD Estevez, Nestor Etcheverry, Jose, MD Etchison, Debbie Etherton, Mark Etti, Roland, MD, FRCP

240 2018 AAN Annual Meeting On-site Guide

Ettle, Benjamin, MD Ettlin, Thierry, MD, FAAN Eubanks, James Evangelou, Nikolaos Evans, David, MBA Evans, Alan Evans, Elizabeth Evaristo, Eli Everett, Christopher, PhD, MBBS Evers, Melvin Eye, Philip Eze, Chigolum Faber, Raymond Fabian, Michelle, MD Fabris, Jessica Facciponte, Giovanni Facciponte, Dominic, B.S. Facheris, Maurizio, MD, MSc Factor, Stewart, DO, FAAN Fadda, Giulia Fadia, Mithila Fadil, Halim Fadilla, Maryam Fahad, Sarmed Faheem, Nida Fahlen, Eva Fahn, Stanley, MD, FAAN Faiola, Jan, BS Faiss, Juergen, MD,MA Fakas, Nikolaos Faktorovich, Svetlana Falah, Masoud Falah, Mohamed Falamarzi, Darya, Bachelorette of Arts Falb, Rina Ilona Falco, Nicolas, MD Fallis, Robert Falsetta, Jonathan

Faxas, Juan Fay, Deborah Fay, Alexander, MD, PhD Fayad, Pierre, MD, FAAN, FAHA Fayed, Hazem Fazl, Arash Fazlic, Emir Fearon, Conor, MD Feasby, Thomas, MD, FAAN Fecto, Faisal, MD, PhD Fedor, Erik, MMS,PA-C Fee, Dominic, MD, FAAN FEELEY, Caroline Feely, Shawna, MS, CGC Fehnel, Corey Fehrenbacher, Kammy Feigenbaum, Danielle Feinberg, Eve Feinberg, Daniel, MD, FAAN Feinstein, Erin Feit, Howard, MD, PhD, FAAN Feitosa, Raul Fekete, Robert Feldman, Robin, MBA Feliciano, Carlos Feliciano-Astacio, Briseida, MD, FAAN Felipe, Naillid, BA Felix, Gloria Felker, Marcia Felt, Roxanne Felt, Larissa Feltner, Doug, MD Feng, Jenny Feng, Xuesheng, MD, PhD Feng, Amy Feng, Guoyu Fenstermacher, Chris Fenton, Dawn, BS

Ferayorni, Lisa Ferencz, Gerald Ferenczi, Emily, MD, PhD Ferguson, Damien Ferguson, Paul Ferjani, Mohamed Ferley, Lisa Fernandes, Americo Fernandes, Ana Cristina Fernandez, Yeva Fernandez, Hubert, MD, FAAN Fernandez, Amanda Fernandez, Roberto, MD, PhD Fernandez, Huberth Antonio Fernandez, Victoria, MD Fernandez Rua Santaf, Nicolas, PharmD Fernandez Uria, Dionisio Fernando, Arjuna, MD, MBBS, MRCP Ferrara, Joseph Ferrari, Louis Ferrari, Andrea, MD Ferraro, Diana, Dr Ferraz-De Paola, Leila Ferree, Thomas Ferreira, Larissa Ferreira, Carla Ferreira, Joao Marcos Ferreira, Glauber Ferreira, Maria Lucia, MD Ferreira de Silva Te, Sergio Ferreira Lima, Karlla Danielle Ferrer, Gerrard Ferro, Ramon Fesenmeier, James Feuer, Naomi Feuerstein, Jeanne Feyissa, Anteneh Fiedler, Sarah, BA

241

2018 ANNUAL MEETING ATTENDEES

Fam, Sami Famakin, Bolanle Fan, Zheng Fan, Anna Fan, Schuber, MD, FAAN Fanelli, Mary-Jean Fang, Xiang, MD, PhD, FAAN Fang, Juanzhi Fara, Michael Farahdel, Behnam Farber, Michael, FRACP Farbman, Eric, MD, FAAN Farenkopf, Ulrich Ernst Farez, Mauricio, MD Fargo, Keith Farhad, Khosro Farhidvash, Fariba Farhood, Ramin, PharmD Faria, Tathyane, BS Farias, Jerrica Farias, Nurys Farias Da Guarda, Suzete, MD, PhD Farias de Araujo, Davi Faridar, Alirexa Farin, Casey Farkas, Nathan Farlow, Martin, MD, FAAN Farmer, Nicole Farnsworth, William Farooq, Omar Farro, Brittany Farzaneh-Far, Ramin Fasano, Alfonso, MD, PhD FASHOLA, Taiwo Faskowitz, Andrew Faucheux, Jean Marc, PhD Faulkner, Larry Fauze, Ricardo

2018 ANNUAL MEETING ATTENDEES Fields, Emmaculate Fields, Anne Fieldsted, Tyson Fife, Terry, MD, FAAN Fifi, Johanna Figg, Gregory Figlo, Judith Figueira, Fernando Figueira Pinto, Lecio Figueiredo, Marcos Ravi Figueroa, Karla, Research Scientist Figueroa-Ildefonso, Erick Filippi, David Filla, Luciane Filley, Christopher, MD, FAAN Fillmore, Ryan Fincher, Contessa Findlay, Andrew, MD Fine, Edward, MD, FAAN Finegan, Eoin Finger, Elizabeth, MD, FAAN Finger, Mary Fink, David, MD, FAAN Fink, Matthew, MD, FAAN Fink, Mary Kay, ACNS-BC Finkel, Richard, MD Finkel, Alan, MD, FAAN, FAHS Finkelstein, Sara Finkelstein, Ian Finkelsztejn, Alessandro Finley DiBenedetto, Laura Finney, Glen Finseth, Taylor Fiol, Marcela Fiore, Cecilia, MD Firouztale, Edward, DO, DSc Firstenfeld, Alfredo, MD Fiscella, Carina, MD

Fischbeck, Kenneth, MD, FAAN Fischbein, Gustavo Fischer, Tanya, MD, PhD Fischer, Johannes Fisher, Kristen, DO Fisher, Mark Fisher, Stanley, MD, FAAN Fisher, Katerina Fisseha, Nahome Fiszer, Urszula Fitzgerald, Keely Fitzgerald, Evan Fitzgerald, Kathryn Fitzpatrick, Joyce Fitzpatrick, Mary, ANP, MPH Fitzpatrick, Tess Fitzsimons, Robin, MBBS, PhD FRACP Flaherty, Mary Flanagan, Eoin, MBBCh Flangini, Alexia Flanigan, Patrick Flannery, Michael Flechter, Shlomo, MD, FAAN Fleischer, Barry Fleming, Meghan Fleming, Erin Fletcher, Madhuri Fletcher, Walter Flippen, Charles, MD, FAAN Flomin, Yanina Florence, Julaine Florendo, Maria Noelle, BS Flores, Fabiola Flores, Francisco Flores, Manuel Flores, Evelyn Flores Aldama, Marco Julio Flores Montero, Carlos

242 2018 AAN Annual Meeting On-site Guide

Florida, Gina Florio, Ciro, MD Flueckiger, Thomas Fockaert, Niels Fogan, Lance, MD,FAAN Fogel, Brent, MD, PhD, FAAN Foglesong, Grant Folatti, Walter Foldvary-Schaefer, Nancy Foley, John Fomin, Dimitry Fong, Man Kei Fong, Regan Fonseca, Raquel Fontoura, Paulo, MD, PhD Footitt, David, MA BMBCh FRCP Ford, Jenna Ford, Blair, MD, FAAN Ford, Corey, MD, PhD, FAAN Ford, Lisa, MD, FAAN Forero Diaz, Lucia Forest, Cathy Forman, Jonathan Forner, Stephen Forte, Jasmine Fortier, Richard, BSc. Fortin, Olivier Fortini, Ida Fortini, Glenn Foster, Laura, MD Foster, Christine Fowler, Nicole Fowler, Glenn, MD, FAAN Fowler, Alexandra, BS Fox, Robert, MD, FAAN Fox, Susan Fox, Edward, MD, PhD, FAAN Fox, Gary Fox-Rosellini, Susan, MBA

Friday, Gary, MD, FAAN Fridinger, Sara Fridman, Ludmila Friedberg, Adit Friedman, Deborah, MD, MPH, FAAN Friedman, Gary Friedman, Josh Frigo, Maura, Dr Frith, Richard, MB, ChB, FRACP Fritschy, Raymond Fritz, Joseph, PhD Frolov, Alexander Fromm, Erin Fronc-Anusiewicz, Edyta, MD Frost, Natasha Frucht, Steven, MD Fry, Keith Frydmanova, Tereza Frye, William Frye, Jeff, Pharm.D Fryer, Robert, MD, PhD Fteeh, Gamil Fu, Paul Fu, Michael Fu, Katherine Fu, Robert, Medical student Fuchs, Tom, BS Fuentes, Janice Fuentes Patarroyo, Sully Fuerst-Recktenwald, Sabine Fugate, Jennifer Fuglesang, Christopher Fuh, Jong-Ling Fujikawa, Denson, MD, FAAN Fujimoto, Atsushi Fujioka, Toshiki Fujita, Koji Fulginiti, Joseph

Fullam, Timothy Fullard, Michelle Fuller, Patrick Fuller, Gregory, MD,PhD Fulton, Tracy Fung, Cindy Furlan, Julio, MBA, MSc Furr-Stimming, Erin Furtado, Sarah, MD, PhD, FRCPC Futrell, Nancy, MD, FAAN Gaber, Mohamed Gaber Rizk, Tamer Gable, Karissa Gabriel, Kristin Gabriel, Piran Gad, Reda GADDE, CHAI Gadoth, Avi Gaekwad, Meghana Gage, Sarah, MBA Gagnon, Alexis Gagnon, Sophie Gaida, Philippe, PhD Gailloud, Philippe, MD Gajaweera, Ashanthi Gal, Julian, MA Galardi, Maria Gale, Leonard Galetta, Steven, MD, FAAN Galgani, Simonetta, MD Galifianakis, Nicholas, MPH Gallagher, Catherine Gallagher, Paul Gallant, Stephanie Gallardo, Christopher Galli, Jonathan, MD Gallo, Segundo Galloway, Gloria, MD, FAAN GALOSI, SERENA

243

2018 ANNUAL MEETING ATTENDEES

Fracaro, Maria, MD Fragoso, Yara Fraint, Avram Franceschino, Carol, MS Francia, Ada, MD Francis, Gordon, MD, FAAN Franco, Andrea, MD Francois, Roosevelt Frank, Rochelle Frank-Briggs, Angela Franklin, Gary, MD, MPH, FAAN Franklin, Cristiane, MD Franklin, Cynthia Franklin, Jeremy, MPH, MBA, FAAP Frasca, Joseph, FRACP, MBBS Frasineanu, Armand Frechette, Eric, MD, PhD Fredane, Lewis Fredericks, Carolyn Frederiksen, Jette Fredrickson, Alice Freedman, Evan Freedman, Mark, MSc MD, FAAN Freeman, Ellen Freeman, Roy, MD Freeman, Marshall, MD, FAAN Freeman, Matthew Freeman, William, MD, FAAN Frei, Karen Freij, Walid Freilich, David Freimer, Miriam Freire, Maria Freitas, Gabriel, MD, PhD French, Jacqueline, MD, FAAN Freshwater, Karen Frey, James, MD, FAAN Frey, Lauren, MD

2018 ANNUAL MEETING ATTENDEES Galvin, Miriam Gamaldo, Charlene, MD, FAAN Gamuac, Richard Gan, Joanna Gandelman, Mariana Gandhi, Sharon Gandhi, Roopali Gandhy, Shreya Gandhy, Rita, MPH Ganesalingam, Jeban, MBBS, PhD Ganesvaran, Gangadharan, FRACP Gangishetti, Umesh Ganguly, Gautam, MD, FAAN Gannon, Kimberly, MD, PhD Ganti, Latha, MD, MS, MBA, FACEP Gao, Mingyang Meah Gao, Er-Kai Gao, Xiao-Ke Gao, Yuan, MD, PhD, MRCP Garabed, Laurianne Garas, Monika Garay, Arturo Garay Calderon, Hugo Enrique Garbin Di Luca, Daniel, MD Garcia, Eduardo, MD, FAAN Garcia, Gabriella García, Ana Lucía Garcia Benitez, Clotilde Garcia Dominguez, Jose Manuel Garcia Fernandez, Ana Elena Garcia Lax, Noelia, MD Garcia Perez, Fernando, MD Garcia Pons, Melissageneral doctor, curr Garcia Santibanez, Rocio Garcia-Monco Garra, Juan Carlos

Garcia-Tarodo, Stephanie Gardner, Kathy Gardner, Raquel Gardner, Renee Gardon, Stephanie Garg, Namita Garg, Neeta, MD Garg, Rajesh Garg, Rohit Kumar, MD, MBBS Garg, Neha Garib, Julio Garland, Erich, MD, FAAN Garnot, Paul, MS, MBA Garone, Caterina Garrett, Colleen Garretto, Nelida, MD Garrido, Jose Garuda, Butchi Raju Garzo Caldas, Nicolas, MD Garzon, Yulieth, MCom Gass, Hans-Joachim, PhD MD Gaston, Tyler Gates, Peter, MBBS, FRACP Gatheridge, Michele Gathier, Celine Gatson, Na Tosha, MD, PhD Gatto, Emilia, MD Gatto, Maurizia, MD Gaudier, Jose Gaughan, Maria Gault, Laura Gavage, Sophie Gawlick, Thomas Gay, Katelyn Gaza, Wendy Gazda, Suzanne Gazdag, Brittany Gebel, Sophie Gebel, Klaus

244 2018 AAN Annual Meeting On-site Guide

Gebel, Nikolaus Gedan, Joel Gee, Allen, MD, PhD, FAAN Gehring, Klaus Gehshan, Adel Geiger, Kenneth, MD, FAAN Geiger, Christopher Geil, Kenneth Geis, Katja Gelb, Douglas, MD, PhD, FAAN Geldmacher, David Geleris, Andrew Gelfand, Amy Gelfand, Jeffrey, MD, MAS, FAAN Genco, Nestor Gendreau, R. Michael Genevieve, Mary Genov, Krasimir Gensicke, Peter Geocadin, Romergryko, MD, FAAN George, Jenie George, Ilena, MD George, Paul, MD, PhD, MSE George, Brenda George, Edwin, MD, PhD George, Tikku, BA Gera, Anjali Geraci, Anthony, MD, FAAN Geraghty, Anna Gericke, Christian, MD, PhD Gerlach, Irene Gerlock, Teresa Gershfield, David Gershwind, Stephen Gervelis, Whitney Gerwin, Robert, MD, FAAN Gerwitz, Lee, MD Geschwind, Daniel, MD, PhD

Gill, Chandler Gill, Jason, MD, PhD Gill, Laura Gill, David, MD, FAAN Gill, Saumya Gill, Anureet, Medical Student Gillard, Michel Gilles, Elizabeth Gillespie, Lauren, BS Gillett, Alan Gillies, Murray GILLIOT, Sixtine Gillum, Leslie, MD, MPH Gilmore, Jane Gilmore, Wendy Gilmour, Gabriela Gilroy, Melody, BS Ginns, Edward, MD, PhD Ginsberg, Matthew Ginsburg, David Ginsburg, Stanley, MD, FAAN Giombetti, Robert Giorgetti, Marco Giovannoni, Gavin Giraldo, Elias, MD, MS, FAAN Girault, Daniele Girfoglio, Daniela Girgis, Marina Gitelman, Darren, MD, FAAN Giugni, Juan, MD Giuliani, Fabrizio Giza, Christopher, MD Gizzi, Martin, MD, PhD, FAAN Gjaurov, Vasil, MD Gjurgevich, Ana Glackin, Mark Gladman, Matthew Glanzman, Robert Glass, Philip

Glasser, Chad E Glassman, Jessica Gleghorn, Diamond Gleichgerrcht, Ezequiel Glick-Shames, Haya, MA optometrist Glisson, Christopher Glisson, Kimberly Glor, Daniel Gloss, David, MD, FAAN Gloude, Crystin Glusman, Steven, MD Glyman, Steven Glymour, M. Maria, Phd Go, Criscely, MD Goadsby, Peter, MD, PhD Gobbi, Claudio Godefroy, Olivier, MD, PhD, FAAN Goedee, Stephan Goel, Mohit Goel, Sandeep Goelz, Susan Goessling, Jens Goetz, Christopher, MD, FAAN Goetze, Rainer Goger, Chirstoph Goglin, Sarah, MD Gogovska, Lodi Gokce, Seyda Figul, PhD Golan, Daniel Gold, Doria Gold, Carl Gold, Michael Gold, Michael, MD, FAAN Goldberger, Kyle Golden, Elisabeth Golden, Debra Goldenberg, James, MD, FAAN Goldfinger, Matthew

245

2018 ANNUAL MEETING ATTENDEES

Geschwind, Michael, MD, PhD Gettings, Edward Geving, Brad Gewirtz, Alexandra Gezalian, Michael Ghabra, Mohammed Ghadiri, Mahtab Ghatali, Mohammad Ghavami, Kimia Ghia, Twinkle Ghia, Darshan, DNB FRACP Ghiaseddin, Ashley Ghimire, Sulochana Ghione, Emanuele Ghode, Reena Ghosh, Ankita Ghosh, Pahari, MD, MBBS, MRCP Ghosh, Partha Ghosh, Pritha Ghosh, Suman Ghosh, Manjeera, MPHARM Gianella-Borradori, Athos Giannini, Lucia, BSc Giannouli, Ermioni Gibbons, Christopher, MD, FAAN Gibbons, Sarah Gibbs, Michael Gibson, Andrew Giede-Jeppe, Antje Giedraitiene, Natasa Giese, Anne-Katrin Giesser, Barbara, MD, FAAN Gignoux, Laurence Gilardelli, Gioia, MD Gilbert, David Gilbert, Donald, MD, FAAN Gilbert, Robert Giles, James

2018 ANNUAL MEETING ATTENDEES Goldman, Jennifer, MD, MS, FAAN Goldman, Myla, MD, MSC Goldman, Robert Goldman, Samuel, MD, MPH Goldsmith, Corey Goldstein, Eric Goldstein, Larry, MD, FAAN, FAHA Goldstein, Warren, MD, FRCPC Goldstein, David, MD, PhD Goldstein, David, MA, MBA Goldstick, Lawrence Goli, Krishna Golini, William, MD, FAAN Goltz, Davida Gomes, Marcilio Gomes, Leo Gomes, Marcelo Gomes, Maria Gomes da Rocha, Fernando Gomes Neto, Antonio, MD Gomez, John Gomez, Christopher, MD, PhD Gomez, Alejandra, MD Gomez, Evelia Gomez, Magdalena Gomez Elias, Claudia Lizbeth Gomez Ramos, Daniel Gomutbutra, Patama Goncalves, Antonio, MD Goncalves, Joana Goncalves, Ricardo Gong, Hui Gonzales, Carmela Gonzales, Nicole Gonzales, Edlin, MA Gonzalez, Natalia Gonzalez, Javier Gonzalez, Maria Nina

Gonzalez, Iliana Gonzalez, Julio Gonzalez, Leonardo Gonzalez, Tania, BS Gonzalez, Felix Gonzalez Aquines, Alejandro Gonzalez Caldito, Natalia Gonzalez Castellon, Marco Gonzalez Roffo, Maria Alejandra, MD Gonzalez Sanchez, Luis Ernesto Gonzalez-Giraldo, Ernesto, MD, PhD Gonzalez-Reiley, Silvana Gooch, Clifton, MD, FAAN Good, David, MD, FAAN Goodin, Douglas Goodman, Tamara Goodman, Clay, MD, FAAN Goodman, Andrew, MD, FAAN Goodsett, Mary, MD, FAAN Goodspeed, Kimberly Goodyear, Alexandra Gopalakrishnan, Ramkumar, MD, MBBS Gopalakrishnan, Srikumar, MD, MBBS Gora, Shaheed, MBBCh Gorantla, Sasikanth Gordan, Richard Gordon, Barry, MD, PhD, FAAN Gordon, David Lee, MD, FAHA, FAAN Gordon, Marc, MD, FAAN Gordon, Victor Gordon, Michael Gordon, Barbara Gordon-Lipkin, Eliza Gore, Russell Gorelick, Philip, MD, MPH,

246 2018 AAN Annual Meeting On-site Guide

FAAN Gori, Horacio, MD Gorinstein, Israel Gorman, John Gorman, Mark Gorni, Ksenija Gornisiewicz, Elzbieta Gorno Tempini, Maria, MD, PhD Gorny, Stephen, MS Gorram, Farida, STUDENT Gorthi, Sankar Gossett, Daniel Goswami, Amartyadeb Gothelf, Yael Gotkine, Marc Gottbreht, Jean, BS Gottesman, Reena Gottesman, Malcolm, MD, FAAN Gottesman, Rebecca Gottlieb, David Goudreau, Guy Gounder, Madhan Gout, Olivier, PhD Govind, Bhuvanesh Govindarajan, Raghav, MD, FAAN Govoni, Alessandra Gowthaman, Kaushik Goyal, Namita, MD Goyal, Munish Goyal, Jaya Goyeneche, Maria, MD Gozke, Eren, MD Graber, Jerome550 17th Avenue, Sui Grace, Melissa Graciani, Mayara Gradinaru, Viviana Graf, Staci

Gregory, Stephanie Gregory, Hugh Greicius, Michael Greig, Megan Gretarsdottir, Helga Grewal, Yuvraj Grgic, Sanja Grice, Susan, CTAGME Grieco, Marcos, MBA Griesbach, Grace, PhD Grieszmayer, Franz Griffin, Lisa, MD, PhD Griffin, Kim Griffith, James Griffith, Neil Griffith, Nancy Griffith, Patrick, MD, FAAN Griffo, Yvona Grig, Maria Griggs, Robert, MD, FAAN Grigoriadis, Nikolaos Grigoryan, Mikayel Grill, Marie, MD Grimaldi, Luigi Maria, MD Grimaldi, Roberto Ugo, MD Grimm, Sean Grimm-Suess, Eva Grippe, Talyta Grira, Mounir Grisold, Wolfgang Grisold, Anna, MD Griswold, Anthony Grodi, Jeffrey Grodinsky, Emily Grody, Wayne, MD, PhD Groeschel, Ana Grogan, James Grogan, Patrick, MD, FAAN Gronseth, Gary, MD, FAAN

Gropman, Andrea Gros, Priti Gross, Robert, MD, PhD, FAAN Gross, Hyman Gross, Jeffrey Gross, Robert Grossman, Scott Grossman, Murray, MD, FAAN Grossman, Tamar Grossmann, Lily, MD Gross-Paju, Katrin Groth, Christopher Grothe, Christoph Grover, Eric Groves, Tim, BS Pharmacy Gruber, Stacey Gruber, Beat Gruis, Kirsten Grujic, Zoran Grundman, Michael, MD, MPH Grunermelova, Marketa Grunho, Miguel, MD GrÃ¼ter, Thomas Grysiewicz, Rebbeca Gsottschneider, Lukas Gu, Yian Guan Zhong, Tan Guarnaccia, Michele, Dr Gucuyener, Kivilcim, MD Gudesblatt, Mark, MD Gudin Rodrigez-Magar, Maria Amparo Gudlavalleti, Aashrai Guduru, Zain Gueguen, Antoine, MD Guekht, Alla Borisovna Guell, Xavier Guenther, Jana, BA Guerra, Hilda

247

2018 ANNUAL MEETING ATTENDEES

Graf, William, MD, FAAN Graf, Christian Graff, Ole Graff-Radford, Jonathan Graff-Radford, Neill, MD, FAAN Graham, Glenn, MD, PhD, FAAN Granadillo, Elias Grand-Perret, Emilie Granetzke, Laura Grant, Ian Grant, Jihan Grant, Michael Granziera, Cristina, MD, PhD Grasso, Roberta, MD Grater, Sara Gratton, Sean Graves, Jennifer, MD, PhD Graves, Tracey, MD, MRCP, PHD Gray, Allison Gray, Helen Grays, Breyanna Green, Jody Green, Mark, MD, FAAN Green, Richard Green, Sean Green, Eric Green, Phillip, MD, FAAN Greenberg, Benjamin, MD, FAAN Greenberg, Jeffrey Greenberg-Abrahami, Michal, M.S.c Greene, Kaitlin, MD Greenert, John, MPH Greenfield, John, MD, PhD, FAAN Greenia, Dana, RN, MS Greenlee, John, MD, FAAN Greer, David, MD, FAAN Gregg, Cara

2018 ANNUAL MEETING ATTENDEES Guerra, Washington, MD Guerra, Angela, PhD, MBA Guerre, Jenny Guerrero, Brooke Guerrero, Waldo Guerrero Fernandez, Manuel Miguel, MD Guerrieri, Simone Guevara-Oliva, Carlos Guevara-Silva, Erik Guggliam, Anu, PhD Guglani, Pulkit Guha, Rahul Guido, Michael Guidon, Amanda Guidry, Andrew Guikema, Ben Guillerminet, Fanny Guillot, Thomas Guinazu, Margarita, MD Guirguis, Samy Guitarri, Carol Jean, MS, RPh Gulati, Sheffali, FAMS; FIAP; FIMSA Guler, Sibel, PhD Guliani, Gaurav Gummi, Rohit, BS Gumus, Haluk, MD GUNAL, Dilek Ince Gunaratne, Padma, MD, FAAN Gunatilake, Saman Gunawardena-Eilers, Bettina Andrea Gunawardhana, Singankutti, MBBS, MRCP Gunduz, Tuncay, PhD Gunnarsdottir, Thorunn Gunturu, Manasa Guo, Chu-Yueh Gupta, Sahil

Gupta, Siddharth Gupta, Avinash, MD, MBBS Gupta, Leenu, MBBS MD Gupta, Sudhir, MBBS, MCh Neurosurge Gupta, Suresh Gupta, Surinder, DM Gupta, Deepak, MBBS Gupta, Praveen, DM Gupta, Rohan Gupta, Suneel Gupta, Pradip, MD, FAAN Gupta, Eric Gupta, Himanshu Guptill, Jeff, MD Gurevich, Michael Gurru, Manoher Gursahani, Roop Gursoy, Nurcan Gursoy, Esra, MD Gurumukhani, Jayanti, MD, DM Guterman, Elan, MD Gutglueck, Eric Gutierrez, Amparo, MD, FAAN Gutierrez, Jose, MD Gutierrez, Paul Gutierrez, Camilo, MD Gutman, Josef Gutman, Boris Gutmann, Laurie, MD, FAAN Guttalu, Kumaraswamy Gutterman, Donna Gutti, Padmaja Gutzwiller, Eveline Guy, John Guzman-Marin, Ruben, MD, PhD Gwathmey, Kelly Gwinn, Katrina, MD, FAAN Gwyn, Bryan

248 2018 AAN Annual Meeting On-site Guide

Gwynne, David Gyang, Tirisham Gyi, Khin, MD, PhD Haas, Juergen Habek, Mario, MD Habib, Ali Haboubi, Michael Hachache, Nacim Hachinski, Vladimir, MD, DSc, FAAN Hackett, Chris, M.A. Hacohen, Yael Hacquard, AurÃ©lien Haddad, Naim Haddad Santos, Diogo Hadden, Michelle Hadi, Ehsan Hadjigeorgiou, Georgios Hadjinicolaou, Aristides Hadley, Gina Haensch, Carl-Albrecht Haffner, Darrah Hafler, David, MD, FAAN HAFNER, Jim Hagedorn, Jeffrey Hagen, Kathryn Haggiag, Shalom, MD Haggiagi, Aya Hagstrom, William Haidri, Nazar Haig, George Hainlen, Meagan Hainline, Brian, MD, FAAN Hajighasemi-Ossareh, Mohammad Hajj-Ali, Rula, MD Hake, Ann, MD, FAAN Hakimi, Ryan Halabi, Anasheh, MD, PhD Haldar, Amit, MD, MBBS, DM

Han, Alexander Han, Jennifer Han, Steve, MD PhD Han, Chaolun Han, Ho-seong Han, Jian Hancer, Ahmet, Symcon Turizm Hancinova, Viera Hancinova, Viera Hand, Peter, MBBS,FRACP Hanna, Julie Estelle Hanna, Georges Hanna, Jerome Hanna AL-Shaikh, Rana Hannon, Peter Hannoun, Anas Hanover-Martin, Carrie, Esq. Hans, Michael Hansen, Gregory Hansen, Klaus Hansen, Johnni Hanson, Ryan Hanson, Leah Hanson, Mariko Hanson, ZacharyOMSII, MA Hanumanthu, Rajanigandhi Haq, Ihtsham Hara, Makoto Harada, Kazuhiro Haralanov, Lyubomir Haramura, Masayuki Harbour, Kathleen, Ph.D. Harburg, Leah, BS Hardeman, Paula Harden, Cynthia, MD Harder, Lana, PhD Hardy, Steven Hardy, Todd Harel, Asaff

Harel, Noam, MD, PhD Hariz, Tarek Harlow, Danielle Harms, Matthew, MD Harp, Julie Harper, Samira Harrer-Haag, Judith Harrington, Emily, MD, PhD Harriott, Andrea, MD Harris, Dorothy, MD, PhD Harris, David Harris, Sally Harris, Colleen Harris, Madison, MAOT Harris, Glenn Harrison, Yvonne Harrison, Antoinette, Pharm.D. Harroud, Adil Harrower, Timothy Harsh, Gupta Hart, John Hart, Sheri Hart, David, MD, FAAN Hartenstein, Brooke Hartikainen, Paivi Hartman, Adam Hartonian, Ivet Hartono, Julisar Hartung, Hans-Peter, MD, FAAN Hartung, Daniel, PharmD, MPH Harvey, Danielle Hasan, Hunaid Hasan, Shabih Hasan, Shemonti, B.S Hasan, Tasneem Hashem, Jafar Hashem, Saher Hashemi, Lobat, ScD Hashim, Salman, BS,

249

2018 ANNUAL MEETING ATTENDEES

Haldar, Nihar Ranjan Haldre, Sulev Hales, Chad, MD, PhD Halfon, Mario, MD Halford, Jonathan Halhouli, Oday Halker, Rashmi Hall, Steven, RPh BS Hall, Ara Hall, Deborah, MD, PhD, FAAN Hall, Mary Hall, Sam Hall, Julianne Haller, Andrea, MD Hallermann, Wilhelm Hallett, Mark, MD, FAAN Hallman-Cooper, Jamika Hallworth, Nicholas Halpern, Jean-Pierre, PhD,FRACP Halstead, Michael, MD, MPH Halvorsen, Mark Hamasaki, Anai Hamdi, Hamid Hamdoon, Mohamed Hamed, Moath Hamedani, Ali, MD, MHS Hameed, Muhammad Amjad Hameed, Natasha, MD Hamid, Basem Hamill, Robert, MD, FAAN Hamilton, Robert Hamilton, Ross Hamilton, Roy, MD, MS, FAAN Hamlet, John Hammack, Julie, MD, FAAN Hammond, Matthew Hammoudi, Mostafa Hamza, Mohsen

2018 ANNUAL MEETING ATTENDEES Haspel, Richard, MD, PhD Hassan, Ayman, MD, FAAN Hassan, Bahaa Hassan, Ahmed Hassan, Ameer Hassan, Anhar, MBBCH Hassanein, Adel Hassanpour, Houry, Neurologist Hassanzadeh, Bahareh Hassett, Catherine Hatami, Neda Hatch, Hayden Hatcher-Martin, Jaime Hatfield, Mandy Hathidara, Mausaminben Haubenberger, Dietrich Hauberg, Janni Hauser, Robert, MD, MBA, FAAN Havrdova, Eva Havsager, Anne-Mette Hawes, Jodi Hawkes, Christopher, MD FRCP Hawkins, Angela Hawkins, Trevor, MD Hawkins, Inga Hawley, Jason Hawong, Hae-young, DO, PhD Hayat, Ghazala, MBBS, FAAN Hayes, Lindsey, MD, PhD Hayes, Tim, MD, PhD Hayes, Lisa Haynes, Jennifer Haynes, Beth Ann Hayreh, Sant He, Ping, MD, PhD HEAD, Brian Heath, Jamie Heatherington, Anne

Heatwole, Katharine Hechem Monfredini, Nayme Hecht, Lauren, LLP Hecker, Michael Hedeman, Jessica Hedtkamp, Marion Hefni, Tahani Hegde, Vijay Hegde, Sheetal Hegen, Harald, MD Heidari, Neda Heidrich, Rudolf Heilman, Kenneth, MD, FAAN Heiman-Patterson, Terry Heindel, Michael Heinl, Nicole Heinzlef, Olivier, MD Heiser, Heather Hejazi, Seyedali, MD, PhD Heller, Scott, MD Hellman, Amy Hellwig, Kerstin, MD Helminiak, Andrzej Helminiak, Iwona Hemat, Spalmai Hemond, Christopher Hemphill, John, MD, FAAN Hemphill, Kafi Henan, Samantha Henchcliffe, Claire, MD, PhD, FAAN Henderson, Victor, MD, FAAN Hendizadeh, Moshe-Samuel Hendricks, Robert, B.S. Henningsen, Henning Henriksen, Tove Henry, Roland Henschel, Kenneth Henschel, Stephan

250 2018 AAN Annual Meeting On-site Guide

Henzler, David Heramia, Almita Heras, Alejandro Herath, Nihal Herath, Chehan, BS Herbst, Heinz-Peter Heredia Nunez, Wilson Heredia Rivera, Carlos Herekar, Arif Dawood Heresi, Carolina Herman, Susan, MD, FAAN Herman, Ann Hermann, Mario Hermanns, Guido Hermanns, Johanna Hermanowicz, Neal Hermanson, Sarah, DNP, ARNP Hernandez, Jose Hernandez, Jose, PhD Hernandez, Natalia Hernandez Clares, Rocio, MD Hernandez Martinez d, Elena Hernandez Perez, Miguel Angel, MD Hernandez-Peraza, Zulma Herndon, John, MD Herndon, Robert, MD, FAAN Herrick, Anne, ANP-C Herring, Rachelle Herrington, Todd Herrmann, Julia Hersch, Mark Hersh, Carrie Hershey, Andrew, MD, PhD, FAHS Hershey, Linda, MD, PhD, FAAN Herskovitz, Steven, MD, FAAN Hervas Garcia, Jose Vicente, MD Hervas Garcia, Miguel

Hingtgen, Cynthia, MD, FAAN Hinkle, Sarah Hinson, Vanessa, MD, PhD, FAAN Hinson, Holly, MD, MCR Hiraldo-Delgado, Rahe Hirano, Michio, MD, FAAN Hirota, Brandon Hirsch, Lawrence, MD, FAAN Hirsch, Eric, BA Hisama, Fuki, MD, FAAN Hisamoto, Yoshimi Hislop, Rachel Hladek, Alexander Hlustik, Petr Ho, Ka-wai Ho, Kwo Wei David, MD, PhD Ho, Carole Ho, Emily, MD, PhD Ho, Michael Ho, Pei-Ran Ho, Joyce Ho, Stacey, M.S. Hoak, David Hobart, Jeremy, BSc PhD FRCP Dip Pub Hochrein, Katherine, BS Hochstetler, Helen Hocker, Sara Hoda, Anwarul, MD, MBBS Hodges, Sarah Hodgson, Trent Hodgson Birkman, Carol Hodics, Timea, MD Hodoba, Nathaniel Hoeftberger, Romana Hoerth, Matthew Hoese, Barbara Hof, Caitlin Hofer, Gert, MD

Hoff, Kasper Hoffman, Benjamin Hoffman, Sarah Hoffman, Bily Hoffmann, Frank Hoffmann, Olaf Martin Hoffman-Snyder, Charlene Hofinger-Renner, Christiane Hofmann, Werner Hogan, Jeremy, MD, FAAN Hohler, Anna, MD, FAAN Hohlfeld, Reinhard Hojnacki, David Hok, Pavel Holden, Samantha Holecko, Matthew Holland, Neil, MBBS, FAAN Hollenbeck, Larry, MD, FAAN Hollist, Mary Holloway, Robert, MD, MPH, FAAN Holmay, Mary, RN, BSN Holmes, Valerie Holtz, Steven, MD, FAAN Holtzman, David, MD, FAAN Holub, Richard Hom, Brian, Bachelor of Science Homonoff, Mark Hon, Jade Hon, Sarah, DO, FAAN Honeycutt, Lucy Hong, William Honganur, Nagaraj Sanchitha Honig, Lawrence, MD, PhD, FAAN Honnorat, Jerome Honorat, Josephe Archie, MD, PhD Honore, Jean-Claude Hood, Daniel

251

2018 ANNUAL MEETING ATTENDEES

Herzig, Roman Herzing, David Herzog, Andrew, MD, MSc, FAAN Heslin, Ryan Hesselbrock, Diane Hessler, Amy Hetrick, Amber Hewitt, David Hewitt, William Hewitt, Lawrence Hibbard, Judi Hickey, Dominic Hidalgo, Gonzalo Hidalgo de la Cruz, Milagros Hierro Abad, Cristina Hiersemenzel, Reinhard Hietaharju, Aki Juhani, MD, PhD Higginbotham, Lenora, MD Higgins, Donald Higgins, Joseph, MD, FAAN Higgins, Michael, MBA Higinbotham, Anthony Hildemann, Steven Hill, Amber Hill, Emily Hill, Jason Hill, Rosamund, FRACP Hill, Marguerite Hill, Morgan Hill, Raymond Hill, Bryan Hill Klein, Marcia, MPH, MSc. Hiller, Amie Hiltbrunner, Beat Hilz, Max, MD, PhD, FAAN Hindman, Andrew Hinds, Sidney Hinds, Andrea

2018 ANNUAL MEETING ATTENDEES Hooker, Juzar, MB ChB MMed DCN Hopkins, Gina Hopkins, Sarah Hopper, Allen Horak, Holli, MD, FAAN Horakova, Dana Horn, Sarah Horng, Sam, MD, PhD Horst, Andreas Horstman, Gabrielle Horstmyer, Jeffrey, MD, FAAN Horton, Lindsay, MD Horton, Heather Hosey, Jonathan, MD, FAAN Hosley, Catherine Hosny, Hassan Hossack, Michael, MD Hostetler, Caroline Hotermans, Christophe, MD, PhD Hottinger, Andreas, MD Hou, Jyhgong Gabriel, MD, PhD Houalla, Thierry, PhD Houston, Dorothy Houtchens, Maria Hovsepian, Dominic How, Colette Howard, James, MD, FAAN Howard, Keiko Howell, Michael, MD, FAAN Howell, Stephen Howell, Kelly Howlett, Marybeth Hoyle, Chad Hoynes, Allison Hoyt, Tamara, MS, CCRC Hreib, Kinan Hsia, Amie, MD Hsiao, Joyce

Hsieh, Annie, MD, PhD Hsieh, Billie, BS Hsiung, Ging-Yuek, MD, FAAN Htut, Min Hu, Nancy Hu, Sherry Hu, Ye Hu, Wei, MD, PhD Hu, Billy Hua, Le Huang, Yonglu, MD, PhD Huang, David, MD, PhD, FAAN Huang, Juebin, MD, PhD Huang, Yi, MD, PhD Huang, Wan-Yu Huang, Yining Huang, Amy Huang, Dennis Hubbard, Ryan Hubble, Jean Huber, Sven, MD Hubsch, Alphonse, DVM Hudson, Satabdi Hudson, R. Tod Huerta Diaz, Enrique Huesmann, Graham, MD, PhD Huether, Asenath, BA Huettner, Clemens Huff, F. Jacob, MD, FAAN Huff, Kenneth Hughes, Stacey Hughes, Bruce, MD, FAAN Hughes, Andrew Hughes, Steven Hughes, Richard Hugos, Lucinda Huhmar, Helena Hui, Edward, MD, PhD Hui, Jennifer

252 2018 AAN Annual Meeting On-site Guide

Huie, J. Russell Huisa, Branko Hull, Mariam Hull, Stephen Hull, Judy, MS, CGC Humayun, Mohammad Humbert, Kelley Hummel, Maryann Hung, Serena Hunt, James Hunter, Michael Hunter, Samuel, MD, PhD Huott, Patrick Hur, Elizabeth Hurry, Fariba, M.S.E. Hurtado, Rafael Husain, Aatif Husain, Asra Husari, Khalil, MD Huser, Sara Huska, Jozef Huskens, Marijke Huss, Georg-Peter Hussain, Shymaa Hussain, Mohammed Hussain, Syed Hussain, Yessar Hussain, Shaun Hussaini, Sharmeen Hussaini, Syed Hussein, Omar Hussein, Haitham Hussey, Richard Hussman, Susan, CMP Huston, Elizabeth Hutchcraft, Nicole Hutchinson, Michael, MD, PhD Hutchison, Kimberly Huttler, Eric

Ingelghem, Erwin Ingersoll, Sarah, RN, PHN, MS, MBA Ingham, Nicholas Inshasi, Jihad, MD, MBBS, FAAN Ioannidis, Panagiotis Ionete, Carolina Iovin, Ramon Iragui-Madoz, Vicente, MD, PhD Irbe, Dainis Ireland, Stephen Irizarry, Eliud Irkec, Ceyla, PhD Irmady, Krithi, MBBS, MD Irodenko, Viktoriya Irumudomon, Obehioya Irvine, Hannah Irwin, Samantha, MD Irwin, David Irwin, Anna Isaacson, Richard, MD Isaacson, Jonathan Isaradisaikul, David Isenberg, Nancy Ishida, Koto Isik, Nihal, MD Isitan, Cigdem Islam, Nazrul, MD, MBBS, MCPS Islinger, Florian Ismail, Fatima Ito, Brian, MD, FAAN Ito, Kazunori Ivashynka, Andrei Ivkov, Nestor Ivy, Autumn, MD, PhD Iyadurai, Stanley, MD, PhD Iyagba, Alagoma Iyer, Ravi

Iyer, Shankar Jaacks, Gonzalo Jabari, Duaa Jabbari, Bahman, MD, FAAN Jack, Clifford, MD Jack, Dominic Jackowiak, Eric Jackson, Lauren Jackson, Robert Jackson, Carlayne, MD, FAAN Jackson, Alan, MD, FAAN Jackson, Leila Jackson, Kenneth Jacob, Sneha Jacob, Cara Jacob, Anu Jacob, Patricia Jacob, Alexandra, MS Jacobo, Miguel Jacobs, Alan, MD, FAAN Jacobs, Bradley, MD, MS Jacobs, Marianne jacobs, david jacobs, heike Jacobson, Mercedes Jacobson, Sheila Jacobson, Anne Jacoby, Nuri Jacquerye, Philippe Jacques, Kayla Jadhav, Ashutosh, MD Jafarpour, Behnam Jaffa, Matthew Jaffee, Michael, MD, FAAN Jafri, Syed Jagannathan, Radhika Jahangirvand, Alex Jain, Aanchal Jain, Ankur

253

2018 ANNUAL MEETING ATTENDEES

Huttner, Hagen Hutton, Everett, Bachelor Huynh, Margaret Hvidston, Jacob Hvizdosova, Lenka Hwang, David, MD Hwynn, Nelson Hyman, Bradley, MD, PhD Iaci, Jennifer, MS Ibegbu, Chinazom Ibrahim, Faisal Ibrahim, Ehab Ibrahim, Gharib Ibrahim, Waseem Ibrahim, Abdullahi, FMCP Ibrahim, Khalid, MD, MBBS, FRCPCH Ibrahim Hussein, Nabil Icay, Karina Ichord, Rebecca, MD Ido, Katsutoshi Idrovo Freire, Luis Igl, Juliane Ignatius, Kurian, MD, MBBS Ikawa, Masamichi Ikeda, Ken, MD, PhD Ikeguchi, Ryotaro Ikenaga, Chiseko Ikonomovic, Milos Ikram, Asad, MD, MBBS Ikram, Amer Illoh, Kachikwu, MPH Imam, Yahia Imam, Anwer Imbus, Charles Imitola, Jaime Inamullah, Ovais Inbarasu, Jery Indala, Rajesh Venkat, DM

2018 ANNUAL MEETING ATTENDEES Jain, Ravin Jain, Sandip Jain, Sanjay Jain, Vikas, MD, MBBS Jain, Abhi Jaiswal, Amit, MD, MBBS Jaiswal, Anupam, MD, MBBS Jaiswal, Shashi Kumar Jakimovski, Dejan Jakkampudi, Venkata Jakubek, George Jakubovski, Ewgeni Jalali, Seyed Jalundhwala, Yash Jamal, Nasheed James, Lynn, MPH James, Jim James, Todd Jamil, Asif Jamison, Jill Janda, Paul, DO, JD Janiak, Dan JANIE, WONG Janjua, Fatima Janjua, Riaz Janjua, Nazli, MD, MBBS Janjua, Khurram Janko Labinac, Dolores, MD Jankovic, Joseph, MD, FAAN Jankowiak, Janet Janosik, John Jansen, Kate Jansen, Kristian Jansson, Anette Japp, Gudrun Jaramillo, Victoria Jarjour, Imad, MD, FAAN, FAAS Jarnot, Jessica Jarrahi, Behnaz

Jarrin Sanchez, Sandra Jarvis, Richard Jasminka, Djelilovic Vranic Jassam, Yasir, MBChB, MRCP Jaureguiberry, Anabel, MD Jauss, Jan, PhD MD Javed, Adil, MD, PhD Javed, Muhammad Javerbaum, Jeffrey, MD, FAAN Javidnia, Monica Jawdat, Omar Jayagopal, Lakshman Jayakumar, Harish, MRC_ Jayaram, A, MD, FAAN Jayaraman, Dilip Kumar Jayaratne, Daya Jazebi, Noushin Jedynak, Jakub, PhD Jeffery, Douglas, MD, PhD Jeffery, Oliver Jeleva, Maria Jendraszek, Lauren Jenkins, Jessica Jenkins, Liberty Jenkins, Stephen Jennings, Tara Jennings, Danna Jensen, Frances, MD, FAAN Jensen, Judd Jensen, Elsebeth Jensen, Rikke Jensky, Nicole Jenson, Chris Jeon, Sung Jeret, Joseph, MD, FAAN Jeromin, Dieter Jeske, Judith Jessen, Kristen, MD, FAAN Jeste, Shafali, MD

254 2018 AAN Annual Meeting On-site Guide

Jestico, John Jeyapalan, Suriya, MD, MPH Jha, Anil, MD, MBBS Jha, Ruchira Jhunjhunwala, Ketan Jia, Cassie Jia, Wan Lu Jiang, TingTing Jiang, Hongquan Jiang, Linda Jiang, Dongmei, MD,PhD Jiang, Mei Jiang, Tong Jiang, Chian Jiang, Lan Jiang, Lina Jiao, Jocelyn Jicha, Gregory, MD, PhD Jichici, Draga, MD, HBSC, FRCP, FAHA Jickling, Glen, MD Jiganti, Max, BS Jillapalli, Devanand, MD, MBBS Jimenez, Christopher Jimenez, Jorge Jimenez Shahed, Joohi Jin, Meiyan Jindal, Anuja Jindal, Parul Jitprapaikulsan, Jiraporn Jo, Jasmin Jo, Hyujin Jobst, Barbara, MD, FAAN Jodoin, Nicolas Jody, Darlene Joe, Elizabeth Joe, Jalyoung Johannesen, Siw Johnson, Kellee

Jordan, Justin, MD, MPH Jordan, Shaun, PhD Jordan, Brittany Jordy, Sergio, MD Jori Birkas, Adrienne Joseph, Preeti Josephs, Lena, BA Josephson, S., MD, FAAN Joshi, Aditya Joshi, Dhrupad Joshi, Astik Joshi, Krutika, BSc Joshua, Robert Joundi, Raed, MD, PhD Jovin, Tudor, MD Joy, Ajo Joyeux, Alexandre Jรณzefowicz, Ralph, MD, FAAN Jozewicz, Laura Ju, Yo-El, MD Jubelt, Burk, MD, FAAN Jucha, Rafal Juel, Vern, MD, FAAN Juergens, Elizabeth Juergens, Jeffery Jullien De Pommerol, Herve Jullien De Pommerol, Herve Junaid, Shaq Junck, Larry Jung, Youngsin, MD, PhD Jung, Karsten Jung Henson, Lily, MD, MMM, FAAN Just, Caroline Juves, Jose, BA Juvinall, Douglas Ka, Mee Jeong Kaarlop, Maarja Kabacinski, Taylor

Kabir, Mohammad Kablan, Yuksel Kachuck, Norman Kadambi, Adesh Kadish, Robert Kafaie, Jafar, MD, PhD Kahancova, Edita Kahawe, Dilum, MD, MBBS Kahlon, Maninder, MD, MBBS Kahlon, Surjit Kahn, David Ethan Kahne, Jenna Kaim, Boris, MD, FAAN Kainth, Pinay Kaiser, Eric, MD, PhD Kaiser, Brian Kaisey, Marwa, MD Kaiway, Sarah Kaji, Ryuji, MD, FAAN Kajii, Yasushi Kak, Manisha Kakadia, Bhavika KAKARIEKA, Algirdas Kakhlon, Or Kakria, Anshuk Kaku, Michelle Kalam, Sabrina Kalari, Sirisha Kalayjian, Laura Kalbe, Irja Kale, Anupama Kale Icen, Nilufer, MD Kaleagasi, Hakan Kalenderoglu, Ahmet Kalia, Junaid Kalita, Jayantee Kallela, Mikko Kallgren, Sofie Kallmann, Boris, MD

255

2018 ANNUAL MEETING ATTENDEES

Johnson, Stephanie Johnson, Kate Johnson, Nicholas, MD Johnson, Kristin Johnson, Steven, MD, PhD Johnson, Michael Johnson, Matt Johnson, Malcolm Johnson, Reed, B.S. Chemistry Johnson, Nicole Johnston, James, MD, JD Johnston, Lori Jolibois, Kern Jolliffe, Evan Jolly, Surindar Jonas, Nicholas Jonason, Alan Jones, Gillian Jones, Stephen Jones, Elaine, MD, FAAN Jones, Lyell, MD, FAAN Jones, Bethany, MD, PhD Jones, Asher Jones, David Jones, James Jones, Kimberly Jones, Robert Jones, Colleen Jones, Eddie, BA Jones, Jamie Jones, Cynthia Jones, Daniel Jones, Daryl Jones, Tashara, BA Jones-London, Michelle Jones-Wall, Carol Jong, Ho-Yann Jong, Laura Jonzzon, Soren

2018 ANNUAL MEETING ATTENDEES Kallur, Sunil, MD, MBBS Kalman, Bernadette, MD, PhD, Dsc, FAAN Kalnina, Jolanta Kalra, Deepak, MD, PhD, MPH Kalsner, Louisa Kaluza, Jennifer Kalvianen, Reetta, Epilepsy Kam, Wayneho Kamal, Syed Kamei, Tetsumasa Kamen, Charles Kamenetsky, Elvira Kaminer, Jaime Kamins, Joshua Kaminski, Patricia Kaminsky, Laraine Kaminsky, David Kamiya-Matsuoka, Carlos Kamson, David Kanakeswaran, Geetha Kanazawa, Nathan Kandukuri, Prasanna Lakshmi, Masters Kang, Peter, MD, FAAN Kang, Un, MD, FAAN Kang, Peter, MD Kang, Hyoin Kang, Yujin, BSc. Kango, Sujay Kanjo, Mahdi Kanmogne, Marlene Kanna, Arvo Kannan, Raj Kanneganti, Prasad Kanner, Andres, MD, FAAN Kansal, Anuraag Kantanen, Anne-Mari Kantarci, Kejal Kanter, Jenna

Kantorova, Ema Kao, Tafline Kao, Justin, MBChB Kapadia, Avni Kapitzoglou, Vassiliki Kaplan, Jeffrey Kaplan, Tamara Kaplan, Matt Kapoor, Ashish Kapoor, Nidhi, MD, MBBS Kapoor, Amita Kappos, Ludwig, MD, FAAN Kaprelyan, Ara Kapur, Kevin Kapur, Raj Kapuria, Abhi Karabudak, Rana, MD KARACHALIOS, GEORGIOS Karadak, Zoran Karageorgiou, Clementine Karagulle, Deniz Karakurum Goksel, Basak Karam, Chafic Karbe, Hans Karch, Christoph Karelis, Guntis Karim, Ali, MD, FAAN Karim, Halima Karim, Shahnawaz Karimi, Sanaz Karl, Jessica Karmarkar, Ameeta Karnani, Mala Karnani, Rajan Karnaze, Dean Karnik, Vikram Karo, Fran, PhD Karp, Barbara Karsan, Nazia

256 2018 AAN Annual Meeting On-site Guide

Karschnia, Philipp, Medical Student Karst, Edward, MS Karwa, Karen Kasarskis, Edward, MD, PhD, FAAN Kasatwar, Nidhi Kase, Carlos, MD, FAAN, FAHA Kaseka, Matsanga Leyila Kashirny, Sergei, MD,PhD Kashyap, Bhavani, MBBS, PhD Kasi Reddy, Sanath Kasius, Kristel Kask Lofstedt, Anneli Kaspar, Brian, Ph. D. Kass, Joseph, MD, JD, FAAN Kassa, Roman Kassiri, Janani, MD, PhD Kasteleijn, Dorothee Kastnerova, Iveta Kastrup, Oliver Kasunich, Alissa, BS Kataki, Maria, MD, PhD Kataria, Lynn Katdare, Ajit Kato, Shinei Kato, Yoshitaka Kattah, Jorge, MD, FAAN Katyal, Roohi Katz, Jonathan Katz, Maya Katz Sand, Ilana Katzan, Irene, MD Katzberg, Hans Kau, Kristen Kaufer, Daniel, MD, FAAN Kaufman, David Kaufman, David, MD, FAAN Kaufman, Mike

Kelemen, John, MD, FAAN Kelleher, Lisa Keller, William, MBA Kellett, Jessica Kelley, Brendan Kelley, Gordon Kelley, Nancy Kelley, Mary, Student DO Kellogg, Marissa, MD, MPH Kelly, Cecilia Kelly, James, MD, FAAN Kelly, Siobhan Kelly, Sean Kelly-Williams, Kristen Kelso, Andrew Kempe-Mehl, Sarah Kenda, Benoit Kendall, Keith, NBA Kennedy, Allison Kennedy, Shayla Kennedy, Shane Kennedy, Rachel Kennedy, Sean, BS Kenner, Phillip, RPh Kenney, Kimbra, MD, FAAN Kenney, Christopher Kenney-Jung, Daniel Kepinska-Wnuk, Alicja Kerasidis, Harry, MD Kerber, Kevin, MD Kerenyi, Levente Laszlo Kern, Kyle, MD, MS Kern, Drew Kern, Ralph Kern, Russell Kerolous, Majid, PharmD, MPH Kerr, Wesley, MD, PhD Kerrick Walker, Jill, Pharm.D. Kerrigan, Deborah

Kerrigan, James Kerrigan, Julia Kerson, Lawrence, MD, FAAN Kertesz, Andrew, MD, FAAN Kesari, Navin1504 TAUB LOOP Kesayan, Tigran, MD Keser, Zafer Keshwani, Shanil Kesner, Vita, MD, PhD Kesraoui, Selma Kesting, Leo Kettani, Hind Khabbaz, Sany Khachanova, Natalia Khaing, Myo Khairallah, Nicole Khalid, Ehtesham, MRCP, FCPS Khalife, Jane Khaliq, Nadeem Khamis, Chaker Khamisani, Saleem Khamishon, Boris Khan, Wasim Khan, Adil Khan, Humaira Khan, Tahsin Khan, Jaffar, MD, FAAN Khan, Omar Khan, Fawad Khan, Shaida Khan, Tarannum, MD, MBBS Khan, Umber Khan, Amanullah, FCPS Khan, Salman Khan, Aisha Khan, Arjumond, BA, BBA Khan, Usaamah Khankhanian, Pouya Khare, Swati, MS

257

2018 ANNUAL MEETING ATTENDEES

Kaufman, Ronald, Pharm.D., BCPP Kaufman Scher, Jonathan Kaufmann, Petra, MD, FAAN Kaufmann, Horacio, MD, FAAN Kaugesaar, Toomas Kaul, Surabhi Kaul, Namita, MD, MBBS Kaur, Sumanjit Kaur, Harleen Kavafian, Dicran Kavanagh, Patricia Kawachi, Izumi, MD, PhD Kawaguchi, Krista Kawashima, Noriko, MD, FAAN Kaweczynska-Lason, Aneta Kay, Jonathan Kayani, Saima Kaye, Amy, PhD, NP Kaye, Lesley, MD Kaye, Kathy Kaye, Wendy Kayed, Deeb, MD, FAAN Kayim Yildiz, Ozlem, PhD Kay-Stacey, Margaret Kazamel, Mohamed Kazerooni, Rashid kazmi, Batool Kazmi, Mohammad Kazmierski, Radoslaw Kaznatcheeva, Elena Kchaou, Mariem Ke, Fanglu Keane, Paul, PhD Kearns, Sean Kedar, Sachin Keegan, Mark Keener, Adrienne Kegler-Ebo, Deena

2018 ANNUAL MEETING ATTENDEES Kharidi, Viswanatha Khatib, Khalil Khatri, Ismail, MD, MBBS, FAAN Khatri, Rakesh Khayambashi, Shahin Khayatkhoei, Mahsa, MBA Khealani, Bhojo Khemani, Pravin, MD, FAAN Khenioui, Hichem Khera, Alka Khodair, Rola Khodavirdi, Ani Khoiny, Amir Khoja, Abeer Khoja, Waleed Ahmed Khokhar, Babar Khorasani, Sara Khoromi, Suzan Khosrowshahi, Samineh Khoury, Jean Khoury, Julie Khoury, Samia, MD, FAAN Khrizman, Marina Khurana, Dheeraj Khurana, Ramesh, MD, FAAN Khwaja, Omar Kianirad, Yasaman Kichula, Elizabeth, MD, PhD Kidd, Grant Kiekhaefer, Michael Kierbs, Amanda Kikuchi, Emy Kilbane, Camilla Kile, Shawn Kilgore, Shannon, MD, FAAN KILIAN, Rachel Kilic, Ahmet Kasim, MD Kilinc Toprak, Munire, PhD

Killiany, Ronald Kim, Diana Kim, Albert Kim, Paul Kim, Song Kim, Nina Kim, Susan Kim, Edward Kim, Hyunmi Kim, James Kim, Jisoon Kim, Joontae, MD, PhD Kim, Lance Kim, Sun-Young Kim, Byung-Su Kim, Chloe KIM, Dong Wook Kim, Heakyung Kim, Hye Won kim, hyeonju Kim, Jiyoung Kim, Liz Kim, Seok Kim, Woo-kyung Kim, Chong Sang Kim, Christian, BS Kim, Na Young Kimber, Thomas, PhD, FRACP Kimberly, Pfleeger Kimura, Jun, MD, FAAN Kinali, Maria Kincaid, John, MD, FAAN Kincaid, Octavia Kiner, Jason King, Katherine King, Kristin King, Allison King, Richard, MD, PhD, FAAN King, J.

258 2018 AAN Annual Meeting On-site Guide

King, Maggie Kingsford, OliviaOMS Kinirons, Peter, MD Kinnane, Emma, PhD Kinnetz, Meghan Kinney, Logan Kinsella, Laurence, MD, FAAN Kiok, Maximo, MD, FAAN Kirby, Leslie Kirjazovas, Aleksandras Kirlangic, Gundem Kirsch, Douglas, MD, FAAN Kisanuki, Yaz Kishta, Ahmed Kissel, John, MD, FAAN Kissela, Brett, MD, FAAN, MS Kitagawa, Yoshihiro Kitley, Joanna Kitt, Donald, MD, FAAN Kittredge, Francis, MD, FAAN Kiylioglu, Nefati Kizhakkedathu Malika, Parameswaran, MD, MBBS Kjaerem, Myassa Kjaerem, Myassa Klaas, James, MD Klahr Miller, Karen, MD Klaman, Lori Klawiter, Eric, MD Kleider, Anno Kleiman, Anne Klein, Julia Klein, Brad, MD, MBA, FAAN Klein, Joshua, MD, PhD, FANA, FAAN Klein, Christopher, MD, FAAN Klein, Pavel Klein, Ilan, MA Klein, Sarica Klein, Gregory

Kochar, Abhishek, MD, MBBS Koehler, Peter, MD, PhD, FAAN Koehler, Michael Carl Koehn, Tyler, MD Koehn, Monica Koelle, David, MD Koendgen, Harold Koepp, Maxine Koester, Jeff Kofahi, Raid Koffler, Irina Koga, Yasutoshi, MD, PhD Koganti, Archana Kogelschatz, Cory Koh, Kishin, MD, PhD Kohen Lanus, Cesar KOHLER, EDUARDO Kohler, Matias, MD Kohn, Ricardo Koike, Tatsuki Koka, Erjon Kolappan, Madhan, PhD, MBBS, MRCP Kolla, Sai Kolpatzik, Katja Kolson, Dennis, MD,PhD Koltun, Arkady Kolychev, Dmitri Komai, Kiyonobu Kompoliti, Aikaterini, MD, FAAN Komso, Milica, MD Konakova, Eva Kondappan, Asokan Kondo, Gustavo Koneru, Sai Sripada Koneru, Sitara Kong, Xiao-Tang, MD, PhD Kong, Wan Yee Konkol, Richard, MD, PhD

Konno, Takuya, MD, PhD Koo, Benjamin Koo, Jaseong Kooiker, Jon, MD, FAAN Kootsikas, Maria, Pharm.D. Kopp, Adam Koppel, Barbara, MD, FAAN Koralnik, Igor Korb, Pearce, MD, FAAN Korhonen, Markku Korich, Julie Koriesh, Ahmed Korner, Eli Koroshetz, Walter, MD, FAAN Korpela, Jaana Kosa, Steven Kosa, Peter Kosaka, Takayuki, MD, PhD Koseoglu Bitnel, Mesrure, MD Koshy, Shiney Koshy, Ruby Kosmidis, Michail Kossak, Brian Kostadima, Vasiliki Kostera-Pruszczyk, Anna Kostich, Walter Kotagal, Suresh, MD, FAAN Kotagal, Prakash, MD, MBBS Kothapally, Vinod, MD, MBBS Kothare, Sanjeev, MD, FAAN Kothari, Ravish Koto, Mary Kotschet, Katya Kottam, Pratheep, MD, MBBS Koul, Prateeka, BA Koulinska, Irene, ScD Kouremenos, Evangelos Kovac, Maria Kovacikova, Lucia

259

2018 ANNUAL MEETING ATTENDEES

Kleinschnitz, Christoph Erich Kleisinger, German, MD Klementowski, Patricia Klenk, Razvan Klenofsky, Britany Kletzl, Heidemarie Klineova, Sylvia Klohe, Stephan, MD Klopstock, Thomas Klotz, Luisa Kluger, Benzi, MD, FAAN Kmetova, Eva Knapek, Stephan, MD Knapik, Joseph, MD, FAAN Knappertz, Volker Kneller, Sian Knepper, Laurie Knievel, Kerry Knights, Karl Knocke, David, RPh, MS Knoefel, Janice Knol, Danella Knopman, David, MD, FAAN Knorn, Philipp Knorre, Eduardo, MD Knupp, Kelly, MD Ko, Pin-Yi Ko, Melissa, MD, FAAN Ko, Nerissa Ko, David Ko, Mia Ko Takizawa, Vivi Kobet, Christopher Kobylka, Jari Kocak, Vedat, PhD Kocaman, Ayse KOCER, EMINE BELGIN Koch, Marcus Kochanek, Patrick, MD, MCCM

2018 ANNUAL MEETING ATTENDEES Kovacova, Slavomira Kovacs, Krisztina Kowalik, Andreas Kowalska, Agnes Kozelka, James Kozinn, Mark, MD, FAAN Kozlovska, Inesa Kraakevik, Jeff Kraft, George Krainman, Jennifer KRAJEWSKA, Agata Kraker, Jessica Kraler, Lironn Kralstein, Jeffrey Kramer, Christopher Krarup, Christian, MD, DMSc, FRcP Krashin, Daniel Kraus, Joerg, MD Kraus, Dominik Krause, Erik Krause, Martin, FRACP Krauss, Gregory KrauÃ&#x;, Martin, Dr. med. Krawczyk, Michal Kreiger, Derk Kreis, Douglas, MBA, BAS, RT Kremen, Sarah KREMER, JANUS Kren, Christine, MS Krendel, David, MD, FAAN Krendl, Reinhard Krett, Jonathan, BSc Kreusel, Boris Krieger, Stephen, MD, FAAN KRIJNEN, Ellen Krim, Elsa, PhD Krish, Nagesh Krishnamurthy, Soumya

Krishnan, Rashi Krishnaswamy, Chandra Kronby, Michael Kronfeld, Kassi Kropog, Kelly KROPSHOFER, Harald Kroushkov, Hristo Kruger, Corey Krulisky, Kathryn Krupp, Lauren, MD, FAAN Krysko, Kristen Krzystanek, Ewa Krzysztof, Selmaj KUBARA, Alexandra Kudrow, David Kuehnapfel, Sarah Kuhelj, Robert Kuhle, Jens, MD Kuhlman, Gregory Kukreja, Pavnit Kukulka, Klaudia Kukulka, Natalie Kukull, Walter, PhD, FAAN Kulakowska, Alina Kulick, Catherine Kulik, Tobias Kulkarni, Sumant90 William St, Apt 8 Kullmann, Jennifer, Phd Kumar, Arooshi Kumar, Pratheep Kumar, Sandeep Kumar, Neeraj, MD Kumar, Rajeev, MD, FRCPC Kumar, Arun Kumar, Erukulla, MD, MBBS Kumar, Kunal Kumar, Parveen, MD, FAAN Kumar, Sanjay, MD, MBBS

260 2018 AAN Annual Meeting On-site Guide

Kumar, Sudhir Kumar, Vikas Kumar, Vivek Kumar, Jinender Kumar, Shekhar, DM Kumar, Keerthana, MPH Kumar, Mukesh, MTech Kumar, Neha, BA Kumbham, Pradeep, MD Kumpinsky, Aliza, MD KUMRAL, DURSUN EMRE Kundu, Prantik Kundu, Uma Kung, Doris Kung, Michael17815 Cecelia Place Kunhi Veedu, Hari Prasad Kuniyoshi, Sandra Kunzi, Michelle Kuo, Sheng-Han Kuppusamy, Krishnamoorthy Kuqo, Altin, MD, PhD Kuramatsu, Joji Kuray, Miguel, MD Kurek, Julie Kurian, Christeena Kurkowska-Jastrzebsk, Iwona Kurt Bekircan, Ebru Can Kurtevski, Sara, B.S., B.A. Kurtulus, Fatma, PhD Kurtuncu, Murat, PhD Kurunawai, Craig Kuruppu, Dulanji Kurz, Daniel Kurz, Jonathan, MD, PhD Kurzweil, Arielle Kuscu, Demet Kushlaf, Hani Kushner, David, MD, FAAN

LAFLAMME, Annik KLafond, Nadine LaFrance, W., MD, MPH, FAAN Lagace, Micheline Lagerlund, Terrence, MD, PhD Lagios, John LaHue, Sara Lai, Joshua Lai, Eugene, MD, PhD, FAAN Lai, Tim Lai, Karen Lai, Sue Lainez Andres, Jose Miguel, MD Lakhan, Shaheen, MD, PhD, MEd, MS, FA Lakhotia, Arpita Lakin, Lynsey Lal, Darshan Lalive d'Epinay, Patrice, MD Lalla, Rakesh, MD, MBBS Lalumiere, Eric Lam, Tanya Lam, Alice Lamb, Christopher Lambert, Nicholas Lambert, Tanya, Bachelor of Science Lamberta, Laura Lammert, Dawn, BA, MA Lamour, Bregenet Lancaster, Eric, MD, PhD Lancaster, Audrey Landete Pascual, Lamberto Landis, Theodor, PhD Landsman, Douglas Landsness, Eric, MD Landwehrmeyer, Bernhard Lane, Michael Lane, Gareth, BSc (hons) Lane, Roger, MPH

Laneuville, Michelle Lang, Anthony, MD, FAAN Lange, Dale, MD, FAAN Langenbach, Kimberly Langer-Gould, Annette, MD, PhD Langford, Douglas Langston, Christopher Langston, Rebekah Lanker, Stefan Lannen, Nicholas Lanning, Katherine Lanoie, Nathalie Lanska, Douglas, MD, FAAN Lanternier, Julio, MD Lanunziata, Kimberly Lanzillo, Roberta, MD Lapekas, Gina Lapierre, Yves Lapointe, Sarah Laranjeira, Jose Ricardo Laranjo, Scott LaRoche, Suzette, MD, FAAN Larsen, Niccole Larson, Danielle Larson, Dewey Larson, Mistie, MBA Larson, Roger Larue, Sandrine Lasker, Aaron Lasner, Ilana Lassek, Christoph Latendresse, Estelle Latov, Norman, MD, PhD Latreille, Veronique Latts, Adam Lau, Kwok Laufer, German Laughlin, Ruple, MD, FAAN

2018 ANNUAL MEETING ATTENDEES

Kutcher, Jeffrey, MD, FAAN Kutscher, Scott Kuwahara, Hiroya, MD, PhD Kuybu, Okkes Kvalsund, Michelle Kvam, Kathryn Kwan, Chung Hon Kwan, Justin, MD, FAAN Kwiatkowski, Arnaud, PhD Kwok, Grace Kwok, Michael Kwok, Charlotte Kwok, Susanna, B.S. Kwon, Eunjin Kwon, Hanim Kwon, Jennifer, MD, FAAN Kwon, Patrick Kyle, Kevin, MB BCh Kymes, Steven Kypraios, Aristeidis L. Johansen, Jens Laaouina, Zouhair Labal, Patricio, MD LaBarte, Theresa Labauge, Pierre, PhD Label, Lorne, MD, MBA, FAAN Labiano Fontcuberta, Andres Labin, Edward Labunski, Dimitriy Lacerda, Cassio Lachance, Daniel, MD, FAAN Lachhwani, Deepak Lackey, Elijah Lackland, Daniel Lackovic, Zdravko, MD, PhD Lacy, Joseph LaFaver, Kathrin Lafaye, Kristina Laffan, Aoife

261

2018 ANNUAL MEETING ATTENDEES Laughton, Sienna, BA Laurenza, Antonio, MD, FAAN Laureys, Guy Lauter, Jody Lauzikiene, Asta Lavian, Monica Lavorgna, Luigi, MD Lawler, Abigail Lawson, Victoria Lawson, Anna, MPharmHons Layton, Kelly, PA-C Layton, Joseph Lazar, Ronald, PhD, FAHA, FAAN Lazarus, Theophilus Lazarus, Joash Lazarus, Kenneth, MD, PhD Lazic, Divna, MSc Le, Scott Le, Viet Le, Thanh Leacock, Rodney Leadbetter, Ruth, MBChB Leal, Fernanda, MD, MSc Leal Ferman, Luis Andre Leary-Chang, Michelle, NMD Leasure, Audrey, BS Leavitt, Blair Leavitt, Victoria Lebovits, Chaim Lechner, Anita Lechner, Sandra Leclerc, Nathalie LeDay, Angela Leduc, Karine Lee, Coronda Lee, Wing Cheong Lee, Yuan Lee, Andrea

Lee, Jae Eun Lee, Joyce Lee, Tiffany Lee, Ian Lee, Kim En Lee, Anthony Lee, Byung Lee, Chi Yan Lee, David Lee, David Lee, Deborah, MD, PhD Lee, Eric Lee, Han Lee, Hyelim Lee, I-Hui Lee, Ikjae Lee, Karen Lee, Virgina, MD Lee, Amy, MD Lee, Hane, PhD Lee, Adreahna Lee, Andrew Lee, Camille Lee, EunMee Lee, Hsiao-Yuan Lee, Hyomin Lee, Ming-Jen, MD,PhD Lee, Si Baek Lee, Soon Hyouk Lee, Zeeihn Lee, Karen Lee, Angela, BA Lee, Bern, M.A. Lee, Eric Lee, Jeannie Lee, Philip Lee Kwen, Peterkin Leehey, Maureen, MD, FAAN Leemann, Beatrice

262 2018 AAN Annual Meeting On-site Guide

Leffler-McCabe, Michael Lefler, Emily LeForce, Bruce, MD, FAAN Legacy, Joseph Legarda, Stella Legault, Catherine Leger, Gabriel, MD, FRCPC Legge, John Legido, Agustin, MD, PhD, MBA Leguizamon, Felisa, MD Lehal, Avneet Lehner, Susan Lehosit, Jessica Lehrieder, Gerald Lehto, Jussi Leider, Richard Leiderman, Deborah, MD, FAAN Leigh, Tyler Leigh-Pemberton, Richard Leighton, Trevor Leira, Enrique, MD, MS, FAAN Leishangthem, Lakshmi, MD, MBBS Leist, Thomas, MD, PhD, FAAN Leite, Paulo Lekkala, Madhavi Leklou, Hakim Lekontseva, Olga Lekoubou Looti, Alain, MD Lelong, Aurelie Lemons, Richard Lening, Christopher Leocani, Annunziata Ma Letizi Leon, Soniza, MD Leon, Kristoffer Leon Hernandez, Juan Leonard, Timothy Leonaviciene, Aurelija LEPPERT, David

Lezaic, Nastasija Li, Huan Li, Jacqueline Li, Yi Li, Hongyan, MD, PhD Li, Judy Li, Yuebing, MD, PhD, FAAN Li, Jin, MD, PhD, FAAN Li, Lily Li, Stephen Li, Jia Hui Li, Xi Liang, John Liang, Bertrand Liang, Grace Liang, Tsao-Wei Liang, Jinjun Liang, Peiri Liao, Bing Libell, David Libell, Eric, BS Liburd, Mario Alberto Licata, Stephanie Licht, Eliot Lichtman, Jeff Licking, Nicole Licorish, Paulette Lieberman, Abraham, MD, FAAN Lieberman, David, MD, PhD Liebeskind, David, MD, FAAN Liebler, Eric Liebman, Jill Liem, Assuncion Liewluck, Teerin Ligtermoet, Matthew, FRACP Likwaicheung, Anne Marie, MChem Lillemoe, Kaitlyn Lim, Chern

Lim, An An, M.Sc, MD Lim, Rodrigo Lim, Shi Lim, Miranda, MD,PhD Lim, Sung Chul Lim, Catalina Lim, Marie, BA Lima, Gabriel Limaye, Kaustubh Limmroth, Volker, MD Lin, Meei Ing Lin, Yushiu Lin, Andrew Lin, Ava Lin, Chi-Ying, MPH Lin, Jessica Lin, Yi-Han Lin, Yicheng Lin, Michelle, MD Lin, Karen Lin, Helen Lin, Henry Lin, James Lin, Mark, MD, PhD, FAAN Lin, Steven Lin, Tanya Lin, Yu-Wei Lin, Hsin-Pin Lin, Amy Lin, Chin Lun Lincoln, Tara, MS Lind, Jonas Lindau, Nicolas, MD Linde, Rasmus Lindeken, Kimberly Lindgren, Kristen, MD, PhD Lindorf, Evangeline Lindsberg, Perttu Linfante, Italo, MD

2018 ANNUAL MEETING ATTENDEES

Lesch, David Leschek-Gelman, Lisa Lescinskiene, Loreta Meilute Leslie, Ryan Lesnevich, Marykate Lesser, Ronald, MD, FAAN Lestch, Stuart Letourneau, Karine Leung, Kenneth Leung, Thomas Leupin, Nicolas Levenson, Jay, JD Leverenz, James, MD, FAAN Levesque, Mathieu Levesque-Roy, Myriam Levi, Lara Levi, Sabrina Raquel Levin, Kerry, MD, FAAN Levin, Morris, MD, FAAN Levine, Joshua Levine, Reed Levine, Todd, MD Levinson, Noah, MD Levit, Alexander, HBSc Levitt, Manuela Levy, Michael, MD, FAAN Levyim, Desiree Levy-Reis, Igor Lewin, James Lewis, Ariane, MD Lewis, Richard, MD, FAAN Lewis, Steven, MD, FAAN Lewis, Jeffrey, MD, PhD Lewis, Kara, MD, FAAN Lewis, Glenda Lewis, Jamie Lewis, Christina, BS Lex, Heidemarie Leys, Didier, MD, FAAN

263

2018 ANNUAL MEETING ATTENDEES Linnoila, Jenny, MD, PhD Linortner, Patricia Linton, Celia, MHSA Liotta, Eric Liou, Jeffrey Lipenko, Valery Lipton, Richard, MD, FAAN Lipton, Anne, MD, PhD Lira, David, MD, FAAN Lisak, Robert, MD, FAAN, FRCP (E), Lisk, Jerome L'Italian, Jim, PhD Little, Dena Little, Allison Litvan, Irene, MD, FAAN Litwiniak, Janete Liu, Andy, M.S. Liu, Simon Liu, Yin Liu, Li Liu, Mike Liu, Ran Liu, Zuolu Liu, Grant, MD, FAAN Liu, Jiangping Liu, Jie Liu, June-Chih Liu, Lei, MD, PhD Liu, Tiffany LIU, LIXU Liu, Tina Livingston, Terrie Livingston, Travis, Student Lizama, Ana Lizrova, Jana Ljubenkov, Peter Llamas Lopez, Leonardo Llaneza Gonzalez, Miguel Angel

Llibre Guerra, Jorge Llinas, Rafael, MD, FAAN Lloyd, Matt Lo, Beth Lo, Albert Lo, Tsz Nga Locher, Andrew, BSc Lockhead, Dean Loddenkemper, Tobias, MD Loeb, Jordan Loeb, Jeffrey, MD, PhD Loewenstein, Leah LOFTUS, Joseph Logan, William, MD, FAAN Loggini, Andrea Logigian, Eric, MD, FAAN Logovinsky, Veronika Logroscino, Giancarlo, MD, PhD, FAAN Loh, Vicki Loiselle, Andre, FRACP, MBBS Lombard, Louise Lombardi, Thomas Lombardo, Lauren, BS London, Zachary, MD, FAAN London, Scott Long, Lucretia, CNP Longardner, Katherine Longbrake, Erin, MD, PhD Longfellow, Katelan Longo, Frank, MD, PhD Looned, Leeza Lopes, Jennifer, BS Lopez, Alfonso Lopez, Jaime, MD Lopez, Oscar, MD, FAAN Lรณpez Hernรกndez, Mario Estuardo Lopez Munoz, Pablo Lopez Real, Ana Maria, MD

264 2018 AAN Annual Meeting On-site Guide

Lopez Roa, Margarita Lopez Ruiz, Minerva Lopez Ruiz, Rocio, MD Lopez Santamaria, Ana, MD Lopez-Bresnahan, Maria, MD, FAAN Lopez-Vizcarra, Marco LORENZATTO, willians Lorenzo Gonzalez, Jose Ramon, MD Loria Rosado, Luis Felipe Lorigan, Holly Loring, Sherrill Loring, David Losey, Travis Losonci, Rita Lotia, Mitesh Lott, Ira, MD Lotze, Timothy Lou, Jau-Shin, MD, PhD, FAAN Loucao, Sofia Loud, Sara, MS, MBA Loughnan, Lucy, BSc Louis, Elan, MD, MS, FAAN Loupe, Pippa Love, Shawn Lovera, Jesus Loverde, Nicole Low, Dominique Low, Justin, MD, PhD Low, Tisiana Lowden, Max, MD, FAAN Lowe, Carolina Lowe, Robert Lowes, Linda Loy, Clement, FRACP Lozano Ros, Alberto, MD Lu, Joseph Lu, Christine Lu, Jyh-Haur, MD, FAAN

Luque, Francisco, MD, PhD, FAAN Luque Navarro, Jacob Luth, Jennifer, PhD Lutley, Alexandria Lutters, Bart Lutzky Saute, Ricardo Luzzi, Saverio Ly, Ina Ly, Anh Ly, Ann Lycan, Sarah Lykins, Charmaine Lynch, Sharon Lyons, Kelly Lyons, Jennifer Lyons, Ann Lyons-Warren, Ariel, MD, PhD Lyustikman, Yelena Ma, Karen Ma, Xiaoping, MD,PhD Ma, Xiaoye Ma, Chaoran Ma, Sirui, BA Maamar-Tayeb, Ali Maas, Eric Maas, Matthew Macaron, Gabrielle Macaskill, Peter Macdonald, Pippa MacDonald, Maria MacDonald, Christine, PhD Macdonell, Richard, MD, FAAN MacDougall, Alexander Macedo, Yuri Macedo, Pedro Machado, Ligia Machado, Gabriela Machado, Duarte

Machado, Natalya Machnouk, Maye, Pharmacist Maciel, Ernane Maciel, Carolina, MD Maciel, Damacio, MD MacIsaac, Ryan Mack, Kenneth, MD, PhD, FAAN Mack, Dave Mack, Joel Macke, Allison Mackenzie, Melissa Mackin, Glenn, MD, FAAN, FACP MacNeil, Blaine, BSc; MBA MacPhail, Karen Madani, Sarah Madani, Abu Baker Madathiparambil, Divya, DM Neurology Madden, John Madhavan, Ramesh Madi, Ebtehal Madigan, Nicolas Maeda, Yasuhiro Maes, Jen Magalhaes, Gerson Magalhaes, Juliana Magdic, Jozef Maghzi, A. Hadi Magnussen, Marcus Magy, Laurent, MD Magyari, Melinda Mah, Jean, MD, FRCPC, FAAN Mah, Cheri, MS Mahajan, Abhimanyu Mahajan, Kedar, MD, PhD Mahajan, Ritika Mahajan MD, Shalini Mahdad, Mehrdad Maheshwari, Atul, MD

265

2018 ANNUAL MEETING ATTENDEES

Lu, Mei Lu, Liang Lu, Xiao-Yu Luber, Gabriele Luber, Ulrich Lubinski, Brooke, BS Lublin, Alex Lucas, Tameka Lucassen, Elisabeth Lucchinetti, Claudia, MD, FAAN Lucero, Larah Lucero, Natalia, MD Luche, Nicole Luciano, Carlos, MD, FAAN Ludolph, David Luebbert, Timothy Lueck, Christian, PhD, FRACP, FAAN Lueck, Kristin Lueers, Lars, MD Luers-Franco, Aimee Luetic, Geraldine, MD Lugassy, Mara, MD Lugo, Tim, BA Lugonjic, Sara, B.S. Lui, For-Shing, MD, FAAN Lui, Hoi Ki, Kate Luk, Vivi-Anne, MRCP Lukas, Joshua Lukasik, Maria, MD, PhD Luke, Rebecca Lumempouw, Silvia Lun, Ronda Luna, Diego Lundeen, Jessica Lundgren, Erik Lungu, Codrin Luo, Jin, MD, PhD, FAAN Lupescu, Tudor, MD, PhD

2018 ANNUAL MEETING ATTENDEES Mahfouz, Talal Mahler, Michael Mahmood, Rana Mahulikar, Advait, MD Mahyari, Nila Maier Peuschel, Monika, MD Maier-Janson, Walter, MD Maimone, Davide, MD Maina, Eric, MMed ECSA Mainardi Villarino, Laura Maiser, Samuel Majer, Mirko Majerczyk, Charlotte Majersik, Jennifer Makari, George Makhani, Naila Maki, Niki Makkawi, Seraj, MBBS, FRCPC, ABPN, M Makki, Achraf Makri, Samira Malani, Rachna Malatesta, Lindsay Malaty, Irene Malek, Hamza Malek, Naveed Malfatti, Edoardo Malhotra, Manoj Malhotra, Ashish, MD, MBBS Malhotra, Raman, MD, FAAN Malhotra, Ram Mali Patil, Sharanagouda, MD, MBBS Malik, Asma Malik, Amer, MD Malik, Saeeda Malik, Rabia Malik, Sudhir Malik, Yasir Malik, Amber

Malik, Moiz Malka Tisserand, Beatrice Malkani, Roneil, MD Malkani, Brijesh Malkoff, Marc, MD, FAAN Mallery, Robert Mallillin, Nelson Anthony Mallonee, William, MD, FAAN Mallory, Matthew Malmierca, Ana, MĂŠdica, NeurĂłloga Malo, Bassam Maloney, Eimer Maloon, Alan Maltezou, Maria Mamangun, Jose Bienson, MD Mameli, Gianfranco, MD Manassah, Alex Manberg, Stephanie Manca, Riccardo, Msc Manchanda, Monika Manchon, Eric Mancoci, Delia, MD, PharmD Mancone, Sarah, BS Mandadi, Natisha Mandava, Karuna Mandel, Jacob Mandel, Matthew Mandelbaum, Max, MD, PhD Mandelbaum, David, MD,PhD, FAAN Mandelbaum, Mark, MD, FAAN Mandge, Vishal Maneen, Matthew Manera, Umberto Maness, Lawrence Manfrini, Marianna Mangieri, Leonardo, MD Mangin, Teresa Mani, Jayanthi

266 2018 AAN Annual Meeting On-site Guide

Mani, Ranjit Mani Bhaskar, Iyswarya Maniar, Tap Manita, Manuel Mankodi, Ami Manly, Jennifer, PhD Mann, Mandeep Mann, Sharan Mannava, Anusha Mannava, Sishir, MD Manners, Jody, MD Mannheim, Glenn Manning, Conrad Manno, Edward, MD, FAAN Mano, Tatsuo, MD, PhD Manon, Auffret Manougian, Jaquelyn Manousakis, Georgios Mantero, Vittorio, MD Manthena, Prasanth Mantilla, Emmanuel Mantri, Sneha Manzanera, Isaac Manzel, Arndt Mao, David Mar, Soe Maraka, Stefania Marangoni, Natalia Maratti, Raghavan, MD, MBBS Marchal, Cecile Marchese, Dominic, R, PH Marchesoni, Cintia, MD Marcinkowski, Tomasz, MD Marcucci, Samuel, BS Marcus, Lydia Marden, Linda, MD, FAAN Marder, Karen, MD, MPH, FAAN Mardosiene, Skirmante Marek, Kenneth

Marshall, Frederick, MD Marshall, Sheryll Marsili, Luca, PhD Marszalek, Jolanta, MD Martel, Anne, MSN, RN Martello, Justin Martin, Bradley, PhD, PA Martin, Gregg Martin, Kirsten Martin, Sarah-Jane, MRCP Martinelli, Vittorio, MD Martinez, Kenneth Martinez, Emmanuel Owen Martinez, Hector Martinez, Julian Martinez, Claudia Martinez, Melissa, BSPH Martinez Cerrato, Jorge Martinez Reyes, Adriano Martinez-Arizala, Alberto, MD, FAAN Martinez-Torres, Francisco Martini, Sharyl, MD,PhD Martino, Christine, MPM Martino Gorbea, Sara, Staff Martins, Joao Martins, Cassio Henrique Taqu Martucci, Maria Maruscak, Mercedes Marvi, Michael, MD MS Marx, Gabe, BA Masangkay, Neil Masdeu, Joseph, MD, PhD, FAAN Masi, Robert Maska, Suzy Maski, Kiran, MD Maslarov, Dimitar Maslinski, Pantcho Mason, Louise

Masrour, Shamin Mass, Michele Massa, Jason Massaad, Cynthia Massaro, Lori, MSN CRNP Massarotto, Maxime Masse, Marc, BAA Massey, Janice, MD, FAAN Massey, E., MD, FAAN Masterman, Donna Matamoros, Rafael Matarazzo, Michele Matarese, Emil Matejcikova, Zuzana Mateos, Valentin Mathenia, Nicholas Mathes, Lenora Mathew, Subin Mathew, Gracykutty Mathew, Paul Mathew, Veena, BS Mathews, Katherine, MD, FAAN Mathews, Joela Mathey, Guillaume, PhD Mathieu, Veronique Mathur, Puja Mathur, Shaguna Mathur, Rajeev Mathur, Rushmi Mathur Kumaraswamy, Vishakhadatta Matiello, Marcelo, MD Matienzo, Lovelyn Matloubi, Nazanin Matos-Diaz, Ivan Matsui, Makoto, MD, PhD Matsumoto, Joseph, MD Mattar, Andrew, MD, PhD Matthews, Brandy, MD, FAAN

267

2018 ANNUAL MEETING ATTENDEES

Mares, Miroslav Marfil-Rivera, Alejandro MARGETIS, CHARALAMPOS Margiotta, Megan Margolesky, Jason Margolin, David, MD,PhD Margolius, Adam Mari, Elisabeth Maria, Pedro Maricich, Yuri Marignier, Romain, PhD Marin Collazo, Iris Marini, Ann Marino, Jennifer Mariotto, Sara Markley, Gregory, DC, MS, MDT, DACO Markowski, Michael, DO, FAAN Marks, Donald Marks, William, MD, FAAN Marky, Blanca, MD, FAAN Marmol, Sarah Marom, Ehud Maroun, Joseph, Business Marquardt, Robert Marques, Ana Marques, Vanessa, MD Marra, Christina, MD, FAAN Marre, Christof Marrie, Ruth-Ann Marrodan, Mariano Marron, Caitlin Marrow, Jonathan, FRACP Mars, Harold, MD, FAAN Marsella, Jennifer Marsh, Elisabeth Marshall, Rita Marshall, Randolph, MD, FAAN Marshall, Gad

2018 ANNUAL MEETING ATTENDEES Matthiesen, Kirsten Mattoscio, Miriam, MD, PhD Mattson, Richard, MD,FAAN Matuk Perez, Yamil Matyusne Csepany, Tunde Cecilia Mauermann, Michelle, MD, FAAN Maul, Harald Maurino, Jorge, Staff Maurousset, Aude, PhD May, Eugene, MD, FAAN May, Francis Mayadev, Angeli Mayer, Stephan Mayeux, Richard, MSc Mayinar, Farooq, MD MRCP Mayo, Mary Catherine Mayo, Ann Mays, Mary Mazdzer, Edward Mazibrada, Gordon Mazowiecki, Michael Mazurek, Kevin Mazziotta, John, MD, PhD, FAAN McAlister, Sarah McAllister, Peter, MD McAnanama, Glenn McAnelly, Robert McArthur, Justin, MBBS, MPH, FAAN McBurney, Robert McCain, Karen, DPT McCammon, Anne, MD, FAAN McCarter, Stuart McCarter, Allison McCarthy, Lucas McCarthy, Richard McCaskill, Matthew

McCaslin, Addason McCaughey, Stella McClean, Jeffrey, MD, FAAN McClean, Mercedes McClendon, Karen McCollum, Lauren McCombe, Jennifer, MPH McConnell, Brice McConvey, Kayla McCormick, Sarah McCormick, Robert, MD Candidate McCoyd, Matthew McCray, Brett, MD McCusker, Emily McDermott, Dana McDermott, Margaret McDermott, Azita, MBA McDonald, Melissa McDonald, Malcolm McDonell, Katherine Mcfalls, Alysha McFarland, Nikolaus, MD, PhD, FAAN McGill, Lora, MD, FAAN McGinley, Marisa McGinnis, Emily McGinnis, Emily, MPH McGown, Caroline McGrail, Alice McGranahan, Tresa McGrath, Emer, MBChB McGrath, Robert McGraw, Christopher, MD, PhD McGregor, Amy McGuigan, Christopher, MD McGuigan, Sabrina McIlraith, Duncan, FRCPC McInerney, Mark

268 2018 AAN Annual Meeting On-site Guide

McInerny, Edward mcintosh, Celia McIntyre, Hugh, MD, PhD, FAAN McKay, Sian McKay, Marc, MBA McKenna, Simon McKenzie, Stephen McKenzie, Marna, BSc McKeon, Andrew, MD McLane, Lauren McManus, Barbara McManus, Anastasia, PharmD McManus, Paul McMichael, Robert, MD, JD McMicken, Carolyn, PsyD McMillan, Hugh McMoon, Patrice McMurtray, Aaron McNeil, Shawn McNeill, Stephanie McNeill, Robert McNicholas, Nuala McNulty, Norman McPhail-Ciufo, Mary McPheeters, Chelsey McPherson, Robyn McQuade, Orla McSweeney, Niamh Mcveigh, Jim, Public Affairs McVicar, William McVige, Jennifer, MD Meador, Kimford, MD, FAAN Meadows, R. Steven Mealy, Maureen, RN, PhD Candidate Mebust, Kimberly Meca Lallana, Jose Eustasio, MD Meca Lallana, Virginia, MD

Mellion, Michelle Melo, Mariana Melo Bicchi, Manuel Meloty-Kapella, Meloty-Kapella Memon, Adeel Memon, Aurangzeb Menascu, Shay Mendelsohn, Matthew, BA Mendelson, Ali Mendes, Maria Fernanda Mendes, Maria Irene, MD Mendes, Shannon Mendes Neto, Nilson, MD Student Mendez, Mario, MD, PhD, FAAN Mendoza, Jason Mendoza, David Menezes, Krishe Meng, Xiangyi Menge, Til, MD Menkedick, Derek Menkes, Daniel, MD, FAAN Menning, Kara Menon, Ravi Menzies, Lauren Meola, Giovanni Merandino, Mallori Merazga, Yamina Mercader, Ivan Mercan, Neslihan, RN Merchant, Carol Mercier, Matthew Mercuri, Matthew Mercurio, Michael Mercury, Michael Merdes, Annette Meredith, Lawrence Merendino, Lauren Meriggioli, Matt, MD

Merino, Jose, MD, MPhil, FAAN Merlin, Lisa, MD, FAAN Merolli, Ines, MBA Merrill, Charlotte Merritt, Diana Mersseman, Luc Mertz, Sandra, PA-C Meschia, James, MD, FAAN Mesher, Richard Meshram, Chandrashekhar Mesias, Mario Mesquita, Hudson Mesraoua, Boulenouar, MD, FAAN Messe, Steven, MD, FAAN, FAHA Messenheimer, John Messer, Jordan Mesulam, M., MD, FAAN Metrus, Nicholas Metwally, Hussein Metzer, David, MSN, RN Metzler, Abby Meucci, Marco, MD Meurer, William Meyer, Anne-Louise Meyer, Jenny Meyer, Ana-Claire Meyer-Arndt, Lil, MD, PhD Meyers, Jeffrey Meysami, Somayeh Meytin, Leon Meza Capcha, Kelly Mezaki, Naomi Mhiri, Chokri Mhjob, Noha Mi, Wei Mian, Nidaullah Michael, Rebecca Michai, Eliav, MBA

269

2018 ANNUAL MEETING ATTENDEES

Mechtler, Laszlo, MD, FAAN, FASN Medeiros, Luisa Medel, Marietta Medel, Rosina Medhurst, Steve Medici, Augusto Medina, Luis Medina, Juan, MD Meghpara, Sanket Megjugorac, Nicholas Mehanna, Raja Mehendale, Rachel MEHICEVIC, ADMIR Mehla, Sandhya, MD Mehle, Suzana, MBA Mehler, Mark, MD, FAAN Mehrizi, Mehyar Mehta, Dev Mehta, Shyamal, MD, PhD Mehta, Anita Mehta, Bijal Mehta, Heeral Mehta, Lahar Mehta, Mona Mehta, Sunil Mehta, Devangi Mehta, Parag Meijer, Kim A, MSc Meir, Jessica Mejia, Nicte, MD Mekies, Claude, PhD Melamed, Esther, MD, PhD Melen, Onur, MD, FAAN Melges, Luiz Meliala, Calvintinus Melikian, David, Pharm.D. Melikyan, Gayane Melis, Maurizio, Dr

2018 ANNUAL MEETING ATTENDEES Michel, Dan Michelassi, Francesco Michels, Kristi, BA Micieli, Andrew Mickeviciene, Dalia, DR Middleton, Robert, BSc Mielke, Michelle Migdadi, Hamzeh Migdady, Ibrahim Mignon, Laurence Mihai, Cornelia, MD, FAAN Mihaylova, Petya, MD Mihu, Nurkia Mikhaylov, Eleina Miki, Mitsuki Mikol, Daniel, MD, PhD MILANLIOGLU, AYSEL Milano, Nicholas Milder, Julie Miles, Rosalyn Miles, J. Douglas, MD, PhD Milford, Christopher Milivojevic, Djordje Millan, Carlos Miller, Colleen, BS,MS,DNS Miller, Lauren Miller, Claire, MD, PhD Miller, Elan Miller, Kristin Miller, Malgorzata Miller, Timothy, MD, PhD Miller, Zachary, MD Miller, Aaron, MD, FAAN Miller, Daniel Miller, Daniella Miller, Hugh Miller, Laura Miller, Robert, MD, FAAN Miller, Scott

Miller, Barry, MA Miller, Henry, PhD, FRACP, MBBS Miller, Lyerka Miller, Tammi Miller, Erin Miller-Kuhlmann, Rebecca Millers, Andrejs Millian, Craig Millichap, John Milligan, Tracey, MD, FAAN Milligan, Justine Millman, Travis, MAPP Mills, Reversa Mills, John, MD, PhD Mills, Christina Milo, Ron Milone, Margherita, MD, FAAN Milstein, Mark, MD, FAAN Min, Ju-Hong Min, Jinny Minagar, Alireza, MD, FAAN Minen, Mia Mineva, Petya Minieka, Michael Minisandram, Aarathi, MS Mink, Jonathan, MD, PhD, FAAN Minshew, Nancy, MD, FAAN Minter, Myles Minton, Neil Mintz, Mark, MD, FAAN Mir, Sarim Mirabella, Massimiliano, MD Miralda, Pablo Miravalle, Augusto, MD, FAAN Mirian, Ario Mirzaei, Mehdi Misbach, Jusuf, MD, FAAN Mishler, R., MS, PT

270 2018 AAN Annual Meeting On-site Guide

Mishra, Arvind, MD, MBBS Mishra, Bikash Kumar Mishra, Shrikant, MD, FAAN Mishra, Sushil, MD, MBBS Misra, Usha, MD, FAAN Misra, Ajay Misra, Shubham, M. Tech Mistry, Deven Mistry, Niraj, MA MB BChir MD MRCP( Mistry, Sona, MD, MBBS Mitchell, Kyle Mitchell, Colin Mitike, Mesfin Mitra, Ananya Mitropanopoulos, Sotiris Mitrovich, Kristin Mitsokostas, Dimos Dimitrios Mitsumoto, Hiroshi, MD, FAAN Mittal, Nonita Mittal, Shivam Miura, Takeshi Miyagawa, Toji, MD, PhD Miyasaki, Janis, MD, FAAN Mizell, Ryan Mizrahi, Eli, MD, FAAN Mizusawa, Hidehiro, MD, PhD Mladenovic, Ana Mnatsakanova, Diana, MD Mnatsakanyan, Lilit Moawad, Heidi Moccia, Rob, MD, PhD Moceri, Jenifer Model, Fabian Modell, Jack Modi, Rick Mody, Cyrus Moeller, Jeremy Mogelof, Jeffrey, MD, FAAN

Montano, Mark Montcuquet, Alexis, PhD Monteith, Teshamae Montellano, Tiffany Montenegro, Monique Monterrey, Priscilla Montes, Jacqueline, PT, EdD, NCS Montes Salinero, Maria Dolores Montmarquette, Annie Montoya, Alonso Moodley, Miriella Moon, Hye-Jin Moondra, Priyanka Moonen, Justine Mooneyham, Caitlyn Moore, Kari, RN, BSN Moore, Henry Moore, J Moore, Helena, PhD Moore, Jack Moore, Lauren, BS Moores, Ginette Moorjani, Bhagwan, MD, FAAP, FAAN Moorthy, Moses Moosavi, Rana Mora Rodriguez, Karla Moral Torres, Maria Ester Morales, Ezequiel Morales Garcia, Melissa Morariu, Mircea Moravec, Trevor Moreau, Thibault, PhD Moreno, Gabriel, MD Moreno, Alberto Moreno, Margarita, MD Moreno, Cristiane, MD, PhD Moreno-Zambrano, Daniel Moretti, Luke

Morgan, John, MD, PhD Morgan, Bethanie Morgan, Christopher Morgan, Patricia Morgan, Annalisa, B.S. Mori, Akihisa Mori, Nicanor Mori, Akiko Mori, Alex, PhD Moriarty, Gerald, MD, FAAN Morimoto, Nobutoshi Morin, Clement Morin, Gilles-Philippe Morley, James, MD,PhD Moro, Elena, MD, FAAN Moroney, Angela, Pharm.D. Morren, John Morris, John, MD, FAAN Morris, Harold, MD, FAAN Morris, Huw, MD, PhD Morris, Martha1645 W Jackson Blvd Morrison, Glenn Morrison-Banks, Elizabeth, MD, MSEd Morrow, Sarah, MD, MSC,FRCPC Morse, Anne, DO MORTEAU, Olivier Morton, Matthew, MD Moschonas, Constantine, MD, FAAN Moser, Tobias Moser, Barbara Moser, Herbert Moses, Howard, MD, MS, FAAN Mosley, Anthony Mosquera Soto, Tomas Moss, Kathryn

271

2018 ANNUAL MEETING ATTENDEES

Moguel-Cobos, Guillermo Mohamed, Ghaieb Mohamed, Ahmed Mohamed Thowfeek, Mohamed Riffsy Mohammed, Walaa Mohammed, Haider Mohammed, Amr Mohammed Shehata, Hatem Mohamud, Jamal Mohan, Samita Moheb, Negar Moheet, Asma Mohile, Nimish, MD Mohl, Leighton Moien Afshari, Farzad Mok, Koby Molaie, Donna Molano, Jennifer, MD, FAAN Molengraft, Joyce Molho, Eric, MD, FAAN Molina Carrion, Luis Enrique Molinari, Robert Molinaro, Maria, BS Molnar, Maria, MD, PhD Molyneux, Paul Mombaur, Busisiwe Momii, Austin Monaghan, Niall Moncayo Gaete, Jorge Mondal, Gouranga Prosad, MD, MBBS Monderer, Renee Mondino, Margaret, MD Mondok, Lileth Joy Mondot, Lydiane, PhD Monrad, Priya Monroe, Deirdre Monsour, Danny Montalvo Perero, Mayra

2018 ANNUAL MEETING ATTENDEES Moss, Brandon, MD Moss, Heather, MD, PhD, FAAN Mostafa, Mohamed MOTA, PATRICIA Motesharei, Kia Motiwala, Rajeev, MD, FAAN Motos García, José Ángel Motta, Rodrigo, DDS Mottershead, John, FRACP Mouchati, Rizkalla Moughamian, Armen, MD, PhD Mourad, Hatem Moury, Heather Mousali, Yahya, MD, FAAN Moussa, Charbel, MB, PhD Moussaoui, Asma Moussaoui, Ali Movva, Sashidhar Mowry, Ellen, MD, FAAN Moya, Antonio, MPH Moyer, Russell Mozaffar, Tahseen, MD, FAAN Mozaffar, Farah Mrugala, Maciej, MD Muddireddy, Chandra Sekhar Reddy Mueed, Sajjad Muehlschlegel, Susanne, MD, MPH Mueller, Erika Mueller, Felix Mueller, Lutz MUELLER, Patrick Mueller, Thomas Mui, Michelle Mujawar, Wasim Mukerji, Shibani Mukherjee, Adreesh Mukherjee, Arabinda, MD, DM Mukhopadhyay, Subhash

Mula, Sai Muley, Suraj Muller, Stefanie, MD Muller, Martijn Mullin, Kathleen Mulo, Kostika, M.S. Mulroy, Eoin, MB BCh BAO Mulukutla, Sarah Mundy, Erica Munger Clary, Heidi, MPH Munirathinam, Bhoopathy, MD, MBBS Muniz, Rafael Munjal, Sagar Munoz, Claudia, MD, MPH Munoz, David Muñoz, Daniel Munschauer, Rick Munsie, Leanne Muppidi, Srikanth Murali, Hema, MD, MBBS Murari, Raisa Saron Mureb, Monica Murillo, Marcela, MD Murinova, Natalia Murk, Jean-Luc Murman, Daniel, MD, FAAN Murphey, Dona Murphy, Kathryn Murphy, Olwen Murphy, William Murphy, Desmond Murphy, Elyse, RN, Msl Murphy, Katherine, MHSA Murphy, Jaclyn, MS Murr, Najib Murray, Eileen, MM Murray, Brian Murray, David

272 2018 AAN Annual Meeting On-site Guide

Murthy, Kolar, MD, FAAN Murty, Pavan Murugan, Ramasamy, MD, MBBS Musch, Bruno Mustafa, Muhammad Muste, Maria Musu, Luigina, MD Musubire, Abdu Mutarelli, Eduardo, MD, FAAN Muth, Christopher Muthukumaran, Abirami Mutiawati, Endang Mutoh, Tatsuro, MD, PhD Mwaisela, Marcella Mwero, Cherisse Myburgh, Gail Myers, Peter Myers, Matthew, MMedSc Myint, Thida Mzahem, Abderrahim Nabhani, Ola Nabizadeh, Reza Nabizadeh-Eraghi, Arastoo, MD, FAAN Nacionales, David Nacopoulos, Dimitrios Nacul, Ruben, MD Naddaf, Elie Nadeau, Janel Nadeau, Stephen, MD, FAAN Nadeau, Elaine Nadelman, Maria, MD Nadj, Congor Nadkarni, Divya Naedele-Risha, RonnAnn Nafziger, Elizabeth, MD Nagaraj, Arun Nagaraja, Nandakumar Nagarajan, Elanagan

Nanjangud Shivamurth, Veeresh Kumar Nannery, Micaela, BS Nano, Gabriela, MD Napierala, Jill Napierala, Marek Naquin-Chappel, Amy Narancic Knez, Nikolina, MD Naranjo, Valeria Narasaram, Kantrigala, MD, MBBS Narasimhalu, Kaavya, MD, PhD Narayan, Ram Narayana, Randhi Narayanan, Nandakumar, MD, PhD Narayanaswami, Pushpa, MBBS, MD, FAAN Narayansingh, Marc Nariai, Hiroki, MD Narimatsu, Keila Narnhofer, Sandra Naryshkin, Nikolai Nasca, Mark Nascimento, Osvaldo Nasir, Sajjad Nasser, Azmi Nasseri, Morad Nassiri, Sahar Nath, Avindra, MD, MBBS, FAAN Nath, Uma Nathan, Barnett, MD Nathoo, Nabeela, MD, PhD Nations, Sharon Navarathna, Kasun Navarre Gimeno, Aranzazu Navarrete Maldonado, Carlos Navas, Angela Navey, Che

Navia, Bradford, MD, PhD Navis, Allison Nayak, Shreya Nayak, Lipika Nayar, Shakti Naylor, David, MD, PhD Naylor, Maria Naylor, Rogerio Nayyar, Ankit Nayyar, Manmohan, MD, FAAN Nayyar, Sonia Naz, Arshi Nazari, Vahid Nazarian, Sarkis, MD, FAAN Nazir, Khurram Nazzal, Yara Neal, Jason Nedd, Kara Nedd, Kester Nedd, Ken Neel, Robert Neelakandan, Shyama Prasad Neelakantan, Anil Neely, Edward Neil, William Neimand, Lindsey Nekoui, Sima Nelson, Charlotte, ANP Nelson, Aaron Nelson, Stephen, FAAP Nelson, Flavia Nelson, Morag Nelson, Mariana Nelson, Sally, PhD, MS Nemade, Dipali Nemeth, Gyorgy NEOGI, ANIRBAN Nersesyan, Hrachya, MD,PhD Nesbitt, Cassie

273

2018 ANNUAL MEETING ATTENDEES

Nagasawa, Glen Nagel, Maria Nagendran, Suku, MD Nageshwaran, Sathiji Naggar, Joseph Nagineni, Lavanya Nagle-Seidel, Kimberly, MA Nagpal, Seema, MD Nagpal, Tarun Nagy, Abraham, MD Nah, Hyun-Wook Nahas, Stephanie, MD, MSEd, FAAN Naidech, Andrew, MD, FAAN Naides, Stanley Naidoo, Shane Naik, Kushal, MPH Nair, Vijayaleskhmi Nair, Sreekumaran, MD, FAAN Nair, Girish, MD, MBBS Nair, Raj Nair, Kavita Naismith, Robert Najib, Umer Najjar, Muhammad Najjar, Souhel Nakamoto, Beau, MD, PhD, MBA, FAAN Nakawah, Mohammad Obadah Nakonechny, Tammy, RAC, BSc, LLB, BA Nalamada, Keerthana Namarasli, Deniz Namiranian, Dina Nance, Christopher Nandanwar, Deepmala Nandipati, Sirisha Nangia, Narinder Nanivadekar, Shruti, Post Baccalaureate

2018 ANNUAL MEETING ATTENDEES Nesper, Grace Neth, Bryan, MD, PhD Neto, Elizeu Neubauer, Astrid Neuberger, Sonia Neustadt, Ira Nevada, Vera Nevel, Kathryn Neveu, Marc, MD, FRCPC New, Pamela, MD, FAAN Newell, Maegan, BS Newman, Nancy, MD, FAAN Newman, Lawrence, MD, FAAN Newsome, Scott, DO, FAAN Ney, John, MD, MPH Neyal, Abdurrahman, PhD Neyal, Ayse Munife, PhD Ng, Marcus Ng, Peng Soon Ng, Wei Ping Kay Ng, Lai Han Betty Ng, Herman Ng, Ho Ng, Jessica Ngan, Vincci N'Gbo N'Gbo Ikazabo, Rosy Nghiemphu, Phioanh Ngo, Tawny Ngo, Hiep Ngo, Stella Ngobeh, Farmanga Nguyen, Thao Nguyen, Thao Nguyen, Alvin Nguyen, Dung Nguyen, Ivy Nguyen, Christina Nguyen, Tina Nguyen, Viet

Nguyen, Jack Nguyen, Mai-Lise Nguyen, Sandy Nguyen, Suzanne Nguyen, Thienhuu Nguyen, Phuong Nguyen, Eric Nguyen, Michelle, BS, MD Nguyen, Rachell Nguyen, Thu, Medical Student Nguyen, Vy, MS Ni, Zhen Niazi, Muhammad Niba, Sidonie Nica, Mihaela Nichol, Kathryn, PhD Nichols, Russell Nichols, Todd Nichols, Weston Nicholson, Katharine Nicola-Antoniu, Iuliana Nicotra, Alessia, MD, PhD, FRCP Nielsen, Amy Nielsen, Kirsten Nielsen, Glenn Niemann, Nicki Niemela, Marja Nieto, Roberto Nieto Gonzalez, Pablo, MD Nieuwoudt, Megan Niezgoda, Adam Nihill, William Niimi, Yoshiki Niino, Masaaki Nik, Andrew Nikpour, Armin Nimocks, Larissa Ninchak, Viola, MSN-NP candidate (5/

274 2018 AAN Annual Meeting On-site Guide

Ning, Kelly Nirenberg, Melissa, MD, PhD, FAAN Nisar, Taha Nishi, Toshiya, DVM Nist, Laura, MD, FAAN Nitrini, Ricardo, MD, FAAN Nizam, Ahmad Niznick, Naomi Nkendjuo, Jean Bertin, PhD Noble, James Nocera, Romy Nocerino, Logan Noe, Katherine, MD, PhD, FAAN Nofal, Pedro, MD Nogles, Teryn, BS Nogueira, Raul, MD Nogues, Martin Alejandro Nolan, Jakai Nolan, Patrick, MD, PhD Nolido, Anna Marie, MD Nolty, Peggy, NA noor, hanaa Noori, Suzan Noorollah, Lori, MD Norby, Erin Nordli, Douglas, MD Nordstroem, Anna Lena Norton, James Nosakhare, Osemwegie Noto, Anthony Nouri, Kasid Novack, Aaron, PhD Novak, Alicia Novakovic, Roberta, MD Novello, Paul Novotny, Vaclav Nowak, Richard Nugent, Melanie

Ogden-Moles, Kandi Ogun, Yomi Ogun, Aminat, Medical student Ogundare, Oladunni Oh, Ahyuda, DrPH Oh, Jiwon, MD Oh, Seong-il Oh, Charles Oh, Angela Ohtomo, Ryo Oishi, Tatsuya Ojha, Kshama Ojha, Ajitesh Okazaki, Erin O'Keefe, Dennis Okhovat, Mahyar Okonkwo-Onuigbo, Obi Okun, Michael, MD, FAAN Okunoye, Olaitan, MSc, FWACP Okuyucu, Emine Esra Olanigan, Rashidat Olapeju, Oguntunde Oldenberg, Angela Olguin-Ramirez, Leticia Alejandra, Resident of neurolog Olichney, John Olinsky, Stuart Oliu, Carlos Olival, Guilherme, MD Olivas, Edgar Olivas, Jaime, MCP Oliveira, Amanda Oliveira, Vanessa Oliveira, Henrique Oliveira, Cristiano Oliveira, Bianca, MD Oliver, Jennifer Oliver, Marion Oliver, G. Athena, PsyD

Olivo, Ricardo Oloyede, Segun, MWACP Olsen, Abby Olshansky, Adel Olson, Sandra, MD, FAAN Olson, Markey, MS Olszewski, Lauren, Student Olvera, Sylvia O'Maley, Tim Omalu, Bennet, MBBS, MPH, MBA Omani, Ouali Omer, Salah Omidvar, Omid Omokunmi, Adekola Omuro, Arthur Omuro, Antonio, MD Ondish, Mary Ann Ondze, Basile, PhD O'Neal, Welton O'Neal, Mary O'Neill, Gilmore, MD, MB, MRCPI Onem, Nina Onikoro, Abimbola, MBS Ono, Yoya Onofrei, Ligia Ontaneda, Daniel, MD Onur, Berfin Onwuegbuzie, Gerald Onwura, Nicolasa Opalka, Jens O'Phelan, Kristine, MD Opie, Warren Opiteck, Greg Oporto Segura, Sabrina Orabi, Mohamad Oravivattanakul, Srivadee O'Regan, Terry Orehek, Eleanor

2018 ANNUAL MEETING ATTENDEES

Nugent, Alexandria Numan, Ahsan, PhD, MBBS, FCPS Nunez, Manuel Nunez-Gomez, Natalie Nunez-Wallace, Karen Nurwahjuni, Caecilia Titik Nuwer, Marc, MD, PhD, FAAN Nwabuobi, Lynda Nwanegwo, Ogechukwu Nwankwo, Chinasa Nye, David, MD, FAAN nygren, kirstin Oas, Kimberly, MSN, RN Obeidat, Ahmed, MD, PhD Obermann, Mark, MD, FAAN Obretenova, Souzana OBrien, Barbara O'Brien, Hope, MD, FAAN O'Brien, Terence, MBBS Ocampo, Ma. Cecilia, MD O'Carroll, Cumara Ocava, Lenore Ocazionez, Francisco Ocejo Gallegos, Antonio O'Connell, Karen O'Connell, John O'Connell, Sile, PhD O'Connor, Edward, MD, FAAN O'Connor, Francis, MD O'Connor, Allan O'Connor, Eileen Odeniyi, Olanike Odia, Yazmin O'Donnell, Steven O'Donnell, Luke O'Dowd, Sean, PhD Ofir, Matan Ogata, Katsuhisa, MD, PhD

275

2018 ANNUAL MEETING ATTENDEES Oren, Sheila, MD, MBA Orjuela, Karen, MD Orlando, Alessandro, MPH Ormseth, Cora Ornelas, Abbie Oropeza Canto, Dante OROS, MYKHAYLO Orozco, Viviana Orr, J., MS Orr, Blair Orrego, Hector Orsnes, Gitte Ortega, Roberto Ortiz, David Ortiz, Gustavo Ortiz Castillo, Rafael, PharmD Ortmeier, Brian Orvidas, Mark, PhD, MPH Osamwonyi, Osawaye Osband, Yardaena Osborne, Summer Osehobo, Ehizele, MS O'Shea, Sarah Oshinaike, Olajumoke Oshinsky, Michael Oskarsson, Bjorn, MD, FAAN Oskoui, Maryam, MD, FAAN Osman, Gamaleldin Osman, Tahir Osorno, Miguel Ospina, Juan Pablo Oster, Joel Osterman, Bradley Ostland, Michael Ostovic, Ada Adela, MD Ostrem, Jill O'Suilleabhain, Padraig Otero, Carlos Otero Cerdeira, Maria ELISA

Otero-Vazquez, Javier, BA Otis, James, MD, FAAN O'Toole, Orna, MD Otto, Volker Oturai, Annette Oudrer, Naima Oujo Giuliani, Griselda, MD Ovbiagele, Bruce, MD, MSc, FAAN Overall, Trenton Overell, James, MSc, MD Oviedo, MarÃa Soledad Owais, Mohammad Owens, Julie, Pharm.D. Owens, James, MD, PhD Owens, Steve Owolabi, Lukman, PhD, MSc,FWACP, FMCP Owyoung, Nelson Oyarce, Marcelo Oyegbile, Temitayo, MD, PhD Ozakbas, Serkan, MD Ozark, Shelly Ozer, Byram Ozturk, Ayhan, PhD Ozturk, Serefnur, MD Pace, Anna Pack, Alison, MD Packer, Cayci, MBA Padilla, Claudia Paduga, Remia Paegle, Anita Pagadala, Vinay, BDS PGDACR PGDBM Pagan, Fernando Pagani Cassara, Fatima, MD Page, Rupert Pagel, Nora Pahwa, Rajesh, MD, FAAN Pai, Ashwini

276 2018 AAN Annual Meeting On-site Guide

Paille, Sabrina Pakdaman, Hossein Paker, Asif, MD, MPH Paksoy, Aysenur Palacio, Melisa, MS Palermo, Frank Palikh, Gaurang Paling, David Pallone, Jennifer Palm, Michael Palma, Jose-Alberto, MD, PhD Palmer, Kevin, BSc Pan, Peter Pana, Angela Pana, Raluca Panagotacos, John Panara, Ramit Panczel Dr, Gyula Ferenc Pandey, Manoj Pandit, Lekha Pandolfo, Massimo, MD, FAAN Pandya, Shree, DPT Pandya, Dipak Pandya, Neil Pandya, Sneha, MS Panea, Cristina, MD, PhD Panjeti-Moore, Deepa, DO, MPH Panjwani, Sharjeel Panossian, Lori Panuganti, Pradeep Panzara, Michael, MPH Pao, Linda Papadopoulou, Athina, MD Papamitsakis, Nikolaos Pappas, James Pappert, Eric Parada, Victoria Parada Marcilla, Ethel, MD Paradowski, Boguslaw

Parpart, Andrea Parres, Christopher Parson, Beverly, CSL Parsons, Angela Partida Medina, Luis Partisano, Annie, PharmD Parulekar, Anjali, MBA Parulekar, Medha, B.S. Parziale, Nicholas Pasanen, Asmo Pasao, Katrina Pasco, Paul Matthew Pascuzzi, Robert, MD, FAAN Pase, Matthew Pasinski, Marie Pasnoor, Mamatha Pasquarelli, Noemi, MD passariello, catherine Passig-Villanueva, Claudia Pastore, Alejandra Pasupuleti, Archana Patchell, Ben Patel, Alok Patel, Akash Patel, Akta Patel, Kishan Patel, Neil Patel, Nimit Patel, Bhavana Patel, Anup, MD, FAAN Patel, Amar Patel, Chilvana Patel, Chirag Patel, Jignasa Patel, Kevin Patel, Neepa Patel, Nitin, MD, FAAN Patel, Rajan Patel, Ronak, FRACP

Patel, Roshan Patel, Ankit, B. Pharm Patel, Ankur, PhD Patel, Chirag Patel, Akshar Patel, Hemali Patel, Maunish Patel, Nishil Patel, Janaki, BS Patel, Nidhi, BS Patel, Urvish, MPH Patel, Ketul, PharmD Paternoster, Mark Paterson, Andrew Pathirana, Gamini, MD, MBBS. FCCP Patil, Rachit Patil, Kiran, MD, FAAN Patino, Jorge Patino, Gustavo, MD, PhD Patira, Riddhi Patni, Rajiv Pato Pato, Antonio, MD Paton, Gillian Patriarche, Julia Patry, David Pattee, Gary Patterson, Jenifer Patterson, Kristina, MD, PhD Patterson, Marc, MD, FAAN, FRACP Patterson, Addie Patterson, Brandon Patterson, Shanna Pattison, Lindsay Patton, Eddie, MD, MS Patwa, Huned Paul, Ashley Paul, Pritikanta Paul, Rachel

277

2018 ANNUAL MEETING ATTENDEES

Parajeles Vindas, Alexander Paramanandam, Vijayashankar, DM Paramo Camino, Maria Dolores, MD Parand, Leila Pardo, Gabriel, MD Pardo-Villamizar, Carlos, MD Parekh, Rikisha Parent, Jack Parhi, Laxmidhar, MD, MBBS Parigger, Silvia, MD Parikh, Prachi Parikh, Simy Parikh, Jayeshkumar Parikh, Alay, BS Park, Jung Yeon Park, Yun Jik Park, Danny Park, David Park, Edwin Park, Heather Park, Hyunmin Park, Kee-Duk Park, Kevin Park, Peter Park, George, DO, Medical Student Park, Han Kyul Park, Henna Park, Jung E Parker, John Parker, Alicia Parker, Braden Parker, David, MS Parkerson, Kimberly, MD,PhD Parks, Andrea Parks, Becky Parlatore, Anna-Maria Parman, Fatma Yesim

2018 ANNUAL MEETING ATTENDEES Paul, Friedemann Paul, Reji Paulson, Henry, MD, PhD, FAAN Pavelka, Julia, APRN - BC Pavlik, Valory Pavlova, Milena Pavwoski, Patrick Pawar, Gauri, MD, FAAN Pawate, Siddharama Pawlak, Mikolaj Payet, Marianne Payne, Mary, MD Payne, Jeremy, MD, PhD Payne, Richard Paz Soldan, M. Mateo, MD, PhD Pazdan, Renee, MD, FAAN Pazdera, Ladislav Pearl, Phillip, MD, FAAN Pearl, Leilani Pearlman, Eric, MD, PhD Pearson, Rachel Pearson, Owen, MBBCh MD FRCP Pearson, Brenda, BS Peavy, Guerry Pederson, Sarah, MS Pedley, Timothy, MD, FAAN Pedouim, Farzin Pedowitz, Elizabeth Pedrini, Marzena Pedro, Matheus Pedroso, Jose Luiz Peglar, Lindsay Pehlivan, Davut, MD Peixoto, Carlos Alberto, MD Peixoto, Lucas Pelaez Vina, Nazaret Pellegrini, Niamh Pelletier, Daniel

Pelletier, Jean Pellicer Espinosa, Isabel Pellinen, Jacob Peltier, Amanda, MD, MS Pena, Ashley PeÃ±a Castellanos, Ivan Pena Martinez, Joaquin Peng, Lifang Penix, LaRoy Pennell, Page Penner, Iris-Katharina Pentsova, Elena Penyak Cipriani, Veronica Pera, Joanna Pereira, Raquel Perello, Carlos, MD Perez, David, MD Perez, Frank Perez, Emmanuel Perez Arena, Andres, MD Perez Bajandas, Coraly Perez Limonte, Leonel, MSHQPS, MHL Perez-Canabal, Alfredo Perie, Maud, PhD Perkins, Candice Perkins, Erik, MD, FAAN Perla, Alexandre, MD Perlmutter, Joel, MD, FAAN Perlow, Mark, MD, FAAN Perovic, Marko Perper, Edward Perren, Fabienne, MD Perrin Ross, Amy, RN,MSN,CNRN Perron, Herve, HDR Perrone, Christopher Perrotta, Gaetano Persaud, Amanda, MD Persi, Gabriel, MD

278 2018 AAN Annual Meeting On-site Guide

Persinger, Rebecca Peterka, Marek Peters, Katherine, MD, PhD Peters, Markus, PhD Petersen, Ulla Lyst, NA Petersen, Ronald, PhD, MD, FAAN Petersen, Nils Petersen, Astrid Heide, Nordic Baltic Medica Peterson, Alexandra Peterson, Josephine Peterson, Lisa Petheram, Kate, BSc MB ChB MRCP Petitclerc, Marc Petracca, Maria Petrinjac-Nenadic, Rada Petrlenicova, Darina Petropoulos, Christos Petrossian, Melita Petruk, Lyudmila Pettinichi Outeda, Juan, MD Petty, Sandra, PhD, FRACP, MBBS Peukert, Thomas Pfefen, Jean-Paul Pfeiffer, Ronald, MD, FAAN Pfentner, Emily Pfeuffer, Steffen Pfister, Brian Pfleger, Claudia Phadke, Jayant Pham, Tammy, MD Pham, Minh Trang Phan, Lise Phan, James Phan, Michael Phankhian, Phanyarat Pharr, Emily

Pineless, Hal Pinheiro, Jennifer Pinroj, Yod Pinto, Marcus Vinicius Pioro, Erik, MD, DPhil Piotrowski, Anna Piovezan, Mauro Roberto Piper, Robin Pippenger, Mark Piquet, Amanda, MD Piquioni, Paulo, MD Piran, Pirouz Pirastehfar, Mohsen Pires, Karina Pirio Richardson, Sarah, MD, FAAN Piriyawat, Paisith Pirzada, Noor, MD, FAAN PISHARODY, Ramdas Pitha, Jiri, MUDr. Pitner, Janet, PharmD, MBA Pittelkow, Thomas, DO, MPH Pittock, Sean Pitts, Jerica Pizarro-Otero, Jose Plante, Danick Plaschke, Michael Platzer, Meril Pleen, Joseph Pleninger, Perrin Plewnia, Katrin, MD Plioplys, Audrius, MD,FRCPC,FAAP,CMD Plotkin, Scott, MD Pniak, Ewa Podell, Jamie Poehlau, Dieter Poehler, Anne-Maria Poewe, Sibylle Poewe, Werner

Pohowalla, Parvez, MD, MPH Poisseroux, Sabrina Pol, Suyog Polanco, Juan Polasek, Melissa Polchinski, Jason Polding, Laura Policherla, Prasad Pollack, Michael Pollard, Shula Polonski, Cori Polusani, Ranjith, MD, MBBS Pomeroy, Scott, MD, PhD Ponce De Leon, Marcus, MD, FAAN Poncelet, Ann Pons Rodriguez, Maria Del Roser Pontius, Angela Ponton, Eric Poole, Elizabeth Poole, Marissa, JD Popovich, Michael Popper, Laura Porada, Stephen, BS Porambo, Michael, MS Poretto, Valentina Portegies, Peter, MD, PhD Porter, Neil Porter, Douglas Porter, Meko Porter, Alyx, MD Portillo Estrada, Eduardo Lopez Posadas Sosa, Francisco Rubén Posadas Zuniga, Gabriel Posas, Jose Poston, Kathleen Postuma, Ronald, MD Potrebic, Sonja, MD, PhD, FAAN Potts, Daniel, MD, FAAN

279

2018 ANNUAL MEETING ATTENDEES

Phelan, Mary, BS, C-TAGME Phielipp, Nicolás Philip, Nancy Philip, Maria Philips, Shino Phillips, Nicholas Phillips, Lauren Phillips, Joel Phillips, Theodore, MD, PhD, FAAN Phillips, Yanny Phillips, Roderick Phinney, Tammy Phipps, Michael, MD, MHS Phipps, Thomas Phuphanich, Surasak, MD, FAAN Picard, Hernan Piccinini, Linda Piccione, Ezequiel Piccolo, Ana Claudia, MD Picher-Martel, Vincent Pichler, Michael Pichon, Pilar Pickford, Lesley Piedrabuena, Raul, MD Pierce, Aimee Pieroni, Miguel, MD Pierpont, John Pierre-Louis, Serge Piet, Jurgen Pietak, Michael Pillai, Jyoti, MD, MBBS, MR, FAAN Pillai, Rammohan, MD, MBBS Pillai, Lakshmi, M.S. Pinchi, Prateeksunder Pineda, Olinda Pineda, Marlyne Pinedo Martin, Guillermo

2018 ANNUAL MEETING ATTENDEES Pourfar, Michael, MD Povedano, Guillermo, MD Powell, Russell Powell, Daniel, Business Powell, Keith Powell, Timothy Powers, William, MD, FAAN Pozdenova, Irena Prabhakar, Subhashini, MD, MBBS Prabhakar, Varsha, BA Prabhu, Aparna Pradhan, Amynah, PhD Pradhan, Ashish Pradilla, Gustavo Pradilla, Oscar Prado, Gilmar Prado, Roberto, MD, PhD Prakash, Neal, MD, PhD Praksova, Petra Pramudita, Esdras Prasad, Sashank Prasad, Atul Prasad, Kameshwar Prasad, Madan, MD, MBBS, FAAN Prasad, Madhurendra, MD, MBBS Prasad, Nalini Pratumsuwan, Piratip Presant, Erin Press, Craig, MD, PhD Preston, David, MD, FAAN Preston, William, MD, FAAN Preul, Christoph, PD MD Price, Raymond Pridmore, Michael, MA Priest, Csilla Priest, Jessica Prieto Gonzalez, Jose Maria

Oscar PRIGOZHIKH, VIACHISLAV Prikrylova, Katerina Primdahl, Ditte Primiani, Christopher, Medical Student Prince, Eric Pringsheim, Tamara, MD, FAAN Prior, Devin Proano Narvaez, Jefferson, MD, MSc Probasco, John, MD Probst-Simmons, Ellyse, Bachelor of Health S Protti, Alessandra, MD Pruitt, Amy, MD Pruzin, Jeremy Przekop, Allison Przybyla, Steven PRZYTULSKI, Boris Puccini, Nicole Puffer, Bettina Pugh, Mary Jo, PhD, RN, FAAN Puhl, Peter Pula, John, MD, FAAN Pulakanti, Varun Pulicken, Mathew, MD,MHS Pulido Valdeolivas, Irene, MD Pullman, Seth, MD, FAAN Pullman, Mariel Pulst, Stefan, MD, FAAN Pulst-Korenberg, Johannes Pulte, Irena Pulver Bloch, Melissa Puniani, Trilok Punn, Jitender PUPE, CAMILA Pupim, Lara, MSCI Purino, M. Pushparasah, Gunasundari

280 2018 AAN Annual Meeting On-site Guide

Puspok, Zsuzsanna Puthemparampil, Marco, MD Putra, Steve, SpS Puwanant, Araya Pyarali, Monika Pyatkevich, Yelena Pyle, Maria Qhavi, Ajaz Qian, Ying, MPH Qian, Peiqing Qian, Liang Qin, Lan, MD, PhD Qiu, Yuqi, MS, Phd student Quebbeman, Jenny Queiroz, Andre Luiz Quesnell, Tara Quezada, Julio Quick, Adam Quijas Aldana, Ivan Quinlan, Miriam Quinn, Kelly QUIÃ&#x2018;ONES, GERARDO Quintana, Yeni Quintana Ayala, Juan Quintana Soria, Juan Quintero, Ramon Quinto, Christine Quiros, Delia Quivron, Benedicte Qureshi, Mohammed Qureshi, Sara Qureshi, Irfan, MD Rabadi, Meheroz, MD, MRCPI, FAAN Rabbani, Bahram, BS Rabinovici, Gil Rabinstein, Alejandro, MD, FAAN Racette, Brad, MD, FAAN Racine Belkoura, Caroline

Rajasekaran, Karthik Rajendran, Sajeesh Rajendran, Vinothkumar Raji, Alaleh Raji, Cyrus Rajuri, Venkatesh, MD, MBBS Rakhit, Amit, MBA, MD Rakhmatullaeva, Gulnora Rakocevic, Goran, MD, FAAN Rakusa, Martin Ralph, Jeffrey, MD Ramacha, Benjamin Ramachandran, Tarakad, MD, FAAN Ramahi, Amani Ramaiah, Guru Ramamurthy, Guhan Raman, Mekala Raman, Ramesh, MD, FACP Ramanan, Vijay, MD, PhD Ramanathan, Murali Ramani, Kunal, Pharm. D. Ramasamy, Balakrishnan, MD, MBBS Ramchandren, Sindhu Rametta, Mark Ramezan-Arab, Nima, MD, FAAN Ramio Torrenta, Lluis, MD Ramirez, Veronica, BSc Ramirez-Abreu, Darwin Ramirez-Montealegre, Denia, MD, MPH, PhD Ramiro, Gail Melissa Rammohan, Kottil Ramo Tello, Cristina Ramos, Vesper Ramos, Eduardo Ramos, Alberto Ramos, Brett

Ramos Estebanez, Ciro Ramquist, Sara Ramsey, Kim Ramsey-Williams, Vicki, MD, PhD Ranadive, Virendra Ranakusuma, Teguh Ranasinghe, Tamra Randhawa, Jaskaren, MD, MBBS Rane, Stanley Ranganathan, Lakshmi, MD, FAAN Rangel Guerra, Ricardo, FACP Rangwala, Shabbir Rani, Prityi Ranjan, Rajeev, MD, MBBS Ranno, Anthony Rao, Kimberly Rao, Preeti Raouf, Mohamed Rapp, Mark, MS4 Rashid, Mehmood Rashid, Shamim, MD, MBBS Rashid, Faisal, BA, MS Rasi, Fabrizio, MD, FAAN Raskova, Michaela Rasmussen, Soeren Rasmussen, Dorte Rasquinha, Russell, MD Rastgardani, Tara, MD Ratchford, John Rath, Subhendu Ratliff, Jeffrey Rattananan, Watcharasarn Ratti, Elena Rauch, Gerd Rauchway, Amy Rauek, Sebastian, MD Rauf, Yasmeen

2018 ANNUAL MEETING ATTENDEES

Racine-Charette, Elaine Racke, Michael, MD Rad, Nazila Radhi, Fatma Radmard, Sara Raduazo, Karen Radunovic, Aleksandar Raefsky, Sophia Rae-Grant, Alexander, MD, FAAN raffaele, michael Rafferty, Trevor Rafiuddin, Asfi Raghunath, Anitha Raghunathan, Uma Ragland, James, MD, FAAN Ragland, Victoria, BS Ragole, Thomas Ragoonanan, Laura Rahangdale, Rahul Rahayel, Shady Rahman, Anisa Rahman, Matiur Rahman, Touhidur, MD, MBBS Rahmilevich, Tamar Rahmlow, Megan Rai, Prashant Rai, Baldev, MD, FAAN Rai, Karandev Raibagkar, Pooja Raina, Harshita, Masters in Pharmaceu Raino, William RAJ, Meenakshi, FRACP Raja, Shruti Rajalingam, Rajasumi Rajan, Suraj Rajangam, Kanya Rajapakse, Thilinie Rajaraman, Rajsekar

281

2018 ANNUAL MEETING ATTENDEES Rauf, Asad Rave, Todd Ravikumar, Sandhya Ravin, Paula Ravindran, Janakan Ravishankar, Mathura, MSc Ravits, John, MD, FAAN Rawat, Sumant, MD, MBBS Rawls, Ashley Ray, Amit Ray, Sutapa Razdan, Sushil, DM Razlog, Lilia, PhD Reams, Nicole Recchia, Luciano, MD Recio Mendoza, Patricia Reda, Al Bahay Reddy, Sujan Teegala Reddy, Anoop Reddy, Gautham Reddy, Ramana Reddy, Neil, BA Redlich, Alysa Redosh, Douglas Ree, Daniel Reed, Robert Reese Jr, James, MD, MPH Reeves, Tricia, MSc Regulier, Etienne Rehberg-Weber, Karin, MD Reich, Stephen, MD, FAAN Reich, Edgardo Reichler, Brion Reichman, Loes Reid, Alison Reif, Robert Reiley, Jorge Reimer, Amanda Reinhart, David

Reiser, Ulrike Reish, Nicholas, MD, PhD Rejdak, Konrad, PhD Relja, Maja Remley, Quentin, BS Remmel, Kerri, MD, PhD Remnitz, Alex Ren, Zheng Rensel, Mary, MD, FAAN Renthal, William Reoma, Lauren Repice, Anna Maria Rita, Dr Respondek, Gesine Restrepo, Lucas Reuter, Katja Revin, Vladyslav Rewinkel, Scott Reyes, Ranier Reyes, Saul Reyes-Iglesias, Yolanda Reyes-Mantilla, Maria Reyna, Sandra Reyneke, Elizabeth, FRACP Reynia, Sarah Reynolds, Jacques Reynolds, Leslie Reynolds, Patrick Reynolds, Wesley Reynolds, Tracy Reynoso, Felix Rezania, Fatemeh Rezende, Nathane Rezendes, David Reznik, Michael Reznik, Regine Rezvani, Zahra Rha, Joung-Ho, MD, PhD RIACHI, Naji Riafrecha, Ariel, MD

282 2018 AAN Annual Meeting On-site Guide

Riant, Nadine Riaz, Anum Riaz, Awais, MD, PhD Riazy, Khashayar Ribeiro, Luciola Riboldi, Giulietta Ricafort, Lawford, MBA Rice, Cory Rice, Jessica Rice, Marcus, MD, FAAN Rice, Courtney Rice, Kenneth, MBA, JD Richard, Jennifer Richards, Nelson, MD,FAAN Richards, Sindhu Richards, Benn Richardson, Perry Richardson Larsson, Ellinore Richie, Bunnie, DO, FAAN Richter, Stephan Friedrich Riddle, Evan Ridha, Samer Ridings, Larry Rieckmann, Peter Riedel, Brandalyn, MSG Riel-Romero, Rosario Maria, MD, FAAN Riemer, Richard Riese, Richard Riggins, Nina Riggs, Kelsey, Bachelor Riley, Claire Riley, David, MD Riley, Patty Riminton, Sean Rincon, Wilson Rind, Jeffrey, MD, PhD Ringel, Steven, MD,FAAN Ringel, Isabel, MD

Roberts, Eiry Robertson, Marilyn Robertson, Wendy, MD, FAAN Robeson, Kimberly Robinson, David Robinson, Maisha, MD, MS Robinson, Jenice Robinson Papp, Jessica, MD, FAAN Robles, Ana, MD, FAAN Roc, Anne Rocca, Walter, MD Roccato, Emanuela, MD Rocha, Maria Rock, Marvin Rodnitzky, Robert, MD Rodrigues, Kamala Rodrigues, Vinicius Rodrigues Pereira, Thaila Rodriguez, Lina Rodriguez, Jayson Rodriguez, Ramon, MD, FAAN Rodriguez, Alejandro, MD Rodriguez, Fabiana RODRIGUEZ, GABRIEL Rodriguez, Iara, MD Rodriguez, Jesus Rodriguez, Jorge, PhD Rodriguez, Jeronimo, MD, FAAN Rodriguez Alfici, Alberto, MD Rodriguez Centeno, Abiezer Rodriguez da Costa V, Marta Rodriguez Hernandez, Janice Rodriguez Kadota, Liliana Rodriguez Navas, Armando Rodriguez Regal, Ana Rodriguez-Hernandez, Adrian Rodriguez-Leyva, Ildefonso, MD, FAAN Rodriguez-Linares, Yvo

Rodriguez-Porcel, Federico Roeltgen, David, MD, FAAN Roesdi, Mirjam Rog, David Rogacki, Nancy Rogers, Sean, MD, PhD Rogers, Ronan90 Burnhamthorpe Roa Rohm, Zachery, MD Rojas, Julio, MD, PhD Roland, Jessica Roloff, Alan Rolsted, Henrik Roman, Gustavo, MD, FAAN Romano, Jose, MD, FAAN Romano, Alissa Romano, Jacob, RPh, BS Romano, Lucas, MD Romanowski, Krzysztof Romero, Charles Romero, Jerome, PhD Rommer, Paulus, PhD Ronan, Lara Rong, Lingling Ronthal, Michael, MD Rooney, Melissa Roos, Raymond, MD, FAAN Roos, Katrin Root, Shane Roque, Ashley Rorabaugh, Jacki Rosa, Gleysson Rosales, Xiomara Rosario, Michael Rosas, Carolina Rosch, Nora Rose, Lee Rose, John, MD, FAAN Rose, Christina, MD MPH

2018 ANNUAL MEETING ATTENDEES

Ringman, John, MD Riolo, Jon Rios Piedra, Edgar A. Rippon, Gregory Rishi, Vivek Risk, Winthrop Riskind, Peter, MD, PhD Riss, Holly Ritaccio, Anthony, MD, FAAN FAES FANA Ritchie, Andrea Ritt, Elissa Ritzl, Eva, MD, FAAN Rivaz, Malihe Rivera, Ana Rivera, Victor, MD, FAAN Rivera Agosto, Ivia Rivera Cruz, Angelica, MD Rivera-Torres, Noellie Rivero, Alberto, MD Riveros, Daniela Riviere, Jessica Rizkallah, Jihad Rizvi, Macym Rizvi, Nasir Rizvi, Syed Rizvi, Syed Rizzi, Dominick Rizzo, Matthew, MD, FAAN, FANA Ro, Susie Roach, E., MD, FAAN Roark, Hunter Robak, Laurie, MD, PhD Robbins, Matthew, MD, FAAN Robbins, Michael Robers, Michael Roberts, Kathryn Roberts, Claire Roberts, Holly

283

2018 ANNUAL MEETING ATTENDEES Rosebraugh, Matthew Rosen, Noah Rosen, Andrew Rosen, Lindsay Rosenbaum, Joshua Rosenberg, Roger, MD, FAAN Rosenberg, Jay, MD, FAAN Rosenberg, Bradley Rosenbloom, Michael, MD, FAAN Rosendale, Nicole, MD Rosenfeld, Jeffrey, PhD, MD, FAAN Rosenfeld, Rebecca Rosenkranz, Josef Rosenthal, Jacqueline Rosenthal, Jonathan Roshanisefat, Homayoun Roshchina, Yelena Rosnizeck, Ina, MD Ross, Stephen, MD, FAAN Ross, Web Ross, Adrienne Ross, Eric Ross, Erika Rossello, Leonardo Rossetti, Stefano Rossknecht, Molly, MPH Rost, Natalia, MD, MPH, FAAN Rostami, Mohamad, MD, PhD, FAAN Rosti, Robert, MSc. DHEd Roth, William Roth, Julie, MD Roth, Gerhard Roth, Serge, PhD Rotstein, Dalia Rottingen, Jennifer, Bachelor Rouleau, Guy, MD, PhD Rountree, Elizabeth, MBA

Rous, Matous Rouse, Stasia, MD Roush, Stephen, Pharm.D. Routh, Janell Rovner, Daniel, MD, FAAN Rowland, Fiona Roxas, Artemio, MD Roy, Ajit Roy, Bhaskar Roy, Gulmohor ROYAL, APRILE Royer-Perron, Louis Roy-Hewitson, Chantal Royter, Vladimir Rozen, Todd, MD, FAAN Rozner, Eduard Rozsa Dr, Csilla Rubeiz, Helene Rubiano, Hernando Rubin, Devon, MD, FAAN Rubin, Bruce Rubin, Michael Rubin, Shoshannah Rucker, Janet, MD Rudinsky, Megan Rudnicki, Stacy, MD, FAAN Rudolph, Alexandria, RN, AGACNP-s Rudzinska-Bar, Monika, MD, PhD Ruet, Aurelie Ruether, Emily Ruff, Melinda Ruggieri, Serena Rugiero Rodriguez, Marcelo, MD Ruhoy, Ilene Ruiz, Andrea Ruiz Junior, Facundo Ruiz Pena, Juan Luis, MD Rukmangadachar, Lokesh

284 2018 AAN Annual Meeting On-site Guide

Rumbaugh, Jeffrey Rumple, Melissa, APN Ruocco, Heloisa Rupasinghe, Jayantha, FRACP Rupert, Rebecca Rusanen, Harri Rusk, Gary Russell, James Russell, Sarah Russell, Susan Russell, Lauren, BS Russo, Maria Julieta Russo, Michael Russo, Grace, BA Russotto, David Rust, Timothy Ruta, Jeffrey Rutatangwa, Alice Ryan, Conor, MD Ryan, Mike Ryan, Aisling, MD Ryan, Keith Ryan, Patrick, Ph.D. Rybinnik, Igor Rydell, Chuck Ryglewicz, Danuta Ryman, Davis Rynkowski, Robert Sa, Maria Jose, MD Saadi, Altaf, MD Saarinen, Jukka Sabella, Lisa Saber, Ahmed Saber, David1732 N. First Street Sabet, Arman Sabin Munoz, Julia Sabir, Marya Sabouni, Ahmad Sabouri, Amir, MD, PhD

Sahai, Supreet Sahai-Srivastava, Soma Sahaya, Kinshuk Sahin, Bogachan Sahler, Kristen Sahn, Leonard Sahota, Pradeep, MD, FAAN Said, Rana, MD Said, Areen Saidha, Shiv Said-Said, Sarita Saifee, Tabish, PhD Saini, Vasu Sairanen, Tiina Saitoh, Yuji Sajjadi, S. Ahmad, MD, PhD, MRCP Saket, Jenny Sakhare, Ashwin Salajegheh, Mohammad, MD, FAAN Salam, Smeer, MD, MBBS Salameh, Johnny Salanga, Virgilio, MD, FAAN Salas, Rachel Marie, MD, FAAN Salazar, Richard Salazar, Hector Salazar Camelo, Ruth Saldanha, Margareth Saldivar, Christina Saleem, Sameer Saleh Velez, Faddi Saleh Velez, Faddi Salera, Constanza, MD Salerian, Justin Salgado, Efrain Salgado, Antonio Salgado, Miran Salih, Ammar Salim Khan, Muhammad

Salinas, Meagen Salinas, Joel, MD Salins, Naomi Salinthone, Sonemany Saliu, Irma Salloukh, Hashem Salmon, Andrea Salokhiddinov, Maruf Saltarelli, Mario, MD, PhD Saltis, Larence Saltonstall, Laura Salvadeeswaran, Meenakshi Sundaram, MD, DM Salvesen, Rolf, MD, PhD Salzman, Rachel Sam, Maria, MD, FAAN Samaha, Elias Samal, Priyanka Samaniego, Edgar, MD Samara, Verena Sambursky, Jacob, B.S. Sami, Hamid, MD, MSc Samimi, Fred Saminejad, Behrang Samivel, Balasubramanian Samkoff, Lawrence, MD Samkutty, Danny Samman, Hala Samoil-Reynolds, Grace Sampat, Ajay, MD Sampat, Radhika Samples, Stephen Sampognaro, Paul Sampson, Jacinda, MD, PhD Samuel, Vijay Samuels, Martin, MD, MACP, FAAN Samuels, Jeffrey, MD Samzadeh, Mojdeh142 West 49 th Street

2018 ANNUAL MEETING ATTENDEES

Sabouri, Milad Sabra, Mark Sabri, Ahmed Sacca, Francesco, MD Saccavino, Tierney Sacco, Ralph, MD, MS, FAHA, FAAN Sacco, Sara Sacco, Nancy Sachar, Pawani Sachdev, Harmeet, MD, FAAN Sachdev, Noor Sachdeva, Kapil Sacheli, Matthew, MSc. CSEP Sacktor, Ned Sadasivan, Shankar Sadeghi, Mahsa Sadeghian, Mona Sadeghikhah, Soha Sader, Chloe Sadi Belouize, Mustapha Sadiq, Saud, MD, MB, FAAN Sadiq, Mohamed Sadjadi, Reza Sadler, Mary Sadreddin, Arshia Sadri-Vakili, Ghazaleh Sadry, Mostafa Sadry, Neema Saeed, Salman Saeed, Yumna Safaei, Arash, MBA Safdieh, Joseph, MD, FAAN Safinia, Layla Sagen, Jessica, M.A. Sagert, Charmin Sagi, Vishwanath Saha, Sam Sahagian, Gregory

285

2018 ANNUAL MEETING ATTENDEES San Luciano, Marta, MD Sanchez, Oscar Sanchez, Rodrigo Sanchez, Dorothea Sanchez De La Rosa, Rainel Sanchez Solino, Olga Sanchez-Vizcaino Bue, Cristina Sanchis Miguel, Juan Jose Sandberg-Wollheim, Magnhild, MD, PhD Sandbrink, Friedhelm Sandbrink, Rupert, MD, PhD Sander, Howard, MD, FAAN Sanders, Katrien Sanders, Amy, MD, FAAN Sanders, Eric Sandler, Joel Sandness, David, BA Sandoval, Gustavo, MD Sandoval, Luis Sandoval Karamian, Amanda Sandoz, George Sandrock, Alfred, MD, PhD Sandrone, Stefano Sandroni, Paola, MD, PhD, FAAN Sands, Tristan, MD, PhD Sangha, Navdeep Sanghani, Nirav Sanguino, Luis Sangurdekar, Dipen Sanjak, Mohammed Sankar, Raman, MD, PhD Sankaranarayanan, Muthukani Sankaraneni, Ram Mohan Sanky, Charles Sanson, June Santa-Cruz, Fidel Santamaria, Pamela Santamaria Jaramillo, Alexis

Santamarina, Rodrigo, MD Santana, Dalileia, MS Santangelo, Roberto, PhD student Santaniello, Amy Santiago, Carla, MS Santibanez, Rocio Santini, Veronica, MA Santo Silva, Paulo Diego Santomasso, Bianca, MD Santoro, Jonathan, MD Santoro, Flavio Santos, Barbara Santos, Mariana, MD Santos, Juan Santos, Andre Luiz Santos, Andreia Santos, Michelle Santos Jr., Waldyr Santos Pinheiro, Fernando Santucci, Joshua Sanya, Emmanuel Sanz, Jonathan Saperstein, David Sapkota, Bishnu Sapkota, Biggya Saposnik, Gustavo Saraceno, Taylor, BSc Saranza, Gerard Raimon Saraogi, Priyadarshan Sarapura Castro, Elison, MD Sarasoja, Paavo Sarasso, Elisabetta Sarco, Dean Saremi, Kaveh Sarfati, David Sarfo, Fred Saris, Christiaan, MD, PhD Sarkar, Nabin, MD, MBBS

286 2018 AAN Annual Meeting On-site Guide

Sarkar, Korak, MD Sarkari, Avijit, MS Sarlakova, Jana, MUDr. Sarraj, Amrou Sarrazin, Anne Sarva, Harini Sarwal, Aarti, MD, FAAN Sarwar, Aliya Sasannejad, Cina Sasikumar, Sanskriti Sass, Erik Sater, Richard, MD, PhD Sathe, Swati Sathian, Krish, MD, PhD Sathyan, Sanish Sato, Aimee, MD Sattar, Shifteh Sattin, Justin Sattiraju, Shekhar, MS, MBA Saul, Ronald, MD,FAAN Saulat, Bilal Saunders-Pullman, Rachel Saurer, Timothy Sauri, Sergio Saute, Jonas Alex Savage, Carolyn, BS Savage-Edwards, Belinda Savica, Rodolfo, MD, MSc Savitt, Daniel Savsek, Lina Sawano, Keiko Sawant, Bapujee, MD, MBBS Sawchuk, Kevin Sawicki, Darlene Sawyer, Colleen Sawyer Jr, Robert Sax, Tracy Saxena, Anand, MD, MBBS Saxena, Aneeta

Schloss, Evan Schlosser Covell, Gretchen Schmahmann, Jeremy, MD, FAAN Schmerler, David Schmidt, John, MD, FAHA, FAAN Schmidt, Stephan Schmidt, Felix, MD Schmidt, Klaus Schmidt, Pete Schmidt, Hollie, MS Schmidt, Bernd, MD, PhD Schmierer, Klaus, MB BS, PhD, FRCP Schmitt, Sarah, MD Schmitt, Andreas, MD Schnaas, Christian Schneider, Logan Schneider, Amy Schneider, Julie, MD, MS Schnider, Armin Schnock, Michael, MD Schobel, Scott Schobel, Virginia, MSc Schoedel, Kerri Scholtz, Marius, MD Scholz, Sonja Schon, Eric, PhD Schonberger, Michael, MBA Schondorf, Ronald Schor, Nina, MD, PhD, FAAN Schorn, Melissa Schotte, Caroline Schrag, Matthew Schreiber, Andrew Schreiber, Martin Schreiber, Steven Schreiner, Teri, MD, MPH Schrock, Lauren

Schrock, Tasha, BS Schteinschnaider, Angeles, MD Schuele, Rebecca, MD Schuele, Stephan, MD, FAAN Schuetz, Sonja Schuh, Kory, PhD Schulte, Jessica, MD Schultz, Charles Schultz, Stephanie Schulz, Hans Schulz, Andreas Schusse, Courtney Schütz, Valerie Schuyler, Erica Schwab, Roland Schwab, Stefan Schwabe, Stefan, MD, PhD Schwartz, Neil, MD, PhD Schwartz, Raymond, MBBS, FRACP, PhD Schwartz, Guy Schwarz, Heidi, MD, FAAN Schwarz, Stefan Schwedt, Todd, MD, FAAN Schweizer, Juliane Schweller, Thomas Scofield, Marla Scola, Rosana, MD Scoles, Daniel Scorr, Laura Scott, Beverly Scott, James Scott, Thomas Seay, Meagan, DO Sebasigari, Denise Sechi, Elia Seehra, Shelley, B.A. Seeldrayers, Pierrette Seferoglu, Meral

287

2018 ANNUAL MEETING ATTENDEES

Sayeed, Shaik Scalfari, Antonio Scanlon, James Scariano, Jack, MD, FAAN Scarlet, Cora Scelsa, Stephen Schaak, Tom, MD Schachter, Daniel Schachter, Jeffrey Schadrack, Jan Schaefer, Sara SCHAEUBLE, Barbara Schafer, Jolie Schäfer, Jakob Schanfield, Paul Scharf, Eugene, MD Scharf, Andrew Scharre, Douglas Schaum, Tanja Schechter, Steven Scheck, Leanna Schecter, Robyn Schenck, Carlos, MD Scher, Ann Scherer, Steven, MD Scherpenhuijzen, Simone Scherz, Tatiana, MD, PhD Scherzberg, Maria-Christina Schesny, Marianne Scheyer, Richard Schick, David Schiess, Mya Schiffmann, Raphael Schiller, Andreas Schilling, Traci Schillings Dr, Michael Schindler, Rachel Schlick, Konrad Schloemer, Fallon

2018 ANNUAL MEETING ATTENDEES Segal, Wendy Segal, J Bradley, MBE Segamarchi, Maria Constanza Segieth, Joanna Segro, Victoria Sehgal, Amita Sehgal, Sandeep, MD, MBBS Seidel, Kornelia SEIFER, Gustavo Seifert, Tad, MD Seifert-Held, Thomas, MD Seijas, Maria Seijo Martinez, Manuel Seiler, Martin Seino, Yusuke, MD, PhD Seipel, Joseph Sejbaek, Tobias Sejvar, James Selcen, Duygu, MD, FAAN Selchen, Daniel Seliverstov, Yury, MD, PhD Sellami, Leila Sellers, Jessie Sellers, Hannah Sellner, Larissa Sellner, Johann, PhD Selvan, V. Arul, MD, DM, FREP Selvanathan, Thiviya Selwa, James, MBA Selwa, Linda, MD, FAAN Semah, Franck, PhD Semenchuk, Marilyn, PharmD, MSc Semmler, Robert, MD, FRCP Sen, Sedat, MD Senanayake, Bimsara, MD, MBBS Senay, Blake Sener, Ugur Senkevich, Konstantin

Seno, Joshua SEO, JEONGHYEON Seok, Beomseok Sequeira, Alexandra Sereike, Ieva, MD Serena, Jacqueline Sergay, Stephen, MB BCh, FAAN Sergerie, Martin Serlin, Yonatan Session II, RA Sethi, Kapil, MD, FRCP (UK), FAAN Sethi, Hartej Sethi, Ajay, B.S. Seto, Anita Severe, Marcel Severi, Sauro, MD Severson, Erin Severt, Lawrence, MD, PhD Severy, Martha, MBA/MPH Sevim, Mustafa Serhan, PhD Sexson, Matt Seynaeve, Laura Sezgin, Mine, Asistant Sfaltou, Alexandra Sguigna, Peter Sha, Sharon Shabbir, Syed Shadbehr, Nasima Shadman, Anna, M.Sc., B.Sc. Shafer, Saulena Shafqat, Rafia Shah, Suma Shah, Amit Shah, Harshit Shah, Kavit Shah, Paarth Shah, Shamik Shah, Shivani

288 2018 AAN Annual Meeting On-site Guide

Shah, Vishank Shah, Snehal Shah, Sona Shah, Aabha Shah, Aashit, MD, FAAN Shah, Arunkumar, MD Shah, Dhara Shah, Disha Shah, Irfan Shah, Laxmi Shah, Nirav Shah, Palak Shah, Raisa Shah, Sunit Kumar, MD, MBBS Shah, Michelle Shah, Nimish Shah, Niren Shah, Ritu Shaheen, Yanal Shaibani, Aziz, MD, FAAN Shaibu, Ojochide Shaikh, Hammad Shaikh, Aasef Shake, Susan, MS Shakir, Maryam Shalaby, Nevin Shamael, Ibrahim Shamasna, Motasem Shamieh, Fayez Shamim, Ejaz, MD, MS, MBA Shane, Bradley Shaner, David, MD, FAAN Shang, Jingzi, MD, PhD Shankar, Sai Shanker, Vicki Shanks, Megan Shanmugam, Paranjothi, MD, MBBS Shannon, Kathleen

Shefner, Jeremy, MD, PhD, FAAN Shehu, Abdullah Sheikh, Muniza, MS, MBA Sheikh, Atif Sheikh, Shuja Sheikh, Nabeel Sheikh, Kazim Sheikh, Sarah, BM Bch,MSc,MRCP Sheikh, Sohail Sheikh, Zulfiqar Sheikh, Shehryar Sheikhbahaei, Sahar Shekhar, Shashank Shelat, Amit, DO, FACP Shelgikar, Anita Shelton, Georgia Shembalkar, Prafula Shemsi, Edlira Shemsi, Kledisa Shen, Xin-Ming Shen, Ding Guo Shenker, Joel, MD, PhD Shenouda, Lydia, PharmD Shenoy, Anant Shenoy, Srinivas Shenoy, Vivek, PhD, MBA Sherman, Alexander, ABD Sherman, Robert Scott Sherrick, Joy, Pharm Sherry, Betsy Sherwood, Karna Sheth, Raj, MD, FAAN Sheth, Sunil Sheth, Bijal Shettar, Basavaraj Shetty, Aakash Shetty, Teena Shetty, Jagat

Shi, Jiong, MD, FAAN Shi, Kaibin Shields, William Shih, Helen Shih, Ian Shim, Hyung Shimamoto, Shoichi Shimazaki, Jean Shimizu, Yuko, MD, PhD Shimizu, Russ Shimohata, Takayoshi, MD, FAAN Shimshak, Jane, MPH Shimshak, Serena Shin, Dong Jin Shin, Dong-Ick, MD, PhD Shin, Kyong Jin Shinholster, James Shinnar, Shlomo, MD, PhD, FAAN Shinobu, Leslie, MD, PhD Shinotoh, Hitoshi Shiota, Debora Shirley, Minta, CNP Shiroishi, Mark Shivdat-Nanhoe, Rosita Shivkumar, Vikram Shivplara, Nandeeshwara Shneyder, Natalya Shoab, Abul Shoemaker, Thomas Shoirah, Hazem Shojaei, Jalil Shoji, Mikio Shook, Donald, MBA Shook, Steven, MD Short, Glenn Shosha, Eslam Shou, James Shoulson, Ira, MD, FAAN

2018 ANNUAL MEETING ATTENDEES

Shao, Wei-Li Shapiro, Rita, DO, FAAN, FACP Shapovalov, Denys Shaqfeh, Mahmoud Sharaf, Nour Sharaf, Nazar, B.Sc. MD PhD MRCP(Ne Shareef, Safiullah Shariff, Umar Sharinova, Irina Sharma, Nooma Sharma, Bhavana Sharma, Jennifer Sharma, Malveeka Sharma, Salil Sharma, Akanksha Sharma, Anumeha Sharma, Kartavya Sharma, Mukesh, MD, MBBS Sharma, Nutan, MD, PhD, FAAN Sharma, Sushma, MD, DM, DNB Sharma, Kartikeya Sharma, Kush Sharma, Pooja Sharobeam, Angelos Sharp, Lydia Sharrack, Basil, MD, PhD, FAAN Sharrief, Anjail Shatzmiller, Ron, MD, MSc Shauger, Kenneth Shaw, Susan Shaw, Kellie Shaw, Michael Shay, Kathi Sheaheed, Nawfal, MD, FAAN Shearin, Amanda Sheehan, Lori Sheerani, Mughis Sheffield, James

289

2018 ANNUAL MEETING ATTENDEES Shouman, Kamal Shpiner, Danielle Shprecher, David Shrestha, Rasmita, DNP, APRN, CNP Shrewsbury, Stephen Shrivastava, Amit, MD, MBBS Shrivastava, Arpan Shroff, Dinesh, MD, MBBS Shtulberg, Kristin Shuaib, Umar Shubin, Richard Shukla, Vijeta Shukla, Amitabh, MD, FAAN Shukla, Chirag, MD, FAAN Shukla, Rachna Shukri, Leylah Shukri, Said Shuler, Sara Shulman, Lisa, MD, FAAN Shulman, Melanie Shulman, Semyon Shum, Florence Shumyatcher, Yana Shuster, Daniel Shutter, Lori, MD, PT Shy, Michael, MD Siavoshi, Sara Sico, Jason, MD Sicotte, Nancy, MD, FAAN Siddiqi, Omar, MD Siddique, Teepu, MD, FAAN Siddiqui, Abdul Siddiqui, Mustafa, MD, FAAN Siddiqui, Sitwat Siddiqui, Mehr Siderowf, Andrew Siegel, David Siegel, Jerome

Siegel, George, MD, FAAN Siegel, Irwin Siegert, Scott Silber, Michael, MB, ChB, FAAN Silberberg, Shai, PhD Silberberg, Donald, MD,FAAN Silberstein, Stephen, MD, FAAN Silva, Andre Silva, Lis Silva, Ana Alexandra, MD Silva, Delson JosÃ© Silva, Leonardo, MD Silver, Brian, MD, FAAN Silverberg, David Silvestri, Nicholas, MD, FAAN Simabukuro, Mateus Simic, Grant, BMedSci Siminovsky, Dvora, MBA Simionescu, Oana Gabriela Simioni, Caio Vinicius Simkhaev, Larisa Simm, Renata, MD Simmons, Daniel Simon, Leanore Simon, Olivier Simon, Kelly Claire, ScD Simon, Robert Simon, Amanda Simone, Isabella Laura, MD Simone, Marta, MD Simonetto, Marialaura Simoni, Michela, MD, PhD Simpkins, Alexis Simpson, David, MD, FAAN Simpson, Ericka, MD, FAAN Simpson, Mark Simschitz, Philipp, MD Simuni, Tanya, MD SINAY, VLADIMIRO

290 2018 AAN Annual Meeting On-site Guide

Sinclair, David Sinclair, David Sindic, Christian Singer, Elyse Singer, Wolfgang Singer, Barry Singer, Carlos Singer, Mike, MD, PhD Singer, Richard, MD, FAAN Singh, Neeraj Singh, Amrinder Singh, Avantika Singh, Dharampreet Singh, Dilip, MD, MBBS Singh, Gobind Singh, Mini Singh, Tarun Singh, Niranjan, MD, FAAN Singh, Anil, MD, MBBS Singh, Asha Singh, Avinash, MD, MBBS Singh, Baljinder Singh, Mamta, MBBS, MD, DM, FAAN Singh, Prabhjeet Singh, Ravinder Singh, Sanjay, MD, FAAN Singh, THANGJAM, MD, MBBS Singh, Vineeta, MD, FAAN Singh, Gurnek, Bachelor of Science Singh, Kanwaljit Singh, Karun Singh, Alvin, M.S. Singh, Tanya Singha, Amrita Singhal, Saurabh Singhal, Divya Singhal, Aneesh, MD, FAAN Singh-Curry, Victoria

Slater, Jeremy SLEIMAN, Marwan Slettedahl, Jamie, RN, NP, DNP Slevin, John, MD, FAAN Slobodin, Tatyana Slowiejko, Diana Slusher, Barbara, PhD Slutzky, Marc, MD, PhD Small, Steven, MD, PhD, FAAN Smart, Shaun Smette, Lori Smid, Jerusa Smikle, Joanne, PhD Smirnoff, Liza Smirnov, Denis Smith, Megan Smith, Bonnie, MHA Smith, Alyssa Smith, Erin Smith, Kelsey Smith, Kyle Smith, Shaun Smith, Gordon, MD, FAAN Smith, Jonathan, MD Smith, Andrew Smith, Aurelia Smith, Daniel Smith, Andrew Smith, Benn, MD, FAAN Smith, Brien, MD, FAAN Smith, Cheryl Smith, Marsha, MD, FAAN Smith, Robert, MD, PhD Smith, Ryan Smith, Douglas, MD Smith, Anne Smith, Bryan Smith, Douglas, MD,PhD Smith, Gerard

Smith, Terence Smith, Jessica, MPH Smith, Michael Smith, Marjorie Smith, Don, MD, FAAN Smith, Richard Smith, Victoria, MS Smith-Grady, Jennifer Snarr, John Snead, O., MD, FAAN Snelgrove, Danuel Snell, Melissa Snellman, Josefin Snider, Jonathan Snider, Joy, MD, PhD Snook, Todd Snyder, Allison Snyder, Heather So, Elson, MD, FAAN So, Yuen, MD, PhD Soares Neto, Herval Sodeifi, Negar Soederman, Andreas, Industry Soffer, Hayley Soh, Derrick Sohail, Amna Sohn, GyeongMo Soinne, Lauri, MD, PhD Sokolova, Elena Sokolowski, Kevin Sokrab, Tag-Eldin, MD,PhD, FAAN Solar Sanchez, Dulce Nombre de Mari Solbrig, Marylou Soldad-Diaz De Valde, Maria Soldatos, Ariane Soleimani-Meigooni, David, MD Solenski, Nina Soler, Carlos

291

2018 ANNUAL MEETING ATTENDEES

Singleton, J. Sinha, Sri, PharmD Sinisi, Leonardo, MD Sinkhorn, Robin Sinor-Anderson, Amy Sintzel, Martina Siow, Charles SIPAL, YUNUS Sirakov, Georgi Sirdar, Bilaal Sirisena, Darshana Sirken, David Sirsat, Ashok Sirven, Joseph, MD, FAAN Sisniega, Daniella Siv, Jenny Siva, Aksel, MD Sivakumar, Keithan Sivakumar, Mambakkam, MD, FAAN Sivakumar, Sanjeev Sivakumar, Shravan Siwoski, Mark-Victor Sjuts, Dustin Skerjanec, Simona Skias, Demetrios Skidmore, Christopher Sklerov, Miriam Skoda, Martin Skoda, Ondrej Skolnick, Brett Skordilis, Monica Skotny, Alicja Skrbec, Alen Skup, Wojciech Skutnik, Lisa Skylar-Scott, Irina Sladky, John SLASSI, Najib

2018 ANNUAL MEETING ATTENDEES Solis-Cohen, Luisa Solomon, Andrew, MD Solomon, Benjamin Soltanzadeh, Payam Soltesz, Ivan, PhD Somani, Sana, MD, MBBS Somani, Suresh, MD, MBBS Somarajan, Anandan Somboon, Thapanee Somerto, Anna Sommerville, R, MD Sondhi, Vishal Soneji, Deepak Song, Nancy Song, Sarah, MD Song, David, MD, PhD Song, Suying Song, David Song, Hong Ki Soni, Madhu, MD Sontakke, Santosh Soo, Sylvia Soo-Jin, Cho Soomro, Bashir Ahmed, MBBS, FCPS Soong, Bing-Wen, MD, PhD, FAAN Soors, Peter Sopko, Mike Sopromadze, Sopio Sorensen, Eva Sorensen, Per Solberg, MD, PhD, FAAN Sorensen, Troels SORMANI, Maria Pia Soronson, Bryan, CRA, FACMPE, MPA Sosa, Maria Del Milagro Sotelo, Hugo, MD Sotelo-Hernandez, Jazmín

Souayah, Nizar, MD, FAAN Sousa, Danielle Sousa, Ary Severino, MD Southerland, Andrew, MD Sowell, Michael Soysal, Aysun Soza, Marco Spaander, Fianne Spahn, Claire Spain, Rebecca Sparagana, Steven Sparks, Susan Sparman, Anthonette Sparr, Steven, MD, FAAN Spatola, Marianna Spears, Christopher, MD Spears, Roderick, MD Spector, Sidney, MD, PhD Speelziek, Scott Spence, Sarah, MD,PhD Spencer, David, MD, FAAN Spencer, Selden Spencer, Karen, MD, MPH Spencer, Sedrick Sperry, Laura, RN, NP Spiegel, Lauren Spierings, Egilius, MD,PhD Spies, Judith, MBBS, PhD Spina, Salvatore Spindler, Meredith Spira, Katherine, FRACP Spitz, Mark, MD, FAAN Splett, Matthew Spolter, Yonatan Sposato, Luciano Springub, Joachim Sproule, Douglas, MD MSc Spurgeon, Elizabeth Spurlock, Charles

292 2018 AAN Annual Meeting On-site Guide

Sreedharan, Harikrishnan Sreenivasan, Varun Sridharan, Sugandhi, MD, MBBS Srinivasan, Avathvadi, MD, FAAN Srinivasan, Jared Sriram, Ashok Srivastava, Arth Srivastava, Madhav St. Hilaire, Melissa, PhD St. Louis, Erik, MD, FAAN Sta. Maria, Mark Anthony Staats, Peter Stacey, Patricio, Nuerólogo Stachnik, Catherine Stack, Thomas, BSc Stacy, Kristin Stadler, Bianca Staff, Nathan, MD,PhD Stafford, James Stahl, Christine Stahl, Mark, MD, PhD Stahl, Nathan Staley, Kevin Stamler, David Stamper, Laura Standridge, Melanie Stangel, Martin, PhD MD Stankiewicz, James, MD Stankowski, Jeannette Stanton, Marilyn Starks, Jamie Starling, Gary Stasiolek, Mariusz Stastna, Eliska Statland, Jeffrey Staunton, Thomas, MD, MBBS Stavros, Kara Stecker, Mark

Stevens, Glen, DO, PhD, FAAN Stevens, Olivier Stevenson, Michael, BSP (Pharmacy) Stewart, Dwight, MD, PhD, FRCP Stewart, Brad Stewart, Nolita Stewart, Sarah Sthole, Clorris Stillman, Carly Stiner, Rachel, MS Stitt, Derek Stitzer, Michael Stochel, Jackie Stock, Elyse, MD Stockner, Michelle Stoeck, Katharina Stoer, Kourtney Stoessl, Jon, MD, FAAN Stogbauer, Florian, PhD MD Stokmaier, Daniela Stoll, Sharon Stolze, Wolfgang, PhD MD Stommel, Elijah, MD, FAAN Stone, Joshua Stone, Sarah Stone, David, MD, PhD Stone, Shane, BS Storelli, Loredana, MS Storey, James, MD, FAAN Story, Tyler, PhD Stosic, Milena Stourac, Pavel Stove, Melvin Stowe, Robert, MD Stoyko, Steve Strattman, Sarah Stratton, Maera Straub, Elizabeth

Straukiene, Agne Straus Farber, Rebecca Street, Andrew Streicher, Nicholas Streit, Janet Streletz, Leopold, MD, FAAN Strikwerda, Dolf Stroh, Matthew Stromillo, Maria Laura, MD Strong, James Strong, Eugene, PhD Stroup, Elizabeth Strowd, Roy Studen, Verena, MD Stueckroth, Mark Stumpf, Erika Stunkel, Leanne Stunnenberg, Bas Sturm, Virginia Sturm, Yvonne Stuve, Olaf, MD, PhD, FAAN Su, Michael Su, Zhen Su, Hongwei Su, Ning Suarez, Jose, MD Suarez Moro, Roberto Suarez-Zambrano, Gustavo Subash, Rajee, MD Subbaratnam, Hema Subbiah, Vanchilingam, MD, MBBS Subedi, Bal, FRACP Subei, Adnan Subhi, Mohammed Subramaniam, Murugesan, MD, MBBS Subramaniam, Poovillam, MD,FAAN Subramony, S, MBBS, FAAN

293

2018 ANNUAL MEETING ATTENDEES

Steele, Laura Steenerson, Kristen Stefanidou, Maria Stefanis, Leonidas Steffensen, Steve Stefoski, Dusan, MD, FAAN Stegemann, Maureen Stegmeier, Johannes, MD Steimberg, Judith, MD Stein, Laura Stein, Thor Stein, Diane Steinberg, Alexis, MD Steinberg, Amy, BA Steiner, Israel, MD Steiner, David Steiner, Sonja Steinerman, Joshua Steingo, Brian Steinich, Ines Steiniger Brach, Bjorn Steininger, Gabriele Stella, Carla Renata Stelzer, Fernando, MD, PhD Stenor, Christian Stephan, Monica, MD, MBA Stephen, Christopher, MB, ChB, MRCP Stephen, Reddel Stephen, Sibin Stephens, Brian Stephens, Roger Stephens, Dane Stepien, Adam Steriade, Claude Stern, John, MD, FAAN Stern, Barney, MD, FAAN Stern, Robert Stevens, James, MD, FAAN

2018 ANNUAL MEETING ATTENDEES Sucha, Jaroslava Suchet, Laurent Suchita, Iffat Ara Suchowersky, Oksana, MD, FAAN Sudarshana, Dattanand Sudbrack Oliveira, Pedro Sudharshan, Namratha, FRCPC Sudyn, Michelle, MSc Suescun, Jessika Suess, Wolfgang Sugg, Rebecca Sugianto, Paulus Suhaib, Omer, MD, MBBS Suko, Jolynn, MPH Sulastri, Emmy, MD, PhD SULJIC MEHMEDIKA, ENRA Sullivan, Lawrence Sullivan, Cynthia Sullivan, Kelly Sultan, Shumaila Sultana, Bushra Sumayo, Royce Sumicad, Matthew Summers, Meadow Summers, Catherine, PhD Sumowski, James Sun, Chung-Huan Sun, Ying Sun, Fang, PhD, BM Sun, Linquan Sun, Xiaoyan, MD, PhD Sun, Lin Sun, Mu Sundar, Bharathi, DM (Neurology) Sundararajan, Jayashree Sundgreen, Claus Sundqvist, Susanne Suneja, Aarushi

Sung, Angela Sung, Gene, MD, MPH Sung, Young Hee Sung, Jen Sunmonu, N. Abimbola Sunmonu, Taofiki, MD, FAAN Supelano, Ana Super, Megan Sur, Nicole, MD Suradi, Rudy Surana, Praveen, MD, MBBS Sureja Patel, Pooja Surenthiran, S.S. Surillo Dahdah, Laura Surkont, Jacob Suryo, Handoyo Suryo, Martin Susatia, Frandy Sutherland, Lorey Suwatcharangkoon, Sureerat Suzuki, Masahiko Suzuki, Yasushi, MD, PhD Svatikova, Anna Svatova, Jindra Svoboda, Andrea Swafford, Collin Swaminathan, Thirukan, MBBS,PhD Swartz, Barbara, MD, PhD, FAAN Sweeney, Michael Sweeney, Colleen Swenson, Andrea Swerdlow, Michael Swibold, Dawn, MBA Swift, Thomas, MD, FAAN Switzer, Aaron, MSc Swope, David Syc, Stephanie Syed, Nadir

294 2018 AAN Annual Meeting On-site Guide

Syed, Anam Syed Farooq, Syed Sylvester, Andrew Synowiec, Andrea Szaflarski, Jerzy, MD, PhD, FAAN Szekely, Anna Szewka, Aimee Szoeke, Cassandra, PhD, FRACP, MBBS GAI Szumski, Nicholas Tabarsi, Elham Tabbal, Samer Tabrizi, Sarah Tabuena, Ma. Daisy Tadi, Prasanna Tadia, Riaz Tadikonda, Mohan Tadjer, Souhila Tagaris, George Tagliati, Michele, MD, FAAN Taha, Mohamed Taha, Karim Taha, Farris Tai, Chao, MB, FRCP Tai, Peter Tai, Wayne Takahashi, Courtney, MD Takewaki, Daiki Takigawa, Sotaro Talaat, Farouk TALABARDON, Jean-Noel Talarico, Todd Talcott, Bradford, MD, PhD, FAAN Talente, Bari Talman, Lauren Talwar, Pumanshi, M.sc Tamam, Serife Banu, PhD Tamam, Yusuf, PhD

Tarjuelo Marcos, Yanira Tarkhan, Mohamed Tarolli, Christopher, MD Tarsy, Daniel, MD, FAAN Tarula, Erick Tarulla, Adriana Tassorelli, Cristina, MD Tatuene, Joseph Tatum, William, DO, FAAN Tauil, Carlos Bernardo, MD Tavares, Eva, MD Tavee, Jinny Taves, Sarah Tavolini, Dario, MD Tavyev Asher, Y. Jane Tawfik, Tarek Tay, Edward Taylor, Andrew Taylor, Breana Taylor, Alexis Taylor, Ryan Taylor, Brittany, Bachelor of Science Taylor, Carolyn Taylor, Jennie Taylor, Jennifer Taylor, Lynne, MD, FAAN Taylor, Mary Taylor, Reid Taylor, Bruce Taylor Meadows, Kristen Tayo, Anatalia Nina Tazen, Sirinan Tchikviladze, Maia Tchoulhakian, Missak Teive, Helio Afonso Teixeira, Hennan, Resident Teixeira da Silva, Luis Sidonio Tejani, Monica

Tememe, Danoushka Tempest, Michael, BsC Temple, Bryan Temple, Carolina Tencer, Tom Teng, Edmond, MD, PhD Tengah, Connie Tenhoopen, Cynthia Tenser, Richard, MD, FAAN Tepper, Stewart, MD Ter Meulen, Bastiaan Termsarasab, Pichet Terner, Jolan Terreri, Adam Terzi, Murat, MD Terzoudi, Maria Tesi Rocha, Ana Carolina Tetrault-Provencher, Gabrielle Thabuy, Florent, PhD Thai, Gaby Thaimuriyil, Nigil Thaisetthawatkul, Pariwat, MD, FAAN Thakkar, Vismay Thakkar, Mahesh Thakore, Nimish Thakre, Mona, MD, FAAN Thakur, Neelima Thakur, Nicklesh Thaler, Alison Thaler, David, MD, PhD Thammongkolchai, Thananan Thangarajh, Mathula, MD, PhD Thapa, Lekhjung, DM (Neurology) Tharp, Emily, BS Thatikunta, Prateek Thebault, Simon, MD Theeler, Brett Theis, Oliver, MD

295

2018 ANNUAL MEETING ATTENDEES

Tamez, Seryna Tamhane, Mitalee Tamula, Giselle Therese Tan, Tracie TAN, ERSIN Tan, Echo Tan, Kevin Tan, Simon Tan, Chenchen, MD Tan, Lucy Tanaka, Masami, MD, FAAN Tanaka, Keiko Tanaka, Masaki Tanaka, Miyabi Tanase, Florin Tanasescu, Radu Tandan, Rup, MD, FRCP, FAAN Taneja, Amishi Taneja, Sanjeev Taney, Melissa Tang, Joyce Tang, Kejian Tang, Yamei Tangefjord, Mattias, Industry Tanha, Farzad Tankou, Stephanie, MD, PhD Tanner, Caroline, MD, PhD, FAAN Tanridag, Tulin Tansey Chevlen, Kate, MBA Tanumihardja, Sylivia Tanveer, Sarah, B.Sc. Tanvir, Imran, MBA Tapanes, Jennifer TAPIA VILLAGOMEZ, DIEGO Taraciuk, Fernando, MD Taraschenko, Olga, MD, PhD Tarawneh, Rawan Tariq, Abdul

2018 ANNUAL MEETING ATTENDEES Theodore, Gwyn Theodros, Mahelate Therrien, Marc Thiagarajan, Ramu Thieben, Mark Thirumala, Parthasarathy, MD, FAAN Thiruvallur, Venkat Thode, Andreas Thoman, Maxton Thomas, Jonathan Thomas, Lionel Thomas, Neil Thomas, Anila Thomas, Florian, MD, MA, PhD, FAAN Thomas, Reji Thomas, Amelia Thomas, Lisa Thomas, Melinda Thomas, Peter Thomas, Nancy, PhD,APN Thomas Jr, George Thomopoulos, Sophia4676 Admiralty Way Thompson, Oluwatosin Thompson, Julia Thompson, Michael Thomson, Alejandro Thomson, Alfredo Thomson, Ruth thomson, christian Thong, Nguyen, MD, FAAN Thorat, Chandana Thordarson, Danielle Thormann, Anja, MD, PhD Thornell, Brenda Thornton, Charles, MD, FAAN Thorpe, Andrew Thorpy, Michael

Thors, Brynhildur, MD, PhD Thrainsdottir, Soley Thuemler, Bjoern-Holger Thulin, Perla Thuringer, Amanda Thurtell, Matthew, MD Thyagarajan, Dominic TIENKEN, FELIPE, MBA Tietjen, Gretchen, MD Tillard, Maria, MD Tilton, Ann, MD, FAAN Tilwalli, Shilpa Tinaz, Sule, MD, PhD Tindall, Richard, MD,FAAN Tintner, Ron, MD, FAAN Tiong, Kristinna Tipton, Philip Tiryaki, Ezgi, MD, FAAN Tisdell, Jonathan Tisel, Sarah Tisovic, Kelly Titoff, Igor Titoff, Victoria Titulaer, Maarten, MD, PhD Tiyapun, Nantaporn Tjandra, Christine Tjandrawidjaja, Girianto Tkachuk, Veronica, MD To, Alex Tobias, Hal, MD, FAAN Tobita, Mari Tobon, Alejandro, MD Todd, William, PhD Todd, Anissia Todman, Donald, MD, MBBS, FAAN Todorov, Alexandre, MD,FAAN Todorova Petrova, Mladenka, MD Toe, Win

296 2018 AAN Annual Meeting On-site Guide

Togasaki, Daniel, MD, PhD Toh, Brian Tohidi, Vahid, MD, PhD Tokhie, Harlori Tokunboh, Ivie655 Kelton Ave, Apt Tolar, Elizabeth Tolbert, Dwain Tolchin, Benjamin, MD Toledano, Michel, MD Tolla, Azam Tolley, Anthony, MBA Tom, Mohamed Tomazin, Stefanie TOMIC, Davorka Tompkins, Patrick, BS Tomyanovich, Mary Lou Toncev, Gordana Tonder, Lisa, MS Tong, Gary, MD, PhD Tong, Yi Toomsoo, Toomas, MD Topakian, Raffi Topel, Jordan, MD, FAAN Topiwala, Karan Torabi Moghaddam, Shayan Tordesillas Lia, Carlos Jose Manuel Torezani, Guilherme Torgovnick, Josh Tormoehlen, Laura Tornes, Leticia Toro, Jaime, MD, FAAN Torres, Luis Torres, Karen Torres, Ruben Torres, Dolores Torres Fernandez, Vicente Torres Gomez, Karylsa Torres Rubio, Diana

Trifan, Gabriela Trifillis, Panayiota Trikamji, Bhavesh TRILLOS, RAMIRO Trimble, Brian, MD, MPH, FAAN Trinka, Eugen Tripathi, Richa Tripathi, Gautam Tripathy, Arushi, BS Trivedi, Madhukar, D.M. Neurology Trivedi, Ashish Trivedi, Jaya, MD, FAAN Trivedi, Aditi, B.S. Troiano, Maria, PhD Trollmo, Christina Trotti, LynnMarie Troxell, Regina Troyer, Matthew Truffinet, Philippe Trugman, Joel, MD, FAAN Truitt, Karen Trujeque, Joshua Truong, Jennifer Truong, Melanie Truong, Daniel, MD, FAAN Truong, Kong Truong, Danny, MS Tsai, Jean, MD, PhD Tsai, Po-Heng Tsai, Richard Tsakadze, Nina, MD,PhD Tsao, Jack, MD, DPhil, FAAN Tsao, Bryan, MD, FAAN Tsao, Doris, PhD Tse, Alexandra, BS TSENG, Brian Tseng-Ong, Linda Tshionyi, Makambo

Tsimerinov, Evgeny, MD, PhD, FAAN TSIMOURTOU, VAIA Tsong, Wan, M.S. Tsonkov, Miroslav Tsoutsouras, Spyridon Tsuboyama, Melissa Tsui, Cindy, BA Tsung, Li Yan Lilian Tubi, Meral, BA Tufekci, Ahmet Tuma, Raphael Tuma, Rogerio Tummala, Sudhakar Tuncer, Nese Turabova, Charoskhon Turan, Omer Faruk Turcano, Pierpaolo Turella, Giorgio Turetsky, Anya Turgut, Nilda Turkoglu, Recai, MD Turner, Ashby, MD Turner, Kelly Turpin, Karen, BScN, MSc, PhD(c) Turwitt, Stefan, MD Tutaj, Marcin Tutuncu, Melih, PhD Tutuncu, Mesude, PhD Tuunainen, Johanna, M.Sc. Tuzun, Erdem, MD Tvaroh, Ales Tworek, David, MS, MBA Twydell, Paul Tyblova, Michaela, MUDr. Tyler, Kenneth, MD, FAAN Tyor, William, MD, FAAN Tyshkov, Charles

2018 ANNUAL MEETING ATTENDEES

Torres-Russotto, Diego, MD, FAAN Torres-Yaghi, Yasar Torrey, Michael Torrigiani, Enzo, MD Torrisi, James Tosches, William, MD, FAAN Toshniwal, Lata Totaro, Rocco, MD Totten, Kristen Touat, Mehdi Toubal, Nadia Tourbah, Ayman, PhD Tournoux, Traci Touserkani, Fatemeh Towfighi, Amy Townson, Louisa Traboulsee, Anthony Traccis, Sebastiano, MD Tracik, Ferenc Tran, Demi Tran, Duc Tran, Lily Tran, Catherine, Masters Tran, Katherine Tran, Catherine Trau, Steven Traykov, Latchezar Traylor, Rhoyge Traynor, Bryan Treat, Lauren Treichel, Elaine Treidler, Simona Trela, Urszula Tremblay, Matthew Tremblay, Sandra Treppendahl, Christina Trevino, Sorleen Triana, Javier

297

2018 ANNUAL MEETING ATTENDEES Tzanetakos, Dimitrios Uc, Ergun Uca, Ali Ulvi, MD Uchoa Cavalcanti, Eduardo, MSc Uddin, Mohammad, MBBS,MD Uddin, Salah Udell, Andrew Ugarcovici, Mihaela, MS Ughreja, Kishan, BA Ugur, Umran Uher, Tomas, PhD Uitdehaag, Bernard, MD, PhD Ulane, Christina, MD, PhD Ulla, Miguel, MD, PhD Ullah, Kifayat Ullrich, Lauren Ulmann, Celine Ulrichts, Peter ULUC, KAYIHAN Uluduz, Derya Ume, Kiddy Umemura, Yoshie Umeton, Raffaella, MD Ummer, Karadan Unal, Zeynep Unal-Cevik, Isin, MD, PhD Unni, Cherukara, MD, MBBS Upadhyayula, Saila Uppal, Salil, MD, MBBS Urbain, Etienne Ure, Robert Uribe, Omar, BS Urion, David, MD, FAAN Urrea-Mendoza, Enrique Urscheler, Niklaus Cristian Urspruch, Alexa Urval, Nikita Us, Onder

Uschmann, Hartmut Uthman, Basim, MD, FACIP, FAAN Uy, Ryan, MD Uzgare, Rajneesh Uzgil, Besim Uzuner, Gulnur, MD Uzuner, Nevzat, MD Vaccaro, John Vachon, Christopher Vachova, Marta Vaishnaw, Akshay, MD Vaitkus, Antanas Vajjala, Vimala Vakani, Ravi Vakrakou, Aglaia Valdes-Sueiras, Miguel Valdez, Alisha Valdivia, Francisco Valenca, Angela Valencia Sanchez, Cristina Valenti, Erik Valentine, David Valenzano, Jonathan Valesani, Nestor, MD Valis, Martin Valizadeh, Navid, MB BCh, BAO, MSc Valles, Jennie Valliere, Steven Vallim, Mariana Valtis, Yannis, BA Valverde, Susana Van Anglen, Lucinda J. Van Baak, Alfred van Beek, Johan Van Cott, Anne, MD, FAAN Van De Vlekkert, Janneke Van Den Berg, Lennie Van den Berg, Leonard

298 2018 AAN Annual Meeting On-site Guide

Van Der Dussen, Donna Van der LindenÂ Mota, Vanessa Van Der Rol, Ronald Van derLinden Junior, Helio Van Es, Michael, MD, PhD Van Hecke, Wim Van Ness, Paul, MD, FAAN Van Oostrom, Melany Van Orden, Kimberlee Van Pesch, Vincent Van Rijckevorsel, Kenou Van Stavern, Gregory, MD, FAAN Van Stavern, Renee, MD, FAAN Van Venrooy, Anna Van Wijmeersch, Bart Van Wingerden, Janneke Vance, Jeffery, MD, PhD Vandeburgh, Joshua Vander Zanden, Jeanne, PharmD, BCPP VanderPluym, Juliana Vanderschelden, Benjamin Vandhuick, Olivier Vaneckova, Manuela Vanegas-Arroyave, Nora Vanek, Zeba, MBBS,DC Vanino, Dana Vanlandingham, Kevan, MD, PhD Vanmeter, Susan Vanopdenbosch, Ludo, MD, FAAN Vaou, Okeanis Varade, Sanjay, DM Varelas, Panayiotis, MD, PhD Varga, Caroline Vargas, Bert, MD, FAAN Vargas, Ruben Vargas, Wendy

Veldkamp, Isabel, MD Velez-Perez, Amarylis Velickovic Ostojic, Lili Velicu, Simona, MBA Vellaiappan, Neethiarasu Veloso, Rolando Vemuri, Rama Vencato Da Silva, Felipe Venkatachalam, Praveen Venkatachalam, Sarah Venkataraman, Chandramouleeswaran, DM Venkatesan, Arun, MD, PhD Venkatesh, Ram, MD, FAAN Venkateswaran, Sunita Venneri, Annalena Verdun Di Cantogno, Elisabetta Verenes, Michael Verhagen Metman, Leonard, MD, PhD Verin, Marc, MD PhD Verma, Geeta Verma, Amit, MD, MBBS Verma, Rajesh, MD, MBBS Verma, Umesh Verma, Ajay, MD, FRACP Vernaleo, Beth Vernillet, Laurent, FCP Vernino, Steven, MD, PhD, FAAN VERON, PABLO Verrips, Aad, MD,PhD Verselis, Lynne Verter, Elizabeth Vesco, Sergio, MD Vest, Christina Vetere, Santiago, MD Vgontzas, Angeliki, MD viaggio, maria Viands, Kelly

Vibha, Deepti Vick, Cassie Vickrey, Barbara, MD, MPH, FAAN Vickroy, Joseph Victorio, Cristina Vidal, Gustavo, MD Videnovic, Aleksandar, MD, MSc, FAAN Vidic, Thomas, MD, FAAN Vieira, Rodrigo, MD Vieira, Vera Lucia Vierhile, Amy Vieta Ferrer, Emile, B.S. Vigelette, Clara, AAS Vijay, Tarun, MD, MBBS Vijayakumar, Dhanya Vijiaratnam, Nirosen, FRACP Villa, Kenneth Villa, Luis Villa, Maria, MD Villabona-Rueda, Andres Villafuentes-Cambero, Abad Villafuerte, Bernardo Villamar, Mauricio Villanueva, Raissa, MD Villanueva, Farah Villazon, Juan Vinahl, Michael, MD Vincent, Stephen, MD, FAAN Vincent, Angela, MBBS,MSc Vincent, Maurice, MD, PhD Vines, Brannon Vingerhoets, Francois Vinjam, Maruthi Virell, Natalie Virketiene, Irena Virmani, Tuhin, MD, PhD Vishwas, Mellekate Visootsak, Jeannie

2018 ANNUAL MEETING ATTENDEES

Vargas, Nicolas Vargas Howell, Roberto Varghese, Rozena Varma, Amitabh, MD, MBBS Varol, Fahri Varon, Matthew Vartanian, Timothy, MD, PhD Vasconcelos, Claudia Cristina, MD Vasile, Titus Mihai Vasiliki, Sakkou Vasireddy, Padmaja Vaslow, Zachary Vasquez Valenzuela, Carlos Vasquez Valenzuela, Pabel Vassef, Parissa Vaughan, Leslie, RPh Vaughan, David Vaughn, Bradley, MD, FAAN Vaughn, Anthony Vaught, Barry Vazirian, Samra Vazquez, Marisel Vazquez, Alejandro Vazquez Do Campo, Rocio Vecsei, Laszlo Imre Veerapandiyan, Aravindhan, MD Veerappan, Venka Veerappan, Venka Vega, Natalia VEGA, PATRICIA Veilleux, Martin Veilleux, Catherine Veilleux Carpentier, Ariane Vela-Duarte, Daniel Velasco, Ana Luisa Velasquez Graziano, Jasmin, DPM Velazquez, Maricruz Veldink, Jan, MD, PhD

299

2018 ANNUAL MEETING ATTENDEES Vissing, John, Proffessor Visvanathan, Natarajan, MD, DM Viswanath, Veena Vitantonio, Daniel Vitek, Jerrold, MD, PhD Vitkova, Marianna Vitt, Jeffrey Vittal, Padmaja, MD, MS Vivar, Carolina Vives-Rodriguez, Ana Viviani, Carlos Vizcarra, Darwin Vladic, Anton, MD Vlaicu Bustuchina, Mihaela, MD Vlaikidis, Nikolaos Vodopic, Maro, MD Vogt, Heinrich Vohra, Ayesha Void, Janice Voinescu, Paula Vojinovic, Slobodan Vojtova, Vladimira Vollmer, Brandi, MPH Von Buren, Gisele Von Glehn Silva, Felipe von Kapff, Aurelia von Oertzen, Tim, MD von Schimmelmann, Melanie Von Schirach, Aida Vonella, Felicia Vongsa, Bounmy Voorhees, Justin Vora, Ronak Vora, Nirali Vora, Puja Vora, Swati Voskuhl, Rhonda Voss, Kellen

Vota, Scott Vottero, John Voulters, Lee Vrech, Carlos Vu, Anh-Thu Vu, Amanda Vukojevic, Vlatka Vukusic, Sandra, MD Vuletic, Vladimira Vulpe, Gabriela Vuong, Mai Vurture, Gregory, BA Vyas, Neeta Vyas, Manav Vyas, Ashish Waalkens, Anne Wabulya, Angela, MB ChB Wach, Daniela, BA Wadman, Renske, MD, PhD Wagle, Binod Wagle, Naveed Wagle-Shukla, Aparna Wagner, Amanda Wagner, Kathryn, MD, PhD Wagner, William Wagner, Bert, MD Wagner, Torsten Wahab, Kolawole Wahba, Mervat Waheed, Mark Waight, Andrew Wainwright, Mark, MD,PhD Wajnsztajn, Fernanda Wakeford, Craig Walbert, Tobias, MD, PhD Walczyk, Allison, NP, DNP Waldemar, Brola Waldman, Amy Waldman, Alex

300 2018 AAN Annual Meeting On-site Guide

Waldmann, Nils Waldrop, Robert Walford, Cherie Walia, Jessy Walk, David Walker, Sian Wall, Anastacia Wallace, Thomas Wallach, Asya Wallery, Shawn Walls, Brooke Wallstroem, Erik, MD, PhD Walmsley, Lori Walsh, Ryan, MD, PhD, FAAN Walsh, Michael, MBBS FRACP Walsh, John Walsh, Bryan Walsh, Ronan Walter, Brooke, Md Waltrip, Royce Wanchoo, Ruchi Wang, Han Wang, Cynthia Wang, Jack, MD, PhD Wang, James Wang, Kristie Wang, Rachel Wang, Yujie Wang, Yun Wang, Angela, MD Wang, David, DO, FAAN, FAHA Wang, Niangui Wang, Annabel Wang, Cindy, MD, PhD Wang, James, MD, PhD, FAAN Wang, Justine, FRACP Wang, Pei-Ning Wang, Qingliang, MD PhD Wang, Yunxia

Wawrzyniak, Julie Wax, Jennifer Way, Christopher Way, Jameson Way, Vincent Waymire, Laura Weathered, Natalie Weathers, Allison, MD, FAAN Weaver, Joshua Weaver, Brenda Weaver, Jeanne Webb, John Weber, Jodie, MHA Weber, Frank, PhD, MD Weber, Kevin, MHA Weber, Joerg Webster, Erika Wechsler, Lawrence, MD, FAAN Wechsler, Robert, MD, PhD, FAAN Weckbecker, Gisbert Wedgewood, Pepper, BS Wee, Claribel Weeks, Robert, MD, Bch, PhD, MRCP Wehr, Angela Wei, Shao-Hwa Wei, Alex, PharmD Weideman, Ann, M.S. Weijma, Robyn Weinberg, Lawrence Weiner, Howard, MD Weiner, Michael, MD Weinkle, Laura, MS Weinmann, Andrea Weinshenker, Brian, MD, FAAN Weinstein, Jessica Weinstock, Leon Weinstock-Guttman, Bianca Weintraub, Scott

Weintraub, Kaley Weisensee, Laurie Weisher, David Weiskopf, Marc Weiss, Michael, MD, FAAN Weisz, Reuben, MD, FAAN Welch, Danielle, MBA Weller, Boaz Welles, Richard Welles, Linda Wellmer, Andreas Weltmer, Elaine, MS Wen, Patrick, MD, FAAN Wendell, Linda Wendt, Jeanette Wendtland, Bernd Wenzlawsh, Vicky Werkling, Marc Wernsdoerfer, Colin Wesley, Sarah Wessel, Thomas Wesslau, Anders West, Dara West, Tyler, BS West-Miles, Jeanna Westwood, Andrew, MD Wetherell Griffin, Kathleen Wettmarshausen, Christine, MD Weygandt, Martin Whalley, Ben Whalley, Ben White, Geoff White, Robin, Phd White, Samantha White, Jessica Whitehead, Shawn Whitesell, Jackie Whitmyre, Kristi Whitney, David

301

2018 ANNUAL MEETING ATTENDEES

Wang, Y. Grace Wang, Jiawei Wang, Lijuan Wang, Hao Wang, Jing Wang, Anson, BS Wang, Camille Wang, Jia-Yi, BS Wang, Ruihao Wangsuwana, Miracle Wani, Mushtaq Wapenski, Joseph Ward, Thomas, MD, FAAN Ward, Jayne Warren, Francesca Warrior, Lakshmi Warwick, Tanya Waseem, Hena, MD Wasilewski, Andrea, MD Wassarman, David, PhD Wasserman, Marc Wasterlain, Claude, MD, FAAN Wasyliw, Sanchea Waterhouse, Elizabeth, MD, FAAN Waters, Cristy Waters, Cheryl, MD, FAAN Waters, Janet, MBA Waters, Michael, MD, PhD, FAAN Waters, Daniel Watson, David, MD, FAAN Watson, James, MD Watson, William Watson, William Watson, Andrew Watson, Colin Watts, Paul Waubant, Emmanuelle, MD, FAAN

2018 ANNUAL MEETING ATTENDEES Whittam, Daniel WICHMANN, Christian Wicklein, Eva-Maria Wicklund, Matthew, MD, FAAN Wicklund, Meredith Widnell, Katherine, MD, PhD Widolff, Michelle Wiedau, Martina Wiedmayer, Christine Wiendl, Heinz, PhD MD Wienholtz, Nita Wiese, Lars, MD Wiesman, Janice, MD, FAAN Wietecha, Linda, BSN, MS Wiggins, Judea, BA Wigley, Christian Wijdicks, Eelco, MD, FAAN Wijegunasinghe, Darshana, MD, MBBS Wijesekera, Jagath, MD, MBBS Wilbur, Colin Wilcox, William Wild, Edward, MRCP Wilder, Ryan Wilhour, Danielle Wilken, Jeffrey Willcourt, Matthew Willekens, Barbara Willems, Carol WILLI, Roman Williams, Lee, JD MBA Williams, Heather Williams, Laura Williams, Korwyn, MD, PhD Williams, Vernon, MD Williams, Armistead Williams, Benjamin, MD, PhD Williams, Shawniqua, MD Williams, Hannah

Williams, James Williams, Rachel, DNP Williamson, Ryan Willie, Jon, MD, PhD Willis, Mary Willis, Virginia Willmer, Jonathan Willmore, Jenny Willoughby, Ernie Willyono, Agoes Wilmot, George, MD, PhD Wilner, Andrew, MD, FACP, FAAN Wilson, Andrew, MS, MBA Wilson, Carey Wilson, Annise Wilson, Michael, MD Wilson, Christina Wilson, Beth Wilson, Robert Wilson, Nancy, RPh Wilson, John, BS, BA Wiltshire, Katie Win, Nichole Winckler, Jorge Luiz, MD Winckler, Pablo, MD Wind, Jessica Winder, Toni, MD, FRCP Windsheimer, Jorg Winger, Ryan Wingerchuk, Dean, MD, FAAN Winkelmann, Alexander Winner, Paul, DO, FAAN Wint, Dylan Wirrell, Elaine, MD, FAAN Wisco, Dolora Wise-Brown, Alexandria Wissel, Benjamin Witek, Natalie

302 2018 AAN Annual Meeting On-site Guide

Witt, Norbert Witte, Elke, MD Witting, Nanna Wnuk, Marcin Wohlgemuth, Marisa Wojcicka-Mitchell, Anna Wojna, Valerie Wold, Jana Wolf, Christian Wolf, Sheldon, MD,FAAN Wolfanger, Lorie, BS Wolfe, Kathy Wolfe, Gil, MD, FAAN Wolford, Connie Wolinsky, Jerry, MD, FAAN Wolk, David, MD Wong, Ho Ming June, MBChB Wong, Bonnie, MD, MPH Wong, Brian Wong, Jeremy, MEng Wong, Joshua Wong, Eric Wong, Ericka Wong, George Wong, Melvin Wong, Victoria Wong, Christine Wong, Denise Wong, Roderick Wong, Gregory, BS Wong, Ka-Ho, B.S Wong-Kisiel, Lily, MD Woo, Andrew, MD, PhD Woo, Kai Woochang, Chun Wood, Carla, MS Woodhill, Nicole Woodman, Karin Woods, Roger

Xia, Alice Xia, Guangbin, MD,PhD Xia, Zongqi, MD PhD Xian, Steven Xiao, Changrui Xiong, Phia Xu, Lei Xu, Michael, MD, FAAN XU, RENSHI XUE, SHOURU Yaari, Roy Yadav, Priyanka Yahalom, Gilad Yale, Kendra Yalinay Dikmen, Pinar Yamada, Takahito Yamagata, Nelson Yamasaki, Tritia, MD, PhD Yammout, Bassam Yan, Peter, MD, MS Yan, Ying, MS Yancey, Justin YANG, I-HUI Yang, Michael Yang, Steven Yang, Haichen Yang, Irene Yang, Keyi, MD, PhD Yang, Kim Yang, Ning Yang, Yiting Yang, Laurice, MD, MHA Yang, Jyun, MD Yang, Michael Yang, Shun-Jen Yang, Sophia, BA Yankey, Jon Yantes, Andrew, RN, NP, DNP Yao, Faith

Yardeni, Tamar Yardi, Ruta Yarema, Valeri Yarema, Kristin Yari, Niloofar Yarlagadda, Ashuthosh Yarraguntla, Kalyan, MS Yaseen, Mohammad Yasuda, Clarissa Yavagal, Dileep, MD, FAAN Yayla, Vildan, PhD Yazdani, Vesta, Medical student Ye, Xiaolan Yeager, Bryan Yeaman, Michael Yeboah, Kevin Yee, Jared Yee, Alan Yegiaian, Sharon Yeh, E. Ann Yener, Ayhan, MD Yeo, Crystal, MD, PhD Yepes, Manuel Yepez, Issac Yerokhin, Oleg Yersak, Jill Yeung, Michael Yeung, MD, MPH, Paul Yildiz, Ozlem Yilgor, Abdullah Yilmaz, Furkan Yilmaz, DenizTY YILMAZ, IBRAHIM ARDA Yim, Clarabella Yim, Eunji, MS Yin, Jie Yin, Sara Yochelson, Michael Yogendran, Lalanthica

303

2018 ANNUAL MEETING ATTENDEES

Woodson, Sarah Woolf, Scott Wooliscroft, Lindsey Worden, Lila, MD Worthge, Shane, Medical Student Woschkolup, Kathleen Wray, Sibyl Wright, Christina Wright, Sarah, MBchB Wright, April, MD Wright, Peter, FRACP Wright, Clinton Wright, Dale Wright, Emily, Bachelor of Science Wright Willis, Allison Wszolek, Zbigniew, MD, FAAN Wu, Abel Wu, Melanie Wu, Ting Wu, Emma, BS Wu, Stacy Wu, Allan Wu, Annie Wu, Chuang-Kuo, MD, PhD Wu, Joyce Wu, Synphen, MD, PhD Wu, Yaojie Wu, Hung-Ming Wu, Jenny Yu-Hui Wu, Arum Wu, Victoria, BA Wu-Chen, Wen-Ying Wuerfel, Jens Wundes, Annette Wyant, Kara Wymer, James, MD, PhD, FAAN Wynn, Daniel Wynn, Michael

2018 ANNUAL MEETING ATTENDEES Yokota, Takanori, MD, PhD Yoldas, Tahir Kurtulus, MD Yomtoob, Jacob Yoneda, Makoto Yong, Ming Hui Yoo, Alexander Youn, Erica Youn, Jina, MD, MS Younce, John Younes, Kyan Young, William, MD, FAAN Young, G., MD, FAAN Young, Eufrosina Young, Pari Young, Richard, MD, FAAN Young, Rosabel, MD, FAAN Young, Robyn, MD, FAAN Young, Drew Young, Rolando Young, Casey Younis, Heewa Yountz, Marcus, MD, FAAN Yousef, Tariq Yousif, Suhaib Youssef, Gilbert Youssef, Michael Youssef, Pamela Youssef, Mariam Youssefian, Leena, MD Yousuf, Asad Ysak, Helen Yu, Yannan Yu, Derek Yu, Edward Yu, Melissa Yu, Michael Yu, Wengui, MD, PhD Yu, Justin Yu, Kwangjae

Yu, Chungping Yuan, Derek Yuce, Semiha Simtel, MD Yucel, Berrak Yuceyar, Ayse Nur, MD Yuen, Tammy Yufe, Robert Yuge, Keith, BA Yuki, April, MD Yuki, Tsubasa Yuliati, Asri Yun, Joo Yeon (Gasong) Yun, Lau Yusta Izquierdo, Antonio Yusuf Solaiman, Ahmad Yusupov, Arkady Zabala, Eduardo Zabaleta Corpas, Diana Patricia Zabalgoitia, Laura, BS Zabel, Matthew Zabeti, Aram Zaborski, Jacek, MD Zacker, Melanie Zackowski, Kathleen, PhD, OTR Zaeem, Zoya Zafar, Faleha Zafar, Saman Zaghlouleh, Mhd Ezzat Zahoor, Salman Zaidi, Syed Zaidman, Craig, MD Zakaria, Magd Fouad ZAKARIA, SHERIN Zakharian, Lusine Zakin, Elina Zakrzewska-Pniewska, Beata, MD Zalazar, Roque, MD Zalewski, Nicholas

304 2018 AAN Annual Meeting On-site Guide

Zaman, Iram Zambrano, Maria Zamora, Maria Zamrini, Edward Zamudio, Jorge, MD, MBA Zamvil, Scott, MD, PhD, FAAN Zamzam, Dina Zande, Jonathan Zanga, Gisela, MD Zanganeh, Nassim, MS Zangiabadi, Amirhossein Zarei, Sara Zarghami, Neda Zarrin, Amy Zavala, Alejandro Zavala, Lucia Zavitz, Allison Zawaly, Kristina, PhDc, MSc, BSc, BA Zawar, Ifrah Zebenigus, Mehila Zecca, Chiara Zee, Phyllis, MD, PhD Zeidman, Lawrence, MD, FAAN Zeifert, Penelope Zeiger, William, MD, PhD Zekeridou, Anastasia Zeldin, Ari Zelikovich, Aaron Zenker, Matthias Zepeda, Rodrigo Zesiewicz, Theresa, MD, FAAN Zeydan, Burcu Zhang, Christina Zhang, Fanglin, MD, PhD Zhang, Qiang Zhang, Hui-Juan, MD, PhD Zhang, Frank, MD, PhD Zhang, Kate

Zinser, William Zipoli, Valentina, MD Zis, Panagiotis, MBBS, PhD Zivadinov, Robert, MD, PhD, FAAN Zivkovic, Sasha Zmira, Ofir Zobiri, Hassene Zohner, Marisa Zolnierz, Daniel Zorn, Meghan, PA Zorrilla, Juan, MD Zoukos, Yiannis Zozulya Weidenfeller, Alla Zubair, Salman Zubair, Yusuf Zuber, Adam Zubkov, Sarah Zuchner, Stephan ZUDAIRE, MYRIAN Zuin, Daniel Zung, Jeremy Zung, Jeremy Zuniga, Leslie Zupetic, Alexandra, MD Zurcher, Michael Zuromskis, Tadas, MD, PhD Zuurbier, Susanna Zuurbier, Charlotte Zuzek, Primoz Zuzuarregui, Rafael Zweifler, Richard Zygmunt, Casimir Zyloney, Carolyn

2018 ANNUAL MEETING ATTENDEES

Zhang, Yong Zhang, Jingya Zhang, Qi Zhang, Jiang-Tao Zhang, Amy Zhang, Andrew, BA Zhang, Yiguan Zhao, Chen Zhao, Yi Jing Zhao, Cong Zhi Zhao, Yu Zhao, Weihua Zhao, Enxu, MS ZHAO, XINGQUAN Zheng, Wei Zheng, Xianzhen Zheng, Nana, AS Zhou, Lily Zhou, Hao Zhou, Weidong Zhou, BS, Clarice, BS Zhu, Jay-Jiguang, MD, PhD Zhu, Bing Zhu, Suiqiang Zhu, Chelsea, BA Zhu, Jia Bao Ziegler, Gabriela, MD Zieman, Glynnis Ziemann, Adam, MD, PhD Zieziula, Gary Zigelbaum, Aaron Ziliotto, Nicole, MSc Zimatore, Giovanni Bosco, MD Zimmer, Jennifer Zimmerman, Andrew, MD, FAAN Zimmerman, Grace, MPH Zimova, Denisa Zinger, Yuliya

305

SEE YOU NEXT YEAR

Philadelphia, PA · May 4–10, 2019

SUNDAY, APRIL 22 Use Your Passport to Visit a World of Exhibitors. }} Bose Noise Canceling Headphones

}} $500 Amazon Gift Card

}} Nest Indoor Camera

}} iPad

}} $500 Amazon Gift Card

}} Daily Specialty Prize

How to Win • Come back each day to fill out that day’s passport and enter yourself in that day’s prize drawing. Stop by each booth listed on that day’s passport. The drawing will culminate on Wednesday with a grand prize drawing of a 2019 Annual Meeting Registration and a three-night stay in an AAN block hotel—all compliments of the AAN. With so many chances to win amazing prizes, there’s never been a better reason to come back each day! • Be sure to bring your “passport” with you when you visit the Exhibit Hall. To enter the contest, submit the passport “stamped” by all exhibitors listed on the backside; print your name, email address, cell phone number, and six-digit AAN ID number found on your name badge; and drop the completed passport in the bin in the designated premier sponsor’s exhibit space during Exhibit Hall hours. This passport is for Sunday, April 22, and is only valid for prizes on Sunday, April 22. • Prizes ranging in value from $300–$500, as well as one specialty prize will be given away daily to the first six names drawn from Sunday, April 22, to Wednesday, April 25. Winning names for each day will be posted at the AAN Information Desk in the south lobby starting on Monday, April 23; winners will also be notified by email. All prizes must be picked up at the AAN Information Desk. Prizes must be collected by 5:30 p.m. on April 26, 2018, or winners forfeit prizes. • Drawing for Sunday’s prizes will occur at the Wolters Kluwer booth #1723 in the Exhibit Hall on Sunday, April 22, 2018, at 3:30 p.m. (PST). NO PURCHASE NECESSARY. The Contest is open to all attendees of the 2018 AAN Annual Meeting who are at least 18 years of age at the time of entry. The Exhibit Hall Passport Contest (“Contest”) begins Sunday, April 22, at 11:30 a.m. (PST) and ends Sunday, April 22, at 3:30 p.m. (PST) during Exhibit Hall hours. For complete details, see official rules available at AAN.com/view/passport.

Name: AAN ID Number: Email: Cell Phone:

Registration ID:

2018 AAN Annual Meeting Passport

SUNDAY, APRIL 22 DROP OFF COMPLETED PASSPORT STAMPED WITH:

Booth 1723

Booth 1523

Booth 1411

Booth 846

Booth 1847

Booth 435

Booth 2129

Booth 1203

Booth 429

Booth 959

Booth 847

Booth 1403

MONDAY, APRIL 23 Use Your Passport to Visit a World of Exhibitors. }} Bose Noise Canceling Headphones

}} $500 Amazon Gift Card

}} Nest Indoor Camera

}} iPad

}} $500 Amazon Gift Card

}} Daily Specialty Prize

How to Win • Come back each day to fill out that day’s passport and enter yourself in that day’s prize drawing. Stop

by each booth listed on that day’s passport. The drawing will culminate on Wednesday with a grand prize drawing of a 2019 Annual Meeting Registration and a three-night stay in an AAN block hotel—all compliments of the AAN. With so many chances to win amazing prizes, there’s never been a better reason to come back each day!

• B e sure to bring your “passport” with you when you visit the Exhibit Hall. To enter the contest, submit the passport “stamped” by all exhibitors listed on the backside; print your name, email address, cell phone number, and six-digit AAN ID number found on your name badge; and drop the completed passport in the bin in the designated premier sponsor’s exhibit space during Exhibit Hall hours. This passport is for Monday, April 23, and is only valid for prizes on Monday, April 23. • P rizes ranging in value from $300–$500, as well as one specialty prize will be given away daily to the first six names drawn from Monday, April 23, to Wednesday, April 25. Winning names for each day will be posted at the AAN Information Desk in the south lobby starting on Monday, April 23; winners will also be notified by email. All prizes must be picked up at the AAN Information Desk. Prizes must be collected by 5:30 p.m. on April 26, 2018, or winners forfeit prizes. •D rawing for Monday’s prizes will occur at the Biogen booth #1411 in the Exhibit Hall on Monday, April 23, 2018, at 3:30 p.m. (PST). O PURCHASE NECESSARY. N The Contest is open to all attendees of the 2018 AAN Annual Meeting who are at least 18 years of age at the time of entry. The Exhibit Hall Passport Contest (“Contest”) begins Monday, April 23, at 11:30 a.m. (PST) and ends Monday, April 23, at 3:30 p.m. (PST) during Exhibit Hall hours. For complete details, see official rules available at AAN.com/view/passport.

Name: AAN ID Number: Email: Cell Phone:

Registration ID:

2018 AAN Annual Meeting Passport

MONDAY, APRIL 23 DROP OFF COMPLETED PASSPORT STAMPED WITH:

Booth

1411

Booth 1523

Booth 2047

Booth 846

Booth 1715

Booth 1847

Booth 2129

Booth 1203

Booth 959

Booth 847

Booth 1403

Mayo Medical Laboratories

Booth 1003

TUESDAY, APRIL 24 Use Your Passport to Visit a World of Exhibitors. }} Bose Noise Canceling Headphones

}} $500 Amazon Gift Card

}} Nest Indoor Camera

}} iPad

}} $500 Amazon Gift Card

}} Daily Specialty Prize

How to Win • Come back each day to fill out that day’s passport and enter yourself in that day’s prize drawing. Stop by each booth listed on that day’s passport. The drawing will culminate on Wednesday with a grand prize drawing of a 2019 Annual Meeting Registration and a three-night stay in an AAN block hotel—all compliments of the AAN. With so many chances to win amazing prizes, there’s never been a better reason to come back each day! • Be sure to bring your “passport” with you when you visit the Exhibit Hall. To enter the contest, submit the passport “stamped” by all exhibitors listed on the backside; print your name, email address, cell phone number, and six-digit AAN ID number found on your name badge; and drop the completed passport in the bin in the designated premier sponsor’s exhibit space during Exhibit Hall hours. This passport is for Tuesday, April 24, and is only valid for prizes on Tuesday, April 24. • Prizes ranging in value from $300–$500, as well as one specialty prize will be given away daily to the first six names drawn from Tuesday, April 24, to Wednesday, April 25. Winning names for each day will be posted at the AAN Information Desk in the south lobby starting on Monday, April 23; winners will also be notified by email. All prizes must be picked up at the AAN Information Desk. Prizes must be collected by 5:30 p.m. on April 26, 2018, or winners forfeit prizes. • Drawing for Tuesday’s prizes will occur at the Sunovion Pharmaceutical’s Inc. booth #1833 in the Exhibit Hall on Tuesday, April 24, 2018, at 3:30 p.m. (PST). NO PURCHASE NECESSARY. The Contest is open to all attendees of the 2018 AAN Annual Meeting who are at least 18 years of age at the time of entry. The Exhibit Hall Passport Contest (“Contest”) begins Tuesday, April 24, at 11:30 a.m. (PST) and ends Tuesday, April 24, at 3:30 p.m. (PST) during Exhibit Hall hours. For complete details, see official rules available at AAN.com/view/passport.

Name: AAN ID Number: Email: Cell Phone:

Registration ID:

2018 AAN Annual Meeting Passport

TUESDAY, APRIL 24 DROP OFF COMPLETED PASSPORT STAMPED WITH:

Booth

1833

Booth 1523

Booth 2047

Booth 1411

Booth 846

Booth 1715

Booth 1847

Booth 2129

Booth 648

Booth 847

Booth 595

Booth 1403

WEDNESDAY, APRIL 25 Use Your Passport to Visit a World of Exhibitors. }} Bose Noise Canceling Headphones

}} $500 Amazon Gift Card

}} Nest Indoor Camera

}} iPad

}} $500 Amazon Gift Card

}} Daily Specialty Prize

How to Win • Come back each day to fill out that day’s passport and enter yourself in that day’s prize drawing. Stop by each booth listed on that day’s passport. The drawing will culminate on Wednesday with a grand prize drawing of a 2019 Annual Meeting Registration and a three-night stay in an AAN block hotel—all compliments of the AAN. With so many chances to win amazing prizes, there’s never been a better reason to come back each day! • Be sure to bring your “passport” with you when you visit the Exhibit Hall. To enter the contest, submit the passport “stamped” by all exhibitors listed on the backside; print your name, email address, cell phone number, and six-digit AAN ID number found on your name badge; and drop the completed passport in the bin in the designated premier sponsor’s exhibit space during Exhibit Hall hours. This passport is for April 25, and is only valid for prizes on Wednesday, April 25. • Prizes ranging in value from $300–$500, as well as one specialty prize will be given away daily to the first six names drawnfrom Wednesday, April 25, to Wednesday, April 25. Winning names for each day will be posted at the AAN Information Desk in the south lobby starting on Monday, April 23; winners will also be notified by email. All prizes must be picked up at the AAN Information Desk. Prizes must be collected by 5:30 p.m. on April 26, 2018, or winners for feit prizes. • Drawing for Wednesday’s prizes will occur at the Teva booth #1261 in the Exhibit Hall on Wednesday, April 25, 2018, at 2:30 p.m. (PST). NO PURCHASE NECESSARY. The Contest is open to all attendees of the 2018 AAN Annual Meeting who are at least 18 years of age at the time of entry. The Exhibit Hall Passport Contest (“Contest”) begins Wednesday, April 25, at 11:30 a.m. (PST) and ends Wednesday, April 25, at 2:30 p.m. (PST) during Exhibit Hall hours. For complete details, see official rules available at AAN.com/view/passport.

Name: AAN ID Number: Email: Cell Phone:

Registration ID:

2018 AAN Annual Meeting Passport

WEDNESDAY, APRIL 25 DROP OFF COMPLETED PASSPORT STAMPED WITH:

Booth

1261

Booth 1523

Booth 1411

Booth 846

Booth 1715

Booth 1847

Booth 429

Booth 847

Booth 959

1066 1068 1067 1166 1168 1167 1266 1268 1267

Career Fair Neighborhood 460

463 562

563 662

461 560

561 660

359 458

351

453

552

763 862

863 962

761 860

861 960

559 658

759 858

859 958

557 656

757 856

Buzz Cafe 1

Food Distribution

447

553 652

329

430 428

429

422

638

639 738

636

637

634

635

734

629

735

729

523

419 518

Charging Hub

417 516 413

311

514 512

623 619 617 615

511 509

612

613

716 712

Charging Hub

829 928

929 1028

827 926

927 1026

825 924

923 1022

823 922

1015

807 906 405 504 502

503

603

1123

703

803 902

907

1008 1006

905 1004 903 1002

132

1023 1019 1118

809 908

1133

1029

1116

1117

1114

1013 1112

707

608

1035

932

Entertainment Park

317

423

1146 947

426 323 424

1260

1157 1256

547 646

529

1262

1159 1258

847

846

549 648

435

335

1161

953

551 650

347

Charging Hub

959

Charging Lounge

1003

1217

1318 1316

1215 1312 1113 1212 1111 1210 1109 1208

1213

Charging Lounge

1202

First Time Exhibitors

Down

2018 ANNUAL MEETING EXHIBIT

Association Neighborhood

1377 1476

1477 1576

1577 1676

1375 1474

1475 1574

1575 1674

1775 1874

1875

1373 1472

1473 1572

1573 1672

1773 1872

1873

1771 1870

1471 1570 1367

1468

1469 1568

1569

1466

1467 1566

1567

1463 1562

1563 1662

261

1972

1666

1769 1868 1767 1866

Buzz Cafe 2

1975 2074 1973 2072 1971 2070

1867

1969 2068 2166 2168 2167 2266 2268 2267

1967 2066

1963 2062

1857

1957

1755

1447

247

1847

1747

1331

Charging Hub

1523

1833

2035

1823

1723

Technology Pavilion

AAN Innovation Hub

2047

2019 2118

1917

1309

1802 1203

1403

1503

2235 2133 2232

2233

2131 2230

2231

2129 2228

2229 2227 2225 2223

2218

2219

2216

2217

2115 2214

2215

2113 2212

2213

2109 2208 2107 2206 2105 2204

2205

2103 2202

2203

Down

T HALL MAP

2003

Publishers' Row

2013 2112

2237

2117

2017 2116 2015 2114

1411

2239

2137 2236

Buzz Cafe 3

2023

1715

1315

2139 2238

VISIT US AT BOOTH #1315

SHINE A LIGHT Come visit Booth #1847 and create your own unique Light Trail art. Your custom digital Light Trail art will be displayed at our booth throughout AAN alongside your colleagues.

03/18